Genbank References
BLAST search against GenBank file v. V 269.0 released on 2025-12-15
(search results include 752868 sequences from 4037 references)
| This page contains a list of all GenBank entries on HIV-1 protease, RT and
integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation. The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence. The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database. |
| Authors | Title | Citation | E-value | # in HIVDB | # in Gb | % in HIVDB | Annotation |
|---|---|---|---|---|---|---|---|
| A Nyanya (2019) | Patterns and correlates of HIV drug resistance mutations among HIV-infected patients receiving antiretroviral treatment in Nairobi Kenya | Unpublished | 1.62e-150 | |
68 68RT |
0 | Unpublished |
| Abad (2022) | Prevalent subtypes and one-year outcomes of an HIV-cohort from an urban Philippine center | Medicine (Baltimore) 100 (51), e28315 (2021) | 0 | 71 71PR 70RT 70IN |
71 69PR 71RT 71IN |
100 | HIVDB |
| Abdellaziz (2015) | Predominance of CRF06_cpx and transmitted HIV resistance in Algeria: update 2013-2014 | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 228 119PR 109RT |
230 119PR 111RT |
99 | HIVDB |
| Abdissa (2014) | Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia | BMC Infect. Dis. 14, 181 (2014) | 0 | 28 28PR 28RT |
29 29PR 29RT |
96 | HIVDB |
| Abdoel Wahid (2016) | HIV-1 genetic diversity and drug-resistance mutations among treatment-naive adult patients in Suriname | AIDS Res. Hum. Retroviruses (2016) In press | 1.42e-176 | 100 99PR 95RT |
100 99PR 95RT |
100 | HIVDB |
| Abdool Karim (2016) | Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Science 329 (5996), 1168-1174 (2010) | 0 | 94 92PR 94RT |
94 92PR 94RT |
100 | HIVDB |
| Abecasis (2007) | RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form | J. Virol. 81 (16), 8543-8551 (2007) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Abecasis (2011) | Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients | AIDS Res. Hum. Retroviruses (2011) In press | 0 | 153 153PR 153RT |
154 154PR 154RT |
99 | HIVDB |
| Abidi (2021) | Molecular epidemiological analysis of HIV-1 outbreak in Larkana | 34484134 | 6.6e-173 | 329 323PR 313RT |
329 329PR 329RT |
100 | HIVDB |
| Abongwa (2019) | Transmitted Drug Resistance in HIV-1 Protease-Reverse transcriptase region among Rural and Urban Populations of Western Cameroon | 31416460 | 0 | 62 62PR 62RT |
62 62PR 62RT |
100 | HIVDB |
| Abott (2018) | The complete genomic sequence of the HIV-1 AAV isolate | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Abraha (2016) | CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic | J. Virol. 83 (11), 5592-5605 (2009) | 2.86e-106 | |
11 11RT |
0 | Case report(s) / study subset |
| Abrahams (2019) | The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation | Unpublished | 0 | |
130 129PR 129RT 130IN |
0 | Proviral DNA Reservoir |
| Acharya (2009) | Human immunodeficiency virus type 1 drug resistance mutations in patients from India | Unpublished | 1e-178 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Acharya (2014) | Development, Validation and Clinical Evaluation of a Low Cost In-House HIV-1 Drug Resistance Genotyping Assay for Indian Patients | PLoS ONE 9 (8), E105790 (2014) | 0 | 206 206PR 206RT |
206 206PR 206RT |
100 | HIVDB |
| Acharya (2015) | Genetic analysis of HIV-1 integrase gene sequences among 1st line treatment experienced patients from India | Unpublished | 0 | |
31 31IN |
0 | Case report(s) / study subset |
| Acharya (2019) | Near-full length genetic characterization of a novel HIV-1 unique recombinant with similarities to A1, CRF01_AE and CRFO2_AG viruses in Yaounde, Cameroon | AIDS Res. Hum. Retroviruses (2019) In press | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Acharya (2019) | Analyses of HIV-1 integrase sequences obtained from infected patients in Cameroon | 32106437 | 0 | 100 100IN |
100 100IN |
100 | HIVDB |
| Achkar (2004) | INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City | Unpublished | 1e-159 | |
34 34PR 3RT |
0 | ARV Rx and/or other data are N/A |
| Adachi (1986) | PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | J. Virol. 59 (2), 284-291 (1986) | 1e-165 | 1PR 1RT 1IN |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Adachi (2017) | Molecular epidemiology HIV-1 in Northern Alberta: a combined analysis of viral genetic and public health data | 28427935 | 1.25e-172 | 1055 1055PR 1055RT |
1055 1055PR 1055RT |
100 | HIVDB |
| Adeniyi (2021) | Genetic Characterization of HIV-1 Subtype A1/C/D/B/K Unique Recombinant Form from Eastern Cape, South Africa | AIDS Res Hum Retroviruses 37 (2), 162-168 (2021) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Adhiambo (2021) | Molecular Diversity of HIV-1 in Teso, Western Kenya | 34046145 | 4.24e-168 | 63 63PR 63RT |
63 63PR 63RT |
100 | HIVDB |
| Adhin (2025) | First reported case of integrase strand transfer inhibitor resistance in Suriname; uncharacteristic drug resistance mutations following exposure to dolutegravir | Unpublished | 0 | |
2 2IN |
0 | Case report (Small sample size) |
| Adojaan (2004) | PREDOMINANCE of a Rare Type of HIV-1 in Estonia | J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) | 0 | 4 4PR 4RT 4IN |
143 143PR 4RT 4IN |
2 | HIVDB |
| Adungo (2016) | Genetic Diversity of HIV-1 in Busia, Kenya | Unpublished | 5.93e-45 | |
71 71PR |
0 | Gene fragment(s) |
| Afonso (2012) | HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola | PLoS ONE 7 (8), E42996 (2012) | 2e-178 | 101 99PR 101RT |
101 101PR 101RT |
100 | HIVDB |
| Aghokeng (2007) | FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages | Virology 360 (2), 407-418 (2007) | 0 | |
5 3PR 5RT 5IN |
0 | NHPL/SIV |
| Aghokeng (2009) | Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries | Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) | 0 | 135 135PR 135RT |
135 135PR 135RT |
100 | HIVDB |
| Aghokeng (2010) | Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions | Infect. Genet. Evol. (2009) In press | 0 | |
20 1PR 5RT 20IN |
0 | NHPL/SIV |
| Aghokeng (2010) | Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa | J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) | 2e-70 | |
1 1IN |
0 | NHPL/SIV |
| Aghokeng (2011) | High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity | J. Clin. Microbiol. 49 (4), 1635-1641 (2011) | 1e-176 | 145 145PR 145RT |
145 145PR 145RT |
100 | HIVDB |
| Aghokeng (2011) | Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients | AIDS 25 (17), 2183-2188 (2011) | 0 | 85 85PR 85RT |
85 85PR 85RT |
100 | HIVDB |
| Aghokeng (2013) | Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon | J Int AIDS Soc 16, 18004 (2013) | 0 | 65 65PR 65RT |
65 65PR 65RT |
100 | HIVDB |
| Aghokeng (2013) | Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia | Clin. Infect. Dis. 58 (1), 99-109 (2014) | 0 | 433 247PR 433RT |
433 247PR 433RT |
100 | HIVDB |
| Agneskog (2008) | CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir | Unpublished | 1e-173 | |
8 3PR 6RT 2IN |
0 | Case report(s) / study subset |
| Agwale (2003) | GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients | AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) | 5e-81 | 18 18PR 18RT |
18 18PR 18RT |
100 | HIVDB |
| Agwu (2008) | Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy | 18479228 | 0 | |
156 156PR 156RT |
0 | Pending |
| Agyingi (2014) | The Evolution of HIV-1 group M Genetic Variability in Southern Cameroon is characterized by Several Emerging Recombinant Forms of CRF02_AG and viruses with drug resistance mutations | 24248638 | 0 | 210 106PR 104RT |
214 106PR 108RT |
98 | HIVDB |
| Ahuka-Mundeke (2010) | Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon. | J Gen Virol | 0 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Ahuka-Mundeke (2011) | Novel Multiplexed HIV/Simian Immunodefi ciency Virus Antibody Detection Assay | Emerging Infect. Dis. 17 (12), 2277-2286 (2011) | 4e-65 | |
7 1RT 7IN |
0 | Gene fragment(s) |
| Ahuka-Mundeke (2017) | Full Genome Characterization of a New Simian Immune Deficiency Virus Lineage in a Naturally Infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo Reveals High Genetic Diversity Among Red-Tailed Monkeys in Central and Eastern Africa | AIDS Res. Hum. Retroviruses (2017) In press | 0 | |
4 1PR 4RT 4IN |
0 | NHPL/SIV |
| Ahumada-Ruiz (2009) | Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations | Infect. Genet. Evol. 9 (5), 933-940 (2009) | 0 | |
136 136PR 136RT |
0 | Pending |
| Ait-Khaled (2003) | Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy | Antivir. Ther. (Lond.) 7 (1), 43-51 (2002) | 3.95e-153 | 156 156RT |
156 156RT |
100 | HIVDB |
| Ajoge (2011) | Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria | AIDS Res. Hum. Retroviruses 28 (1), 115-118 (2012) | 0 | 56 28PR 28RT |
56 28PR 28RT |
100 | HIVDB |
| Akapirat (2013) | Clinical variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NHMAb) production from Thai human immunodeficiency virus type 1-infected individuals | 24437318 | 6.47e-147 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Akouamba (2016) | HIV-1 genetic diversity in antenatal cohort, Canada | Emerging Infect. Dis. 11 (8), 1230-1234 (2005) | 2.01e-120 | |
103 103RT |
0 | Gene fragment(s) |
| Akrim (2012) | HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005 | AIDS Res Ther 9 (1), 5 (2012) | 7.68e-151 | 107 58PR 49RT |
107 58PR 49RT |
100 | HIVDB |
| Al Kindi (2025) | HIV treatment naive patients | Unpublished | 0 | |
5 5PR 5RT |
0 | Unpublished |
| Alampalli (2018) | Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India | PLoS ONE 12 (12), e0188603 (2017) | 0 | |
9 9PR 9RT 9IN |
0 | Case report(s) / study subset |
| Alaoui (2016) | Genetic analysis of HIV-1 integrase gene from antiretoviral treatment naive and experienced patients in Morocco | 29884219 | 0 | 155 155IN |
155 155IN |
100 | HIVDB |
| Albert (1992) | PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera | J. Virol. 66 (9), 5627-5630 (1992) | 5e-55 | |
20 20RT |
0 | Case report(s) / study subset |
| Albert (1995) | Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes | J. Virol. 68 (9), 5918-5924 (1994) | 2.97e-141 | 23 23RT |
26 26RT |
88 | HIVDB |
| Alcalde (2011) | Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of Sao Paulo, Brazil | Virol. J. 9, 156 (2012) | 0 | 45 45PR 45RT |
249 249PR 249RT |
18 | HIVDB |
| Alcalde (2016) | Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinants forms which is circulating in Sao Paulo city, Brazil | 17686543 | 2.82e-169 | 43 43PR 43RT |
44 44PR 44RT |
97 | HIVDB |
| Alcantara (2012) | HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures | J. Clin. Virol. 54 (1), 15-20 (2012) | 6.04e-173 | 76 75PR 76RT |
76 75PR 76RT |
100 | HIVDB |
| Alcantara (2012) | Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil. | J Med Virol. 2013 Mar;85(3):396-404. | 2.85e-174 | 55 55PR 55RT |
58 58PR 58RT |
94 | HIVDB |
| Aleman (2014) | Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba | 25671421 | 0 | |
14 14PR 14RT |
0 | Case report(s) / study subset |
| Alencar (2012) | Prevalence of genotypes and primary drug resistance among HIV+ Brazilian blood donors | 23507660 | 0 | 300 300PR 300RT |
327 327PR 327RT |
91 | HIVDB |
| Alene (2019) | Reverse transcriptase gene HIV | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Alessandri-Gradt (2017) | HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors | J. Antimicrob. Chemother. 72 (9), 2431-2437 (2017) | 7.63e-173 | 39 39IN |
39 39IN |
100 | HIVDB |
| Alexiev (2015) | Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity | J. Antimicrob. Chemother. (2015) In press | 1.22e-149 | 221 221PR 219RT |
221 221PR 221RT |
100 | HIVDB |
| Alexiev (2016) | Origin and spread of HIV-1 in persons who inject drugs in Bulgaria | Infect. Genet. Evol. (2016) In press | 1.39e-149 | |
26 26PR 26RT |
0 | Pending |
| Alexiev (2018) | Origin and Spread of HIV-1 Subtype B Among Heterosexual Individuals in Bulgaria | AIDS Res. Hum. Retroviruses (2018) In press | 1.3e-149 | |
45 45PR 45RT |
0 | Pending |
| Alexiev (2020) | Molecular Epidemiology of the HIV-1 Subtype B Sub-Epidemic in Bulgaria | Viruses 12 (4), 441 (2020) | 1.54e-149 | |
467 467PR 467RT |
0 | ARV Rx and/or other data are N/A |
| Alexiev (2021) | Molecular Epidemiological Analysis of the Origin and Transmission Dynamics of the HIV-1 CRF01_AE Sub-Epidemic in Bulgaria | Viruses 13 (1), 116 (2021) | 0 | |
181 181PR 181RT |
0 | Pending |
| Alexiev (2022) | Analysis of the Origin and Dissemination of HIV-1 Subtype C in Bulgaria | Viruses 14 (2), 263 (2022) | 0 | |
20 20PR 20RT |
0 | Quasispecies |
| Ali (2010) | Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones | J. Med. Chem. 53 (21), 7699-7708 (2010) | 0 | |
6 6PR 6RT |
0 | Laboratory/experimental isolate |
| Alizon (1986) | GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients | Cell 46 (1), 63-74 (1986) | 1e-165 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Allan (1993) | SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys | J. Virol. 65 (6), 2816-2828 (1991) | 2e-33 | |
8 8IN |
0 | Laboratory/experimental isolate |
| Allen (2005) | SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution | J. Virol. 79 (21), 13239-13249 (2005) | 0 | |
14 14PR 14RT 14IN |
0 | Quasispecies |
| Allen (2008) | Epidemiologically-Linked Transmission of HIV-1 Illustrates the Impact of Host Genetics on Virological Outcome | Unpublished | 2.23e-42 | |
23 23PR 23RT |
0 | Sequence quality |
| Alonso (2024) | Prevalence of adquired resistance to antiretrovirals in children and adolescents with HIV in clinical follow-up at the roosevelt hospital in Guatemala | J Infect Public Health | 0 | 66 62PR 66RT |
66 62PR 66RT |
100 | HIVDB |
| Altfeld (2003) | HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus | Nature 420 (6914), 434-439 (2002) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Alves (2018) | Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy | Viruses 9 (12), E392 (2017) | 0 | |
31 23PR 23RT 23IN |
0 | Proviral DNA Reservoir |
| Alves (2019) | Estimating HIV-1 Genetic Diversity in Brazil Through Next-Generation Sequencing | Front Microbiol 10, 1-11 (2019) | 0 | 31 22PR 26RT 27IN |
38 33PR 29RT 34IN |
81 | HIVDB |
| Alves (2022) | Adaptation to HLA-associated immune pressure in acute HIV infection and in circulating HIV-1 strains | 36525463 | 0 | |
228 201PR 224RT 126IN |
0 | ARV Rx and/or other data are N/A |
| Aman (2016) | Optimization of full-length sequencing of HIV type 1 from Senegal | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Ambike (2018) | Determination of pre-treatment drug resistance (PDR) in HIV-2 infected individuals from Maharashtra, India | 30681008 | 8.99e-128 | 32 32PR 32RT |
32 32PR 32RT |
100 | HIVDB |
| Amer (2023) | Direct Submission | Submitted (20-JUN-2023) Medical Microbiology and I | 4.82e-175 | |
52 52RT |
0 | Unpublished |
| Amoedo (2011) | Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression | PLoS ONE 6 (8), E24118 (2011) | 1e-60 | |
198 198PR |
0 | Proviral DNA Reservoir |
| Amogne (2016) | Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 133 133PR 133RT 24IN |
151 151PR 151RT 24IN |
88 | HIVDB |
| An (2012) | Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China | J. Virol. (2012) In press | 0 | 39 39PR 39RT 39IN |
39 39PR 39RT 39IN |
100 | HIVDB |
| An (2016) | A Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) among heterosexuals in Nei Monggoi Autonomous Region in China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| An (2022) | Independent epidemic patterns of HIV-1 CRF01_AE lineages driven by frequent population mobility in Shenzhen, China: an imply to the targeting interventions | 35299786 | 0 | 757 757PR 757RT |
757 757PR 757RT |
100 | HIVDB |
| An (2022) | The Viral Founder Effect and Economic-Driven Human Mobility Shaped the Distinct Epidemic Pattern of HIV-1 CRF01_AE in Northeast China | Front Med (Lausanne) 8, 769535 (2021) | 1.04e-179 | 335 335PR 335RT |
335 335PR 335RT |
100 | HIVDB |
| Ana Planinic (2014) | The prevalence and patterns of genotypic resistance to antiretroviral drugs in patients with virological failure from Croatia: 2008-2012 | Thesis (2014) University Hospital for Infectous Di | 3.01e-136 | |
101 101PR 101RT |
0 | Unpublished - Final |
| Ana Planinic (2016) | The prevalence and patterns of genotypic resistance to antiretroviral drugs in patients with virological failure from Croatia: 2008-2015 | Unpublished | 1.89e-135 | |
43 43PR 43RT |
0 | Unpublished - Final |
| Ana (2024) | Identification of a new HIV-1 circulating recombinant form (CRF148_cpx) derived from subtypes B, C, and F1 | Unpublished | 0 | |
9 9PR 9RT 3IN |
0 | Case report (Small sample size) |
| Anderson (2000) | TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E | J. Virol. 74 (22), 10752-10765 (2000) | 1e-164 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Anderson (1993) | ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques | Virology 195 (2), 616-626 (1993) | 5e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Andersson (1999) | MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa | Virology 261 (1999) In press | 2e-66 | 7 7RT |
7 7RT |
100 | HIVDB |
| Andreani (2008) | CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina | 21824422 | 0 | |
120 120PR 120RT |
0 | Quasispecies |
| Andreotti (2009) | Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique | AIDS Res. Hum. Retroviruses 25 (7), 707-711 (2009) | 5.72e-148 | |
296 147PR 149RT |
0 | Quasispecies |
| Andresen (2007) | CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine | AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) | 0 | 17 17PR 17RT 17IN |
17 17PR 17RT 17IN |
100 | HIVDB |
| annan (2021) | Direct Submission | Submitted (18-JUN-2021) Virology, National Institu | 1.31e-59 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Anta (2010) | Identification of a new HIV-1 circulating recombinant form in Spain | Unpublished | 0 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Antar (2020) | Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy | J. Clin. Invest. (2020) In press | 0 | |
384 235PR 286RT 335IN |
0 | Sequence quality |
| Anton (2004) | GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens | Unpublished | 0 | |
219 219PR 219RT |
0 | ARV Rx and/or other data are N/A |
| Antoniadou (2013) | Short Communication: Molecular Epidemiology of HIV Type 1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV Type 1 Subtype A1 Drug-Resistant Strains Among Men Who Have Sex with Men | AIDS Res. Hum. Retroviruses 30 (3), 225-232 (2014) | 8.79e-150 | 196 98PR 98RT |
196 98PR 98RT |
100 | HIVDB |
| Antonova (2019) | The molecular epidemiologicial analysis of HIV infection in Izhevsk | Unpublished | 0 | |
42 42PR 42RT |
0 | Unpublished |
| Antonova (2022) | Genetic profile and characteristics of HIV-1 drug resistance mutations in the Krasnodar Territory in the period from 2014 to 2019 | Unpublished | 0 | 55 55PR |
422 422PR 422RT |
13 | HIVDB |
| Antonova (2022) | Untitled | Unpublished | 0 | 310 310PR 310RT |
475 473PR 475RT |
65 | HIVDB |
| Antonova (2025) | The importance of assessing HIV-1 genetic diversity in vaccine development | Unpublished | 0 | |
79 79PR 79RT |
0 | Unpublished |
| Anwar (2022) | Identification of Drug Resistance Mutations among HIV-1 infected Individuals in Pakistani population | Unpublished | 0 | |
10 10RT 10IN |
0 | Case report(s) / study subset |
| Anwar (2025) | Direct Submission | Submitted (06-SEP-2025) Departmeny of Virology, Na | 1.92e-159 | |
14 14RT |
0 | Unpublished |
| Apetrei (1998) | HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility | J. Virol. 72 (5), 3534-3538 (1998) | 1e-77 | 14 14RT |
14 14RT |
100 | HIVDB |
| Apetrei (2003) | HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy | AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) | 1e-117 | 163 77PR 86RT |
163 77PR 86RT |
100 | HIVDB |
| Apetrei (2004) | DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection | J. Virol. 78 (21), 11506-11518 (2004) | 4e-71 | |
18 18IN |
0 | Laboratory/experimental isolate |
| Apetrei (2005) | MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm | J. Virol. 79 (14), 8991-9005 (2005) | 4e-90 | |
47 47IN |
0 | NHPL/SIV |
| Apetrei (2006) | POTENTIAL for HIV transmission through unsafe injections | AIDS 20 (7), 1074-1076 (2006) | 1e-148 | |
27 27PR 27RT |
0 | ARV Rx and/or other data are N/A |
| Apetrei (2007) | SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys | Unpublished | 3e-70 | |
96 96IN |
0 | NHPL/SIV |
| Appah (2023) | Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage | Viruses 15 (1), 128 (2022) | 0 | 180 91PR 91RT 89IN |
256 167PR 167RT 165IN |
70 | HIVDB |
| Araujo (2018) | Phylogenetic characterization of HIV-1 sub-subtype A1 in Portugal | Unpublished | 1.4e-143 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Araujo (2019) | Characterization of a large cluster of HIV-1 A1 infections detected in Portugal and connected to several Western European countries | 31076722 | 0 | 34 34PR 34RT |
34 34PR 34RT |
100 | HIVDB |
| Arenas (2016) | Influence of mutation and recombination on HIV-1 in vitro fitness recovery | Mol. Phylogenet. Evol. 94 (PT A), 264-270 (2016) | 0 | |
12 12PR 12RT 12IN |
0 | Laboratory/experimental isolate |
| Arias (2018) | Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments | Int J Environ Res Public Health 15 (8), E1697 (201 | 0 | |
24 24PR 24RT |
0 | Case report(s) / study subset |
| Arien (2005) | REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time | AIDS 19 (15), 1555-1564 (2005) | 0 | 23 23PR 23RT |
23 23PR 23RT |
100 | HIVDB |
| Arien (2016) | Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398 | J. Antimicrob. Chemother. (2016) In press | 0 | |
4 4PR 4RT |
0 | HIVDB |
| Arien (2016) | The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates | J. Virol. 79 (14), 8979-8990 (2005) | 5.41e-103 | |
15 15RT |
0 | Gene fragment(s) |
| Arimide (2018) | HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013 | PLoS ONE 13 (10), e0205446 (2018) | 1.71e-175 | 67 67PR 67RT |
67 67PR 67RT |
100 | HIVDB |
| Arimide (2022) | Molecular Epidemiology and Transmission Dynamics of the HIV-1 Epidemic in Ethiopia: Epidemic Decline Coincided With Behavioral Interventions Before ART Scale-Up | Front Microbiol 13, 821006 (2022) | 0 | 144 144PR 144RT |
144 144PR 144RT |
100 | HIVDB |
| Arimide (2022) | Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia | Viruses 14 (4), 729 (2022) | 0 | 459 459IN |
460 460IN |
99 | HIVDB |
| Armenia (2011) | Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing | J Infect Dis (2012) | 1e-168 | 40 40IN |
40 40IN |
100 | HIVDB |
| Armenia (2024) | Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings | J Clin Virol 130, 104534 (2020) | 0 | 1139 558PR 558RT 581IN |
1189 591PR 594RT 595IN |
95 | HIVDB |
| Armenia (2024) | Direct Submission | Submitted (05-JUN-2024) Departimental Faculty, Sai | 0 | 91 90PR 91RT |
91 90PR 91RT |
100 | HIVDB |
| Arnold (1995) | AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England | AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) | 1e-126 | |
4 4PR |
0 | Case report(s) / study subset |
| Arora (2016) | Genotyping protease-inhibitor-related mutations in an HIV-1 isolate from a treatment-naive patient in Chandigarh, India | Unpublished | 1.31e-46 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Arroyo (2004) | HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania | AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) | 0 | 20 20PR 20RT 20IN |
20 20PR 20RT 20IN |
100 | HIVDB |
| Arroyo (2006) | HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania | AIDS 19 (14), 1517-1524 (2005) | 0 | 14 14PR 14RT 14IN |
14 14PR 14RT 14IN |
100 | HIVDB |
| Arruda (2012) | Short communication: intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil | AIDS Res. Hum. Retroviruses 27 (2), 153-156 (2011) | 1.68e-151 | 148 74PR 74RT |
148 74PR 74RT |
100 | HIVDB |
| Arruda (2009) | Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil | AIDS Res. Hum. Retroviruses 26, 1 (2010) | 1e-168 | 76 76IN |
76 76IN |
100 | HIVDB |
| Arruda (2018) | Virological characterization from HIV-1-infected subjects undergoing DC-based immunotherapy | Unpublished | 2.49e-169 | |
56 56PR 56RT |
0 | Case report(s) / study subset |
| Arruda (2010) | Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy | 18838582 | 0 | 911 911PR 911RT |
911 911PR 911RT |
100 | HIVDB |
| Arruda (2016) | Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a large survey of naive-treatment individuals | 29504269 | 5.55e-168 | 1566 1566PR 1566RT |
1566 1566PR 1566RT |
100 | HIVDB |
| Asio (2025) | Emergence of acquired HIV drug resistance among individuals receiving dolutegravir-based antiretroviral therapy in Uganda: A national laboratory-based survey 2023 | Unpublished | 0 | |
1033 474PR 474RT 559IN |
0 | HIVDB |
| Atkinson (2000) | CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine | J. Infect. Dis. 182 (2), 420-427 (2000) | 1e-123 | 49 49PR |
78 50PR 28RT |
62 | HIVDB |
| Augier (2019) | Identification of a novel SIV infected African Green Monkey (Chlorocebus tantalus) confirms that tantalus monkeys in Cameroon are infected with a mosaic SIVagm lineage | AIDS Res. Hum. Retroviruses (2019) In press | 0 | |
2 2RT 2IN |
0 | NHPL/SIV |
| Aulicino (2004) | CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina | AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) | 0 | 1 1PR 1RT 1IN |
3 3PR 3RT 1IN |
33 | HIVDB |
| Aulicino (2005) | SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant | AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Aulicino (2009) | HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations | Antivir. Ther. (Lond.) 15 (4), 641-650 (2010) | 2.73e-160 | 71 71PR 71RT |
71 71PR 71RT |
100 | HIVDB |
| Aulicino (2013) | Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12_BF pol gene mosaic patterns and high diversity of BF unique recombinant forms | Infect. Genet. Evol. 11 (2), 349-357 (2011) | 6.74e-162 | 123 123PR 123RT |
123 123PR 123RT |
100 | HIVDB |
| Aulicino (2015) | Drug resistance in HIV infected children from Argentina | Unpublished | 2.59e-154 | |
23 23PR 23RT |
0 | Case report(s) / study subset |
| Aulicino (2018) | Pre-treatment drug resistance and HIV-1 subtype in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission | J. Antimicrob. Chemother. (2019) In press | 7.85e-159 | 115 115PR 115RT |
115 115PR 115RT |
100 | HIVDB |
| Aulicino (2024) | HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H | J Antimicrob Chemother (2022) In press | 0 | |
9 9IN |
0 | Pending |
| Auswinporn (2001) | GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand | Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 | 1e-121 | 27 27PR 27RT |
27 27PR 27RT |
100 | HIVDB |
| Auwanit (2001) | FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand | AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) | 1e-165 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Auwanit (2009) | Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand | AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) | 4e-173 | 109 59PR 50RT |
189 139PR 50RT |
57 | HIVDB |
| Avanzi (2016) | Direct Submission | Submitted (08-MAR-2016) Virology Laboratory, Unive | 0 | |
32 32PR 32RT |
0 | Case report(s) / study subset |
| Avelino (2024) | Protease inhibitors resistance and HIV-1 genetic variability in V3 region in people living with HIV/AIDS under ART over 10 years in Belem, Para, Northern Brazil | Unpublished | 1.48e-65 | |
9 9PR |
0 | Case report(s) / study subset |
| Avi (2009) | Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. | Scand J Infect Dis | 1e-144 | 55 55PR 55RT |
55 55PR 55RT |
100 | HIVDB |
| Avi (2009) | Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. | ARHR | 1e-164 | 112 112IN |
114 114IN |
98 | HIVDB |
| Avi (2009) | Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 | 20964489 | 4e-172 | 90 90PR 90RT |
90 90PR 90RT |
100 | HIVDB |
| Avi (2015) | Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population | Unpublished | 0 | 10 8PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Avi (2009) | Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia | J. Med. Virol. 81 (6), 953-958 (2009) | 9.16e-161 | 142 86PR 56RT |
143 87PR 56RT |
99 | HIVDB |
| Avi (2014) | Failure of ddI Containing HAART is Associated with the Selection of L74V and L74I Mutations in HIV-1 CRF06_cpx Infected Patients in Estonia | 26291050 | 1.28e-161 | 45 45PR 45RT |
45 45PR 45RT |
100 | HIVDB |
| Avi (2012) | Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010. | AIDS Res Hum Retroviruses. 2014 Mar;30(3):278-83. | 1e-169 | 244 244PR 244RT |
244 244PR 244RT |
100 | HIVDB |
| Avidor (2013) | Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy | PLoS ONE 8 (3), E57789 (2013) | 5.23e-146 | 232 232PR 232RT |
236 236PR 236RT |
98 | HIVDB |
| Avila-Rios (2013) | National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico | PLoS ONE 6 (11), E27812 (2011) | 0 | 1648 1648PR 1639RT |
1648 1648PR 1639RT |
100 | HIVDB |
| Ay (2020) | Direct Submission | Submitted (22-NOV-2018) Department of Retroviruses | 0 | 133 86PR 86RT |
133 86PR 86RT |
100 | HIVDB |
| Ay (2016) | Transmitted Drug Resistance in Newly Diagnosed, Treatment-Naive, HIV Type 1- Infected Patients in Hungary | Unpublished | 0 | 164 82PR 82RT |
164 82PR 82RT |
100 | HIVDB |
| AYEHUMIE (1991) | Human immunodeficiency virus type 1 proviral DNA | Unpublished (1991) | 4e-41 | |
8 8PR |
0 | Gene fragment(s) |
| Ayitewala (2020) | Direct Submission | Submitted (10-JAN-2019) CFAR, JCRC, Lubowa, Kampal | 0 | 168 66PR 168RT |
169 90PR 169RT |
99 | HIVDB |
| Ayouba (2009) | Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study | AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 | 2e-171 | 534 267PR 267RT |
534 267PR 267RT |
100 | HIVDB |
| Ayouba (2013) | Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire | AIDS 27 (15), 2488-2491 (2013) | 0 | 1 1PR 1RT 1IN |
3 2PR 2RT 2IN |
33 | HIVDB |
| Ayouba (2015) | Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys | Infect. Genet. Evol. 30, 65-73 (2015) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Azam (2012) | Prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 infected patients | 23888308 | 4e-61 | 104 104PR |
104 104PR |
100 | HIVDB |
| Azam (2014) | Trends of drug-resistance-associated mutations in the reverse transcriptase gene of HIV type 1 isolates from North India | Arch. Virol. 159 (4), 719-725 (2014) | 7.23e-149 | 103 103RT |
103 103RT |
100 | HIVDB |
| Azevedo-Pereira (1998) | Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. | J Virol. | 2e-97 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Baalwa (2012) | Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones | Virology 436 (1), 33-48 (2013) | 0 | |
500 216PR 216RT 500IN |
0 | Quasispecies |
| Babic (2005) | PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 | Virus Res. 118 (1-2), 156-163 (2006) | 0 | 76 76PR 76RT |
77 77PR 77RT |
98 | HIVDB |
| Babic (2005) | MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 | J. Med. Virol. 78 (8), 997-1002 (2006) | 0 | 1 1PR 1RT |
7 7PR 7RT |
14 | HIVDB |
| Bacchus-Souffan (2020) | CD4 T cell proliferation and differentiation contribute to HIV persistence during antiretroviral therapy | Unpublished | 0 | |
205 198PR 179RT 143IN |
0 | Unpublished |
| Bacheler (2000) | HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy | Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) | 1e-130 | 3669 3646PR 3662RT |
3708 3708PR 3708RT |
98 | HIVDB |
| Bacheler (2001) | GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy | J. Virol. 75 (11), 4999-5008 (2001) | 1e-126 | 67 66PR 67RT |
87 84PR 87RT |
77 | HIVDB |
| Bacque (2019) | Identification of a new HIV-1 BF circulating recombinant form in Spain and Paraguay | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Bacque (2019) | Identification of a new HIV-1 BF intersubtype recombinant form (CRF75_BF) circulating in Spain, Italy and Brazil | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Bacque (2021) | Identification of CRF66_BF, a new HIV-1 circulating recombinant form of South American origin | Front Microbiol (2021) In press | 0 | |
23 19PR 19RT 9IN |
0 | Case report(s) / study subset |
| Bacque (2023) | Identification of a HIV-1 circulating BF1 recombinant form (CRF75_BF1) of Brazilian origin that also circulates in Southwestern Europe | Front Microbiol 14 (2023) In press | 0 | |
3 3PR 3RT 2IN |
0 | Case report(s) / study subset |
| Badreddine (2007) | IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found | AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) | 0 | 60 6PR 6RT 60IN |
60 6PR 9RT 60IN |
100 | HIVDB |
| Baesi (2013) | Antiretroviral drug resistance and new subtypes in HIV-infected patients in Tehran, Iran | 24740443 | 2.32e-162 | |
84 84RT |
0 | ARV Rx and/or other data are N/A |
| Baesi (2020) | Direct Submission | Submitted (17-APR-2020) Hepatitis and AIDS, Pasteu | 5.26e-158 | |
48 48IN |
0 | Unpublished |
| Baeten (2014) | Risk factors associated with HIV acquisition from outside of identified sexual partnership | 21963939 | 2.08e-162 | 296 286PR 294RT |
296 287PR 296RT |
100 | HIVDB |
| Baeten (2011) | Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons | J. Infect. Dis. 203 (1), 117-121 (2011) | 1.19e-169 | |
65 65RT |
0 | Case report(s) / study subset |
| Baeten (2013) | Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | N. Engl. J. Med. 367 (5), 399-410 (2012) | 0 | |
176 176PR 176RT |
0 | Case report(s) / study subset |
| Bahls (2014) | Prevalence of transmitted drug resistance in recently and chronically infected individuals from northwestern and northern Parana | Unpublished | 8.13e-171 | |
163 160PR 162RT |
0 | ARV Rx and/or other data are N/A |
| Baier (1990) | COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence | Virology 176 (1), 216-221 (1990) | 1e-109 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Bailey (2016) | Arteriviruses, pegiviruses, and lentiviruses are common among wild African monkeys | J. Virol. (2016) In press | 0 | |
33 33PR 33RT 33IN |
0 | NHPL/SIV |
| Bailey (2007) | EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape | J. Infect. Dis. 196 (1), 50-55 (2007) | 0 | |
43 37PR 38RT 6IN |
0 | Quasispecies |
| Bailey (2008) | TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor | J. Virol. 82 (15), 7395-7410 (2008) | 0 | |
14 7PR 7RT 14IN |
0 | Case report(s) / study subset |
| Bailey (2016) | Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells | J. Virol. 80 (13), 6441-6457 (2006) | 6.42e-129 | |
1604 1604RT |
0 | SGS |
| Baker (2007) | HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. | J Int Assoc Physicians AIDS Care (Chic) | 0 | 46 45PR 46RT |
46 45PR 46RT |
100 | HIVDB |
| Balakrishnan (2005) | HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India | AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) | 1e-139 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Balamane (2012) | Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine | Antimicrob. Agents Chemother. (2012) In press | 1e-176 | 10 10RT |
10 10RT |
100 | HIVDB |
| Balamurugan (2016) | Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination | J. Virol. 82 (6), 2784-2791 (2008) | 6.82e-105 | |
28 28PR 28RT |
0 | Gene fragment(s) |
| Baldanti (2010) | Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens | J. Med. Virol. 82 (1), 116-122 (2010) | 1e-156 | 11 11IN |
11 11IN |
100 | HIVDB |
| Baldrich-Rubio (2001) | A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa | J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) | 1e-161 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Balinda (2021) | Characterization of Unique Recombinant Viruses Identified Within Subtype D HIV-1 Transmitted Founder Viruses in a Ugandan Acute Infection Cohort | 35215928 | 0 | 30 30PR 30RT 30IN |
30 30PR 30RT 30IN |
100 | HIVDB |
| Balinda (2025) | Evolutionary Dynamics of HIV-1 Recombinants: Analysis of Contemporary and Historical Viral Populations in East Africa | Unpublished | 0 | |
17 17PR 17RT 17IN |
0 | Unpublished |
| Balinda (2025) | Direct Submission | Submitted (02-SEP-2025) Viral Pathogen, MRC/UVRI & | 0 | |
4 4PR 4RT 4IN |
0 | Unpublished |
| Balode (2010) | Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia | J. Med. Virol. 82 (12), 2013-2018 (2010) | 0 | 117 117PR 117RT |
124 124PR 124RT |
94 | HIVDB |
| Balotta (2000) | Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. | JAIDS | 1e-133 | 149 132PR 149RT |
157 137PR 157RT |
94 | HIVDB |
| Balotta (2000) | PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals | Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) | 1e-128 | 71 33PR 38RT |
71 33PR 38RT |
100 | HIVDB |
| Balotta (2001) | INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences | J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) | 1e-100 | 19 19PR 19RT |
19 19PR 19RT |
100 | HIVDB |
| Bang (2007) | PREVALENCE of primary antiretroviral resistance: trends in Korea | AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) | 0 | 81 81PR 81RT |
81 81PR 81RT |
100 | HIVDB |
| Bangalee (2021) | Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa | J Antimicrob Chemother (2021) In press | 1.28e-176 | |
125 125PR 125RT |
0 | Pending |
| Banin (2019) | Development of a Versatile, Near Full Genome Amplification and Sequencing Approach for a Broad Variety of HIV-1 Group M Variants | Viruses 11 (4), E317 (2019) | 0 | 18 18PR 18RT 18IN |
24 24PR 24RT 24IN |
75 | HIVDB |
| Banke (2009) | Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations | J. Virol. 83 (17), 8916-8924 (2009) | 4e-60 | 364 364PR |
364 364PR |
100 | HIVDB |
| Bannert (2019) | Reconstruction of the genetic history and the current spread of HIV-1 subtype A in Germany | J. Virol. (2019) In press | 1.13e-172 | 9 9PR 9RT |
10 10PR 10RT |
90 | HIVDB |
| Bansode (2011) | Drug Resistance Mutations in Drug-Naive HIV Type 1 Subtype C-Infected Individuals from Rural Malawi | AIDS Res. Hum. Retroviruses 27 (4), 439-444 (2011) | 5.07e-164 | 101 45PR 56RT |
432 232PR 200RT |
23 | HIVDB |
| Bao (2008) | MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China | AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) | 0 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Bao (2014) | Characteristics of HIV-1 Natural Drug Resistance-Associated Mutations in Former Paid Blood Donors in Henan Province, China | PLoS ONE 9 (2), E89291 (2014) | 0 | 107 99PR 107RT |
107 107PR 107RT |
100 | HIVDB |
| Bar (2010) | Wide variation in the multiplicity of HIV-1 infection among injection drug users | J. Virol. 84 (12), 6241-6247 (2010) | 3e-16 | |
390 390IN |
0 | Quasispecies |
| Bar-Magen (2009) | Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes | AIDS. 2010 Sep 10;24(14):2171-9. | 1e-165 | |
2 2IN |
0 | Laboratory/experimental isolate |
| Barabona (2019) | Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring | J. Antimicrob. Chemother. (2019) In press | 5.55e-172 | 160 159PR 160RT |
160 160PR 160RT |
100 | HIVDB |
| Barber (2012) | Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor | J. Antimicrob. Chemother. (2012) In press | 0 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Barbian (2015) | Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas | MBio 6 (2), e00296-15 (2015) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Barbian (2017) | Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee | Retrovirology 14 (1), 35 (2017) | 0 | |
170 170PR 170RT 170IN |
0 | NHPL/SIV |
| Barditch-Crovo (2001) | PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults | Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) | 4e-96 | 14 14RT |
14 14RT |
100 | HIVDB |
| Bareng (2023) | HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads | Infect Drug Resist 15, 7565-7576 (2022) | 0 | 72 60PR 69RT |
76 60PR 75RT |
94 | HIVDB |
| Barik (2018) | Archived DNA among patients of undetected target level of HIV-1 RNA of first line art patients of Agra region, India | Unpublished | 0 | |
9 7PR 9RT |
0 | Proviral DNA Reservoir |
| Barik (2020) | Identification and differential expression of serotransferrin andapolipoprotein A-I in the plasma of HIV-1 patients treated with first-lineantiretroviral therapy | BMC Infect Dis (2021) In press | 0 | 4 4PR 4RT |
4 4PR 4RT |
100 | HIVDB |
| Barik (2021) | Drug resistant HIV-1 mutants of Agra Region, India | Unpublished | 0 | |
53 52PR 53RT |
0 | Unpublished |
| Barlow (2001) | RECOMBINANT strains of HIV type 1 in the United Kingdom | AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) | 1e-109 | |
12 12PR 9RT |
0 | ARV Rx and/or other data are N/A |
| Barlow (2003) | CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) | J. Virol. 77 (12), 6879-6888 (2003) | 3e-92 | |
2 1PR 1RT 2IN |
0 | NHPL/SIV |
| Barnett (1993) | DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain | J. Virol. 67 (2), 1006-1014 (1993) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Barnett (1996) | DIRECT Submission | Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala | 2e-98 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Barral (2014) | Analysis of HIV-1 drug resistance mutations in the reverse transcriptase C-terminal portions and co-occurrence with polymerase domain mutations in different subtypes from patients under virological failure in southern Brazil | 27875905 | 0 | |
47 7PR 47RT |
0 | ARV Rx and/or other data are N/A |
| Barreto (2006) | Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. | JAIDS | 1.01e-146 | 341 341PR 341RT |
341 341PR 341RT |
100 | HIVDB |
| Barrie (1996) | NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 | Virology 219 (2), 407-416 (1996) | 1e-126 | |
37 37PR |
0 | Case report(s) / study subset |
| Bartolo (2007) | HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. | JAIDS | 0 | 113 37PR 77RT |
113 48PR 112RT |
100 | HIVDB |
| Bartolo (2007) | Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. | AAC | 1e-170 | 139 19PR 120RT |
140 19PR 140RT |
99 | HIVDB |
| Bartolo (2010) | Origin and epidemiological history of HIV-1 CRF14_BG. | PLoS One | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Bartolo (2008) | Analysis of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique | 19582896 | 4.02e-152 | 75 74PR 1RT |
76 76PR 73RT |
98 | HIVDB |
| Bartolo (2009) | Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic | Infect. Genet. Evol. 9 (4), 672-682 (2009) | 6e-169 | 123 122PR 1RT |
124 122PR 119RT |
99 | HIVDB |
| Bartolo (2014) | HIV-1 diversity, transmission dynamics and primary drug resistance in Angola. | PLoS One. 2014 Dec 5;9(12):e113626. | 0 | 280 140PR 140RT |
281 141PR 140RT |
99 | HIVDB |
| Bartolo (2016) | Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes H and J from Cabinda, Angola | 27098898 | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Baryshev (2011) | Genetic characterisation of HIV-1 strains recombinant form AG circulating in Siberia, Russia | Zh Mikrobiol Epidemiol Immunobiol | 0 | 17 17PR 17RT 17IN |
17 17PR 17RT 17IN |
100 | HIVDB |
| Basimane-Bisimwa (2020) | Molecular study and geographical distribution of chronic viral hepatitis and their HIV co-infection in the Central African Republic | Unpublished | 3.58e-61 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Basson (2021) | HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance | PLoS One 15 (6), e0234937 (2020) | 0 | 58 58RT |
58 58RT |
100 | HIVDB |
| Baudi (2016) | Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe | J. Med. Virol. (2016) In press | 5.55e-168 | 164 164PR 164RT |
164 164PR 164RT |
100 | HIVDB |
| Baxter (2006) | GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir | J. Virol. 80 (21), 10794-10801 (2006) | 0 | 4996 3195PR 3195RT |
4999 3198PR 3198RT |
99 | HIVDB |
| Bbosa (2018) | The molecular epidemiology and transmission dynamics of HIV-1 in networks of fisher folk communities of Lake Victoria, female sex workers and general population cohorts in Uganda | 30705307 | 0 | 562 562PR 562RT |
1974 1974PR 1974RT 1IN |
28 | HIVDB |
| Bbosa (2024) | Near full-length genome analysis of the first-reported HIV-1 Circulating Recombinant Form (CRF)_10CD in Uganda | AIDS Res Hum Retroviruses (2024) In press | 0 | |
14 14PR 14RT 14IN |
0 | Case report(s) / study subset |
| Beamud (2019) | Characterization of New Recombinant Forms of HIV-1 From the Comunitat Valenciana (Spain) by Phylogenetic Incongruence | Front Microbiol 10, 1006 (2019) | 0 | |
9 9PR 9RT 8IN |
0 | Case report(s) / study subset |
| Beck (2007) | OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes | 18614915 | 1.02e-153 | |
79 50PR 36RT |
0 | Case report(s) / study subset |
| Beck (2025) | HIV resistance to dolutegravir varies with co-administered agents | Clin Infect Dis (2025) In press | 1.2e-179 | |
28 14PR 14RT 14IN |
0 | HIVDB |
| Becker (1995) | MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate | Unpublished | 1e-100 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Becker-Pergola (2000) | ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults | AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) | 1e-115 | 54 27PR 27RT |
54 27PR 27RT |
100 | HIVDB |
| Beer (1999) | SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies | J. Virol. 73 (9), 7734-7744 (1999) | 4e-97 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Beer (2000) | PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir | J. Virol. 74 (8), 3892-3898 (2000) | 3e-99 | |
3 3PR 3RT 3IN |
0 | NHPL/SIV |
| Beer (2001) | CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) | J. Virol. 75 (24), 12014-12027 (2001) | 1e-133 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Beerenwinkel (2002) | DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype | Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) | 1e-126 | |
489 466PR 467RT |
0 | Sequence Quality |
| Belec (2014) | Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays. | Niger Med J. 2015 Nov-Dec;56(6):420-4. | 0 | 43 43PR 43RT |
67 66PR 66RT |
64 | HIVDB |
| Belec (2013) | HIV drug resistance mutations in HIV1 variants from adults living in Gabon | 25767633 | 8.87e-142 | |
30 27PR 28RT |
0 | ARV Rx and/or other data are N/A |
| Bello (2023) | Monitoring of Virological Response and Acquired HIV-1 Drug Resistance Among Patients Initiating Antiretroviral Therapy in the Centre Region of Cameroon | Unpublished | 0 | |
64 32PR 32RT 32IN |
0 | Unpublished |
| Bello (2019) | Phylogeographic Analyses Reveal the Early Expansion and Frequent Bidirectional Cross-Border Transmissions of Non-pandemic HIV-1 Subtype B Strains in Hispaniola | Front Microbiol 10, 1340 (2019) | 2.37e-168 | 127 127PR 127RT |
127 127PR 127RT |
100 | HIVDB |
| Bello (2021) | Increasing prevalence and local transmission of non-B HIV-1 subtypes in the French Antilles and French Guiana between 1995 and 2018 | Virus Evol 6 (2), veaa081 (2020) | 2.67e-174 | |
390 390PR 390RT |
0 | Pending |
| Bellocchi (2009) | Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme | J Med Virol (2005) | 1e-177 | 59 59PR 59RT |
59 59PR 59RT |
100 | HIVDB |
| Beloukas (2016) | Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships | 22429620 | 4.84e-147 | |
9 5PR 4RT |
0 | Case report(s) / study subset |
| Beltran-Pavez C (2022) | Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997-2017) | Sci Rep 10 (1), 16891 (2020) | 0 | |
55 55PR 53RT |
0 | Case report(s) / study subset |
| Belyhun (2015) | Long term antiretroviral therapy is responsible for high rate of HBV polymerase and HBs antigen escape mutations during HIV-1 co-infection in Ethiopia | 27354181 | 0 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Bender (2020) | The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections | Cell Host Microbe 26 (1), 73-85 (2019) | 0 | |
15 15PR 15RT 15IN |
0 | NHPL/SIV |
| Bender (2020) | The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections | Cell Host Microbe 26 (1), 73-85 (2019) | 0 | |
200 173PR 185RT 166IN |
0 | SGS |
| Benn (1993) | Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire | Science | 1e-166 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| BENVENISTE (1988) | Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. | J Virol. 1988 Jun;62(6):2091-101. | 6e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Berg (2016) | A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING | J. Clin. Microbiol. (2015) In press | 0 | |
56 56PR 56RT 56IN |
0 | Pending |
| Bermudez-Aza (2011) | Antiretroviral resistance in MSM in Brazil | 21857316 | 0 | 162 162PR 162RT |
162 162PR 162RT |
100 | HIVDB |
| Bernardin (2003) | PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination | AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Bernardin (2004) | HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes | J. Virol. 79 (17), 11523-11528 (2005) | 0 | 18 18PR 18RT 18IN |
18 18PR 18RT 18IN |
100 | HIVDB |
| Bernardin (2006) | DIRECT Submission | Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re | 0 | |
13 13PR 13RT 13IN |
0 | Case report(s) / study subset |
| Bertine (2015) | High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients | 25985400 | 1.5e-146 | 81 38PR 43RT |
86 43PR 43RT |
94 | HIVDB |
| Bessong (2004) | CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence | AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) | 1e-168 | 26 13PR 13RT |
26 13PR 13RT |
100 | HIVDB |
| Bessong (2005) | RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals | AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) | 1e-177 | 75 40PR 35RT |
75 40PR 35RT |
100 | HIVDB |
| Bessong (2010) | Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa | 23455469 | 1e-164 | 88 88IN |
89 89IN |
98 | HIVDB |
| Betancor (2012) | Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy | Retrovirology 9 (1), 68 (2012) | 0 | 216 216PR 216RT |
216 216PR 216RT |
100 | HIVDB |
| Bhalla (2009) | Antiretroviral resistance-associated mutations and genomic diversity in reverse transcriptase and protease gene among drug-naive patients | Unpublished | 2.82e-161 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Bhatta (2020) | Drug resistance mutation pattern among ART naive HIV infected adults in Kolkata, India | Unpublished | 0 | |
6 4PR 6RT |
0 | Case report(s) / study subset |
| Bhatta (2020) | HIV Drug Related | Unpublished | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Bhattacharya (2007) | Founder effects in the assessment of HIV polymorphisms and HLA allele associations | Science 315 (5818), 1583-1586 (2007) | 2e-59 | |
122 122PR |
0 | Pending |
| Bhusal (2013) | Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal | 27697032 | 0 | 35 35PR 35RT 8IN |
47 47PR 47RT 10IN |
74 | HIVDB |
| Bhusal (2017) | Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal | Curr. HIV Res. 14 (6), 517-524 (2016) | 0 | |
10 10PR 10RT |
0 | HIVDB |
| Bibollet-Ruche (1996) | GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale | J. Virol. 71 (1), 307-313 (1997) | 1e-30 | |
10 10IN |
0 | Gene fragment(s) |
| Bibollet-Ruche (2004) | NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade | J. Virol. 78 (14), 7748-7762 (2004) | 0 | |
12 5PR 7RT 12IN |
0 | NHPL/SIV |
| Bibollet-Ruche (2005) | COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) | AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Bibollet-Ruche (2005) | GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O | 9686641 | 0.00000003 | |
14 14IN |
0 | Gene fragment(s) |
| Bibollet-Ruche (2012) | Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation | J. Clin. Invest. 122 (5), 1644-1652 (2012) | 0 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Bibollet-Ruche (2022) | A chimpanzee SIV envelope glycoprotein with germline-targeting properties elicits V2-directed antibodies that cross-neutralize HIV-1 | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Biesinger (2007) | CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells | Virology 370 (1), 184-193 (2008) | 0 | |
8 8RT |
0 | Case report(s) / study subset |
| Bila (2012) | Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique | 23935858 | 0 | 265 265PR 253RT 1IN |
377 377PR 366RT 1IN |
70 | HIVDB |
| Billings (2015) | The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006 | PLoS ONE 10 (8), E0135124 (2015) | 0 | 58 58PR 58RT 58IN |
58 58PR 58RT 58IN |
100 | HIVDB |
| Billings (2017) | HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 97 95PR 95RT 97IN |
98 95PR 95RT 98IN |
98 | HIVDB |
| Billings (2019) | New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men who have Sex with Men | J. Acquir. Immune Defic. Syndr. (2019) In press | 0 | 154 152PR 152RT 10IN |
160 158PR 158RT 10IN |
96 | HIVDB |
| Billings (2019) | HIV-1 genetic diversity and demographic characteristics in Bulgaria | PLoS ONE 14 (5), e0217063 (2019) | 0 | |
15 15PR 15RT 15IN |
0 | Pending |
| Billong (2013) | Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance | PLoS ONE 8 (8), E72680 (2013) | 0 | 146 146PR 146RT |
146 146PR 146RT |
100 | HIVDB |
| Binverted question markelec (2000) | HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy | J. Infect. Dis. 181 (5), 1808-1812 (2000) | 1e-128 | 100 100PR |
100 100PR |
100 | HIVDB |
| Bircher (2021) | High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania - A prospective cohort study | PLoS One 15 (1), e0227600 (2020) | 0 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Bishop (2024) | Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomised antiretroviral treatment trial | 39175843 | 1.66e-162 | |
578 261PR 261RT 317IN |
0 | Pending |
| Bivigou-Mboumba (2022) | Virological profile of HIV-1 infected individuals in Libreville, capital of Gabon in its first months of doulutegravir-based regimen transition | Unpublished | 1.44e-158 | 166 166RT |
166 166RT |
100 | HIVDB |
| Bivigou-Mboumba (2023) | Direct Submission | Submitted (08-SEP-2022) Virology, Centre Interdisc | 4.29e-163 | |
3 3IN |
0 | Pending |
| Bivigou-Mboumba (2023) | Dolutegravir resistance by the accumulation of E138K, G140A, and Q148R mutations in Gabon: a real need to perform genotype test resistance before switching treatment | Unpublished | 1.62e-167 | |
3 3PR 3RT |
0 | Pending |
| Blanco (2015) | Near full length HIV-1 subtype B from Cuban individuals | 26947278 | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Blankson (2007) | ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors | J. Virol. 81 (5), 2508-2518 (2007) | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Blankson (2009) | HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject | J Infect Dis. 2009 Dec 15;200(12):1820-4. | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Bleiber (2001) | INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 | J. Virol. 75 (7), 3291-3300 (2001) | 1e-112 | |
21 15PR 15RT |
0 | Case report(s) / study subset |
| Blick (2006) | THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient | J. Infect. Dis. 195 (9), 1250-1259 (2007) | 1e-163 | |
13 13PR 13RT |
0 | Case report(s) / study subset |
| Bobkova (2025) | Real-World Efficacy of Bictegravir in Patients Infected with HIV-1Subtype A6 Harboring the L74I Mutation | Unpublished | 0 | |
100 100PR 100RT |
0 | HIVDB |
| Bobkova (2025) | Real-World Efficacy of Bictegravir in Patients Infected with HIV-1 Subtype A6 Harboring the L74I Mutation | Unpublished | 0 | |
96 96IN |
0 | HIVDB |
| Bodelle (2004) | IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon | AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Boeri (2003) | EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure | AIDS Res. Hum. Retroviruses (2003) In press | 0 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Boerma (2017) | Favorable outcomes in children on second-line protease inhibitor-based antiretroviral treatment in Uganda | Unpublished | 0 | |
36 36PR 36RT |
0 | Case report(s) / study subset |
| Boerma (2016) | High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children | J Int AIDS Soc 19 (1), 21140 (2016) | 0 | 90 90PR 90RT |
191 191PR 191RT |
47 | HIVDB |
| Bogh (2001) | INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART | Unpublished | 1e-133 | |
180 112PR 68RT |
0 | ARV Rx and/or other data are N/A |
| Boillot (2015) | Programmatic feasibility of dried blood spots for the virological follow-up of patients on antiretroviral treatment in Nord Kivu, Democratic Republic of the Congo | J. Acquir. Immune Defic. Syndr. (2015) In press | 0 | 55 42PR 55RT |
55 42PR 55RT |
100 | HIVDB |
| Bokharaei (2019) | HIV-1 Reverse Transcriptase and Protease Mutations for Drug-Resistance Surveillance among Treatment Experienced and Naive HIV-infected Iranian Individuals | 32119691 | 0 | |
61 61PR 61RT |
0 | ARV Rx and/or other data are N/A |
| Bokharaei-Salim (2018) | Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonates | Arch. Virol. (2018) In press | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Bokharaei-Salim (2021) | Evaluation of CCR5-Delta32 mutation and Drug Resistance to Antiretrovirals in PBMCs of long-term non-progressors of HIV-1 infected individuals | Unpublished | 0 | |
15 15PR 15RT |
0 | Case report(s) / study subset |
| Bokharaei-Salim (2023) | Determining HIV-1 Drug-Resistance among Treatment-Experienced Individuals after a median follow-up of 6 years Implementation of Antiretroviral Therapy | 38310469 | 0 | |
24 12RT 12IN |
0 | Pending |
| Bolcic (2011) | A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina. | J Med Virol. 2012 Apr;84(4):570-81. | 0 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Bolivar (2009) | The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain | J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 | 1e-161 | |
1 1IN |
0 | Case report(s) / study subset |
| Boltz (2017) | Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA | Retrovirology 13 (1), 87 (2016) | 2.51e-79 | |
3516 3516RT |
0 | Quasispecies |
| Bond (2015) | Natural history of epidemic and non-epidemic HIV-2 groups | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Bonhoeffer (2008) | Evidence for positive epistasis in HIV-1 | Science 306 (5701), 1547-1550 (2004) | 0 | 9467 9467PR 9467RT |
9467 9467PR 9467RT |
100 | HIVDB |
| Bonney (2014) | Antiretroviral resistance mutation profiles of patients on second-line therapy in Accra, Ghana | Unpublished | 0 | |
40 40PR 29RT |
0 | ARV Rx and/or other data are N/A |
| Bonny (2020) | Outcomes of donor-derived superinfection testing in HIV+ to HIV+ kidney and liver transplantation | 32730756 | 1.69e-116 | |
5667 5667RT |
0 | Quasispecies |
| Bonsignori (2017) | Staged Induction of HIV-1 Glycan-Dependent Broadly Neutralizing Antibodies | Unpublished | 6.65e-25 | |
1222 1222IN |
0 | Gene fragment(s) |
| Bontell (2011) | Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam | Infect. Genet. Evol. 12 (2), 448-452 (2012) | 7.51e-161 | 63 63PR 63RT |
63 63PR 63RT |
100 | HIVDB |
| Bonura (2010) | Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. | ARHR | 0 | 109 109PR 109RT |
109 109PR 109RT |
100 | HIVDB |
| Bouchard (2004) | HIV Type 1 Drug Resistance among Naive Patients from Venezuela | AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) | 1e-140 | 37 17PR 20RT |
37 17PR 24RT |
100 | HIVDB |
| Bouchonnet (2012) | Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues | J. Virol. 79 (2), 812-822 (2005) | 0 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Boue (2015) | High Rate of Simian Immunodeficiency Virus (SIV) Infections in Wild Chimpanzees in Northeastern Gabon | Viruses 7 (9), 4997-5015 (2015) | 7e-93 | |
56 56IN |
0 | Gene fragment(s) |
| Bourara (2007) | TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 | PLoS Pathog. 3 (10), 1477-1485 (2007) | 4e-52 | |
2 2PR |
0 | Case report(s) / study subset |
| Bourlet (2018) | Evaluation of the efficacy of first-line antiretroviral regimen in blood, saliva and genital reservoir of newly-diagnosed individuals in Bamako, Mali | 30285106 | 0 | 90 90PR 90RT |
90 90PR 90RT |
100 | HIVDB |
| Bourlet (2019) | Evidence of HIV-1 genital compartmentalization before and after antiretroviral therapy initiation in females recently diagnosed in Bamako, Mali | Unpublished | 0 | |
10 10PR 10RT |
0 | Case report(s) / study subset |
| Bouzeghoub (2005) | HIGH Diversity of HIV Type 1 in Algeria | AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) | 1e-149 | 252 135PR 117RT |
252 135PR 117RT |
100 | HIVDB |
| Bouzeghoub (2008) | FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria | AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) | 2e-173 | 117 62PR 55RT |
117 62PR 55RT |
100 | HIVDB |
| Boyce (2022) | Minority frequency pre-antiretroviral drug resistant variants in pregnant women and associations with virologic failure at term | Unpublished | 0 | 63 62PR 63RT 62IN |
63 62PR 63RT |
100 | HIVDB |
| Boyce (2021) | Maternal HIV drug resistance is associated with vertical transmission and is prevalent in infected infants | Clin Infect Dis (2021) In press | 3.25e-176 | |
465 465PR 465RT |
0 | Pending |
| Boyce (2024) | Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine) | Open Forum Infect Dis 11 (7), ofae383 (2024) | 5.29e-175 | |
1399 1367PR 1399RT |
0 | Pending |
| Bozzi (2019) | No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication | Sci Adv 5 (9), eaav2045 (2019) | 0 | |
986 986PR 986RT |
0 | Quasispecies |
| Bracho (2016) | Emerging trends in CRF02_AG variants transmission among men who have sex with men in Spain | J. Acquir. Immune Defic. Syndr. 65 (3), E130-E133 | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Brachtel (2002) | DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils | AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) | 1e-62 | |
43 43PR |
0 | Case report(s) / study subset |
| Bradley-Stewart (2017) | HIV-1 integrase inhibitor resistance among treatment naive patients in the West of Scotland | 28494325 | 0 | 91 91IN |
91 91IN |
100 | HIVDB |
| Brado (2018) | Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa | Sci Rep 8 (1), 4709 (2018) | 0 | 91 91IN |
91 91IN |
100 | HIVDB |
| Bradshaw (2007) | NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase | Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) | 0 | 13 4PR 13RT |
13 4PR 13RT |
100 | HIVDB |
| Brandin (2003) | POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy | AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) | 3e-97 | 30 30PR 30RT |
30 30PR 30RT |
100 | HIVDB |
| Brandt (2021) | Tracking HIV-1 Infected Cell Clones Using Integration Site-Specific qPCR | Unpublished | 0 | |
2 2PR 2RT 1IN |
0 | Case report(s) / study subset |
| Brann (2006) | FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness | J. Virol. 80 (12), 6136-6145 (2006) | 2.55e-51 | |
2 2PR |
0 | Case report(s) / study subset |
| Braun (2018) | Pretreatment and acquired HIV drug resistance among Ugandan adults attending an urban out-patient clinic | 29771783 | 0 | 163 163PR 163RT |
163 163PR 163RT |
100 | HIVDB |
| Braun (2024) | Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation | Viruses 12 (11), 1330 (2020) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Brehm (2011) | Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase | J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 | 0 | 105 105RT |
106 106RT |
99 | HIVDB |
| Brehm (2012) | Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors | Clin. Infect. Dis. (2012) In press | 0 | 138 138RT |
138 138RT |
100 | HIVDB |
| Brener (2015) | Disease progression despite protective HLA expression in an HIV-infected transmission pair | Retrovirology 12, 55 (2015) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Brennan (2009) | Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. | Transfusion | 0 | 65 62PR 62RT 3IN |
65 62PR 62RT 3IN |
100 | HIVDB |
| Brennan (1997) | GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma | AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) | 6.26e-115 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Brennan (2007) | HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants | AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) | 1e-167 | 82 82IN |
85 85IN |
96 | HIVDB |
| Brennan (2009) | The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 | J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 | 1e-166 | 572 572IN |
573 3RT 573IN |
99 | HIVDB |
| Brennan (2011) | Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007 | Transfusion 50 (12), 2707-2712 (2010) | 0 | 203 203PR 203RT |
203 203PR 203RT |
100 | HIVDB |
| Brenner (2006) | HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture | AIDS 20 (9), F9-F13 (2006) | 0 | 1 1PR 1RT |
5 5PR 5RT |
20 | HIVDB |
| Brenner (2006) | HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection | J. Infect. Dis. 195 (7), 951-959 (2007) | 0 | |
38 38PR 38RT |
0 | Case report(s) / study subset |
| Brenner (2010) | Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors | J. Med. Virol. 83 (5), 751-759 (2011) | 0 | 157 157IN |
157 8PR 8RT 157IN |
100 | HIVDB |
| Brenner (2010) | Transmission networks of drug resistance acquired in primary/early stage HIV infection | AIDS 22 (18), 2509-2515 (2008) | 1.18e-146 | |
4 4PR 4RT |
0 | ARV Rx and/or other data are N/A |
| Brenner (2011) | Spread of HIV-1 Drug-Resistant Sub-epidemics | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Brenner (2011) | Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec | J. Infect. Dis. 204 (7), 1115-1119 (2011) | 0 | |
215 215PR 215RT |
0 | Case report(s) / study subset |
| Brenner (2016) | HIV-1strains associated with large cluster networks show accelerated escape from integrase inhibitors | 30119633 | 0 | 3 3IN |
8 8IN |
37 | HIVDB |
| Brenner (2016) | Case Study of Dolutegravir Escape in First-Line Therapy through Acquisition of G118R in HIV-1 Integrase | 27029845 | 0 | 1 1IN |
1 1IN |
100 | HIVDB |
| Brenner (2017) | Human immunodeficiency virus type 1 strains associated with large cluster transmissions show rapid escape from integrase inhibitors in cell culture | 28472323 | 0 | 4 4IN |
9 9IN |
44 | HIVDB |
| Brenner (2021) | Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir | J Antimicrob Chemother (2021) In press | 0 | 3 3PR 3RT |
4 4PR 4RT |
75 | HIVDB |
| Brenner (2023) | Doravirine activity against HIV-1 viruses bearing nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs) resistance mutations | 37303226 | 0 | 5 5RT |
5 5RT |
100 | HIVDB |
| Brigido (2005) | SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil | AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) | 0 | |
251 125PR 126RT |
0 | ARV Rx and/or other data are N/A |
| Brigido (2008) | HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil | AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) | 0 | 321 185PR 195RT |
322 186PR 196RT |
99 | HIVDB |
| Brigido (2010) | Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil | AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) | 0 | 232 221PR 221RT |
1460 1233PR 1235RT 15IN |
15 | HIVDB |
| Brindeiro (1999) | SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals | Antimicrob. Agents Chemother. (1999) In press | 2e-91 | 18 18RT |
18 18RT |
100 | HIVDB |
| Brindeiro (2003) | BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals | AIDS 17 (7), 1063-1069 (2003) | 1e-145 | 350 199PR 191RT |
357 199PR 199RT |
98 | HIVDB |
| Briones (2000) | DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy | Virus Res. 66 (1), 13-26 (2000) | 1e-128 | |
186 180PR 186RT |
0 | Quasispecies |
| Briones (2003) | MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus | J. Mol. Biol. 331 (1), 213-229 (2003) | 1e-126 | |
15 15PR 15RT |
0 | Quasispecies |
| Brockman (2012) | Uncommon Pathways of Immune Escape Attenuate HIV-1 integrase Replication Capacity | J. Virol. 86 (12), 6913-6923 (2012) | 1e-167 | 88 88IN |
88 88IN |
100 | HIVDB |
| Brooks (2013) | Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions | BMC Infect. Dis. 13 (1), 509 (2013) | 2.37e-163 | 274 274PR 274RT |
274 274PR 274RT |
100 | HIVDB |
| Brooks (2016) | Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya | J Int AIDS Soc 19 (1), 20798 (2016) | 1.67e-168 | 35 35RT |
35 35RT |
100 | HIVDB |
| Brooks (2020) | HIV-1 variants are archived throughout infection and persist in the reservoir | PLoS Pathog. 16 (6), e1008378 (2020) | 0 | |
186 186PR 186RT 186IN |
0 | Proviral DNA Reservoir |
| Brown (2009) | Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions | J. Infect. Dis. 199 (3), 427-431 (2009) | 0 | 165 165PR 165RT |
165 165PR 165RT |
100 | HIVDB |
| Brown (1999) | SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy | J. Infect. Dis. 180 (4), 1043-1049 (1999) | 1e-130 | |
55 55PR 55RT |
0 | Sequence Quality |
| Brown (2005) | BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines | J. Virol. 79 (10), 6089-6101 (2005) | 0 | 21 21PR 21RT 21IN |
21 21PR 21RT 21IN |
100 | HIVDB |
| Bruel T (2022) | Elimination of HIV-1-infected cells by broadly neutralizing antibodies | Nat Commun 7, 10844 (2016) | 1.56e-168 | |
1 1PR 1RT |
0 | Proviral DNA Reservoir |
| Brumme (2007) | EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 | PLoS Pathog. 3 (7), E94 (2007) | 0 | 1054 824PR 824RT |
1055 825PR 824RT |
99 | HIVDB |
| Brumme (2009) | HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins | PLoS ONE 4 (8), E6687 (2009) | 0 | 1661 683PR 1059RT 976IN |
1667 689PR 1078RT 1129IN |
99 | HIVDB |
| Brumme (2019) | Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth | 30325763 | 3.67e-168 | |
204 204PR 204RT |
0 | Pending |
| Bruner (2016) | Defective proviruses rapidly accumulate during acute HIV-1 infection | Nat. Med. (2016) In press | 0 | |
207 107PR 181RT 160IN |
0 | Quasispecies |
| Bruselles (2009) | Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection | AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Bruzzone (2015) | Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project) | AIDS Res. Hum. Retroviruses 31 (8), 837-840 (2015) | 3.15e-147 | 37 37PR 37RT |
37 37PR 37RT |
100 | HIVDB |
| Bruzzone (2016) | Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin | J. Clin. Virol. 47 (4), 372-375 (2010) | 3.85e-134 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Buckheit (2012) | Long-term control of viral replication in a Group O, human immunodeficiency virus type 1-infected individual. | AIDS Res Hum Retroviruses. 2014 Jun;30(6):511-3. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Buckheit (2012) | Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs | Nat Commun (2012) In press | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Buckheit (2013) | Evolution of an attenuated HIV-1 isolate in an elite suppressor. | AIDS Res Hum Retroviruses. 2014 Mar;30(3):284-8. | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Buckton (2008) | DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance | J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) | 0 | |
24 17PR 24RT |
0 | Case report(s) / study subset |
| Budambula (2015) | HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users | AIDS Res Ther 12, 27 (2015) | 3e-63 | 132 132PR |
132 132PR |
100 | HIVDB |
| Budayanti (2018) | Molecular antiretroviral resistance markers of Human Immunodeficiency Virus-1 of CRF01_AE subtype in Bali, Indonesia | 30714528 | 0 | 42 42PR 42RT |
42 42PR 42RT |
100 | HIVDB |
| Bui (2016) | Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir | 28328934 | 0 | |
3525 3092PR 3521RT 831IN |
0 | Proviral DNA Reservoir |
| Bui (2017) | Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells | 28225830 | 0 | |
1576 1576PR 1576RT |
0 | Proviral DNA Reservoir |
| Bulgheroni (2001) | UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility | J. Clin. Virol. 29 (1), 27-32 (2004) | 4e-77 | |
3 3RT |
0 | Case report(s) / study subset |
| Bull (2018) | Low-level plasma viremias are not associated with systemic inflammation but disproportionate expression of HIV virions predicted to use CXCR-4 co-receptor | Unpublished | 6.08e-149 | |
1268 1268RT |
0 | SGS |
| Bull (2021) | Direct Submission | Submitted (17-DEC-2019) Center for Global Infectio | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Bull (2022) | HIV reservoirs with intact proviruses linked to low-level-viremias (LLV) persist during antiretroviral therapy (ART) via cellular proliferation and suppression of immune responses | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Buonaguro (2006) | SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy | J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Buranapraditkun (2011) | Viral Escape from a Novel Immunodominant HLA-Cw*0102-Restricted Gag Epitope in HIV-1 Clade A/E Infection | Unpublished | 0.006 | |
2 2PR |
0 | Gene fragment(s) |
| Burda (2005) | HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common | AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) | 2.19e-57 | |
20 20PR |
0 | Sequence quality |
| Burda (2009) | HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon | J. Med. Virol. 82 (2), 187-196 (2010) | 0 | 49 49RT |
49 49RT |
100 | HIVDB |
| Bure (2011) | Genetic analysis of pol gene of HIV-1 in Indian children | 25674767 | 2e-60 | |
13 13PR 13RT |
0 | Case report(s) / study subset |
| Burkala (2005) | COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus | AIDS 19 (7), 675-684 (2005) | 1e-152 | |
140 140PR 140RT |
0 | Quasispecies |
| Burns (2005) | SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes | AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) | 1e-159 | 21 21IN |
21 21IN |
100 | HIVDB |
| Bussmann (2005) | HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. | Antivir Chem Chemother | 0 | 71 71PR 71RT |
71 71PR 71RT |
100 | HIVDB |
| Butoyi (2019) | Direct Submission | Submitted (28-FEB-2019) Institute of Tropical Medi | 2.05e-154 | |
15 15RT |
0 | Case report(s) / study subset |
| Buzon (2008) | Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. | Antivir Ther | 1e-167 | 123 123IN |
135 135IN |
91 | HIVDB |
| Buzon (2011) | Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes | J. Acquir. Immune Defic. Syndr. (2011) In press | 6.36e-146 | |
72 36PR 36RT |
0 | Quasispecies |
| Bwire (2025) | High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam | Unpublished | 0 | |
31 22PR 19RT 30IN |
0 | HIVDB |
| Bychenko (2009) | Isolation, characterization, and sequence analysis of a novel HIV type 1 subtype A1 strain from Russia. | AIDS Res Hum Retroviruses. 2012 Sep;28(9):1139-46. | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Byrn (2006) | HIV-1 in semen: an isolated virus reservoir | Lancet 350 (9085), 1141 (1997) | 5e-58 | |
37 37PR |
0 | Case report(s) / study subset |
| Cabana (1999) | EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors | J. Med. Virol. 59 (4), 480-490 (1999) | 1e-125 | 92 54PR 38RT |
92 54PR 38RT |
100 | HIVDB |
| Caetano (2019) | A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up | BMC Infect. Dis. 19 (1), 588 (2019) | 0 | |
28 1PR 1RT 28IN |
0 | Case report(s) / study subset |
| Caetano (2013) | Epidemiological and molecular profile of HIV infection among female sex workers in central Brazil | 23066700 | 5.1e-169 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Calazans (2003) | LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism | J. Infect. Dis. 191 (11), 1961-1970 (2005) | 1e-126 | 51 51PR 51RT |
52 52PR 51RT |
98 | HIVDB |
| Caldeira (2024) | Direct Submission | Submitted (02-SEP-2024) Retrovirology, Federal Uni | 0 | |
803 250PR 248RT 305IN |
0 | Unpublished |
| Cale (2020) | Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound | J. Clin. Invest. (2020) In press | 0 | |
360 360PR 360RT 114IN |
0 | Quasispecies |
| Cali (2004) | EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort | AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) | 0 | |
15 15PR 15RT 15IN |
0 | Case report(s) / study subset |
| Calugi (2006) | ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env | J. Virol. 80 (23), 11892-11896 (2006) | 0 | |
1 1PR 1RT 1IN |
0 | Sequence quality |
| Calvez (2002) | IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial | Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) | 2e-94 | |
26 26RT |
0 | ARV Rx and/or other data are N/A |
| Canada (2020) | Identification of an HIV-1 BC Intersubtype Recombinant Form, which is circulating in Spain | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Canada (2021) | Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain | Viruses 13 (1), 93 (2021) | 0 | |
19 19PR 19RT 3IN |
0 | Case report(s) / study subset |
| Canada (2022) | Viruses previously identified in Brazil as belonging to circulating recombinant form (CRF) 72_BF represent two closely related CRFs, one of which is also circulating in Spain | Front Microbiol (2022) In press | 0 | |
11 11PR 11RT 3IN |
0 | Quasispecies |
| Candotti (1999) | AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection | J. Med. Virol. 62 (1), 1-8 (2000) | 1e-165 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Candotti (2019) | High rate of HCV and HIV false-positive results in serological screening can impair blood supply in Sub-Saharan Africa | Unpublished | 1e-61 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Canducci (2008) | Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. | AIDS | 1e-154 | 37 37IN |
37 37IN |
100 | HIVDB |
| Canducci (2011) | Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir | J. Infect. Dis. 204 (11), 1811-1815 (2011) | 1e-167 | 38 38IN |
38 38IN |
100 | HIVDB |
| Cao (2024) | Direct Submission | Submitted (22-NOV-2024) Department of Infectious D | 0 | |
18 18PR 18RT 18IN |
0 | Unpublished |
| Cao (2024) | HIV-1 DNA genotypic drug resistance test guides antiretroviral therapy in patients with low-level viremia | Unpublished | 0 | |
11 6PR 6RT 5IN |
0 | Unpublished |
| Cao (2023) | Using molecular network analysis to understand current HIV-1 transmission characteristics in an inland area of Yunnan, China | Epidemiol Infect, 1-31 (2023) In press | 0 | |
516 516PR 516RT |
0 | Transmission cluster |
| Capel (2012) | Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness | J. Gen. Virol. 93 (PT 12), 2625-2634 (2012) | 1e-59 | 150 150PR |
150 150PR |
100 | HIVDB |
| Capel (2013) | Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates | Virology 444 (1-2), 274-281 (2013) | 0 | 94 94IN |
94 94IN |
100 | HIVDB |
| Caplinskas (2012) | Distinct HIV-1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 27 27PR 27RT |
27 27PR 27RT |
100 | HIVDB |
| Capoferri (2020) | Recombination analysis of near full-length HIV-1 sequences and the identification of a potential new Circulating Recombinant Form from Rakai, Uganda | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 274 274PR 274RT 274IN |
274 274PR 274RT 274IN |
100 | HIVDB |
| Capoferri (2021) | Direct Submission | Submitted (25-FEB-2021) Research, BioInfoExperts, | 1.85e-46 | |
19 19RT |
0 | Unpublished |
| Capoferri (2021) | Persistence of HIV after allogeneic bone marrow transplant in a dually-infected individual | Unpublished | 1.51e-45 | |
4 4RT |
0 | Case report(s) / study subset |
| Capoferri (2024) | The Fraction of Infected Cells with HIV Unspliced RNA is not Associated with Levels of Plasma Viremia | 39190360 | 0 | |
2051 2047PR 2051RT |
0 | Quasispecies |
| Capoferri (2024) | The Fraction of Infected Cells with HIV Unspliced RNA is not Associated with Levels of Plasma Viremia | Unpublished | 1.07e-124 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Capoferri (2025) | In vivo detection of HIV-1 antisense transcripts in untreated and ART-treated individuals | Unpublished | 0 | |
14 11PR 11RT 3IN |
0 | Proviral DNA Reservoir |
| Cappy (2019) | Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing | Transfusion (2019) In press | 1.77e-180 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Caragounis (2008) | Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem | Acta Neurol. Scand. 117 (2), 108-116 (2008) | 2.08e-148 | |
56 28PR 28RT |
0 | Quasispecies |
| Cardoso (2009) | HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil | J. Clin. Virol. 46 (2), 134-139 (2009) | 5.54e-178 | 97 97PR 97RT |
97 97PR 97RT |
100 | HIVDB |
| Cardoso (2009) | High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil | AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 | 1.18e-172 | 48 48PR 48RT |
48 48PR 48RT |
100 | HIVDB |
| Cardoso (2010) | HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil | J. Med. Virol. 82 (3), 351-357 (2010) | 1.13e-175 | |
77 77PR 77RT |
0 | ARV Rx and/or other data are N/A |
| Cardoso (2011) | Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil | AIDS Res. Hum. Retroviruses (2011) In press | 2.97e-175 | 27 27PR 27RT |
27 27PR 27RT |
100 | HIVDB |
| Caride (2000) | DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART | Virology 275 (1), 107-115 (2000) | 5e-89 | |
14 14RT |
0 | ARV Rx and/or other data are N/A |
| Caride (2001) | GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART | Virus Genes 23 (2), 193-202 (2001) | 1e-123 | 14 14PR |
28 28PR |
50 | HIVDB |
| Carlson (2014) | HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck | Science 345 (6193), 1254031 (2014) | 0 | |
868 868PR 868RT 868IN |
0 | Quasispecies |
| Carlson (2016) | Transmitted and de novo cellular immune escape drive HIV-1 disease progression | 27183217 | 0 | |
64 64PR 64RT |
0 | Quasispecies |
| Carneiro-Proietti (1997) | DIRECT Submission | Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni | 1e-128 | |
1 1PR |
0 | Case report(s) / study subset |
| Caron (2008) | HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa | AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) | 1.04e-134 | 40 21PR 19RT |
40 21PR 19RT |
100 | HIVDB |
| Caron (2011) | Increasing HIV-1 Polymorphism Diversity and Resistance to Antiretroviral Drugs in Untreated Pregnant Women from Gabon, central Africa | 22433277 | 0 | 107 105PR 97RT |
107 105PR 107RT |
100 | HIVDB |
| Carr (1996) | Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand | J. Virol. 70 (9), 5935-5943 (1996) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Carr (1998) | FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants | Virology 247 (1), 22-31 (1998) | 1e-164 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Carr (1999) | CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing | AIDS 13 (14), 1819-1826 (1999) | 1e-166 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Carr (1999) | DIRECT Submission | Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac | 1e-164 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Carr (2001) | THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon | Virology (2001) In press | 0 | 7 7PR 7RT 7IN |
8 8PR 8RT 8IN |
87 | HIVDB |
| Carr (2001) | DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America | AIDS 15 (15), F41-F47 (2001) | 1e-165 | 21 21PR 21RT 21IN |
21 21PR 21RT 21IN |
100 | HIVDB |
| Carr (2004) | OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan | J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) | 0 | 239 238PR 237RT 12IN |
246 246PR 246RT 12IN |
97 | HIVDB |
| Carr (2005) | HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria | Unpublished | 0 | 23 23PR 23RT 7IN |
23 23PR 23RT 7IN |
100 | HIVDB |
| Carr (2006) | HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon | Unpublished | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Carr (2010) | HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon | Retrovirology. 2010 Apr 28;7:39. | 0 | 24 24PR 23RT 24IN |
24 24PR 24RT 24IN |
100 | HIVDB |
| Carr (2016) | Isolation of a Simian Immunodeficiency Virus from the Malbrouck (Chlorocebus cynosuros) | 27804019 | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Carrera (2010) | Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo | AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) | 2.11e-31 | |
2 1RT 1IN |
0 | Gene fragment(s) |
| Carrion (2002) | CIRCULATING Recombinant Form CRF02_AG in South America | AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) | 1e-163 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Carrion (2004) | DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay | AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) | 0 | 2 2PR 2RT 2IN |
7 7PR 7RT 2IN |
28 | HIVDB |
| Carrion (2009) | Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru | AIDS Res. Hum. Retroviruses (2009) In press | 1e-173 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Carvalho (2010) | Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. | ARHR | 1.51e-178 | 52 52PR 52RT |
60 60PR 60RT |
86 | HIVDB |
| Carvalho (2015) | Analysis of a Local HIV-1 Epidemic in Portugal Highlights Established Transmission of Non-B and Non-G Subtypes | J. Clin. Microbiol. 53 (5), 1506-1514 (2015) | 3.89e-149 | 289 289PR 286RT |
289 289PR 289RT |
100 | HIVDB |
| Casado (2019) | Direct Submission | Submitted (09-JUN-2019) Servicio Virologia Molecul | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Casado (2003) | NEAR Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain | AIDS Res. Hum. Retroviruses 19 (8), 719-725 (2003) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Casado (2007) | IDENTIFICATION of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba | J. Acquir. Immune Defic. Syndr. 40 (5), 532-537 (2005) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Castelbranco (2010) | Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola | AIDS Res. Hum. Retroviruses 26 (12), 1313-1316 (20 | 2.61e-145 | 35 35PR 35RT |
35 35PR 35RT |
100 | HIVDB |
| Castillo (2009) | Surveillance of HIV Type 1 Drug Resistance among Naive Patients from Venezuela | AIDS Res. Hum. Retroviruses (2009) In press | 4e-173 | 133 68PR 65RT |
133 68PR 65RT |
100 | HIVDB |
| Castley (2017) | A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012 | PLoS ONE 12 (5), E0170601 (2017) | 2.09e-130 | 4871 4871PR 4870RT |
4871 4871PR 4871RT |
100 | HIVDB |
| Castro (2002) | MOLECULAR epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection | J. Acquir. Immune Defic. Syndr. 32 (3), 338-344 (2003) | 7e-77 | |
2 1PR 1RT |
0 | Case report(s) / study subset |
| Castro (2004) | BODY Compartments Follow-up & HIV-1 Mosaic Genome Definition. E7109254 | (in) EXTENDED ABSTRACT BOOK, XV INTERNATIONAL AIDS CONFERENC | 1e-135 | |
4 4RT |
0 | Case report(s) / study subset |
| Castro (2004) | RESISTANCE mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure | Unpublished | 1e-136 | |
41 20PR 29RT |
0 | ARV Rx and/or other data are N/A |
| Castro (2004) | Resistence mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure | Unpublished | 2.11e-46 | |
1 1PR |
0 | Case report(s) / study subset |
| Castro (2005) | Trends of HIV-1 molecular epidemiology in Venezuela: introduction of subtype C and identification of a novel B/C mosaic genome | J. Clin. Virol. 32 (3), 257-258 (2005) | 1.37e-148 | |
3 3RT |
0 | Gene fragment(s) |
| Castro (2006) | Highly conserved HIV-1 subtype B strains circulating in Honduras | (in) 3RD IAS CONFERENCE ON HIV PATHOGENESIS AND TR | 3.72e-140 | |
6 3PR 3RT |
0 | Case report(s) / study subset |
| Castro (2009) | HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland | AIDS Res. Hum. Retroviruses 26 (11), 1233-1238 (20 | 0 | 30 30PR 30RT |
30 30PR 30RT |
100 | HIVDB |
| Caumont (2001) | Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh city, Vietnam. | ARHR | 9e-98 | 26 24PR 2RT |
27 25PR 2RT |
96 | HIVDB |
| Cavaco-Silva (2014) | HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen | PLoS ONE 9 (3), E92747 (2014) | 2e-128 | 79 79IN |
83 83IN |
95 | HIVDB |
| Ceccherini-Silberstein (2005) | IDENTIFICATION of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure | AIDS 18 (12), F11-F19 (2004) | 0 | 479 478PR 479RT |
479 479PR 479RT |
100 | HIVDB |
| Ceccherini-Silberstein (2006) | HIGH sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations | J. Virol. 79 (16), 10718-10729 (2005) | 0 | 178 178PR 178RT |
178 178PR 178RT |
100 | HIVDB |
| Ceccherini-Silberstein (2007) | IMPACT of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients | J. Infect. Dis. 196 (8), 1180-1190 (2007) | 0 | 674 673PR 674RT |
674 673PR 674RT |
100 | HIVDB |
| Ceccherini-Silberstein (2007) | CHARACTERIZATION and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors | J. Virol. 81 (20), 11507-11519 (2007) | 0 | |
75 75PR 75RT |
0 | ARV Rx and/or other data are N/A |
| Ceccherini-Silberstein (2010) | Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors | Antimicrob. Agents Chemother. 54 (9), 3938-3948 (2 | 0 | |
458 433RT 457IN |
0 | Quasispecies |
| Cenci (1997) | SELECTED nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL | AIDS Res. Hum. Retroviruses 13 (7), 629-632 (1997) | 5e-49 | |
1 1RT |
0 | Case report(s) / study subset |
| Cenci (2003) | LOW Intra-Host Diversity in HIV-1 Protease Gene in Untreated Primary Infection: a Crucial Role for Purifying Selection | 10763884 | 1e-126 | |
67 67PR |
0 | Quasispecies |
| Cenci (2004) | HIV-1 pol genotype divergence in the plasma and cerebrospinal fluid (CSF) of untreated patients in acute and chronic infection | Unpublished | 7.57e-129 | |
62 44PR 18RT |
0 | Case report(s) / study subset |
| Cevallos (2017) | An updated genomic characterization and molecular evolution analysis of BF recombinant HIV-1 strains among Argentinean men-who-have-sex with men reveals a complex scenario | 29244833 | 0 | |
230 230PR 230RT 15IN |
0 | ARV Rx and/or other data are N/A |
| Cevallos (2017) | Direct Submission | Submitted (11-AUG-2017) Facultad de Medicina - Uni | 0 | |
38 38PR 38RT |
0 | Case report (Small sample size) |
| Chabadova (2014) | Direct Submission | Submitted (21-FEB-2014) NRC for HIV AIDS Preventio | 7.76e-111 | |
144 16PR 143RT |
0 | Gene fragment(s) |
| Chaillon (2017) | Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies | Retrovirology 14 (1), 15 (2017) | 0 | 342 342RT |
342 342RT |
100 | HIVDB |
| Chaix (2003) | Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. | AIDS | 1e-116 | 244 244RT |
244 244RT |
100 | HIVDB |
| Chakrabarti (1999) | SEQUENCE of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses | Nature 328 (6130), 543-547 (1987) | 1e-98 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Chakrabarti (2011) | HIV-1 recombinants among Maipur IDUs | 22710995 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Chakraborty (2003) | FAILURE to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus | AIDS Res. Hum. Retroviruses 20 (9), 1026-1031 (2004) | 0 | |
162 81PR 81RT |
0 | Quasispecies |
| Chakraborty (2003) | CAN HIV-1 superinfection compromise antiretroviral therapy? | AIDS 18 (1), 132-134 (2004) | 2e-87 | |
8 8RT |
0 | Case report(s) / study subset |
| Chaloin (2004) | ANTIVIRAL activity of reverse trancriptase inhibitors with different HIV strains and isolates | Unpublished | 0 | |
14 14RT 8IN |
0 | ARV Rx and/or other data are N/A |
| Chamberland (2011) | Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. | Sex Transm Infect | 0 | 127 127PR 127RT |
127 127PR 127RT |
100 | HIVDB |
| Chamberland (2016) | Characterization of drug resistance in a cohort of subjects on antiretroviral therapy infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso | 18389909 | 2.22e-158 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Chandrakanta (2022) | Direct Submission | Submitted (24-AUG-2022) Medical Microbiology, PGIM | 1.93e-100 | |
30 30RT |
0 | Unpublished |
| Chang (2008) | Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. | J Antimicrob Chemother | 6.74e-167 | 3 3PR 3RT |
3 3PR 3RT |
100 | HIVDB |
| Chang (2019) | Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia | J Int AIDS Soc 21 (11), e25204 (2018) | 0 | 178 127PR 127RT 178IN |
178 127PR 127RT 178IN |
100 | HIVDB |
| Chang (2015) | Direct Submission | Submitted (27-MAY-2015) Academy of Military Medica | 0 | |
2 2RT |
0 | Case report(s) / study subset |
| Chang (2016) | Direct Submission | Submitted (06-NOV-2015) AIDS Research, Institute o | 0 | 478 434PR 478RT 59IN |
478 442PR 478RT 61IN |
100 | HIVDB |
| Chang (2016) | Direct Submission | Submitted (27-MAR-2015) AIDS Research, Beijing Ins | 0 | |
17 17RT |
0 | Case report(s) / study subset |
| Chang (2006) | MOLECULAR Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07)BC Infection in Intravenous Drug Users | AIDS Res. Hum. Retroviruses 22 (11), 1055-1066 (2006) | 1.63e-166 | 152 152PR 152RT |
152 152PR 152RT |
100 | HIVDB |
| Chang (2014) | Slow immunological progression in injecting drug users infected with human immunodeficiency virus type 1 CRF07_BC in Taiwan | 26038447 | 0 | 122 122PR 122RT 1IN |
127 127PR 127RT 1IN |
96 | HIVDB |
| Chang (2016) | Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07_BC Infection in Intravenous Drug Users | 18227088 | 2.22e-165 | 3 3PR 3RT |
3 3PR 3RT |
100 | HIVDB |
| Chang (2000) | DIFFERENTIAL stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses | AIDS Res. Hum. Retroviruses 15 (17), 1591-1596 (1999) | 1e-163 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Chang (2000) | SEQUENCE features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A | AIDS Res. Hum. Retroviruses 15 (18), 1703-1706 (1999) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Chang (2023) | Identification of a newly emerging HIV-1 Second-Generation Recombinants (CRF01_AE/CRF07_BC) among Men Who Have Sex with Men in Yunnan, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Chang (2025) | Identification of two novel HIV-1 circulating recombinant forms, CRF190_BC and CRF191_BC, in southeastern Yunnan Province | Unpublished | 0 | |
648 648PR 648RT 12IN |
0 | Pending |
| Chantratita (1999) | HIV-1 resistant to antiretroviral drugs in Thailand | 12118466 | 1e-128 | 26 26PR 26RT |
722 342PR 469RT |
3 | HIVDB |
| Chantratita (2005) | Prevalence of mutations related to HIV-1 antiretroviral drug resistance in Thailand, 2003 | Unpublished | 2.48e-143 | 784 331PR 453RT |
784 331PR 453RT |
100 | HIVDB |
| Chantratita (2016) | Prevalence of primary HIV drug resistance with short reverse transcriptase genotypic resistance assay for the detection of primary HIV drug resistance in Thailand | 26828876 | 3.83e-64 | |
307 307RT |
0 | Gene fragment(s) |
| Chaplin (2011) | Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy | AIDS Res. Hum. Retroviruses 27 (1), 71-80 (2011) | 1e-168 | 2 2PR 2RT |
2 2PR 2RT |
100 | HIVDB |
| Chaplin (2017) | Distinct pattern of TAMs with K65R in patients failing tenofovir-based antiretroviral therapy | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 382 382PR 382RT |
382 382PR 382RT |
100 | HIVDB |
| Charpentier (2009) | Prevalence of HIV-1 drug resistance in HIV-1 infected patients treated in Douala, Cameroon | 20977359 | 0 | 56 54PR 56RT |
56 54PR 56RT |
100 | HIVDB |
| Charpentier (2011) | High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. | Antivir Ther | 7e-173 | 47 47RT |
47 47RT |
100 | HIVDB |
| Charpentier (2011) | Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir. | Antimicrob Agents Chemother. 2011 Mar;55(3):1293-5. | 1e-100 | 11 11IN |
12 12IN |
91 | HIVDB |
| Charpentier (2011) | Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen | 20802293 | 1e-166 | 33 12PR 12RT 9IN |
33 12PR 12RT 9IN |
100 | HIVDB |
| Charpentier (2014) | Genotypic resistance profiles of HIV-2-treated patients in Cote d'Ivoire, West Africa | 24583671 | 1.36e-146 | 55 29PR 25RT 1IN |
55 29PR 25RT 1IN |
100 | HIVDB |
| Charpentier (2016) | High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger | 21555827 | 2.86e-169 | 140 140RT |
140 140RT |
100 | HIVDB |
| Chaturbhuj (2010) | Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. | ARHR | 0 | 34 34PR 34RT |
34 34PR 34RT |
100 | HIVDB |
| Chaturbhuj (2017) | Phylogenetic Evidence of Non-vertical HIV Transmission in Children from Maharashtra, India | Unpublished | 4.75e-173 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Chaves (2021) | High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil | Biomed Res Int 2021, 5567332 (2021) | 0 | |
92 91PR 92RT |
0 | Pending |
| Chehadeh W (2016) | Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait. | Med Princ Pract. | 0 | 62 62PR 62RT |
62 62PR 62RT |
100 | HIVDB |
| Chehadeh (2013) | Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naive people in Kuwait | J. Med. Virol. 87 (9), 1521-1526 (2015) | 2.31e-151 | 60 30PR 30RT |
60 30PR 30RT |
100 | HIVDB |
| Chehadeh (2017) | Mutations and polymorphisms in the HIV-1 integrase region from patients never exposed to integrase inhibitors | 29212076 | 0 | 53 53IN |
53 53IN |
100 | HIVDB |
| Chehadeh (2022) | Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting | Antivir Chem Chemother 28 (2020) | 0 | 7 7IN |
7 7IN |
100 | HIVDB |
| Chen (2015) | HIV drug resistance and antiretroviral drug detection in HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061 | 25861015 | 0 | |
192 192PR 192RT |
0 | ARV Rx and/or other data are N/A |
| Chen (2017) | Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 165 165IN |
165 165IN |
100 | HIVDB |
| Chen (2018) | Molecular Characterization of HIV-1 minority subtypes in Hong Kong: A recent epidemic of CRF07_BC among the men who have sex with men (MSM) population | 31142258 | 0 | 284 284PR 284RT |
284 284PR 284RT |
100 | HIVDB |
| Chen (2010) | Near full-length genomic characterization of a novel HIV-1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China | AIDS Res. Hum. Retroviruses (2010) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Chen (2024) | Identification of two evolutionarily related HIV-1 circulating recombinant forms (CRF149_01B and CRF150_cpx) among men who have sex with men in China | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Chen (2024) | Preplanned Studies: Characterization of a New HIV-1 Circulating Recombinant Form CRF142_BC - Yunnan, China, 2015 and 2021 | China CDC Wkly 6 (42), 1080-1085 (2024) | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Chen (2025) | Identification of a Novel Second-Generation HIV-1 Circulating Recombinant Form (CRF174_0708) Arising from CRF07_BC and CRF08_BC in Yunnan, China | AIDS Res Hum Retroviruses (2025) In press | 0 | |
7 7PR 7RT 7IN |
0 | Case report (Small sample size) |
| Chen (2019) | The Changing HIV-1 Genetic Characteristics and Transmitted Drug Resistance among Newly Infected Individuals in Yunnan, China | 29534773 | 0 | 271 271PR 271RT |
271 271PR 271RT |
100 | HIVDB |
| Chen (2012) | Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China | BMC Infect. Dis. 12, 382 (2012) | 0 | 299 299PR 299RT |
299 299PR 299RT |
100 | HIVDB |
| Chen (2015) | The Combination of Phylogenetic Analysis with Epidemiological and Serological Data to Track HIV-1 Transmission in a Sexual Transmission Case | PLoS ONE 10 (3), E0119989 (2015) | 0 | |
21 21PR 21RT |
0 | Case report(s) / study subset |
| Chen (2018) | HIV-1 genetic characteristics and transmitted drug resistance among men who have sex with men in Kunming, China | PLoS ONE 9 (1), e87033 (2014) | 0 | 129 129PR 129RT |
129 129PR 129RT |
100 | HIVDB |
| Chen (2019) | HIV-1 genetic transmission networks among men who have sex with men in Kunming, China | 29698467 | 0 | 179 179PR 179RT |
179 179PR 179RT |
100 | HIVDB |
| Chen (2021) | Spatial clusters of HIV-1 genetics in recently infected population in Yunnan, China | 31357947 | 0 | 411 411PR 411RT |
411 411PR 411RT |
100 | HIVDB |
| Chen (2023) | Identification of a new HIV-1 second-generation circulating recombinant form (CRF134_0185) in Yunnan, China | J Infect (2023) In press | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Chen (2024) | Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China | J Infect, 106126 (2024) In press | 0 | |
10 10PR 10RT 10IN |
0 | Case report(s) / study subset |
| Chen (2024) | Identification of a complex second-generation HIV-1 circulating recombinant form (CRF158_0107) among men who have sex with men in China | J Infect 89 (3), 106230 (2024) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Chen (2025) | Identification of a long-standing HIV-1 circulating recombinant form (CRF178_BC) in different high-risk populations along the China-Myanmar border region | J Infect 90 (4), 106477 (2025) | 0 | |
4 4PR 4RT 4IN |
0 | Case report (Small sample size) |
| Chen (2025) | Characterization of the first unambiguous HIV-1 CRF07_BC/CRF08_BC circulating recombinant form (CRF160_0708) in Yunnan, China | J Infect 90 (2), 106383 (2025) | 0 | |
6 6PR 6RT 6IN |
0 | Case report (Small sample size) |
| Chen (2013) | HIV-1 genotypes and drug resistance threshold survey in Honghe Prefecture of Yunnan Province in 2011 | 23346648 | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| CHEN (2012) | Molecular epidemiology and drug resistance of HIV type 1 in patients within late-stage infection in Guangdong province, China | 23144953 | 0 | 179 179PR 179RT |
179 179PR 179RT |
100 | HIVDB |
| Chen (2015) | Changing subtype dominance and shift in resistance of HIV-1 in the southwest border of China | 25207977 | 0 | 285 284PR 285RT |
285 285PR 285RT |
100 | HIVDB |
| Chen (2017) | First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar | Virulence (2016) In press | 0 | 31 31PR 31RT 31IN |
31 31PR 31RT 31IN |
100 | HIVDB |
| Chen (2020) | Laos is Affected by HIV CRF01_AE and the Newly Identified CRF97_01B | Virol Sin (2020) In press | 0 | 61 59PR 57RT 59IN |
61 61PR 61RT 61IN |
100 | HIVDB |
| Chen (2016) | HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China | PLoS ONE 11 (2), E0149215 (2016) | 0 | |
30 30PR 30RT |
0 | Case report(s) / study subset |
| Chen (2019) | Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region | Virulence 9 (1), 1195-1204 (2018) | 0 | |
73 73PR 73RT |
0 | Pending |
| Chen (2021) | Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region | Virulence 9 (1), 1195-1204 (2018) | 4.97e-176 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Chen (2022) | Inferring proportion of potential non-disclosed men who have sex with men among self-reported heterosexual men with HIV in Southwest China: Molecular analysis of HIV genetic net-works | 37000807 | 1.44e-179 | |
209 209PR 209RT |
0 | Transmission cluster |
| Chen (2018) | Increased predominance of HIV-1 CRF01_AE and its recombinants in Philippines | 30676308 | 0 | 23 23PR 23RT 23IN |
23 23PR 23RT 23IN |
100 | HIVDB |
| Chen (2017) | Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan | PLoS ONE 11 (12), E0167839 (2016) | 0 | 36 34PR 34RT 36IN |
36 34PR 34RT 36IN |
100 | HIVDB |
| Chen (2021) | Analyses of near full-length HIV-1 genome sequences from Vietnam | Unpublished | 0 | |
36 36PR 36RT 36IN |
0 | Unpublished |
| Chen (2015) | Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China | J. Acquir. Immune Defic. Syndr. (2015) In press | 0 | |
294 23PR 23RT 294IN |
0 | Quasispecies |
| Chen (2021) | HIV-1 subtype diversity and transmission strain source among men who have sex with men in Guangxi, China | Sci Rep 11 (1), 8319 (2021) | 0 | |
58 58PR 58RT |
0 | Pending |
| Chen (1996) | GENETIC characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop | J. Virol. 70 (6), 3617-3627 (1996) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Cheng (2020) | Identification of a Novel HIV-1 Unique CRF01_AE/C Recombinant in Yan'an City, Shaanxi Province | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Cheng (1992) | MOLECULAR characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells | Adv. Exp. Med. Biol. 312, 83-88 (1992) | 2e-24 | |
1 1PR |
0 | Laboratory/experimental isolate |
| Chenhao (2015) | High Proportion of CRF01_AE and Multiple Recombination Form Strains of HIV-1 Were Circulating in Suzhou and Suqian, Jiangsu | 27386334 | 5.1e-133 | |
32 32PR 32RT |
0 | Case report(s) / study subset |
| Cheong (2014) | Cross-Border Sexual Transmission of the Newly Emerging HIV-1 Clade CRF51_01B | PLoS ONE 9 (10), E111236 (2014) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Cheong (2015) | Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages | PLoS ONE 10 (7), E0133883 (2015) | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Cheong (2015) | Genome sequence of complex HIV-1 unique recombinant forms (URFs) sharing common recombination breakpoint identified in Malaysia | 26543107 | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Cheriro (2015) | High Prevalence of HIV Low abundance Drug resistant variants in a treatment naive population in North Rift Kenya | AIDS Res. Hum. Retroviruses (2015) In press | 5.86e-168 | 59 55PR 59RT |
59 55PR 59RT |
100 | HIVDB |
| Cheriro (2016) | Drug resistance testing in HIV infected individuals on treatment and naive: Implications on treatment outcome | J HIV Clin Sci Res 2 (2), 62-68 (2015) | 0 | |
100 100PR 100RT |
0 | Pending |
| Chibo (2011) | HIV Transmissions During Seroconversion Contribute Significantly to New Infections in Men Who Have Sex with Men in Australia | AIDS Res. Hum. Retroviruses 28 (5), 460-464 (2012) | 1.37e-177 | 209 209PR 209RT |
209 209PR 209RT |
100 | HIVDB |
| Chikata (2013) | Host-specific adaptation of HIV-1 subtype B in the Japanese population | 24522911 | 0 | 363 363PR 360RT 363IN |
363 363PR 363RT 363IN |
100 | HIVDB |
| Chikata (2024) | Molecular basis for selection and control of HIV-1 escape virus by T cells and KIR2DL2+ NK cells | Unpublished | 1.38e-118 | |
41 41RT |
0 | Case series (immunological study) |
| Chimukangara (2014) | Drug Resistance Mutations from Whole Blood Proviral DNA among Patients on Antiretroviral Drugs in Zimbabwe | Curr. HIV Res. (2014) In press | 1.34e-141 | |
108 108RT |
0 | Methods paper |
| Chimukangara (2016) | HIV drug resistance testing among patients failing second line antiretroviral therapy. Validation of an in-house sequencing method | 27894862 | 1.53e-165 | 25 25PR 25RT |
48 48PR 48RT |
52 | HIVDB |
| Chimukangara (2016) | Successful Sustainable Community Based ART in Rural Zimbabwe | 28899102 | 1.88e-139 | |
8 8RT |
0 | Case report(s) / study subset |
| Chimukangara (2021) | Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa | 34656129 | 1.79e-175 | 115 115PR 115RT |
115 115PR 115RT |
100 | HIVDB |
| Chimukangara (2021) | Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals | J Antimicrob Chemother 75 (11), 3319-3326 (2020) | 5.5e-178 | 215 215PR 215RT |
215 215PR 215RT |
100 | HIVDB |
| Chin (2009) | Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. | ARHR | 0 | 76 76PR 76RT |
76 76PR 76RT |
100 | HIVDB |
| Chin (2006) | INVERSE Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections | AIDS Res. Hum. Retroviruses 22 (11), 1142-1147 (2006) | 1e-147 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Chin (2007) | EARLY identification of seronegative human immunodeficiency virus type 1 infection with severe presentation | J. Clin. Microbiol. 45 (5), 1659-1662 (2007) | 1e-143 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Chin (2007) | FACTORS Associated with Short-term Clinical Parameters after Genotypic Resistance Assay in Korean Patients with HIV-1 Subtype B Virologic Failure | J Korean Med Sci. 2009 Dec;24(6):1031-7. Epub 2009 Nov 7. | 1e-146 | |
40 40PR 40RT |
0 | Pending |
| Chin (2015) | Increase of K103N Transmitted Drug Resistance in Korean HIV-1 Infected Patients: A Single Center Experience | 25826122 | 0 | 131 131PR 131RT |
131 131PR 131RT |
100 | HIVDB |
| Chin (2010) | Genetic analysis of a UNAIDS HIV type 1 from Brazil revealed an unexpected recombination pattern. | AIDS Res Hum Retroviruses. 2010 Dec;26(12):1261-3. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Chinula (2023) | Efficacy and safety of three antiretroviral therapy regimens started in pregnancy through 50 weeks postpartum: a multicentre, open-label randomised controlled trial | Lancet HIV (2023) In press | 0 | |
91 84PR 84RT 73IN |
0 | HIVDB |
| Chiu (2018) | Laboratory Validation of a Clinical Metagenomic Sequencing Assay for Pathogen Detection in Cerebrospinal Fluid | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Cho (2023) | Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing | Proc Natl Acad Sci U S A 119 (4) (2022) | 0 | |
3779 3616PR 3549RT 2743IN |
0 | Proviral DNA Reservoir |
| Cho (2024) | Effect of Korean Red Ginseng combination therapy for HIV infection in the era of integrase strand transfer inhibitors | 39583165 | 0 | |
148 69PR 106RT 121IN |
0 | Pending |
| Cho (2005) | Phylogenetic analysis of near full-length HIV type 1 genomic sequences from 21 Korean individuals. | AIDS Res Hum Retroviruses. 2013 Apr;29(4):738-43. | 0 | 21 21PR 21RT 21IN |
44 44PR 44RT 44IN |
47 | HIVDB |
| Cho (2006) | High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng. | Curr HIV Res. 2006 Oct;4(4):447-57. | 0 | 1 1PR 1RT 1IN |
4 1PR 1RT 4IN |
25 | HIVDB |
| Cho (2012) | Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV type 1 | Unpublished | 0 | |
36 31PR 36RT |
0 | Case report(s) / study subset |
| Cho (2013) | Frequent genetic defects in long-term survivors for more than 26 years in the absence of antiretroviral therapy in Korea: its association with ginseng treatment | Unpublished | 0 | |
9 9PR 9RT 9IN |
0 | Case report(s) / study subset |
| Cho (2016) | High frequency of gross deletion on pol gene | Unpublished | 0 | |
315 48PR 306RT 252IN |
0 | ARV Rx and/or other data are N/A |
| Cho (2018) | High frequency of gross deletions in the HIV-1 pol gene is associated with the Korean red ginseng intake | Unpublished | 0 | |
321 158PR 291RT 282IN |
0 | ARV Rx and/or other data are N/A |
| Cho (2018) | High frequency of genetic defects in long term slow progressors infected with HIV-1 | Unpublished | 0 | |
9 8PR 6RT 7IN |
0 | Case report(s) / study subset |
| Cho (2018) | Impact of HIV-1 subtype and Korean red ginseng on AIDS progression: comparison of subtype B and subtype D | Unpublished | 9.62e-135 | |
1 1RT |
0 | Case report(s) / study subset |
| Cho (2019) | Phylogenetic analysis of near full-length sequences of Korean subclade of HIV-1 subtype B | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Cho (2019) | A long-term slow progressor reveals high proportion of genetic defects in HIV-1 | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Cho (2019) | Genetic analysis for the full-length gag gene of the earliest Korean subclade B of HIV-1: Outbreak among Korean Hemophiliacs | Unpublished | 1.28e-23 | |
5 5PR |
0 | Case report(s) / study subset |
| Cho (2019) | Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy | 31695572 | 0 | |
228 74PR 186RT 210IN |
0 | Sequence quality |
| Cho (2019) | Phylogenetic analysis of near full-length sequences from the earliest Korean subclade B of HIV-1 | 23199052 | 0 | |
32 32PR 32RT 32IN |
0 | HIVDB |
| Cho (2019) | Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy | Unpublished | 0.21 | |
1 1RT |
0 | Case report(s) / study subset |
| Cho (2020) | The frequency of defective genes in vif and vpr genes in 20 hemophiliacs are associated with Korean Red Ginseng and highly active antiretroviral therapy: The impact of lethal mutations in vif and vpr genes on HIV-1 evolution | Unpublished | 2.19e-71 | |
4 4IN |
0 | Case report(s) / study subset |
| Cho (2020) | Phylogenetic analysis of near full-length sequences from the earliest Korean Subclade B of HIV-1 | Unpublished | 0 | |
65 60PR 59RT 55IN |
0 | Case report(s) / study subset |
| Cho (2021) | Korean Red Ginseng-based combination therapy suppresses the development of resistance mutation to INSTI | Unpublished | 0 | |
345 273PR 341RT 142IN |
0 | Unpublished |
| Cho (2021) | Proportion of resistance mutations in the simultaneous ginseng based combination group was much lower than that in the cART group | Unpublished | 0 | |
97 73PR 91RT 74IN |
0 | Pending |
| Cho (2021) | Significant correlations between the amount of Korean Red Ginseng (KRG) and sequence length in env gene, and the amount of KRG and CpG number | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Cho (2021) | Changes in sequence length, the number of CpG, and coreceptor in env gene over 30 years in HIV-1 Korean subclade B infected patients | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Cho (2023) | Origin of CRF16_A2D in Korea: the earliest transmission from Africa | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Cho (2024) | Impact of combination of Korean Red Ginseng with integrase strand transfer inhibitor | 39583165 | 0 | |
219 133PR 164RT 171IN |
0 | Pending |
| Cho (2025) | Effects of Korean Red Ginseng treatment on the sequence length of env gene and the frequency of CpG dinucleotides in the env gene of HIV-1 subtype B infected patients | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report (Small sample size) |
| Cho (2025) | The earliest CRF16 A2D transmission within local community in Korea | Unpublished | 8.45e-164 | |
1 1PR 1RT |
0 | Case report (Small sample size) |
| Cho (2016) | Low frequency of registance mutation on ginseng based combination therapy | Unpublished | 0 | |
580 351PR 558RT 392IN |
0 | ARV Rx and/or other data are N/A |
| Cho (2008) | HIGH Frequency of Gross Deletions in the 5' LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red Ginseng | AIDS Res. Hum. Retroviruses 24 (2), 181-193 (2008) | 1e-167 | |
256 29PR 211RT 226IN |
0 | Case report(s) / study subset |
| Cho (2014) | Long term follow up of HIV-infected Korean haemophiliacs, after infection from a common source of virus | 25545303 | 0 | |
99 86PR 99RT 69IN |
0 | Case report(s) / study subset |
| Cho (2001) | LONG-TERM intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed | Int. Immunopharmacol. 1 (7), 1295-1305 (2001) | 4e-96 | 10 10RT |
37 37RT |
27 | HIVDB |
| Cho (2002) | FREQUENCY of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea | J. Clin. Microbiol. 40 (4), 1319-1325 (2002) | 1e-118 | 6 6RT |
23 6PR 22RT |
26 | HIVDB |
| Cho (2003) | MOLECULAR epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 | Vox Sang. 92 (2), 113-120 (2007) | 0 | |
192 155PR 177RT 8IN |
0 | Pending |
| Cho (2005) | FULL sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box | AIDS Res. Hum. Retroviruses 21 (11), 961-964 (2005) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Cho (2010) | Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV-1 | AIDS Res. Hum. Retroviruses (2010) In press | 0 | |
201 180PR 201RT 163IN |
0 | Pending |
| Cho (2013) | First Report on a T69-ins Insertion in CRF06_cpx HIV Type 1 | AIDS Res. Hum. Retroviruses 29 (7), 1079-1084 (201 | 0 | |
41 34PR 41RT 14IN |
0 | Case report(s) / study subset |
| Cho (2021) | Sequence Length of HIV-1 Subtype B Increases over Time: Analysis of a Cohort of Patients with Hemophilia over 30 Years | Viruses 13 (5), 806 (2021) | 0 | |
33 32PR 23RT 24IN |
0 | ARV Rx and/or other data are N/A |
| Chohan (2023) | Virologic non-suppression and HIV drug resistance among people who inject drugs and their sexual and injecting partners in Kenya | AIDS Res Hum Retroviruses (2023) In press | 0 | 309 309PR 309RT |
309 309PR 309RT |
100 | HIVDB |
| Choi (1997) | HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant | AIDS Res. Hum. Retroviruses 13 (4), 357-361 (1997) | 1e-164 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Choi (2018) | Integrase Strand Transfer Inhibitor Resistance Mutation among HIV Naive and Treatment Experienced Patients in Korea | 30229661 | 0 | 99 94PR 94RT 99IN |
99 94PR 94RT 99IN |
100 | HIVDB |
| Choi (2022) | Near full-length sequence of HIV from Korea HIV/AIDS cohort | Unpublished | 0 | |
14 14PR 14RT 14IN |
0 | Case report(s) / study subset |
| Choi (2010) | Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay | J. Clin. Virol. (2010) In press | 0 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Cholette (2020) | HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade | 32857765 | 2.24e-165 | 290 290PR 290RT |
290 290PR 290RT |
100 | HIVDB |
| Chomont (2022) | HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections | Unpublished | 0 | |
168 149PR 148RT 131IN |
0 | Proviral DNA Reservoir |
| Chourasia (2014) | Prevalence of antiretroviral drug resistance mutations in HIV-1 infected patients in eastern India after second-line treatment failure | 26572102 | 3e-180 | 16 16PR 16RT |
18 18PR 18RT |
88 | HIVDB |
| Chow (2012) | Genome Sequences of a Novel HIV-1 CRF53_01B Identified in Malaysia | J. Virol. 86 (20), 11398-11399 (2012) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Chow (2013) | Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters | PLoS ONE 8 (5), E62560 (2013) | 0 | 128 114PR 112RT |
128 126PR 112RT |
100 | HIVDB |
| Chow (2014) | A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia. | PLoS One. 2014 Jan 22;9(1):e85250. | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Chow (2014) | Genome Sequence of a Complex HIV-1 Unique Recombinant Form Involving CRF01_AE, Subtype B, and Subtype B' Identified in Malaysia | Genome Announc 2 (2), e00139-14 (2014) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Chow (2016) | Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries | PLoS ONE 11 (8), E0161853 (2016) | 0 | 154 152PR 143RT |
154 154PR 143RT |
100 | HIVDB |
| Chung (2015) | Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya | J. Acquir. Immune Defic. Syndr. 67 (3), 246-253 (2 | 3.38e-168 | 159 48PR 159RT |
202 106PR 202RT |
78 | HIVDB |
| Chung (2020) | Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial | Lancet HIV (2020) In press | 2.49e-175 | 566 72PR 566RT |
637 72PR 637RT |
88 | HIVDB |
| Church (2009) | Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. | J Infect Dis | 0 | 49 49PR 49RT |
49 49PR 49RT |
100 | HIVDB |
| Church (2007) | HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D | AIDS Res. Hum. Retroviruses 23 (6), 764-768 (2007) | 0 | 245 245PR 245RT |
245 245PR 245RT |
100 | HIVDB |
| Churina (2019) | HIV-1 drug-resistance and molecular epidemiology in patients with art failure in veliky novgorod | Vichinfektsiia Immunosuppr 9 (1), 82-92 (2017) | 0 | |
22 22PR 22RT |
0 | Pending |
| Ciccozzi (2005) | MOLECULAR Diversity of HIV in Albania | J. Infect. Dis. 192 (3), 475-479 (2005) | 0 | 66 66PR 66RT |
66 66PR 66RT |
100 | HIVDB |
| Ciccozzi (2007) | THE HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries | AIDS Res. Hum. Retroviruses 24 (6), 771-779 (2008) | 6.96e-167 | 81 80PR 79RT |
81 81PR 81RT |
100 | HIVDB |
| Ciccozzi (2010) | Genetic Diversity of HIV-1 in Montenegro | AIDS Res. Hum. Retroviruses (2010) In press | 0 | 32 32PR 32RT |
32 32PR 32RT |
100 | HIVDB |
| Ciccozzi (2012) | HIV-1 origin and transmission dynamics among different risk groups in Sardinia: molecular epidemiology within the close boundaries of an Italian island | AIDS Res. Hum. Retroviruses (2012) In press | 1.59e-100 | |
215 215RT |
0 | ARV Rx and/or other data are N/A |
| Ciccozzi (2014) | Viral Sequence Analysis of HIV-Positive Women and Their Infected Children: Insight on the Timing of Infection and on the Transmission Network | AIDS Res. Hum. Retroviruses 30 (10), 1010-1015 (20 | 4.01e-146 | |
33 33PR 33RT |
0 | Case report(s) / study subset |
| Ciccozzi (2016) | An outbreak of HIV-1 subtype G among Italian IDUs | 17502735 | 5.38e-150 | |
14 14PR 14RT |
0 | Case report(s) / study subset |
| Cilla (2001) | MOLECULAR evidence of homosexual transmission of HIV type 2 in Spain | AIDS Res. Hum. Retroviruses 17 (5), 417-422 (2001) | 0.00007 | 4 4RT |
4 4RT |
100 | HIVDB |
| Cinque (2001) | EFFECT of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid | AIDS Res. Hum. Retroviruses 17 (5), 377-383 (2001) | 1e-129 | 33 15PR 18RT |
57 24PR 33RT |
57 | HIVDB |
| Claassen (2009) | Direct Submission | Submitted (16-NOV-2007) NHLS/University of Stellen | 7e-173 | |
150 150RT |
0 | Pending |
| Clarke (2005) | REVERSE transcriptase and protease sequences from HIV-1 non-subtype B infected persons in the United Kingdom | 15839752 | 0 | 296 140PR 156RT |
519 363PR 379RT |
57 | HIVDB |
| Clarke (2016) | Reverse transcriptase and protease sequences from HIV-1 non subtype B infected persons in the United Kingdom | 15839752 | 2.19e-57 | 15 15PR |
16 16PR |
93 | HIVDB |
| Clavel (1996) | MOLECULAR cloning and polymorphism of the human immune deficiency virus type 2 | Nature 324 (6098), 691-695 (1986) | 1e-98 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Cleland (1996) | EVOLUTION of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1), 6-1 | 1e-123 | |
370 370RT |
0 | Gene fragment(s) |
| Clevenbergh (2002) | LONG-TERM virologic outcome in patients infected with multi-nucleoside analogue resistant HIV-1 | Antivir. Ther. (Lond.) (2002) In press | 1e-121 | 24 12PR 12RT |
24 12PR 12RT |
100 | HIVDB |
| Clewley (1998) | A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus | J. Virol. 72 (12), 10305-10309 (1998) | 0 | |
2 2PR 2RT 1IN |
0 | NHPL/SIV |
| Clipman (2022) | Antiretroviral Drug Resistance in HIV Sequences from People who Inject Drugs and Men who have Sex with Men Across 21 Cities in India | 36225747 | 0 | 915 915PR 915RT |
915 915PR 915RT |
100 | HIVDB |
| Cloyd (1990) | SPECTRUM of biological properties of human immunodeficiency virus (HIV-1) isolates | Virology 174 (1), 103-116 (1990) | 1e-164 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Clutter (2017) | Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing | J. Infect. Dis. 216 (3), 387-391 (2017) | 0 | 61 16PR 61RT |
61 16PR 61RT |
100 | HIVDB |
| Coelho (2015) | Transmission of a multi drug resistant HIV-1 by occupational exposure | 26244399 | 9e-62 | |
28 28PR |
0 | Case report(s) / study subset |
| Coelho (2017) | Transmitted drug Resistence Among Adults in Sao Paulo, Brzil | Unpublished | 3.24e-153 | |
354 354PR 354RT |
0 | Pending |
| Coelho (2018) | Transmitted Drug Resistance among Recently Diagnosed Adults in Sao Paulo, Brazil | 30569276 | 4.42e-75 | |
593 593PR 593RT |
0 | Gene fragment(s) |
| Coetzee (2018) | HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study | PLoS ONE 12 (12), e0188606 (2017) | 8.95e-174 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Coetzee (2025) | Full-Pol Gene PCR and Rapid ONT Library Preparation for Accurate Drug Resistance Sequencing | Unpublished | 0 | |
68 68PR 68RT 67IN |
0 | Unpublished |
| Coetzer (2013) | Extensive Drug Resistance in HIV-Infected Cambodian Children Who Are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines | AIDS Res. Hum. Retroviruses 29 (7), 985-992 (2013) | 2.11e-150 | 58 58RT |
58 58RT |
100 | HIVDB |
| Colby (2019) | Ad26, MVA vaccines in acutely treated HIV: Safety, immunogenicity and effect on viral rebound | 32235883 | 0 | |
132 82PR 82RT 132IN |
0 | Quasispecies |
| Colby (2018) | Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection | Nat. Med. (2018) In press | 0 | |
255 225PR 225RT 70IN |
0 | SGS |
| Cole (2021) | In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia | Nat Commun (2021) In press | 0 | |
369 359PR 350RT 304IN |
0 | SGS |
| Cole (2022) | In-depth characterization of HIV-1 reservoirs reveals links to viral rebound during treatment interruption | 35476994 | 0 | |
106 106PR 106RT 106IN |
0 | Proviral DNA Reservoir |
| Coleman (2011) | Direct Submission | Submitted (16-FEB-2011) Infectious Diseases and Pa | 0 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Collins (2021) | Functional impairment of HIV-specific CD8+ T cells precedes aborted control of viremia | Unpublished | 0 | |
17 17PR 17RT 17IN |
0 | Case series (immunological study) |
| Collins-Fairclough (2015) | HIV Drug Resistance Surveillance Among Jamaican Men Who Have Sex with Men Should Be Prioritized for Reducing HIV Transmission | AIDS Res. Hum. Retroviruses 31 (8), 841-844 (2015) | 9.81e-168 | |
70 70PR 70RT |
0 | ARV Rx and/or other data are N/A |
| Collman (2000) | An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. | J Virol | 1e-163 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Colonno (2004) | IDENTIFICATION of I50L as the Signature Atazanavir (ATV)Resistance Mutation in Treatment-Naive HIV-1Infected Patients Receiving ATV-Containing Regimens | J. Infect. Dis. 189 (10), 1802-1810 (2004) | 1e-59 | 22 22PR |
22 22PR |
100 | HIVDB |
| Colson (2019) | Primary infections with Human immunodeficiency virus type 1 in 2017 in Southeastern France | Unpublished | 0 | |
37 13PR 13RT 11IN |
0 | Unpublished |
| Colson (2014) | HIV infection en route to endogenization: two cases | Clin. Microbiol. Infect. (2014) In press | 0 | |
22 4PR 5RT 15IN |
0 | Case report(s) / study subset |
| Conce Albert (2020) | HIV Diversity Considerations in the Application of the Intact Proviral DNA Assay (IPDA) | Unpublished | 2.15e-99 | |
57 57PR 57RT |
0 | Proviral DNA Reservoir |
| Condra (1996) | GENETIC correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor | J. Virol. 70 (12), 8270-8276 (1996) | 1e-130 | 421 421PR |
421 421PR |
100 | HIVDB |
| Cong (2006) | THE Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions | J. Virol. 81 (6), 3037-3041 (2007) | 1e-172 | |
4 4RT |
0 | Laboratory/experimental isolate |
| Coovadia (2008) | PERSISTENT Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy | Clin. Infect. Dis. (2009) In press | 1e-168 | |
99 99RT |
0 | Pending |
| Corbet (1999) | ENV sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area | J. Virol. 74 (1), 529-534 (2000) | 1e-147 | 1 1PR 1RT 1IN |
3 1PR 1RT 3IN |
33 | HIVDB |
| Cornelissen (1997) | POL gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D | J. Virol. 71 (9), 6348-6358 (1997) | 1e-126 | 41 41PR 41RT |
42 42PR 42RT |
97 | HIVDB |
| Cornelissen (2000) | SPREAD of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa | J. Gen. Virol. 81 (Pt 2), 515-523 (2000) | 2e-86 | 20 20PR 20RT |
21 21PR 21RT |
95 | HIVDB |
| Council (2024) | Evidence for Episodic Formation of the Long-lived HIV-1 Reservoir | Unpublished | 3.53e-88 | |
420 420IN |
0 | Proviral DNA Reservoir |
| Courgnaud (1992) | GENETIC differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque | J. Virol. 66 (1), 414-419 (1992) | 6.88e-114 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Courgnaud (2001) | CHARACTERIZATION of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family | J. Virol. 75 (2), 857-866 (2001) | 1e-76 | |
3 1PR 3RT 3IN |
0 | NHPL/SIV |
| Courgnaud (2002) | CHARACTERIZATION of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny | J. Virol. 76 (16), 8298-8309 (2002) | 4e-97 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Courgnaud (2003) | PARTIAL Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) | J. Virol. 77 (1), 744-748 (2003) | 1e-149 | |
5 5RT 5IN |
0 | NHPL/SIV |
| Courgnaud (2003) | IDENTIFICATION of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon | J. Virol. 77 (23), 12523-12534 (2003) | 0 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Courtney (2016) | Monitoring HIV-1 Group M Subtypes in Yaounde, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 109 109RT |
109 109RT |
100 | HIVDB |
| Courtney (2017) | Contrasting antibody responses to intrasubtype superinfection with CRF02_AG | PLoS ONE 12 (3), E0173705 (2017) | 7.99e-112 | |
798 798RT |
0 | Quasispecies |
| Cousins (2014) | A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation | PLoS ONE 9 (6), E101043 (2014) | 0 | |
138 138PR 138RT |
0 | ARV Rx and/or other data are N/A |
| Cousins (2017) | Population sequencing analysis of samples from the MetroMates Study | Unpublished | 0 | 104 104PR 104RT |
104 104PR 104RT |
100 | HIVDB |
| Couto-Fernandez (2006) | PHYLOGENETIC Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil | AIDS Res. Hum. Retroviruses 22 (2), 207-211 (2006) | 0 | 5 5IN |
10 5PR 5RT 5IN |
50 | HIVDB |
| Crandall (1999) | PARALLEL evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection | Mol. Biol. Evol. 16 (3), 372-382 (1999) | 1e-121 | |
41 41PR |
0 | Quasispecies |
| Crandall (1999) | ADVANCES in understanding the evolution of HIV | AIDS 13, S39-S47 (1999) | 1e-102 | |
49 49PR |
0 | Quasispecies |
| Crawford (2014) | Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy. | AIDS. 2014 Jan 28;28(3):442-5. | 2.98e-145 | 28 14PR 14RT |
28 14PR 14RT |
100 | HIVDB |
| Crispim (2019) | Transmission clusters of antiretroviral drug resistance and HIV-1 subtypes among recently diagnosed blood donors in three public health blood donors from the Brazilian Amazon | 31498798 | 1.14e-166 | 227 227PR 227RT |
227 227PR 227RT |
100 | HIVDB |
| Crowell (2003) | OPTIMIZATION of Oligonucleotide Ligation Assay for Detection of Drug Resistance Mutations in Non-Subtype B HIV-1 | Unpublished | 1e-133 | |
18 17PR 18RT |
0 | ARV Rx and/or other data are N/A |
| Crowell (2023) | Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries | Clin Infect Dis 73 (7), e2311-e2322 (2021) | 0 | 851 849PR 851RT |
870 868PR 870RT |
97 | HIVDB |
| Cuevas (2015) | Extremely high mutation rate of HIV-1 in vivo | 26375597 | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Cuevas (2010) | Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men | Euro Surveill. 14 (47) (2009) | 0 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| Cuevas (2009) | HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain | J. Acquir. Immune Defic. Syndr. 51 (1), 99-103 (20 | 1.18e-151 | 287 287PR 287RT |
287 287PR 287RT |
100 | HIVDB |
| Cuevas (2010) | Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment | AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25 | 0 | 25 25PR 25RT 25IN |
28 28PR 28RT 28IN |
89 | HIVDB |
| Cuevas (2015) | Direct Submission | Submitted (13-JUL-2015) Unidad de Biologia y Varia | 0 | |
79 79PR 79RT 49IN |
0 | Unpublished - Final |
| Cuevas (2017) | Direct Submission | Submitted (26-SEP-2017) Unidad de Biologia y Varia | 0 | |
18 18PR 18RT |
0 | Unpublished |
| Cummins (2017) | Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study | PLoS Med. 14 (11), e1002461 (2017) | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Cunha (2016) | Distribution of Human Immunodeficiency Virus Type 1 (HIV-1) Subtypes in North Region of Brazil: Identification of C Subtype in the State of Amazonas | 22249428 | 2.1e-169 | |
23 23RT |
0 | Case report(s) / study subset |
| Cunningham (2002) | Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. | J Infect Dis. 2002 Jul 15;186(2):181-8. Epub 2002 Jun 26. | 5e-92 | |
79 79RT |
0 | ARV Rx and/or other data are N/A |
| Cunningham (2017) | Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK | J. Antimicrob. Chemother. 72 (1), 227-234 (2017) | 0 | |
70 70PR 70RT |
0 | Case report(s) / study subset |
| Currier (2006) | CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response | BMC Immunol. 7, 8 (2006) | 3.45e-20 | |
36 36PR |
0 | Pending |
| D'arc (2015) | Origin of the HIV-1 group O epidemic in western lowland gorillas | Proc. Natl. Acad. Sci. U.S.A. (2015) In press | 0 | |
7 4PR 5RT 7IN |
0 | NHPL/SIV |
| D'Arrigo (2007) | GP41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure | AIDS Res. Hum. Retroviruses 23 (10), 1296-1302 (2007) | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| D'Ettorre (2013) | An HIV Type 2 Case Series in Italy: A Phylogenetic Analysis | AIDS Res. Hum. Retroviruses 29 (9), 1254-1259 (201 | 7.79e-144 | 17 17PR 17RT |
17 17PR 17RT |
100 | HIVDB |
| da Costa (2017) | High HIV-1 Genetic Diversity in Patients from Northern Brazil | AIDS Res. Hum. Retroviruses 32 (9), 918-922 (2016) | 7.96e-149 | 305 305PR 305RT |
305 305PR 305RT |
100 | HIVDB |
| da Costa (2019) | HIV-1 genetic diversity and transmitted drug resistance mutations in female sex workers from a Brazilian municipality in the Amazon region | AIDS Res. Hum. Retroviruses (2019) In press | 9.46e-166 | |
21 21PR 21RT |
0 | ARV Rx and/or other data are N/A |
| da Costa (2013) | Transmitted HIV Resistance Among Pregnant Young Women Infected with HIV-1 in Brazil | AIDS Patient Care STDS 27 (8), 439-441 (2013) | 9.07e-167 | 18 18PR 18RT |
18 18PR 18RT |
100 | HIVDB |
| da Silva (2022) | Identification of a new circulating recombinant form of human immunodeficiency virus type 1, CRF124_cpx involving subtypes A, G, H, and CRF27_cpx in Angola | Front Microbiol (2022) In press | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| da Silveira (2011) | HIV Type 1 Molecular Epidemiology in pol and gp41 Genes Among Naive Patients from Mato Grosso do Sul State, Central Western Brazil | AIDS Res. Hum. Retroviruses 28 (3), 304-307 (2012) | 3.56e-175 | 49 49PR 49RT |
49 49PR 49RT |
100 | HIVDB |
| Dagba Gbessin (2023) | HIV-1 genetic diversity and drug resistance mutations among children infected in Benin | Unpublished | 0 | 32 32PR 32RT |
32 32PR 32RT |
100 | HIVDB |
| Dagnra (2016) | High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lome, Togo | J Int AIDS Soc 14, 30 (2011) | 0 | 46 46PR 46RT |
46 46PR 46RT |
100 | HIVDB |
| Dahake (2013) | Drug Resistance Mutations and Polymorphisms in HIV-1 Subtype C Protease in a Patient Cohort from Mumbai | Unpublished | 6e-58 | |
25 25PR 20RT |
0 | Case report(s) / study subset |
| Dahake (2013) | Direct Submission | Submitted (01-MAR-2013) Virology, Haffkine Institu | 1.47e-103 | |
8 8RT |
0 | Gene fragment(s) |
| Dalai (2016) | Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe | AIDS 23 (18), 2523-2532 (2009) | 1.13e-168 | 151 151RT |
151 151RT |
100 | HIVDB |
| Dalai (2019) | Combining Phylogenetic and Network Approaches to Identify HIV-1 Transmission Links in San Mateo County, California | Front Microbiol 9, 2799 (2018) | 8.58e-179 | |
317 317PR 317RT |
0 | Pending |
| Dam (2016) | Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss | PLoS Pathog. 5 (3), E1000345 (2009) | 2.06e-162 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Dambaya (2019) | HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children | Unpublished | 0 | 63 63PR 62RT |
63 63PR 62RT |
100 | HIVDB |
| Damond (2004) | Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. | J Clin Microbiol. 2005 Jan;43(1):484-7. | 5e-25 | 94 94PR |
94 94PR |
100 | HIVDB |
| Damond (2006) | IDENTIFICATION of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification | AIDS Res. Hum. Retroviruses 20 (6), 666-672 (2004) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Dan (2019) | Assessing the Efficacy of Second-Line Antiretroviral Regimen for HIV Drug Resistant Patients in Sichuan China: A Retrospective Observational Study | 35749212 | 0 | 101 101PR 101RT |
101 101PR 101RT |
100 | HIVDB |
| Daniel (1993) | SIMIAN immunodeficiency virus from African green monkeys | J. Virol. 62 (11), 4123-4128 (1988) | 1e-33 | |
1 1RT |
0 | Gene fragment(s) |
| Daniel (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 0 | 52 53PR 53RT |
53 53PR 53RT |
98 | HIVDB |
| Daniele (2024) | Direct Submission | Submitted (05-JUN-2024) Departimental Faculty, Sai | 0 | 91 91IN |
91 91IN |
100 | HIVDB |
| Dapp (2017) | Patterns and rates of viral evolution in HIV-1 subtype B infected females and males | PLoS ONE 12 (10), E0182443 (2017) | 2.48e-24 | |
1804 1804PR |
0 | Gene fragment(s) |
| Darcissac (2016) | HIV-1 Pol Gene Polymorphism and Antiretroviral Resistance Mutations in Treatment-Naive Adult Patients in French Guiana Between 2006 and 2012 | AIDS Res. Hum. Retroviruses (2016) In press | 1.72e-179 | 304 303PR 304RT |
306 304PR 305RT |
99 | HIVDB |
| Dash (2007) | EXCEPTIONAL molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype-C infection | Retrovirology 5 (1), 25 (2008) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Datir (2020) | In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix | mBio (2020) In press | 1.83e-56 | 13 13PR |
15 15PR |
86 | HIVDB |
| Dau (2010) | Connection domain mutations in treatment-experienced patients in the OPTIMA trial | J. Acquir. Immune Defic. Syndr. 54 (2), 160-166 (2 | 0 | 420 420PR 420RT |
420 420PR 420RT |
100 | HIVDB |
| Daumer (2009) | Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source | AIDS Res. Hum. Retroviruses 26 (3), 275-278 (2010) | 0 | |
40 40PR 40RT |
0 | Quasispecies |
| Dauwe (2016) | Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate | BMC Infect. Dis. 15, 524 (2015) | 1.95e-130 | 820 410PR 410RT |
820 410PR 410RT |
100 | HIVDB |
| Davaalkham (2011) | Identification of a Current Hot Spot of HIV Type 1 Transmission in Mongolia by Molecular Epidemiological Analysis | AIDS Res. Hum. Retroviruses 27 (10), 1073-1080 (20 | 2.69e-180 | |
10 10PR 10RT |
0 | ARV Rx and/or other data are N/A |
| Davydenko (2024) | Direct Submission | Submitted (16-NOV-2024) Laboratory of HIV Immunolo | 0 | 33 32PR 32RT 1IN |
33 32PR 32RT 1IN |
100 | HIVDB |
| Dazza (2003) | CHARACTERIZATION of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti) | J. Virol. 79 (13), 8560-8571 (2005) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| de Almeida Rego (2023) | Genomic Detection of the Emerging, Highly Pathogenic HIV-1 Subtype D in Bahia, Northeast Brazil | Viruses 15 (8), 1650 (2023) | 4.47e-167 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| De Arellano (2007) | IMPACT of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy | AIDS Res. Hum. Retroviruses 23 (7), 891-894 (2007) | 9.19e-158 | |
22 22PR 12RT |
0 | Case report(s) / study subset |
| de Azevedo (2022) | HIV-1 Diversity and Drug Resistance in Treatment-Naive Children and Adolescents from Rio de Janeiro, Brazil | Viruses 14 (8), 1761 (2022) | 2.17e-177 | 131 131PR 131RT |
131 131PR 131RT |
100 | HIVDB |
| de Baar (2001) | NATURAL residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo | AIDS Res. Hum. Retroviruses 16 (14), 1385-1394 (2000) | 2e-17 | 5 5PR 5RT |
5 5PR 5RT |
100 | HIVDB |
| de Felipe (2011) | Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010 | Virol. J. 8 (1), 416 (2011) | 3.43e-163 | 182 91PR 91RT |
182 93PR 92RT |
100 | HIVDB |
| De Gascun (2012) | Human immunodeficiency virus type 1 in ireland: phylogenetic evidence for risk group-specific subepidemics | AIDS Res. Hum. Retroviruses 28 (9), 873-881 (2012) | 1.97e-136 | 824 824PR 824RT |
824 824PR 824RT |
100 | HIVDB |
| de Goede (2013) | HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption | 22177848 | 0 | |
34 34PR 34RT 4IN |
0 | ARV Rx and/or other data are N/A |
| De Lima Guerra Corado (2017) | HIV-1 Genetic Diversity and Antiretroviral Drug Resistance among Individuals from Roraima State, Northern Brazil | 28301548 | 2.28e-173 | 73 73PR 73RT |
73 73PR 73RT |
100 | HIVDB |
| De Maio (2012) | APOBEC3 mediated edition in HIV-1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability | 22145963 | 2e-53 | |
93 93IN |
0 | Gene fragment(s) |
| de Medeiros (2011) | Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naive population from Southernmost Brazil: analysis of primary resistance mutations | J. Med. Virol. 83 (10), 1682-1688 (2011) | 3.14e-172 | 99 99PR 99RT |
99 99PR 99RT |
100 | HIVDB |
| de Mendoza (2005) | RESISTANCE to non-nucleoside reverse transcriptase inhibitors and non-B subtypes are on the rise among recent HIV-1 infections in Spain | Unpublished | 0 | |
20 20PR 20RT |
0 | Case report(s) / study subset |
| de Mendoza (2009) | Changes in drug resistance patterns following the introduction of HIV-1 non-B subtypes in Spain | AIDS Res Hum Retroviruses. 2009 Oct;25(10):967-72 | 0 | |
185 185PR 170RT |
0 | ARV Rx and/or other data are N/A |
| De Miguel (2021) | Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) | EBioMedicine 55, 102779 (2020) | 0 | 40 40PR 40RT 32IN |
40 40PR 40RT 32IN |
100 | HIVDB |
| de Moraes (2023) | High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil | Front Microbiol 14 (2023) In press | 3.01e-171 | 19 19PR 19RT |
19 19PR 19RT |
100 | HIVDB |
| de Mulder (2011) | Dynamics of Drug Resistance Prevalence and Susceptibility in the Madrid Cohort of HIV-1 Infected Children: a two decade (1993-2010) analysis | 29403002 | 0 | 240 228PR 200RT |
274 263PR 245RT |
87 | HIVDB |
| de Mulder (2013) | High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain | PLoS ONE 7 (12), E52155 (2012) | 1.78e-146 | 6 6PR 4RT |
6 6PR 4RT |
100 | HIVDB |
| de Oliveira (2008) | HIGH frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil | Arch. Virol. 153 (10), 1799-1806 (2008) | 0 | |
264 150PR 150RT |
0 | Pending |
| De Oliveira (2016) | Multiple HIV-1/m + HIV-1/o dual infections and new HIV-1/mo inter-group recombinant forms detected in Cameroon | 28086923 | 0 | 18 18PR 17RT 1IN |
34 33PR 33RT 9IN |
52 | HIVDB |
| De Pasquale (2004) | DIFFERENCES in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy | Unpublished | 0 | |
39 39PR 39RT |
0 | ARV Rx and/or other data are N/A |
| de Pina-Araujo (2014) | Profile of the HIV Epidemic in Cape Verde: Molecular Epidemiology and Drug Resistance Mutations among HIV-1 and HIV-2 Infected Patients from Distinct Islands of the Archipelago | PLoS ONE 9 (4), E96201 (2014) | 3.47e-155 | 37 37PR 37RT |
164 164PR 164RT |
22 | HIVDB |
| de Ronde (2001) | ESTABLISHMENT of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus | J. Virol. 75 (2), 595-602 (2001) | 2e-91 | |
8 8RT |
0 | Case report(s) / study subset |
| De Sa-Filho (2008) | HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in Santos, Brazil | AIDS Res. Hum. Retroviruses (2008) In press | 1e-154 | 83 83PR 83RT |
83 83PR 83RT |
100 | HIVDB |
| De Scheerder (2019) | HIV rebound is fueled by viral expansions from diverse reservoirs | Unpublished | 1.77e-54 | |
1 1IN |
0 | Gene fragment(s) |
| de Silva (2010) | HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form | Retrovirology 7 (1), 82 (2010) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Deacon (1995) | GENOMIC structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients | Science 270 (5238), 988-991 (1995) | 1e-161 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Dean (2012) | Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study | AIDS Res. Hum. Retroviruses 27 (7), 797-801 (2011) | 3.4e-144 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| deCamp (2018) | Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120 | PLoS ONE 12 (11), e0185959 (2017) | 0 | |
483 473PR 473RT 483IN |
0 | SGS |
| Deeks (1999) | NOVEL four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome | J. Infect. Dis. 179 (6), 1375-1381 (1999) | 1e-127 | 15 15PR 15RT |
16 16PR 16RT |
93 | HIVDB |
| Dehghani (2003) | UNIQUE Pattern of Convergent Envelope Evolution in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques: Association with CD4-Independent Usage of CCR5 | J. Virol. 77 (11), 6405-6418 (2003) | 1e-101 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Deho (2008) | Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland | AIDS Res. Hum. Retroviruses 24 (2), 323-325 (2008) | 9.39e-167 | 47 47PR 47RT |
47 47PR 47RT |
100 | HIVDB |
| Del Prete (2013) | Comparative Characterization of Transfection- and Infection-Derived SIV Challenge Stocks for In Vivo Non-Human Primate Studies | J. Virol. (2013) In press | 0 | |
38 38PR 38RT 38IN |
0 | Laboratory/experimental isolate |
| Delatorre (2012) | Evidence of Multiple Introductions and Autochthonous Transmission of the HIV Type 1 CRF02_AG Clade in Brazil | AIDS Res. Hum. Retroviruses 28 (10), 1369-1372 (20 | 2e-168 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Delatorre (2013) | Tracing the Origin and Northward Dissemination Dynamics of HIV-1 Subtype C in Brazil | PLoS ONE 8 (9), E74072 (2013) | 5.16e-168 | |
31 31PR 31RT |
0 | Case report(s) / study subset |
| Delatorre (2016) | Tracing the origin of a singular HIV-1 CRF45_cpx clade identified in Brazil | Infect. Genet. Evol. (2016) In press | 0 | 3 3PR 3RT |
15 10PR 10RT 7IN |
20 | HIVDB |
| Delatorre (2016) | High HIV-1 diversity and prevalence of transmitted drug resistance among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 87 87PR 87RT |
87 87PR 87RT |
100 | HIVDB |
| Delatorre (2017) | HIV-1 Genetic Diversity in Northeastern Brazil: high prevalence of non-B subtypes | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 140 140PR 140RT |
140 140PR 140RT |
100 | HIVDB |
| Delaugerre (2003) | SELECTION of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF | J. Clin. Virol. 32 (3), 241-244 (2005) | 1e-142 | 1 1RT |
1 1RT |
100 | HIVDB |
| Delaugerre (2011) | HIV-1 group N: travelling beyond Cameroon. | Lancet. 2011 Nov 26;378(9806):1894. | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Delfino (2020) | High frequency of hepatitis D virus and coinfections with different hepatitis B virus serological markers in hospital patients from Argentina | Unpublished | 0 | |
11 11IN |
0 | Case report(s) / study subset |
| Delgado (2008) | High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study. | JAIDS | 0 | 207 207PR 207RT |
207 207PR 207RT |
100 | HIVDB |
| Delgado (2001) | ANALYSIS of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study | AIDS Res. Hum. Retroviruses 17 (8), 753-758 (2001) | 0 | 199 100PR 100RT 1IN |
199 100PR 100RT 1IN |
100 | HIVDB |
| Delgado (2002) | IDENTIFICATION of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure | J. Acquir. Immune Defic. Syndr. 29 (5), 536-543 (2002) | 0 | 9 9PR 9RT 9IN |
9 9PR 9RT 9IN |
100 | HIVDB |
| Delgado (2010) | Identification of a new HIV-1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile | AIDS Res Hum Retroviruses. 2010 Jul;26(7):821-6. | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Delgado (2013) | Direct Submission | Submitted (24-OCT-2012) Biology and Variability of | 0 | |
12 11PR 12RT 11IN |
0 | Unpublished - Final |
| Delgado (2015) | Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe | PLoS ONE 10 (11), E0143325 (2015) | 0 | 62 62PR 61RT 16IN |
91 91PR 91RT 16IN |
68 | HIVDB |
| Delgado (2017) | Near full-length genomes of HIV-1 isolate deposited at NIBSC | Unpublished | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Delgado (2019) | Diverse HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain | Front Microbiol 10, 655 (2019) | 0 | |
179 179PR 179RT 5IN |
0 | Pending |
| Delgado (2019) | Direct Submission | Submitted (01-JUN-2019) Centro Nacional de Microbi | 0 | |
73 73PR 73RT |
0 | Unpublished |
| Delgado (2021) | Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America | Sci Rep 11 (1), 11442 (2021) | 0 | |
22 22PR 22RT 5IN |
0 | Case report(s) / study subset |
| Delgado (2025) | Direct Submission | Submitted (02-JUL-2025) Centro Nacional de Microbi | 0 | |
10 10PR 10RT 8IN |
0 | Unpublished |
| Delobel (2004) | EVIDENCE for compartmentalization of human immunodeficiency virus type 1 in different blood cell types during prolonged suppressive antiretroviral therapy | 16227781 | 1e-129 | |
212 212RT |
0 | Quasispecies |
| Delwart (2011) | Genetic Diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. | J Infect Dis | 0 | 319 319PR 319RT |
321 321PR 321RT |
99 | HIVDB |
| Demarest (2009) | Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism | Antimicrob. Agents Chemother. 53 (3), 1116-1123 (2 | 0 | |
16 16PR 16RT |
0 | Case report(s) / study subset |
| Dementeva (2020) | Prevalence and spatiotemporal dynamics of the HIV-1 circulating recombinant form 03_AB (CRF03_AB) in the former Soviet Union countries | 33095842 | 0 | 61 61PR 61RT |
61 61PR 61RT |
100 | HIVDB |
| Demeter (2000) | DELAVIRDINE susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) | Antimicrob. Agents Chemother. 44 (3), 794-797 (2000) | 4e-96 | 67 67RT |
67 67RT |
100 | HIVDB |
| Demeter (2001) | IMPACT of Clinical Reverse Transcriptase Sequences on the Replication Capacity of HIV-1 Drug-Resistant Mutants | 11437654 | 4e-96 | |
15 15RT |
0 | Laboratory/experimental isolate |
| Deng (2010) | Molecular tracing of HIV type 1 transmission in Hainan province of China | AIDS. 2009 May 15;23(8):977-85 | 0 | |
1 1PR 1RT |
0 | HIVDB |
| Deng (2016) | Molecular tracing of HIV type 1 transmission in Hainan province of China | 19359980 | 0 | 82 82PR 82RT |
82 82PR 82RT |
100 | HIVDB |
| Deng (2025) | Changes in HIV-1 molecular epidemiology, antiviral drug resistance patterns, and socio-demographics among blood donors in Northeastern China between 2011 and 2024 | Unpublished | 1.95e-156 | |
200 200RT |
0 | Unpublished |
| Dennis (2017) | Direct Submission | Submitted (05-FEB-2017) Medicine, University of No | 0 | 425 425PR 425RT |
425 425PR 425RT |
100 | HIVDB |
| Dennis (2012) | Phylogenetic insights into HIV transmission in North Carolina | AIDS (2012) In press | 0 | 1238 1238PR 1238RT |
1373 1373PR 1373RT |
90 | HIVDB |
| Dennis (2018) | HIV-1 transmission clustering and phylodynamics highlight the important role of young men who have sex with men | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 2915 2911PR 2913RT |
2915 2911PR 2913RT |
100 | HIVDB |
| Derache (2006) | GENETIC Diversity and Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 from Untreated Patients in Bamako, Mali | Antivir. Ther. (Lond.) (2007) In press | 1.42e-156 | 98 97PR 96RT |
98 97PR 96RT |
100 | HIVDB |
| Derache (2008) | EVOLUTION of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 | J. Antimicrob. Chemother. 62 (3), 456-463 (2008) | 1.78e-167 | 193 193PR 186RT |
193 193PR 186RT |
100 | HIVDB |
| Derache (2014) | HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program | 25635815 | 0 | 123 119PR 123RT |
178 173PR 178RT |
69 | HIVDB |
| Derache (2018) | Impact of HIV pre-treatment drug resistance on virological outcomes in the ANRS 12249 treatment as prevention trial | 30321314 | 0 | 1148 1148PR 1148RT |
1148 1148PR 1148RT |
100 | HIVDB |
| Deris (2011) | Direct Submission | Submitted (17-NOV-2011) Department of Medical Micr | 7e-177 | 26 26PR 26RT |
61 61PR 61RT |
42 | HIVDB |
| Deris (2012) | Genotype testing and antiretroviral resistance patterns in HIV-1 children failing treatment in Kelantan, Malaysia | 22729198 | 1.7e-164 | 18 18PR 18RT |
18 18PR 18RT |
100 | HIVDB |
| Deris (2014) | Direct Submission | Submitted (17-NOV-2013) Department of Medical Micr | 5.54e-178 | |
36 36PR 36RT |
0 | ArV Rx and/or other data are N/A |
| Deroo (2002) | HIV-1 subtypes in Luxembourg, 1983-2000 | AIDS 16 (18), 2461-2467 (2002) | 1e-133 | |
568 284PR 284RT |
0 | ARV Rx and/or other data are N/A |
| Desai (2008) | DIRECT Submission | Submitted (05-AUG-2008) Department of Neurovirology, Nationa | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Desai (2009) | Molecular characterization of a full-length genome of a HIV-2 isolate from India. | J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):329-35. | 5.65e-27 | |
1 1PR 1IN |
0 | HIVDB |
| Desai (2016) | Direct Submission | Submitted (31-AUG-2006) Neurovirology, National In | 1.65e-21 | |
2 2PR |
0 | Case report(s) / study subset |
| Desai (2000) | MOLECULAR cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences | Proc. Natl. Acad. Sci. U.S.A. 83 (21), 8380-8384 (1986) | 6e-74 | |
2 2PR |
0 | Gene fragment(s) |
| Descamps (1997) | SUSCEPTIBILITY of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses | J. Virol. 71 (11), 8893-8898 (1997) | 3e-19 | 10 10PR 10RT |
10 10PR 10RT |
100 | HIVDB |
| Descamps (2011) | Direct Submission | Submitted (16-DEC-2010) Laboratoire de Virologie, | 0 | 465 465RT |
573 573RT |
81 | HIVDB |
| Deshpande (2004) | MOLECULAR characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations | AIDS Res. Hum. Retroviruses 20 (9), 1032-1035 (2004) | 1e-146 | 248 122PR 126RT |
248 122PR 126RT |
100 | HIVDB |
| Deshpande (2009) | Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008 | AIDS Res. Hum. Retroviruses 25 (6), 633-635 (2009) | 2e-173 | 383 383RT |
383 383RT |
100 | HIVDB |
| Deshpande (2010) | Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines | AIDS Res. Hum. Retroviruses 26 (3), 343-350 (2010) | 9e-171 | 27 27RT |
27 27RT |
100 | HIVDB |
| Deshpande (2011) | Drug Resistance Mutations in HIV Type 1 Isolates from Naive Patients Eligible for First Line Antiretroviral Therapy in JJ Hospital, Mumbai, India | AIDS Res. Hum. Retroviruses 27 (12), 1345-1347 (20 | 5e-172 | 101 50PR 51RT |
101 50PR 51RT |
100 | HIVDB |
| Desire (2001) | QUANTIFICATION of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay | J. Clin. Microbiol. 39 (4), 1303-1310 (2001) | 0.000000000000003 | |
16 16RT 16IN |
0 | Gene fragment(s) |
| Deuba (2021) | Virological failure and HIV-1 drug resistance among ART-experienced people living with HIV in Nepal: a nationally representative surveillance study | 37709138 | 0 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Deuzing (2014) | Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses. | J Virol. 2015 Jan;89(1):833-43. | 0 | 72 72RT |
74 74RT |
97 | HIVDB |
| Devereux (1999) | RAPID decline in detectability of HIV-1 drug resistance mutations after stopping therapy | AIDS 13 (18), 123-127 (1999) | 1e-128 | |
48 47PR 43RT |
0 | Quasispecies |
| Devereux (1999) | SUBSTANTIAL correlation between HIV-1 drug-associated resistance mutations detected in plasma and peripheral blood mononuclear cells in heavily treated patients | 10933616 | 3.77e-166 | |
114 76PR 76RT |
0 | Quasispecies |
| Devereux (2000) | REDUCTION in human immunodeficiency virus type 1 mutations associated with drug resistance after initiating new therapeutic regimens in pretreated patients | J. Infect. Dis. 181 (5), 1804-1807 (2000) | 1.16e-166 | |
120 80PR 80RT |
0 | Quasispecies |
| Devereux (2000) | IN vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution | J. Med. Virol. 66 (1), 8-12 (2002) | 1e-122 | |
213 122PR 91RT |
0 | Quasispecies |
| Devereux (2001) | REPLICATIVE fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations | J. Med. Virol. 65 (2), 218-224 (2001) | 1e-124 | |
27 27PR 27RT |
0 | Quasispecies |
| Dewhurst (1993) | SEQUENCE analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 | Nature 345 (6276), 636-640 (1990) | 1e-101 | |
5 2PR 2RT 5IN |
0 | Laboratory/experimental isolate |
| Deymier (2015) | Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance | PLoS Pathog. 11 (9), E1005154 (2015) | 0 | |
156 156PR 156RT 156IN |
0 | Quasispecies |
| Dhummakupt (2025) | Direct Submission | Submitted (23-MAY-2025) Pediatric Infectious Disea | 0 | |
5 5PR 5RT 5IN |
0 | Unpublished |
| Di Giallonardo (2019) | Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia | Viruses 11 (5), E482 (2019) | 0 | |
70 69PR 70RT |
0 | Pending |
| Di Giallonardo (2021) | Increased HIV Subtype Diversity Reflecting Demographic Changes in the HIV Epidemic in New South Wales, Australia | Viruses 12 (12), E1402 (2020) | 3.26e-151 | 235 235RT |
235 235RT |
100 | HIVDB |
| Di Giallonardo (2021) | Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia | J Int AIDS Soc 24 (1), e25655 (2021) | 0 | 347 347PR 347RT |
347 347PR 347RT |
100 | HIVDB |
| Diallo (2003) | THE M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates | Antimicrob. Agents Chemother. 47 (7), 2376-2379 (2003) | 1e-135 | |
6 3PR 3RT |
0 | Laboratory/experimental isolate |
| Diallo (2012) | Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country | Int J Mol Epidemiol Genet 3 (1), 56-65 (2012) | 2e-179 | 76 76PR 76RT |
152 152PR 152RT |
50 | HIVDB |
| Diallo (2015) | Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria | AIDS Res. Hum. Retroviruses 31 (5), 564-575 (2015) | 1.79e-173 | 267 267PR 267RT |
267 267PR 267RT |
100 | HIVDB |
| Diamond (2002) | MONITORING Fidelity Change of Simian Immunodeficiency Virus Reverse Transcriptase (RT) During the Course of Viral Infection: A New RT Mutation Responsible for In Vivo RT Fidelity Change | Unpublished | 0.017 | |
2 2RT |
0 | Laboratory/experimental isolate |
| Diamond (2016) | Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection | J. Biol. Chem. 276 (26), 23624-23631 (2001) | 7.78e-167 | |
1 1RT |
0 | NHPL/SIV |
| Diamond (2024) | No Antagonism or Cross Resistance and a High Barrier to the Emergence of Resistance In Vitro for the Combination of Islatravir and Lenacapavir | Antimicrob Agents Chemother (Bethesda) (2024) In p | 0 | |
374 374RT |
0 | Pending |
| Diaz (2007) | High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil | 17328661 | 4.75e-129 | 142 73PR 69RT |
143 74PR 69RT |
99 | HIVDB |
| Diaz (2008) | SELECTIVE regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic | Virology 381 (2), 184-193 (2008) | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Diaz (2015) | The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use | PLoS ONE 10 (10), E0139677 (2015) | 0 | 7491 7486PR 7444RT |
7491 7491PR 7491RT |
100 | HIVDB |
| Dietrich (1997) | A highly divergent HIV-2-related isolate | Nature 342 (6252), 948-950 (1989) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Dietrich (2015) | Genetic Characterization of Near Full Length SIVdrl Genomes from Four Captive Drills (Mandrillus leucophaeus) | AIDS Res. Hum. Retroviruses 31 (3), 353-357 (2015) | 0 | |
4 4PR 4RT 4IN |
0 | NHPL/SIV |
| Dieudonne (2005) | HIGH prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates | Invest. Clin. 47 (1), 27-34 (2006) | 1e-145 | |
30 22PR 30RT |
0 | ARV Rx and/or other data are N/A |
| Digban (2018) | Direct Submission | Submitted (22-JAN-2018) Microbiology and Biochemis | 0 | 62 18PR 12RT 32IN |
128 52PR 44RT 32IN |
48 | HIVDB |
| Digban (2019) | Direct Submission | Submitted (27-FEB-2019) Microbiology and Biochemis | 0 | 16 16IN |
16 16IN |
100 | HIVDB |
| Dilernia (2007) | HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina | AIDS Res. Hum. Retroviruses 23 (10), 1201-1207 (2007) | 0 | 283 283PR 283RT |
283 283PR 283RT |
100 | HIVDB |
| Dinesha (2016) | Genotypic HIV-1 drug resistance among patients failing Tenofovir based first-line HAART in South India | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 167 167RT |
167 167RT |
100 | HIVDB |
| Diniz (2017) | Dolutegravir has a highly potent activity against most primary HIV-2 isolates including those that are resistant to raltegravir | Unpublished | 2.39e-129 | 16 16IN |
16 16IN |
100 | HIVDB |
| Diop-Ndiaye (2010) | Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal | AIDS Res. Hum. Retroviruses 26 (10), 1133-1138 (20 | 0 | 125 125PR 125RT |
125 125PR 125RT |
100 | HIVDB |
| Diop-Ndiaye (2016) | HIV-1 epidemiology trends and primary drug resistance in men having sex with men in Senegal | 24035811 | 0 | 70 70PR 70RT |
70 70PR 70RT |
100 | HIVDB |
| Diop-Ndiaye (2025) | Direct Submission | Submitted (12-JUL-2025) Bacteriology-Virology, Che | 4.13e-177 | |
63 11PR 63RT |
0 | Unpublished |
| Diop-Ndiaye (2025) | Direct Submission | Submitted (14-JUL-2025) Bacteriology-Virology, Che | 0 | |
16 16IN |
0 | Unpublished |
| Diouara (2014) | Use of dried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal | 24122937 | 5.09e-180 | 43 25PR 43RT |
113 87PR 113RT |
38 | HIVDB |
| Diouara (2014) | Virological monitoring of antiretroviral treatment in HIV-1 infected patients followed in decentralized settings in three West Africa countries (Senegal, Mali and Republic of Guinea) | 25527333 | 2.28e-180 | 30 17PR 30RT |
30 17PR 30RT |
100 | HIVDB |
| Diphoko (2018) | Prevalence of Rilpivirine and Etravirine resistance mutations in HIV-1 Subtype C-infected patients failing non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy in Botswana | 29732907 | 0 | 168 168PR 168RT |
168 168PR 168RT |
100 | HIVDB |
| Ditshwanelo (2020) | Validation of an affordable and sensitive house HIV-1 subtype C integrase genotyping assay | 31751353 | 0 | 5 5IN |
22 22IN |
22 | HIVDB |
| Djojosugito (2024) | Narra J | 39816057 | 1.94e-173 | |
117 112PR 1RT 4IN |
0 | Pending |
| Djojosugito (2024) | Direct Submission | Submitted (27-AUG-2024) Medical Microbiology, Univ | 6.95e-180 | |
222 114RT 108IN |
0 | Pending |
| Djoko (2016) | HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea | AIDS Res. Hum. Retroviruses 26 (9), 1027-1031 (201 | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Djoko (2016) | High HIV Type 1 Group M pol Diversity and Low Rate of Antiretroviral Resistance Mutations Among the Uniformed Services in Kinshasa, Democratic Republic of the Congo | AIDS Res. Hum. Retroviruses 27 (3), 323-329 (2011) | 0 | 94 94PR 94RT |
94 94PR 94RT |
100 | HIVDB |
| Dlamini (2016) | Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa | J. Acquir. Immune Defic. Syndr. 58 (3), 304-308 (2 | 0 | 61 55PR 61RT |
61 55PR 61RT |
100 | HIVDB |
| Do (2017) | An alarmingly high proportion of anti-retroviral drugs resistant HIV-1 infection among high risk groups in central Vietnam: A sub-study of the national sentinel survey | Jpn. J. Infect. Dis. (2017) In press | 5.31e-170 | 40 40PR 40RT |
40 40PR 40RT |
100 | HIVDB |
| Dong (2020) | First detection of a HIV-1 CRF01_AE/08_BC Circulating Recombinant Form with Drug Resistant mutations Identified in Sichuan, China | 32370607 | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Dong (2025) | Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China | Unpublished | 0 | |
50 50IN |
0 | HIVDB |
| Dong (2025) | Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China | Unpublished | 0 | |
19 19PR 19RT |
0 | HIVDB |
| Dong (2016) | Near Full-Length Genomic Characterization of a Novel HIV type 1 CRF01_AE/CRF07_BC Recombinant form Transmitted between a Heterosexual Couple in Guangxi, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Dorazehi (2022) | A survey of Integrase Drug-Resistance Mutations in INSTI-Naive Patients, in Iran | Unpublished | 1.04e-166 | |
26 26IN |
0 | Unpublished |
| Dos Anjos Silva (2015) | HIV-1 Genetic Diversity and Transmitted Drug Resistance in Antiretroviral Treatment-Naive Individuals from Amapa State, Northern Brazil | AIDS Res. Hum. Retroviruses (2015) In press | 6.12e-173 | 97 97PR 97RT |
97 97PR 97RT |
100 | HIVDB |
| Dos Ramos Farias (2012) | HIV, HBV and HCV molecular epidemiology among trans (transvestites, transsexuals and transgender) sex workers in Argentina | 21742530 | 0 | |
62 61PR 62RT |
0 | ARV Rx and/or other data are N/A |
| Dos Santos (2016) | Molecular epidemiology of B-clade HIV-1 strains in the Caribbean | Unpublished | 2.26e-152 | |
413 413RT |
0 | Unpublished - Final |
| Doualla-Bell (2007) | HIGH prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens | Antimicrob. Agents Chemother. 50 (12), 4182-4185 (2006) | 1e-176 | 23 23RT |
25 25RT |
92 | HIVDB |
| Dourado (2005) | HIV in the general population of an urban center in northeast Brazil | Unpublished | 2e-57 | |
6 6PR |
0 | Case report(s) / study subset |
| Dow (2019) | HIV-1 Antiretroviral Therapy Resistance Mutations in an Adolescent Tanzanian Cohort | 30724834 | 4.49e-150 | |
72 72PR 71RT |
0 | Pending |
| Dow (2017) | HIV Resistance with Correlation to PMTCT Regimen in HIV-Infected Infants in Northern Tanzania | 28797181 | 8.43e-156 | 67 67PR 67RT |
67 67PR 67RT |
100 | HIVDB |
| Dowling (2002) | FORTY-ONE near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants | AIDS 16 (13), 1809-1820 (2002) | 1e-166 | 41 41PR 41RT 41IN |
41 41PR 41RT 41IN |
100 | HIVDB |
| Dragas (2022) | Evolutionary insight into the HIV epidemic in Montenegro through phylogenetic and statistical approach | Unpublished | 5.52e-165 | |
58 58PR 58RT |
0 | Transmission cluster |
| Dragoni (2023) | Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones | J Clin Invest (2023) In press | 0 | |
148 148PR 3RT 3IN |
0 | Proviral DNA Reservoir |
| Drexler (2006) | RATES of and Reasons for Failure of Commercial Human Immunodeficiency Virus Type 1 Viral Load Assays in Brazil | J. Clin. Microbiol. 45 (6), 2061-2063 (2007) | 1.89e-154 | |
19 19PR 19RT |
0 | Case report(s) / study subset |
| Du (2017) | Phylogeographical Analysis Reveals Distinct Sources of HIV-1 and HCV Transmitted to Former Blood Donors in China | AIDS Res. Hum. Retroviruses 33 (3), 284-289 (2017) | 0 | |
19 19PR 19RT |
0 | Case report(s) / study subset |
| Duan (2001) | INHIBITION of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates | J. Infect. Dis. 184 (10), 1336-1340 (2001) | 5e-89 | |
2 2RT |
0 | Laboratory/experimental isolate |
| Duan (2025) | Identification of a novel HIV-1 circulating recombinant form in Henan, China | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report (Small sample size) |
| Dube (2023) | Spontaneous HIV expression in CD4+ T cells during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells | 37708853 | 0 | |
34 34PR 30RT 25IN |
0 | Proviral DNA Reservoir |
| Duerr (2020) | Shaping immune responses in epidemiologically linked HIV-1 transmission and superinfection | Unpublished | 2.49e-113 | |
18 18RT |
0 | Unpublished |
| Duette (2022) | Direct Submission | Submitted (14-DEC-2021) Centre for Virus Research, | 0 | |
161 149PR 150RT 100IN |
0 | Proviral DNA Reservoir |
| Dufour (2022) | Single cell proviral sequencing reveals the phenotypic diversity of clonally expanded HIV reservoir cells during ART | Unpublished | 0 | |
582 520PR 565RT 526IN |
0 | Proviral DNA Reservoir |
| Dufour (2022) | Near full length proviral sequencing in multiple anatomical compartments collected post-mortem reveals multiple clonal expansions shared among various deep tissues that persist during ART | Unpublished | 0 | |
331 320PR 315RT 252IN |
0 | Proviral DNA Reservoir |
| Dumans (2002) | PREVALENCE of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil | Antimicrob. Agents Chemother. 46 (9), 3075-3079 (2002) | 1e-129 | 101 54PR 47RT |
102 55PR 47RT |
99 | HIVDB |
| Dumans (2004) | SYNONYMOUS Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance | J. Infect. Dis. 189 (7), 1232-1238 (2004) | 0 | 184 82PR 129RT |
188 84PR 131RT 1IN |
97 | HIVDB |
| Dumans (2007) | DISTINCT resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure | Infect. Genet. Evol. 9 (1), 62-70 (2009) | 0 | 158 158PR 95RT |
184 174PR 112RT |
85 | HIVDB |
| Dunne (2001) | COMPARISON of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs | AIDS 15 (12), 1471-1475 (2001) | 1e-124 | 17 17PR 17RT |
17 17PR 17RT |
100 | HIVDB |
| Duque (1999) | Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. | Clin Microbiol Infect | 1e-126 | 29 29PR |
31 31PR |
93 | HIVDB |
| Duque (2002) | THERAPEUTICS failure: Portuguese Cohort | Unpublished | 1e-128 | 104 104RT |
316 212PR 104RT |
32 | HIVDB |
| Duque (2002) | HUMAN immunodeficiency virus type 1 M36TV insertion in protease sequence | Unpublished | 1e-78 | |
2 2PR |
0 | Case report(s) / study subset |
| Durkin (2020) | Pooled CRISPR Inverse PCR sequencing (PCIP-seq): simultaneous sequencing of viral insertion points and the integrated virus in thousands of cells with long reads | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Dutta Choudhury (2009) | Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients | 20180140 | 7e-169 | |
30 30RT |
0 | Case report(s) / study subset |
| Dvali (2010) | Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia | J. Med. Virol. 84 (7), 1002-1008 (2012) | 6.28e-149 | 62 62PR 62RT |
62 62PR 62RT |
100 | HIVDB |
| Dvali (2014) | Characterization of HIV-1 subtypes and drug resistance mutations among infected individuals in Georgia | 22585715 | 3.32e-145 | 91 91PR 91RT |
91 91PR 91RT |
100 | HIVDB |
| Dykes (2004) | DETECTION of Minority Drug-Resistant Variants of HIV-1 During Virologic Failure of Zidovudine (ZDV), Lamivudine (3TC), and Indinavir (IDV) | 14999613 | 0 | |
270 270PR 212RT |
0 | Quasispecies |
| Dzissyuk (2011) | Direct Submission | Submitted (16-DEC-2010) Science, Republican Center | 3e-60 | |
49 49PR |
0 | ARV Rx and/or other data are N/A |
| Dzissyuk (2013) | Short communication: molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces. | AIDS Res Hum Retroviruses. 2014 Aug;30(8):769-74. | 0 | 267 155PR 162RT |
269 157PR 162RT |
99 | HIVDB |
| Dzissyuk (2013) | Analysis of pol gene of HIV-1 variants circulating in Kazakhstan | Unpublished | 1.91e-162 | |
2 2RT |
0 | ARV Rx and/or other data are N/A |
| Dzissyuk (2016) | Direct Submission | Submitted (21-MAR-2011) Science, Republican Center | 4.11e-160 | |
46 1PR 45RT |
0 | ARV Rx and/or other data are N/A |
| Eberle (2008) | SEQUENCE of a HIV-1 Subtype F that is underquantified by Roche COBAS TaqMan and COBAS Amplicor Virus Load Tests | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Eberle (2013) | Human immunodeficiency virus type 2 infections in Austria. | Wien Klin Wochenschr. 2014 Apr;126(7-8):212-6. | 2e-128 | 12 7PR 7RT 5IN |
12 7PR 7RT 5IN |
100 | HIVDB |
| Eberle (2016) | Sequence of the gag gene of a HIV-1 Subtype A1 that is underquantified by Roche COBAS TaqMan | Unpublished | 0.000000000747 | |
1 1PR |
0 | Gene fragment(s) |
| Edmonson (1998) | EVOLUTION of a simian immunodeficiency virus pathogen | J. Virol. 72 (1), 405-414 (1998) | 4e-22 | |
1 1IN |
0 | Laboratory/experimental isolate |
| Edoul (2020) | High HIV burden and recent transmission chains in rural forest areas in southern Cameroon, where ancestors of HIV-1 have been identified in ape populations | Infect. Genet. Evol. 84 (2020) In press | 0 | 188 188PR 187RT |
188 188PR 188RT |
100 | HIVDB |
| Egger (2025) | HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST) | BMJ Open 14 (8), e085819 (2024) | 0 | 27 16PR 16RT 11IN |
53 29PR 29RT 24IN |
50 | HIVDB |
| Egger (2025) | HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST) | BMJ Open 14 (8), e085819 (2024) | 0 | |
163 82PR 82RT 81IN |
0 | HIVDB |
| Ekollo Mbange (2018) | Direct Submission | Submitted (15-JAN-2018) Centre Hospitalier Univers | 3.22e-171 | 85 37PR 85RT |
85 37PR 85RT |
100 | HIVDB |
| Ekollo Mbange (2020) | Direct Submission | Submitted (14-JAN-2018) Centre Hospitalier Univers | 8.69e-168 | 27 19PR 27RT |
27 19PR 27RT |
100 | HIVDB |
| Ekollo Mbange (2024) | Direct Submission | Submitted (11-DEC-2018) Centre Hospitalier Univers | 0 | |
59 44PR 59RT |
0 | Pending |
| Ekushov (2024) | Characterization of a new HIV-1 second-generation circulating recombinant form CRF173_63A6 in Jewish Autonomous Region of Russia | Unpublished | 0 | |
19 19PR 19RT 19IN |
0 | Case report(s) / study subset |
| El Annaz (2010) | Presence of drug resistance mutations among drug-naive patients in Morocco | AIDS Res. Hum. Retroviruses (2010) In press | 2e-173 | 165 83PR 82RT |
165 83PR 82RT |
100 | HIVDB |
| El Annaz (2011) | Drug Resistance Mutations in HIV Type 1 Isolates from Patients Failing Antiretroviral Therapy in Morocco | AIDS Res. Hum. Retroviruses 28 (8), 944-948 (2012) | 3e-180 | 90 45PR 45RT |
90 45PR 45RT |
100 | HIVDB |
| El Moussi (2014) | Genetic Diversity of HIV-1 in Tunisia | 27473255 | 0 | 196 196PR 196RT |
196 196PR 196RT |
100 | HIVDB |
| El-Badry (2020) | Better viral control despite higher CD4+ T cell activation during acute HIV-1 infection in Zambian women is linked to the sex hormone estradiol | J. Virol. (2020) In press | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| El-Daly (2020) | Direct Submission | Submitted (18-JUN-2019) Special Infectious Agents | 4.94e-179 | 57 57PR 57RT |
57 57PR 57RT |
100 | HIVDB |
| El-Khatib (2011) | Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa | AIDS 24 (11), 1679-1687 (2010) | 3e-175 | 129 47PR 129RT |
129 47PR 129RT |
100 | HIVDB |
| El-Khatib (2011) | Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa | J AIDS Clin Res 2 (117) (2011) | 1e-171 | |
12 12RT |
0 | Case report(s) / study subset |
| Ellenberger (1997) | Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. | ARHR | 7e-86 | 20 20PR |
23 23PR |
86 | HIVDB |
| Ellis (2009) | Increased detection of HIV-1 drug-resistance at primary diagnosis in peripheral blood cells compared to plasma | 20181911 | 0 | |
65 65PR 65RT |
0 | Quasispecies |
| Ellis (2011) | Selection of HIV Resistance Associated with Antiretroviral Therapy (ART) Initiated due to Pregnancy and Suspended Postpartum | J Acquir Immune Defic Syndr (2011) | 0 | |
42 42PR 42RT |
0 | Case report(s) / study subset |
| Elodie Teclaire (2021) | Increased resistance to Tenofovir in patients experiencing treatment failure in First line HIV treatment in Cameroon between 2014 and 2016 following the WHO 2013 recommendations | Unpublished | 3.81e-175 | |
53 53RT |
0 | Unpublished |
| Engelbrecht (2013) | The molecular characterization of HIV-1 in a Cape Town cohort investigated for HAND | Unpublished | 0 | |
47 47PR 47RT |
0 | ARV Rx and/or other data are N/A |
| Engelbrecht (2013) | HIV-1 subtypes B and C Unique Recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa | 24609015 | 2e-178 | 65 52PR 57RT |
65 53PR 65RT |
100 | HIVDB |
| Engelbrecht (2014) | Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes A, B, G and unique recombinant AC and AD viral strains identified in South Africa | 25492033 | 0 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Engelbrecht (2018) | Near full-length HIV-1 subtype B sequences from the early South African epidemic, detecting a BD unique recombinant form from 1985 | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| English (2011) | Transmission of highly distinct HIV-1 variants from a single donor | 21736738 | 5e-174 | |
67 67RT |
0 | Case report(s) / study subset |
| Engone-Ondo (2021) | High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy | J Antimicrob Chemother (2021) In press | 1.92e-124 | 45 45RT |
45 45RT |
100 | HIVDB |
| Engone-Ondo (2022) | Direct Submission | Submitted (01-MAR-2022) Virology, International Ce | 4.99e-169 | 98 98IN |
100 100IN |
98 | HIVDB |
| Eremin (2019) | Molecular epidemiology of HIV-1 subtype A6 in Belarus | Unpublished | 0 | |
105 105PR 105RT |
0 | Unpublished |
| Eremin (2010) | CRF02_A/G isolated from patient on HAART with NRTIs and NNRTIs high level resistance | Unpublished | 1e-178 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Eremin (2010) | Genotyping HIV-1 isolated from HIV-infected children born to HIV-infected mothers | 21534848 | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Eremin (2012) | HIV-1 molecular epidemiology in Belarus, 2008-2011 | Unpublished | 0 | |
203 203PR 203RT |
0 | ARV Rx and/or other data are N/A |
| Eremin (2014) | HIV subtypes in Belarus | Unpublished | 0 | |
37 37PR 37RT |
0 | Pending |
| Eremin (2016) | HIV-1 subtype A with high level resistance to NRTIs and NNRTIs | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Eron (1998) | RESISTANCE of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission | AIDS 12 (15), F181-F189 (1998) | 1e-130 | |
59 59PR 59RT |
0 | Quasispecies |
| Escoto-Delgadillo (2007) | DRUG-RESISTANCE mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico | HIV Med. 6 (6), 403-409 (2005) | 3.83e-152 | 46 38PR 8RT |
83 54PR 45RT |
55 | HIVDB |
| Eshleman (2001) | IMPACT of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study) | J. Infect. Dis. 184 (7), 914-917 (2001) | 1e-110 | 102 102PR 102RT |
102 102PR 102RT |
100 | HIVDB |
| Eshleman (2001) | ANALYSIS of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) | J. Infect. Dis. 183 (12), 1732-1738 (2001) | 1e-129 | 229 229PR 229RT |
229 229PR 229RT |
100 | HIVDB |
| Eshleman (2002) | SURVIVAL of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) | J. Acquir. Immune Defic. Syndr. 31 (3), 327-330 (2002) | 1e-112 | 54 54PR 54RT |
54 54PR 54RT |
100 | HIVDB |
| Eshleman (2003) | USE of uracil N-glycosylase (UNG) negative Escherichia coli to clone dUTP-containing HIV-1 DNA generated using a commercial HIV-1 genotyping system | 14513567 | 0 | |
20 20PR 20RT |
0 | Laboratory/experimental isolate |
| Eshleman (2004) | CHARACTERIZATION of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) | J. Acquir. Immune Defic. Syndr. 35 (2), 126-130 (2004) | 0 | 178 178PR 178RT |
178 178PR 178RT |
100 | HIVDB |
| Eshleman (2004) | PERFORMANCE of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains | J. Clin. Microbiol. 42 (6), 2711-2717 (2004) | 0 | 124 124PR 124RT |
124 124PR 124RT |
100 | HIVDB |
| Eshleman (2004) | COMPARISON of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 | AIDS Res. Hum. Retroviruses 20 (6), 595-599 (2004) | 0 | 76 76PR 76RT |
78 78PR 78RT |
97 | HIVDB |
| Eshleman (2005) | LIMITED Evolution in the HIV Type 1 pol Region among Acute Seroconverters in Pune, India | AIDS Res. Hum. Retroviruses 21 (1), 93-97 (2005) | 0 | 29 29PR 29RT |
33 33PR 33RT |
87 | HIVDB |
| Eshleman (2005) | NEVIRAPINE (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP | J. Infect. Dis. 192 (1), 30-36 (2005) | 0 | 65 65PR 65RT |
67 67PR 67RT |
97 | HIVDB |
| Eshleman (2005) | DISTINCT patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012 | J. Acquir. Immune Defic. Syndr. 40 (1), 24-29 (2005) | 0 | |
81 81PR 81RT |
0 | Quasispecies |
| Eshleman (2006) | PHENOTYPIC drug resistance patterns in subtype A HIV-1 clones with non-nucleoside reverse transcriptase (NNRTI) resistance mutations | AIDS Res. Hum. Retroviruses (2005) In press | 0 | 35 35PR 35RT |
35 35PR 35RT |
100 | HIVDB |
| Eshleman (2006) | NEVIRIPINE Resistance in Malawian Infants | AIDS. 2005 Dec 2;19(18):2167-9. | 0 | |
78 78PR 78RT |
0 | Pending |
| Eshleman (2007) | ANTIRETROVIRAL drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection | AIDS 21 (9), 1165-1174 (2007) | 0 | 195 195PR 195RT |
195 195PR 195RT |
100 | HIVDB |
| Eshleman (2009) | Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay | AIDS Res. Hum. Retroviruses 25 (3), 343-345 (2009) | 1e-167 | 110 110IN |
120 96RT 120IN |
91 | HIVDB |
| Eshleman (2009) | Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda | AIDS 27 (7), 845-852 (2009) | 0 | 104 104PR 104RT |
104 104PR 104RT |
100 | HIVDB |
| Eshleman (2011) | Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial | J. Infect. Dis. (2011) In press | 0 | |
226 226PR 226RT |
0 | Quasispecies |
| Eshleman (2016) | Treatment as prevention: Characterization of partner infections in the HIV prevention trials network 052 trial | 27532476 | 0 | |
160 160PR 160RT |
0 | ARV Rx and/or other data are N/A |
| Eshleman (2022) | HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention | J Infect Dis (2022) In press | 0 | 162 162IN |
162 162IN |
100 | HIVDB |
| Espinosa (2002) | INTERSUBTYPE BF recombinants of HIV-1 in a population of injecting drug users in Argentina | J. Acquir. Immune Defic. Syndr. 36 (1), 630-636 (2004) | 0 | 21 21PR 21RT |
34 34PR 34RT |
61 | HIVDB |
| Esteban (2021) | Full genome sequence of a Simian immunodeficiency virus infecting a western lowland gorilla (Gorilla gorilla gorilla) with high viral load in stools | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Esteves (2007) | FULL-LENGTH HIV-1 subtype G molecular clone | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Etiebet (2011) | Tenofovir Disoproxil Fumarate based regimens associated with less nucleoside reverse transcriptase inhibitors drug resistance mutations in Nigerian patients failing first-line anti-retroviral therapy | 23079810 | 1.35e-172 | 21 21PR 21RT |
175 175PR 175RT |
12 | HIVDB |
| Etienne (2012) | Non-invasive follow-up of simian immunodeficiency virus infection in wild-living non-habituated western lowland gorillas in Cameroon | J. Virol. (2012) In press | 2e-25 | |
6 6IN |
0 | Gene fragment(s) |
| Etienne (2013) | Single real-time RT-PCR assay for the detection and quantification of genetically diverse HIV-1, SIVcpz and SIVgor viruses | J. Clin. Microbiol. (2013) In press | 1.19e-142 | |
9 9RT |
0 | Case report(s) / study subset |
| Etienne (2016) | Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms | Retrovirology 8 (1), 4 (2011) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Etschel (2012) | HIV-1 mRNA electroporation of PBMC: A simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients | J. Immunol. Methods 380 (1-2), 40-55 (2012) | 0.005 | |
1 1PR |
0 | Gene fragment(s) |
| Evering (2020) | Drug-resistance mutation frequency of SGA-derived HIV-1 polymerase genomes in the CSF and plasma of HIV-1-infected individuals under non-suppressive therapy | 32759323 | 2.44e-163 | |
811 811PR 811RT |
0 | SGS |
| Eyer-Silva (2002) | REMISSION of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy | AIDS 16 (17), 2367-2369 (2002) | 4e-47 | |
1 1PR |
0 | Case report(s) / study subset |
| Eyer-Silva (2006) | MOLECULAR epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies | J. Acquir. Immune Defic. Syndr. 41 (5), 664-670 (2006) | 4.74e-150 | |
58 58PR 58RT |
0 | ARV Rx and/or other data are N/A |
| Eyer-Silva (2007) | MOLECULAR Epidemiology of HIV Type 1 in Inner Rio De Janeiro State, Brazil | AIDS Res. Hum. Retroviruses 23 (2), 303-308 (2007) | 0 | 30 30PR 30RT |
85 85PR 85RT |
35 | HIVDB |
| Eyer-Silva (2008) | AUTOCHTHONOUS horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil | Mem. Inst. Oswaldo Cruz 102 (7), 809-815 (2007) | 0 | 64 64PR 64RT |
64 64PR 64RT |
100 | HIVDB |
| Eyre (2006) | MULTIPLE drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy | Urology 55 (4), 591 (2000) | 6e-59 | |
35 35PR |
0 | Case report(s) / study subset |
| Eyzaguirre (2006) | FIRST Molecular Surveillance Report of HIV Type 1 in Injecting Drug Users And Female Sex Workers along The U.S.-Mexico Border | AIDS Res. Hum. Retroviruses 23 (2), 331-334 (2007) | 1e-149 | |
11 11PR 11RT |
0 | Case report(s) / study subset |
| Eyzaguirre (2007) | Genetic characterization of HIV-1 strains circulating in Kazakhstan | J. Acquir. Immune Defic. Syndr. 46 (1), 19-23 (200 | 0 | 85 85PR 85RT 6IN |
91 91PR 91RT 6IN |
93 | HIVDB |
| Eyzaguirre (2011) | Low HIV-1 viral load associated with increased prevalence of defective proviruses in Natural Viral Suppressors | 23791226 | 0 | |
46 46PR 46RT 46IN |
0 | Case report(s) / study subset |
| Eyzaguirre (2011) | Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations and the comparison with Acute HIV-1 Subtype B Infection | 22357663 | 0 | 14 14PR 14RT 14IN |
14 14PR 14RT 14IN |
100 | HIVDB |
| Ezeonwumelu (2018) | Phylogenetic analysis of an unusual father-to-son HIV-1 transmission case | 30073842 | 0 | |
30 30IN |
0 | Case report(s) / study subset |
| Fabeni (2015) | Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy | PLoS ONE 10 (8), E0135325 (2015) | 0 | |
35 35PR 35RT |
0 | Case report(s) / study subset |
| Fabeni (2020) | Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy | Viruses 12 (8), E791 (2020) | 0 | 726 726PR 726RT |
726 726PR 726RT |
100 | HIVDB |
| Fabeni (2021) | Direct Submission | Submitted (19-JAN-2021) Virology and Biosafety Lab | 1.64e-170 | 229 229PR 229RT |
229 229PR 229RT |
100 | HIVDB |
| Fabeni (2024) | Direct Submission | Submitted (01-MAR-2024) Laboratory of Virology, IN | 0 | 4169 2373PR 2373RT 1796IN |
4169 2356PR 2373RT 1796IN |
100 | HIVDB |
| Fall (2024) | Direct Submission | Submitted (02-FEB-2024) Bacteriology-Virology, Che | 2.36e-180 | |
131 131RT |
0 | Unpublished |
| Fall-Malick (2014) | HIV-1 drug resistance and genetic diversity among the national treated cohort in Mauritania | 24318486 | 0 | 68 58PR 65RT |
68 58PR 67RT |
100 | HIVDB |
| Falloon (2000) | COMBINATION therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity | Clin. Infect. Dis. 30 (2), 313-318 (2000) | 1e-118 | 40 20PR 20RT |
40 20PR 20RT |
100 | HIVDB |
| Fan (2023) | Direct Submission | Submitted (04-JUL-2022) Department of HIV/AIDS Con | 0 | |
1 1PR 1RT 1IN |
0 | Pending |
| Fan (2023) | Direct Submission | Submitted (02-FEB-2023) Clinical Laboratory, The P | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Fan (2023) | Bdd015a | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Fan (2023) | 4 sequences | 38849496 | 0 | |
4 3PR 4RT 4IN |
0 | Pending |
| Fan (2024) | Direct Submission | Submitted (19-NOV-2022) Clinical Laboratory, The P | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Fan (2024) | CRF159_10301 | 38849496 | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Fan (2022) | Characterization of a New HIV-1 CRF01_AE/B Recombinant Virus Form Among Men Who Have Sex with Men inBaoding, Hebei,China | AIDS Res Hum Retroviruses (2022) In press | 0 | |
1 1RT 1IN |
0 | Case report(s) / study subset |
| Fan (2022) | Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China | Front Genet 13, 975397 (2022) | 0 | 127 127IN |
131 131IN |
96 | HIVDB |
| Fang (2000) | GENETIC Variability of the HIV-1 Sequences from Plasma and Cervical Compartments | Unpublished | 1e-164 | |
42 42PR 42RT 18IN |
0 | Quasispecies |
| Fang (2001) | ANALYSIS of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1 | AIDS Res. Hum. Retroviruses 17 (15), 1395-1404 (2001) | 1e-163 | |
10 10PR 10RT 10IN |
0 | Case report(s) / study subset |
| Fang (2004) | LONG-TERM Survivors in Nairobi: Complete HIV-1 RNA Sequences and Immunogenetic Associations | J. Infect. Dis. 190 (4), 697-701 (2004) | 0 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Fang (2002) | PCR-MEDIATED recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA | Nat. Med. 5 (2), 239-242 (1999) | 1e-163 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Fang (2003) | RECOMBINATION following superinfection by HIV-1 | AIDS 18 (2), 153-159 (2004) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Fang (1995) | UNIQUE insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells | J. Virol. 69 (1), 75-81 (1995) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Faria (2012) | Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A | J. Gen. Virol. 93 (PT 4), 889-899 (2012) | 1.67e-127 | 84 84PR 84RT |
84 84PR 84RT |
100 | HIVDB |
| Faria (2019) | Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa | PLoS Pathog. (2019) In press | 0 | |
338 338PR 338RT |
0 | Pending |
| Farinre (2021) | Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa | Retrovirology 18 (1), 11 (2021) | 2.09e-60 | 358 358PR |
369 369PR 3RT |
97 | HIVDB |
| Farrar (1991) | CHARACTERISATION of a series of human immunodeficiency virus isolates derived sequentially from a single patient | J. Med. Virol. 34 (2), 104-113 (1991) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Farrokhi (2015) | Evalution of variations in HIV-1 protease gene sequence in order to provide a mechanism to predict drug resistance in Iran patient | 29026792 | 6e-63 | 27 27PR |
63 63PR |
42 | HIVDB |
| Fayssel (2016) | HIV-1 genotyping and antiretroviral drug-resistance mutations determination among drug-naive individuals infected in Morocco | Unpublished | 5.58e-153 | 240 162PR 78RT |
240 162PR 78RT |
100 | HIVDB |
| Federico (1989) | BIOLOGIC and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate | AIDS Res. Hum. Retroviruses 5 (4), 385-396 (1989) | 1e-165 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Feng (2021) | Direct Submission | Submitted (31-MAY-2021) Faculty of Life Science an | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Feng (2013) | The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s | AIDS 27 (11), 1793-1802 (2013) | 0 | 75 75PR 75RT 75IN |
75 75PR 75RT 75IN |
100 | HIVDB |
| Feng (2023) | Characterization of a Novel HIV-1 Circulating Recombinant Form,CRF01_AE/B'/C, in Yunnan, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Pending |
| Feng (2014) | Identification of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) in Jilin, China | AIDS Res. Hum. Retroviruses 30 (8), 819-822 (2014) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Feng (2016) | Diverse intersubtype recombinants and high frequency of drug-resistance mutations of HIV-1 among newly diagnosed and antiretroviral treatment naive HIV-infected individuals in Baoshan, a western prefecture of Yunnan, China | Unpublished | 0 | 103 103PR 103RT |
103 103PR 103RT |
100 | HIVDB |
| Feng (2025) | Identification of a newly emerging second generation HIV-1 circulating recombinant form | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Unpublished |
| Feng (2014) | Geographic origin and evolutionary history of two closely-related circulating recombinant forms, CRF07_BC and CRF08_BC, in China | 26763952 | 0 | 20 19PR 20RT 20IN |
20 20PR 20RT 20IN |
100 | HIVDB |
| Feng (2014) | Identification of a Novel HIV Type 1 Circulating Recombinant Form (CRF65_cpx) Composed of CRF01_AE and Subtypes B and C in Western Yunnan, China | AIDS Res. Hum. Retroviruses 30 (6), 598-602 (2014) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Feng (2016) | Genomic Characterization of a Novel Circulating Recombinant Form (CRF86_BC) identified from Yunnan, China | 27593341 | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Feng (2018) | First characterization of a novel HIV-1 recombinant form CRF100_01C comprising CRF01_AE and C among heterosexuals in Yunnan, China | 30389423 | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Feng (2020) | HIV-1 CRF85_BC from Yunnan | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Feng (2019) | Untitled | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Fernandez (2006) | FITNESS Landscape of Human Immunodeficiency Virus Type 1 Protease Quasispecies | J. Virol. 81 (5), 2485-2496 (2007) | 4e-60 | |
308 308PR |
0 | Quasispecies |
| Fernandez (2014) | Emergence of novel A/G recombinant HIV-1 strains in Argentina | 25417788 | 1.89e-155 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Fernandez-Garcia (2008) | DEVELOPMENT of a Panel of Well-Characterized Human Immunodeficiency Virus Type 1 Isolates from Newly Diagnosed Patients Including Acute and Recent Infections | AIDS Res. Hum. Retroviruses 25 (1), 93-102 (2009) | 0 | 20 20PR 20RT 20IN |
20 20PR 20RT 20IN |
100 | HIVDB |
| Fernandez-Garcia (2009) | Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia | AIDS Res. Hum. Retroviruses 25 (11), 1187-1191 (20 | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Fernandez-Garcia (2010) | Identification of a new HIV-1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain | AIDS Res. Hum. Retroviruses (2010) In press | 0 | 4 4PR 4RT 2IN |
7 7PR 7RT 2IN |
57 | HIVDB |
| Fernandez-Garcia (2012) | The analysis of near full-length genome sequences of HIV-1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Fernandez-Garcia (2015) | Identification of a new HIV-1 circulating BG intersubtype recombinant form (CRF73_BG) circulating in Portugal and Spain | 26900693 | 0 | 4 4PR 4RT 2IN |
4 4PR 4RT 2IN |
100 | HIVDB |
| Fernandez-Garcia (2017) | Identification of a new HIV-1 BF circulating recombinant form propagating in Bolivia | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Ferradini (2012) | High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia | J Int AIDS Soc 14, 14 (2011) | 6.36e-154 | 45 2PR 43RT |
45 2PR 43RT |
100 | HIVDB |
| Ferrari (2004) | HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians. | Hum Immunol. 2004 Jun;65(6):648-59. | 0.00000008 | |
11 11PR |
0 | Gene fragment(s) |
| Ferrari (2011) | Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection | PLoS Pathog. 7 (2), E1001273 (2011) | 1.15e-143 | |
44 44RT |
0 | Quasispecies |
| Ferre (2022) | Direct Submission | Submitted (20-SEP-2022) Inserm UMR1137, Universite | 0 | |
175 88PR 87RT |
0 | ARV Rx and/or other data are N/A |
| Ferreira (2008) | Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. | Mem Ins Oswaldo Cruz | 0 | 37 37PR 37RT |
37 37PR 37RT |
100 | HIVDB |
| Ferreira (2011) | Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil | J. Med. Virol. 83 (8), 1301-1307 (2011) | 7.31e-176 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| Ferreira (2010) | Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil | AIDS Res. Hum. Retroviruses 26 (2), 229-232 (2010) | 0 | 40 40PR 40RT |
40 40PR 40RT |
100 | HIVDB |
| Ferreira (2010) | Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil | Adv Virol 2013, 878237 (2013) | 1.09e-174 | 3 3PR 3RT |
3 3PR 3RT |
100 | HIVDB |
| Ferreira (2023) | Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regiment | 37292785 | 4.62e-115 | |
1362 1362RT |
0 | Proviral DNA Reservoir |
| Ferreiro (2022) | The evolution of the HIV-1 protease folding stability | Unpublished | 7.77e-65 | |
311 311PR |
0 | Pending |
| Ferrer (2016) | APOBEC could explain low viral load in HIV patient with highly active therapy (HAART) with nucleoside analog reverse-transcriptase inhibitors (NRTIs) and non-nucleoside reverse-transcriptase inhibitors (NNRTIs) resistance but without clinical consequences | Unpublished | 3.39e-159 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Fily F (2018) | HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line. | Trop Med Int Health. | 0 | 69 69PR 69RT |
69 69PR 69RT |
100 | HIVDB |
| Finzi (1997) | IDENTIFICATION of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Science 278 (5341), 1295-1300 (1997) | 1e-124 | |
12 12PR 12RT |
0 | Proviral DNA Reservoir |
| Fischer (2012) | Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages | J. Virol. 86 (24), 13217-13231 (2012) | 0 | |
24 24PR 24RT 24IN |
0 | NHPL/SIV |
| Fischetti (2003) | MOLECULAR epidemiology of HIV in Ghana: dominance of CRF02_AG | J. Med. Virol. 73 (2), 158-166 (2004) | 4e-85 | |
235 235RT |
0 | Gene fragment(s) |
| Fish (2010) | Natural polymorphisms of integrase among HIV type 1-infected South African patients | AIDS Res. Hum. Retroviruses 26 (4), 489-493 (2010) | 1e-163 | 73 73IN |
73 73IN |
100 | HIVDB |
| Fisher (2022) | Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes | 35201897 | 0 | |
1003 890PR 884RT 986IN |
0 | Quasispecies |
| Fisher (2023) | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 | Unpublished | 0 | |
436 414PR 416RT 320IN |
0 | Proviral DNA Reservoir |
| Fisher (2024) | Emergence of genetically distinct HIV-1 populations is associated with transient virological control during analytical interruption of antiretroviral therapy | Unpublished | 0 | |
81 77PR 78RT 67IN |
0 | Unpublished |
| Fisher (2024) | Emergence of genetically distinct HIV-1 populations is associated with transient virological control during analytical interruption of antiretroviral therapy | Unpublished | 0 | |
423 393PR 393RT 419IN |
0 | Proviral DNA Reservoir |
| Fisher (2012) | Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen | J. Virol. 86 (11), 6231-6237 (2012) | 3.29e-179 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Fitzgibbon (1991) | IN vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy | AIDS Res. Hum. Retroviruses 7 (3), 265-269 (1991) | 3e-56 | |
18 18RT |
0 | Case report(s) / study subset |
| Fitzgibbon (1993) | HUMAN immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs | J. Virol. 67 (12), 7271-7275 (1993) | 9e-94 | |
23 23RT |
0 | Case report(s) / study subset |
| Fitzgibbon (1993) | A new type of G-->A hypermutation affecting human immunodeficiency virus | AIDS Res. Hum. Retroviruses 9 (9), 833-838 (1993) | 6e-67 | |
2 2RT |
0 | Case report(s) / study subset |
| Fitzgibbon (1993) | HUMAN immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine | Antimicrob. Agents Chemother. 36 (1), 153-157 (1992) | 8e-54 | 17 17RT |
17 17RT |
100 | HIVDB |
| Fitzgibbon (2001) | EMERGENCE of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens | AIDS Res. Hum. Retroviruses 17 (14), 1321-1328 (2001) | 1e-126 | 51 28PR 23RT |
51 28PR 23RT |
100 | HIVDB |
| Flaherty (1997) | MOLECULAR and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus | J. Virol. 71 (8), 5790-5798 (1997) | 5e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Florea (2012) | HIV transmitted drug resistance in Romania 2007-2010 | Unpublished | 0 | 65 65PR 65RT |
65 65PR 65RT |
100 | HIVDB |
| Flores (1999) | HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America | Emerging Infect. Dis. 5 (3), 481-483 (1999) | 1e-130 | 19 19PR |
19 19PR |
100 | HIVDB |
| Fofana (2023) | Direct Submission | Submitted (13-FEB-2023) Medicine, University of Sc | 0 | 71 71IN |
74 74IN |
95 | HIVDB |
| Fogel (2012) | Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis | AIDS. 2011 Apr | 0 | |
62 61PR 62RT |
0 | Pending |
| Fogel (2016) | HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial | J. Acquir. Immune Defic. Syndr. (2016) In press | 0 | |
185 185PR 185RT |
0 | ARV Rx and/or other data are N/A |
| Fogel (2019) | HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States | AIDS (2019) In press | 0 | 280 142PR 142RT 138IN |
280 142PR 142RT 138IN |
100 | HIVDB |
| Fokam (2012) | Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon | Pediatr. Infect. Dis. J. 30 (12), 1062-1068 (2011) | 0 | 80 80PR 80RT |
80 80PR 80RT |
100 | HIVDB |
| Fokam (2015) | Is There a Need for Third-Line Antiretroviral Regimens in Sub-Saharan Africa. Preliminary Analysis among HIV-infected Individuals in Cameroon | 28034359 | 0 | 57 57PR 57RT |
57 57PR 57RT |
100 | HIVDB |
| Fokam (2015) | Population-based surveillance of HIV-1 drug resistance in Cameroonian adults initiating antireviral therapy displays discrepant levels of mutations based on the recently updated world health organization guidelines | 26602836 | 0 | 53 53PR 53RT |
53 53PR 53RT |
100 | HIVDB |
| Fokam (2016) | Similar Thresholds of Pretreatment HIV-1 Drug Resistance between Urban and Rural Settings in the Littoral Region of Cameroon | Unpublished | 0 | |
45 45PR 45RT |
0 | Unpublished - Final |
| Fokam (2019) | Pre Treatment HIV Drug Resistance | Unpublished | 0 | 104 102PR 101RT |
104 102PR 101RT |
100 | HIVDB |
| Fokam (2019) | Pretreatment HIV Drug Resistance in 3 Cameroonian Regions | Unpublished | 0 | 83 82PR 83RT |
84 83PR 84RT |
98 | HIVDB |
| Fokam (2020) | Multiresistant HIV-1 to Dolutegravir and Darunavir in Cameroon: Lessons and implications in the era of transition to Dolutegravir-based regimens | 32843050 | 0 | |
5 3PR 3RT 2IN |
0 | Pending |
| Fokam (2021) | High effectiveness of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: Toward a successful transition to dolutegravir-based regimens in low and middle-income countries | 34864527 | 0 | |
65 65IN |
0 | Pending |
| Fokam (2022) | Evaluation of circulating and archived HIV-1 integrase drug-resistance variants among patients on third-line ART in Cameroon: implications for dolutegravir-containing regimens in resource-limited settings | Microbiol Spectr (2022) In press | 0 | |
18 18IN |
0 | Pending |
| Fokam (2023) | Direct Submission | Submitted (14-MAY-2023) Virology, Chantal Biya Int | 4.96e-139 | |
466 466PR 466RT |
0 | Pending |
| Fokam (2023) | Direct Submission | Submitted (26-JUL-2023) Virology, Chantal Biya Int | 0 | |
556 553PR 554RT 17IN |
0 | Pending |
| Fokam (2025) | Direct Submission | Submitted (16-JAN-2025) Virology, Chantal Biya Int | 3.2e-151 | |
9 7PR 9RT |
0 | Pending |
| Fokam (2025) | Acquired HIV-1 drug resistance among people failing antiretroviral therapy in Cameroon and implications for future treatment options | Unpublished | 1.15e-175 | |
190 189PR 190RT |
0 | Pending |
| Fomsgaard (1991) | A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey | Virology 182 (1), 397-402 (1991) | 1e-113 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Fomsgaard (2008) | FULL-LENGTH Characterization of A1/D Intersubtype Recombinant Genomes from a Therapy-Induced HIV Type 1 Controller during Acute Infection and His Noncontrolling Partner | AIDS Res. Hum. Retroviruses 24 (3), 463-472 (2008) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Fonjungo (2000) | HUMAN immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features | J. Clin. Microbiol. 40 (3), 837-845 (2002) | 1e-121 | 110 110PR |
111 111PR |
99 | HIVDB |
| Fortuin (2024) | Performance of an in-house multiplex PCR for HIV-1 drug resistance testing - a cheaper alternative | 39303923 | 0 | |
99 45PR 45RT 54IN |
0 | Pending |
| Foster (2012) | Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. | PLoS One. 2014 Jan 15;9(1):e83337. | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Fourati (2012) | E138K and M184I Mutations in HIV-1 Reverse Transcriptase Emerge Concomitantly as a result of APOBEC3 Editing in the Absence of Drug Exposure | 22695298 | 7e-174 | 601 601RT |
601 601RT |
100 | HIVDB |
| Fourati (2012) | HIV Proviral DNA Is Often Defective In PBMCs And Rectal Tissue After Long-Term HAART as a Result of APOBEC3 Editing and Correlates With A Low Size Of Reservoirs | 22687892 | 6.57e-138 | |
577 577RT |
0 | Laboratory/experimental isolate |
| Fourati (2014) | Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments. | AIDS. 2014 Feb 20;28(4):487-91. | 8.62e-164 | |
44 22PR 22RT |
0 | Case report(s) / study subset |
| Frahm (2006) | INCREASED Sequence Diversity Coverage Improves Detection of HIV-Specific T Cell Responses | J. Immunol. 179 (10), 6638-6650 (2007) | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Franca (2017) | HIV among crack cocaine users in one Brazilian region far from the epicenter of the HIV epidemic | Unpublished | 1.09e-170 | |
12 12PR 12RT |
0 | Case report(s) / study subset |
| Franchini (1996) | MOLECULAR and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone | Proc. Natl. Acad. Sci. U.S.A. 86 (7), 2433-2437 (1989) | 1.29e-113 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Franchini (2004) | SEQUENCE of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses | Nature 328 (6130), 539-543 (1987) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Frange (2008) | NEW and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study | 18673538 | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Frange (2012) | Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency | PLoS ONE 7 (2), E31695 (2012) | 0 | 989 7PR 989RT |
990 7PR 990RT |
99 | HIVDB |
| Freitas (2012) | Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in portugal | AIDS Res. Hum. Retroviruses 29 (2), 318-328 (2013) | 0 | |
119 77PR 89RT 3IN |
0 | Gene fragment(s) |
| Frenkel (2002) | MULTIPLE Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy | J. Virol. 77 (10), 5721-5730 (2003) | 1e-135 | |
979 777PR 823RT |
0 | Quasispecies |
| Frenkel (2003) | DRUG-RESISTANT mutants of human immunodeficiency virus type 1 persist at higher concentrations in peripheral blood mononuclear cells compared to plasma and are detected at a higher rate by OLA compared to consensus sequencing | Unpublished | 1e-136 | |
107 57PR 99RT |
0 | ARV Rx and/or other data are N/A |
| Frentz (2012) | Limited cross-border infections in patients newly diagnosed with HIV in Europe | Retrovirology 10, 36 (2013) | 3.08e-178 | 1630 1621PR 1630RT |
1630 1621PR 1630RT |
100 | HIVDB |
| Fujii (2021) | Anti-HBV monotherapy caused M184V/I mutation prior to initiation of antiretroviral therapy in recent years in Japan | Unpublished | 0 | 3350 1757PR 1748RT 1589IN |
3353 1760PR 1760RT 1592IN |
99 | HIVDB |
| Fujisaki (2009) | An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan | AIDS Res. Hum. Retroviruses 25 (1), 15-21 (2009) | 1.3e-168 | 133 133PR 133RT |
133 133PR 133RT |
100 | HIVDB |
| Fukasawa (1999) | SEQUENCE of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group | Nature 333 (6172), 457-461 (1988) | 1e-109 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Fumin (2002) | CLONING and Characterization of a Virtually Full-Length HIV-1 Genome of a Prevalent Subtype B-Thai Strain in Central China | 15650789 | 1e-162 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Fun (2012) | Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity | J. Antimicrob. Chemother. 65 (11), 2300-2304 (2010 | 1e-164 | |
5 5IN |
0 | Case report(s) / study subset |
| Gaballah (2020) | Direct Submission | Submitted (07-MAR-2020) Microbiology Department, A | 1.11e-169 | |
21 21PR 21RT |
0 | Unpublished |
| Gaebler (2019) | Quadruplex qPCR approach facilitates qualitative and quantitative analysis of the HIV-1 latent reservoir | 31350309 | 0 | |
757 757PR 757RT 757IN |
0 | Proviral DNA Reservoir |
| Gaebler (2020) | Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA | 33361426 | 0 | |
3360 3064PR 3135RT 2541IN |
0 | Proviral DNA Reservoir |
| Gaebler (2022) | Prolonged viral suppression with anti-HIV-1 antibody therapy | Nature 606 (7913), 368-374 (2022) | 0 | |
5405 5171PR 5177RT 4472IN |
0 | Proviral DNA Reservoir |
| Gafarova (2008) | Direct Submission | Submitted (19-NOV-2008) Biotechnology, The D.I. Iv | 1e-166 | 43 43IN |
44 1PR 1RT 43IN |
97 | HIVDB |
| Gafarova (2009) | The sequence of fragment of HIV-1 subtype G pol gene from Russia patient 0110 | Unpublished | 1e-177 | |
2 1PR 2RT 1IN |
0 | Case report(s) / study subset |
| Gafarova (2009) | Full sequence of HIV-1 subtype G protease gene, isolated from Russia patient 104 | Unpublished | 5e-49 | |
1 1PR |
0 | Case report(s) / study subset |
| Galimand (2016) | Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort | AIDS Res. Hum. Retroviruses 26 (6), 645-651 (2010) | 3.67e-146 | |
49 49RT |
0 | Case report(s) / study subset |
| Galkin (2004) | FULL-LENGTH Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia | AIDS Res. Hum. Retroviruses 22 (11), 1192-1197 (2006) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Galkin (2006) | SEQUENCING and analysis of full-length HIV-1 CRF06_cpx isolate from Russia | Unpublished | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Galkin (2009) | The study of long-term HAART treatment effect for resistance-connected alterations in HIV-1 subtype B genes of 4 Austrian IDU patients | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Gall (2014) | Complete Genome Sequence of the WHO International Standard for HIV-1 RNA Determined by Deep Sequencing. | Genome Announc. 2014 Feb 6;2(1). pii: e01254-13. | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Gallant (2005) | EARLY Virologic Non-Response to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral Naive Subjects | J. Infect. Dis. (2005) In press | 1e-173 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Galli (2007) | RECOMBINATION analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms | J. Gen. Virol. 89 (PT 12), 3119-3125 (2008) | 3.89e-160 | |
46 46PR 46RT |
0 | Case report(s) / study subset |
| Galluzzo (2012) | Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda | AIDS Res. Hum. Retroviruses 23 (11), 1449-1451 (20 | 3.69e-147 | 144 72PR 72RT |
144 72PR 72RT |
100 | HIVDB |
| Gao (2022) | Direct Submission | Submitted (26-OCT-2021) Ragon Institute of MGH MIT | 0 | |
31 31PR 31RT 31IN |
0 | Unpublished |
| Gao (2001) | RECOMBINATION in human immunodefeciency virus type 2 | Unpublished | 1e-100 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Gao (2003) | COMPLETE genomes of HIV-1 subtype C viruses in South Africa | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Gao (1999) | ORIGIN of HIV-1 in the chimpanzee Pan troglodytes troglodytes | Nature 397 (6718), 436-441 (1999) | 1e-155 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Gao (1996) | MOLECULAR cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization | J. Virol. 70 (3), 1651-1667 (1996) | 1e-162 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Gao (1996) | THE heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin | J. Virology 70 (10), 7013-7029 (1996) | 1e-164 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Gao (1998) | AN isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I) | J. Virol. 72 (12), 10234-10241 (1998) | 1e-161 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Gao (1998) | A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 | J. Virol. 72 (7), 5680-5698 (1998) | 1e-166 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Gao (2001) | MOLECULAR characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo | AIDS Res. Hum. Retroviruses 17 (12), 1217-1222 (2001) | 1e-166 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Gao (2001) | EVIDENCE of two distinct subsubtypes within the HIV-1 subtype A radiation | AIDS Res. Hum. Retroviruses 17 (8), 675-688 (2001) | 1e-164 | 6 5PR 5RT 6IN |
10 9PR 6RT 6IN |
60 | HIVDB |
| Gao (1992) | HUMAN infection by genetically diverse SIVSM-related HIV-2 in west Africa | Nature 358 (6386), 495-499 (1992) | 5e-66 | 3 3RT |
16 16RT 16IN |
18 | HIVDB |
| Gao (1993) | GENETIC typing of HIV-2 from a Senegalese/German heterosexual transmission | AIDS Res. Hum. Retroviruses 9 (7), 703-704 (1993) | 2e-64 | |
2 2RT 2IN |
0 | Case report(s) / study subset |
| Gao (1994) | GENETIC diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology | J. Virol. 68 (11), 7433-7447 (1994) | 1e-111 | 2 2RT |
6 6RT 4IN |
33 | HIVDB |
| Gao (2021) | Evaluation of a novel in-house HIV-1 genotype drug resistance assay using clinical samples in China | 34515004 | 0 | 58 58PR 58RT |
116 116PR 116RT |
50 | HIVDB |
| Gao (2021) | Genetic characteristics of a New HIV-1 subtype B/C intersubtype circulating recombinant form (CRF118_BC) identified in Yunnan, China | J Infect 83 (2), 237-279 (2021) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Gao (2021) | Direct Submission | Submitted (06-AUG-2020) Department of Laboratory M | 0 | |
123 1PR 1RT 123IN |
0 | Case report(s) / study subset |
| Garaev (2006) | 5' region of HIV-1 G subtype pol gene | 17338229 | 1e-163 | |
82 15PR 82RT |
0 | Pending |
| Garaev (2007) | DIRECT Submission | Submitted (08-NOV-2006) Biotechnology, The D.I. Ivanovsky In | 1e-161 | |
13 13PR 13RT |
0 | ARV Rx and/or other data are N/A |
| Garaev (2016) | Direct Submission | Submitted (09-NOV-2006) Biotechnology, The D.I. Iv | 1.93e-143 | |
1 1PR 1RT |
0 | ARV Rx and/or other data are N/A |
| Garaev (2016) | Fragment of HIV-1 A subtype RT gene | Unpublished | 1.09e-146 | |
3 3RT |
0 | ARV Rx and/or other data are N/A |
| Garaev (2016) | Fragment of HIV-1 B subtype RT gene | Unpublished | 4.4e-150 | |
1 1RT |
0 | ARV Rx and/or other data are N/A |
| Garcia (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 21820763 | 0 | 40 40PR 40RT |
40 40PR 40RT |
100 | HIVDB |
| Garcia (2021) | Direct Submission | Submitted (19-OCT-2021) Microbiology, Hospital Uni | 0 | |
108 108PR 107RT |
0 | Unpublished |
| Garcia-Arriaza (2007) | CHARACTERIZATION of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications | Virus Res. 129 (2), 123-134 (2007) | 1.8e-87 | |
9 9PR 9RT |
0 | Case report(s) / study subset |
| Garcia-Broncano (2020) | Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile | Sci Transl Med 11 (520) (2019) | 0 | |
406 387PR 391RT 360IN |
0 | Proviral DNA Reservoir |
| Garcia-Bujalance (2005) | COMPARISON between Sequence Analysis and a Line Probe Assay for Testing Genotypic Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Drugs | J. Clin. Microbiol. 43 (8), 4186-4188 (2005) | 1e-123 | 108 54PR 54RT |
108 54PR 54RT |
100 | HIVDB |
| Garcia-Knight (2016) | Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection | Sci Rep 6, 29536 (2016) | 0 | |
53 49PR 47RT 47IN |
0 | Pending |
| Garcia-Lerma (2001) | INCREASED ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons | Proc. Natl. Acad. Sci. U.S.A. 98 (24), 13907-13912 (2001) | 5e-89 | |
7 7RT |
0 | Pending |
| Garcia-Lerma (2004) | TRANSMITTED Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine | J. Virol. 78 (14), 7545-7552 (2004) | 1e-142 | |
6 6RT |
0 | Pending |
| Garcia-Lerma (2016) | Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir | PLoS Med. 5 (2), E28 (2008) | 5.44e-17 | |
3 3RT |
0 | Gene fragment(s) |
| Garcia-Lerma (2019) | Direct Submission | Submitted (27-OCT-2018) Division of HIV/Aids Preve | 3.78e-128 | |
135 135IN |
0 | NHPL/SIV |
| Garcia-Lerma (2019) | Emergence of cabotegravir resistance in macaques | Unpublished | 1.76e-110 | |
39 39IN |
0 | NHPL/SIV |
| Garcia-Vallejo (2009) | Molecular epidemiology of Human immunodeficiency virus (HIV-1) antiviral resistance in isolates from patient of Colombian Caribbean Region | Unpublished | 0 | |
118 59PR 59RT |
0 | ARV Rx and/or other data are N/A |
| Garcia-Vallejo (2009) | First Report of Human Immunodeficiency Virus type 2 (HIV-2) Infection in the Colombian Caribbean Region | Unpublished | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Gare (2022) | High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally represented pre-treatment HIV drug resistance study | Unpublished | 9.89e-179 | 316 316PR 316RT |
316 316PR 316RT |
100 | HIVDB |
| Garrido (2009) | Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection | J. Antimicrob. Chemother. 65 (2), 320-326 (2010) | 1e-166 | 417 417IN |
418 418IN |
99 | HIVDB |
| Garrido (2010) | Dynamics in the selection of resistance mutations in HIV patients failing Raltegravir and following its discontinuation | 21457126 | 1e-166 | 34 34IN |
53 53IN |
64 | HIVDB |
| Garrido (2012) | Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens | Antimicrob. Agents Chemother. 56 (6), 2873-2878 (2 | 1e-166 | 61 61IN |
62 62IN |
98 | HIVDB |
| Garriga (2010) | HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations | J. Antimicrob. Chemother. 64 (2), 251-258 (2009) | 0 | 153 153PR 153RT |
153 153PR 153RT |
100 | HIVDB |
| Garshasbi (2020) | The Frequency of HIV-1 Infection and Surveillance Drug-resistant Mutation Determination among Iranians with High-risk Behaviors | Unpublished | 0 | |
12 6PR 7RT 6IN |
0 | Case report(s) / study subset |
| Gashnikova (2011) | Biological and Genetic Characterization of HIV-1 Strains Circulating in Siberia, Russia | Unpublished | 1e-176 | |
31 31PR 31RT |
0 | ARV Rx and/or other data are N/A |
| Gashnikova (2015) | A Rapid Expansion of HIV-1 CRF63_02A1 Among Newly Diagnosed HIV-Infected Individuals in the Tomsk Region, Russia | AIDS Res. Hum. Retroviruses 31 (4), 456-460 (2015) | 3e-60 | 46 46PR |
46 46PR |
100 | HIVDB |
| Gashnikova (2016) | Predominance of CRF63_02A1 and multiple patterns of unique recombinant forms of CRF63_A1 among individuals with newly diagnosed HIV-1 infection in Kemerovo Oblast, Russia | Arch. Virol. (2016) In press | 0 | 94 46PR 46RT 48IN |
96 48PR 48RT 48IN |
97 | HIVDB |
| Gasich (2021) | Direct Submission | Submitted (13-MAY-2021) Laboratory for HIV and Opp | 0 | |
29 29IN |
0 | Unpublished |
| Gasich (2023) | Genetic diversity and drug resistance mutations of HIV in the Republic of Belarus | Unpublished | 0 | |
867 853PR 867RT |
0 | Unpublished |
| Gasich (2025) | Direct Submission | Submitted (20-MAY-2025) Laboratory for HIV and Opp | 0 | |
6 6PR 6RT |
0 | Unpublished |
| Gaspareto (2012) | Genetic diversity and primary resistance among HIV-1-positive patients from Maringa, Parana, Brazil. | Rev Inst Med Trop Sao Paulo | 1e-51 | 14 14PR |
14 14PR |
100 | HIVDB |
| Gaspareto (2012) | Study of the genetic diversity and of the primary resistance rates in HIV-1 positive individuals in surveillance at the Division of Specialized Care in STD/AIDS in the city of Maringa, Parana | 22850992 | 1.88e-163 | 82 34PR 48RT |
82 34PR 48RT |
100 | HIVDB |
| Gatanaga (1999) | ACTIVE HIV-1 redistribution and replication in the brain with HIV encephalitis | Arch. Virol. 144 (1), 29-43 (1999) | 1e-52 | |
261 261RT |
0 | Quasispecies |
| Gatanaga (1999) | ANTI-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors | AIDS Res. Hum. Retroviruses 15 (17), 1493-1498 (1999) | 1e-126 | 15 15PR |
15 15PR |
100 | HIVDB |
| Gatanaga (2000) | DISCORDANCE between plasma- and PBMC-derived HIV-1 genotypes on protease inhibitor resistance | Unpublished | 1e-130 | |
70 70PR |
0 | ARV Rx and/or other data are N/A |
| Gatanaga (2011) | Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan | Antiviral Res. 75 (1), 75-82 (2007) | 0 | 4861 4577PR 4541RT |
8121 5282PR 5348RT 2330IN |
59 | HIVDB |
| Gay (2025) | Age inversely correlates with T cell response to modified vaccinia Ankara vectored mosaic vaccines, MVA.HIVconsvX in people with HIV on antiretroviral therapy | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Unpublished |
| Ge (2018) | Near full-length genome sequence of a novel HIV-1 second-generation recombinant form (CRF01_AE/CRF07_BC) detected among men who have sex with men in Tianjin, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Ge (2019) | Genomic Characterization of a Novel HIV-1 CRF01_AE/07_BC Recombinant Virus From a Married Men Who Have Sex with Men in Tianjin, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ge (2019) | Identification of a Novel HIV-1 Second-Generation (CRF01_AE/B) Among Men Who Have Sex with Men in Tianjin, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Geels (2003) | IDENTIFICATION of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual | J. Virol. 77 (23), 12430-12440 (2003) | 0 | |
7 7PR 7RT 7IN |
0 | Case report(s) / study subset |
| Geels (2005) | DIFFERENTIAL loss of human immunodeficiency virus type I (HIV-1)-specific T-helper responses in two HIV-1 infected individuals following CTL escape | 16246391 | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Geller (2015) | The external domains of the HIV-1 envelope are a mutational cold spot | Nat Commun 6, 8571 (2015) | 0 | |
1 1IN |
0 | Laboratory/experimental isolate |
| Gemechu (2024) | Pretreatment HIV drug resistance mutations | Unpublished | 0 | |
74 66PR 72RT |
0 | HIVDB |
| Gendelman (1987) | MOLECULAR characterization of a polymerase mutant human immunodeficiency virus | Virology 191 (1), 529 (1992) | 1e-98 | |
3 3RT |
0 | Laboratory/experimental isolate |
| Geng (2010) | Indinavir resistance pathway in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification | 20960178 | 0 | |
172 143PR 172RT |
0 | Case report(s) / study subset |
| George (2018) | Rapid Development of High Level Resistance to Dolutegravir with Emergence of T97A Mutation in Two Treatment Experienced Individuals with Baseline Partial Sensitivity to Dolutegravir | Open Forum Infect Dis (2018) In press | 0 | 2 1PR 1RT 2IN |
2 1PR 1RT 2IN |
100 | HIVDB |
| Georges-Courbot (1998) | NATURAL infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus | J. Virol. 72 (1), 600-608 (1998) | 5e-71 | |
1 1IN |
0 | NHPL/SIV |
| Gerasimova (2014) | Phylogenetic analysis is objective component of epidemiological investigation case of HIV-infections | Unpublished | 0 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Gerstenberg (2024) | Therapeutic Drug Monitoring of Long Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection - A Case Series of Five Patients with One Virologic Failure after Development of Two-Class Resistance | 39286033 | 0 | 6 3PR 3RT 3IN |
6 3PR 3RT 3IN |
100 | HIVDB |
| Getaneh (2025) | Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia | J Glob Antimicrob Resist 30, 418-427 (2022) | 4.23e-176 | |
699 698PR 699RT |
0 | HIVDB |
| Ghafari (2017) | Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naive persons in the Southwest of Iran, 2014-2015 | Arch. Virol. (2017) In press | 1.38e-170 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Ghosh (1998) | HUMAN Immunodeficiency Virus type 1 complete genomic sequence | Unpublished | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ghosh (1993) | A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes | Virology 194 (2), 858-864 (1993) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ghosn (2011) | X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI | PLoS ONE 6 (8), E23301 (2011) | 1.58e-131 | |
326 178PR 148RT |
0 | Quasispecies |
| Giandhari (2015) | Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients | AIDS Res. Hum. Retroviruses 31 (8), 776-782 (2015) | 1.38e-47 | 40 40PR |
40 40PR |
100 | HIVDB |
| Gibson (2019) | A 28-Year History of HIV-1 Drug Resistance and Transmission in Washington, DC | Front Microbiol 10, 369 (2019) | 1.92e-156 | |
303 297PR 303RT |
0 | Sequence quality |
| Gil (2022) | Transmission Clusters, Predominantly Associated With Men Who Have Sex With Men, Play a Main Role in the Propagation of HIV-1 in Northern Spain (2013-2018) | Front Microbiol 13, 782609 (2022) | 0 | |
61 61PR 61RT |
0 | Transmission cluster |
| Giovanetti (2022) | Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naive patients in South Sudan | J Med Virol (2022) In press | 0 | 30 30IN |
30 30IN |
100 | HIVDB |
| Giri (2000) | CASE report of a novel amino acid deletion in codon 67 and T69G substitution in the RT of HIV-1 | 11075943 | 2e-76 | |
2 2RT |
0 | Case report(s) / study subset |
| Gittens (2002) | THE Molecular Epidemiology and Drug Resistance Determination of HIV Type 1 Subtype B Infection in Barbados | AIDS Res. Hum. Retroviruses 19 (4), 313-319 (2003) | 1e-126 | 27 27PR |
71 27PR 44RT |
38 | HIVDB |
| Giuliani (2008) | NON-B HIV Type 1 Subtypes among Men Who Have Sex with Men in Rome, Italy | AIDS Res. Hum. Retroviruses 25 (2), 157-164 (2009) | 0 | |
116 116PR 116RT |
0 | ARV Rx and/or other data are N/A |
| Gladkov (2023) | Direct Submission | Submitted (17-FEB-2022) Ragon Institute of MGH MIT | 0 | |
39 37PR 38RT 30IN |
0 | Unpublished |
| Glenn (2006) | A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection | Virology 325 (2), 297-307 (2004) | 8e-19 | |
1 1IN |
0 | Laboratory/experimental isolate |
| Gnanadurai (2016) | Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys | J. Virol. 84 (23), 12245-12254 (2010) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Godwe (2023) | Structural features and genetic diversity in Gag gene of rare HIV-1 subtypes from the Democratic Republic of Congo | AIDS Res Hum Retroviruses (2023) In press | 1.05e-59 | 148 148PR |
148 148PR |
100 | HIVDB |
| Godwe (2024) | Evolutionary dynamics of HIV-1 group M in Cameroon | 39386075 | 5.56e-83 | |
149 113PR 36IN |
0 | Evolutionary study |
| Goldberg (2009) | Coinfection of Ugandan red colobus (Procolobus [Piliocolobus] rufomitratus tephrosceles) with novel, divergent delta-, lenti-, and spumaretroviruses | J. Virol. 83 (21), 11318-11329 (2009) | 2e-45 | |
3 3IN |
0 | Gene fragment(s) |
| Goldsamt (2011) | Prevalence of sexually-acquired antiretroviral drug resistance in a community sample of HIV-positive MSM in New York City | AIDS Patient Care STDS (2011) | 1.41e-172 | 188 188PR 188RT |
188 188PR 188RT |
100 | HIVDB |
| Gomez-Carrillo (2004) | DRUG Resistance Testing Provides Evidence of the Globalization of HIV Type 1: A New Circulating Recombinant Form | AIDS Res. Hum. Retroviruses 20 (8), 885-888 (2004) | 0 | 589 589PR 589RT |
589 589PR 589RT |
100 | HIVDB |
| Gomez-Carrillo (2006) | ANALYSIS of HIV Type 1 Diversity in Pregnant Women from Four Latin American and Caribbean Countries | AIDS Res. Hum. Retroviruses 22 (11), 1186-1191 (2006) | 0 | |
121 121PR 121RT |
0 | ARV Rx and/or other data are N/A |
| Goncalves (2024) | HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021 | 38349224 | 0 | |
58 58PR 58RT 53IN |
0 | Pending |
| Gondim (2021) | Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption | Sci Transl Med 13 (576), eabd8179 (2021) | 0 | |
584 252PR 255RT 584IN |
0 | Quasispecies |
| Gonelli (2024) | Subclinical SIV infections in macaques during antibody immunoprophylaxis | Unpublished | 0 | |
111 111PR 111RT 111IN |
0 | NHPL/SIV |
| Gonsalez (2011) | Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. | Virus Res | 1.22e-170 | 13 13PR 13RT |
14 14PR 14RT |
92 | HIVDB |
| Gonzales (2002) | EXTENDED spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors | AIDS 17 (6), 791-799 (2003) | 2e-97 | 286 286RT |
287 287RT |
99 | HIVDB |
| Gonzales (2003) | PROTEASE and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions | AIDS Res. Hum. Retroviruses 19 (10), 909-915 (2003) | 1e-173 | 99 38PR 61RT |
100 38PR 62RT |
99 | HIVDB |
| Gonzales (2003) | COLINEARITY of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing | J. Acquir. Immune Defic. Syndr. 34 (4), 398-402 (2003) | 0 | 43 7PR 36RT |
82 8PR 75RT |
52 | HIVDB |
| Gonzalez Perez (2003) | EPIDEMIOLOGICAL and molecular characteristics of HIV and HTLV infection in Equatorial Guinea | Unpublished | 1e-169 | 41 41RT |
41 14PR 41RT |
100 | HIVDB |
| Gonzalez (2019) | Barcoding analysis of HIV drug resistance mutations using Oxford Nanopore MinION (ONT) sequencing | 10.1101/240077 | 0 | |
31 31PR 31RT |
0 | Methods paper |
| Gonzalez (2004) | DETECTION of Human Immunodeficiency Virus Type 1 Antiretroviral Resistance Mutations by High-Density DNA Probe Arrays | J. Clin. Microbiol. 42 (7), 2907-2912 (2004) | 0 | |
178 89PR 91RT |
0 | ARV Rx and/or other data are N/A |
| Gonzalez (2009) | Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia | AIDS Res. Hum. Retroviruses 26 (7), 795-803 (2010) | 0 | 122 122PR 122RT |
122 122PR 122RT |
100 | HIVDB |
| Gonzalez-Alba (2011) | Molecular Surveillance of HIV-1 in Madrid, Spain: a Phylogeographic Analysis | J. Virol. 85 (20), 10755-10763 (2011) | 0 | |
165 164PR 165RT |
0 | ARV Rx and/or other data are N/A |
| Gonzalez-Domenech (2017) | Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naive patients in southern Spain | PLoS ONE (2018) In press | 0 | 114 57PR 57RT |
114 57PR 57RT |
100 | HIVDB |
| Gonzalez-Domenech (2019) | High prevalence of transmission clusters within newly-diagnosed HIV-1 patients in southern Spain (2004-2015) | 32240038 | 5.98e-151 | 168 90PR 78RT |
168 90PR 78RT |
100 | HIVDB |
| Gonzalez-Ittig (2015) | A retrospective approach of the HIV-1 epidemic in Cordoba, the second largest city of Argentina: subtype characterization using the pol and env genes | Unpublished | 4.11e-171 | |
16 16PR 16RT |
0 | Case report(s) / study subset |
| Gonzalez-Serna (2012) | Direct Submission | Submitted (15-MAY-2012) Laboratory Program, BC CfE | 1e-163 | |
2 2IN |
0 | ARV Rx and/or other data are N/A |
| Gooey (2015) | Analysis of transmitted HIV drug resistance from 2005-2013: a comparison of the old and the new | Unpublished | 0 | |
7 7IN |
0 | ARV Rx and/or other data are N/A |
| Gopalan (2017) | Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring | PLoS ONE 12 (8), E0183080 (2017) | 6e-152 | |
26 26RT |
0 | Case report(s) / study subset |
| Gopalan (2019) | Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug resistance and virological failure in children | J. Med. Virol. 91 (6), 1036-1047 (2019) | 1.8e-156 | 115 115RT |
249 249RT |
46 | HIVDB |
| Gordon (2002) | MOLECULAR characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies | J. Virol. 77 (4), 2587-2599 (2003) | 2e-99 | 72 72PR 72RT |
75 75PR 75RT |
96 | HIVDB |
| Got (2021) | Absence of Resistance Mutations in the Integrase Coding Region among ART-Experienced Patients in the Republic of the Congo | Microorganisms 9 (11), 2355 (2021) | 0 | 190 66PR 77RT 47IN |
191 67PR 77RT 47IN |
99 | HIVDB |
| Gottlieb (2009) | Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. | Clin Infect Dis. 2009 Feb 15;48(4):476-83. | 0 | 170 170PR 170RT |
170 170PR 170RT |
100 | HIVDB |
| Gottlieb (2011) | HIV-2 Integrase Variation in Integrase Inhibitor-Naive Adults in Senegal, West Africa | PLoS ONE 6 (7), E22204 (2011) | 1e-101 | 113 113IN |
122 122IN |
92 | HIVDB |
| Gottlieb (2016) | HIV-2 Protease, Reverse Transcriptase & Envelope Viral Variation in the PBMC and Genital Tract of ARV-naive Women in Senegal | 18544024 | 5.47e-140 | 185 63PR 122RT |
185 63PR 122RT |
100 | HIVDB |
| Goujon (2000) | PHYLOGENETIC analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1 | J. Virol. 74 (6), 2525-2532 (2000) | 1e-137 | |
186 186RT |
0 | Case report(s) / study subset |
| Gouklani (2017) | Transmitted Drug Resistance Mutations in Antiretroviral-Naive Patients | 28983848 | 9.09e-170 | 44 44PR 43RT |
44 44PR 44RT |
100 | HIVDB |
| Gouklani (2018) | HIV drug resistance and subtypes in treated patients of Bandar Abbas | 31311021 | 7.49e-169 | 41 41PR 41RT |
42 42PR 42RT |
97 | HIVDB |
| Grabowski (2017) | The validity of self-reported antiretroviral use in persons living with HIV: a population-based study | AIDS (2017) In press | 0 | |
12 12PR 12RT |
0 | Case report(s) / study subset |
| Grace (2025) | Prevalence, patterns and factors associated with HIV-1 drug resistance among individuals experiencing persistent low-level viremia on first-line antiretroviral therapy in Uganda | Unpublished | 0 | |
75 49PR 49RT 26IN |
0 | Unpublished |
| Graf (1998) | CLONING and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China | AIDS Res. Hum. Retroviruses 14 (3), 285-288 (1998) | 1e-161 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Graf (2011) | HIV-1 genetic diversity and drug resistance among treatment naive patients from Southern Brazil: An association of HIV-1 subtypes with exposure categories | J. Clin. Virol. 51 (3), 186-191 (2011) | 0 | 163 82PR 82RT 81IN |
163 82PR 82RT 81IN |
100 | HIVDB |
| Graf (2015) | The contribution of epidemiological predictors in unravelling the phylogeographic history of HIV-1 subtype C in Brazil | J. Virol. (2015) In press | 0 | |
248 245PR 248RT |
0 | Pending |
| Grant (2020) | Pervasive and non-random recombination in near-full length HIV genomes from Uganda | 32395255 | 0 | |
1467 1464PR 1324RT 1380IN |
0 | Pending |
| Grant (2022) | A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism | Retrovirology 19 (1) (2023) In press | 0 | 111 106PR 102RT 109IN |
135 113PR 132RT 131IN |
82 | HIVDB |
| Grant (2002) | ACCURACY of the TRUGENE HIV-1 Genotyping Kit | J. Clin. Microbiol. 41 (4), 1586-1593 (2003) | 1e-128 | |
18 9PR 9RT |
0 | Case report(s) / study subset |
| Grant-McAuley (2020) | Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic | PLoS One 15 (10), e0240890 (2020) | 0 | 165 138PR 138RT 27IN |
165 138PR 138RT 27IN |
100 | HIVDB |
| Green (2011) | Drug Resistance and Coreceptor Usage in HIV Type 1 Subtype C-Infected Children Initiating or Failing Highly Active Antiretroviral Therapy in South Africa | AIDS Res. Hum. Retroviruses (2011) In press | 0 | 54 54PR 54RT |
54 54PR 54RT |
100 | HIVDB |
| Greninger (2018) | Direct Submission | Submitted (31-AUG-2018) Virology, University of Wa | 0 | |
7 1PR 1RT 6IN |
0 | Case report(s) / study subset |
| Greninger (2018) | HIV-NGS_and_Sanger | 30305383 | 0 | |
139 106PR 106RT 33IN |
0 | Pending |
| Grgic (2013) | Primary resistance of Human immunodeficiency virus 1 to antiretroviral drugs | Thesis (2012) University Hospital for Infectious D | 1.37e-135 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Grisson (2004) | INFECTIOUS molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination | J. Virol. 78 (24), 14066-14069 (2004) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Grossman (2004) | MUTATION D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir | Antimicrob. Agents Chemother. 48 (6), 2159-2165 (2004) | 4e-50 | 100 100PR |
100 100PR |
100 | HIVDB |
| Grossman (2014) | Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes | PLoS ONE 9 (1), E86239 (2014) | 3.18e-148 | 217 217PR 217RT |
250 250PR 250RT |
86 | HIVDB |
| Grossman (2015) | Following the HIV Epidemic in Israel using phylogenetic tools | 26302493 | 1.51e-150 | |
476 476PR 476RT |
0 | Pending |
| Grossman (2020) | Transmission Dynamics of HIV Subtype A in Tel Aviv, Israel: Implications for HIV Spread and Eradication | 31363777 | 0 | |
229 229PR 229RT |
0 | ARV Rx and/or other data are N/A |
| Gryseels (2019) | A near-full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue | bioRxivorg (2019) | 0 | |
1 1PR 1RT 1IN |
0 | Sequence quality |
| Gu (2017) | Direct Submission | Submitted (18-AUG-2016) Mount Sinai Medicine, Medi | 2.07e-63 | |
20 20PR 20RT |
0 | Laboratory/experimental isolate |
| Guan (2021) | Multiple HIV-1 subtypes were found circulating in Jiangmen District of Guangdong, China | Unpublished | 3.9e-159 | 188 188RT |
209 209PR 209RT |
89 | HIVDB |
| Guan (2021) | Genetic characterization of a novel HIV-1 CRF55_01B/CRF07_BC Recombinant Form Identified in Jiangmen, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Guan (2022) | Genetic characterization of a novel HIV-1 CRF55_01B/CRF07_BC Recombinant Form Identified in Jiangmen, China | Unpublished | 8.35e-141 | |
5 5RT |
0 | Case report(s) / study subset |
| Guenthard (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 26362944 | 0 | 10 10PR 10RT |
10 10PR 10RT |
100 | HIVDB |
| Guevara (2015) | HIV Sequence Screening to Determine Group and Subtype from African Patient Samples | Unpublished | 0 | |
159 159IN |
0 | Sequence quality |
| Gui (2015) | Genetic Characterization of a unique recombinant originated from CRF55_01B and CRF07_BC in Shenzhen of China | 25748656 | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Guichet (2016) | High viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa | AIDS Res. Hum. Retroviruses (2016) In press | 3.11e-168 | 446 433PR 446RT |
446 433PR 446RT |
100 | HIVDB |
| Guichet (2016) | Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon | J. Virol. Methods 237, 121-126 (2016) | 3e-169 | |
15 13PR 15RT |
0 | Case report(s) / study subset |
| Guillon (1996) | COMPLETION of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patient | AIDS Res. Hum. Retroviruses 11 (12), 1537-1541 (1995) | 1e-165 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Guillot (2016) | Mutational patterns and prevalence in patients failing Raltegravir containing regimens | Unpublished | 0 | |
14 14IN |
0 | Unpublished - Final |
| Guimaraes (2008) | IDENTIFICATION of two new CRF_BF in Rio de Janeiro State, Brazil | AIDS 22 (3), 433-435 (2008) | 0 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Guimaraes (2009) | Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates | Retrovirology 6, 39 (2009) | 0 | 9 4PR 9RT 4IN |
9 4PR 9RT 4IN |
100 | HIVDB |
| Guimaraes (2010) | Analysis of HIV-1 BF pr/rt recombinant strains from Rio de Janeiro/Brazil reveals multiple unrelated mosaic structures | Infect. Genet. Evol. (2010) In press | 1e-167 | 24 24IN |
24 24IN |
100 | HIVDB |
| Guimaraes (2012) | The HIV-1 epidemic in Bolivia is dominated by subtype B and CRF12_BF 'family' strains | Virol. J. 9 (1), 19 (2012) | 1.78e-147 | |
51 51PR 51RT |
0 | ARV Rx and/or other data are N/A |
| Guimaraes (2013) | Temporal Dynamics of HIV-1 Circulating Subtypes in Distinct Exposure Categories in Southern Brazil | 23234345 | 0 | |
82 82PR 82RT |
0 | ARV Rx and/or other data are N/A |
| Guimaraes (2015) | Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in Sao Paulo, Brazil | AIDS Res. Hum. Retroviruses 31 (12), 1219-1224 (20 | 4e-147 | 220 217PR 215RT |
220 217PR 215RT |
100 | HIVDB |
| Guimaraes (2015) | Assessing the HIV-1 Epidemic in Brazilian Drug Users: A Molecular Epidemiology Approach | PLoS ONE 10 (11), E0141372 (2015) | 0 | 1154 1154PR 1154RT |
1156 1156PR 1156RT |
99 | HIVDB |
| Gunthard (1998) | HUMAN immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy | J. Virol. 72 (3), 2422-2428 (1998) | 1e-128 | |
50 34PR 50RT |
0 | Quasispecies |
| Gunthard (1999) | HIGHER selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol | Virology 259 (1), 154-165 (1999) | 1e-130 | |
72 72PR 72RT |
0 | Sequence Quality |
| Guo (2008) | Near Full-Length Genome Characterization of an HIV Type 1 CRF01_AE Strain from China | 19534629 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Guo (2014) | Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011. | BMC Public Health. 2015 Feb 10;15:120. | 1.4e-148 | 126 126PR 126RT |
126 126PR 126RT |
100 | HIVDB |
| Guo (2008) | First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China | AIDS Res. Hum. Retroviruses 25 (4), 463-467 (2009) | 0 | 15 15PR 14RT 1IN |
16 16PR 15RT 1IN |
93 | HIVDB |
| Guo (2014) | A Novel HIV-1 CRF01_AE/B recombinant among men who have sex with men in Jiangsu Province, China. | AIDS Res Hum Retroviruses. 2014 Jul;30(7):706-10. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Guo (2015) | The identification of a novel HIV-1 CRF01_AE/B recombinant using the near full length genome in Jiangsu Province, China | AIDS Res. Hum. Retroviruses 30 (12), 1239-1242 (20 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Guo (2015) | Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011 | BMC Public Health 15 (1), 1489 (2015) | 2.22e-143 | 4 4PR 4RT |
4 4PR 4RT |
100 | HIVDB |
| Guo (2014) | Genetic characterization and drug resistance of HIV type 1 in sexually acquired cases in Guangzhou and Shenzhen, China | Unpublished | 0 | |
69 69PR 69RT |
0 | ARV Rx and/or other data are N/A |
| Gupta (2008) | EVIDENCE for HIV-1 gag as a determinant of susceptibility to protease inhibitors using a full length subtype A and C gag-protease | AIDS. 2010 Jul 17;24(11):1651-5. | 0 | |
2 2PR 2RT 1IN |
0 | Laboratory/experimental isolate |
| Gupta (2000) | Cloning and Sequencing of HIV-1 Gag (C-subtype) from Indian strain | Unpublished | 0.00000161 | |
1 1PR |
0 | Gene fragment(s) |
| Gupta (2000) | CLONING and Sequencing of HIV-1 Gag (B-subtype) from Indian Strain | Unpublished | 1e-16 | |
1 1PR |
0 | Gene fragment(s) |
| Gupta-Wright (2022) | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study | Lancet HIV 7 (9), e620-e628 (2020) | 0 | 336 329PR 334RT 312IN |
336 328PR 336RT 312IN |
100 | HIVDB |
| Gurgo (1988) | ENVELOPE sequences of two new United States HIV-1 isolates | Virology 164 (2), 531-536 (1988) | 1e-161 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Gurtler (1994) | A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon | J. Virol. 68 (3), 1581-1585 (1994) | 1e-144 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Gurusinghe (1995) | REVERSE transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS | J. Med. Virol. 46 (3), 238-243 (1995) | 1e-89 | |
7 7RT |
0 | Case report(s) / study subset |
| Gutierrez (2003) | PREVALENCE of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain | J. Med. Virol. 74 (4), 521-527 (2004) | 2e-49 | |
1 1PR |
0 | Case report(s) / study subset |
| Habekova (2016) | Genetic subtypes of HIV type 1 circulating in Slovakia | AIDS Res. Hum. Retroviruses 26 (10), 1103-1107 (20 | 3.57e-140 | |
16 8PR 16RT |
0 | Case report(s) / study subset |
| Habib (2018) | Detection of Human immunodeficiency virus type-1 proviral DNA in peripheral blood mononuclear cells of the Iranian neonates born to mothers infected with the virus | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Hachiya (2007) | A novel mutation, N348I, in HIV-1 Reverse transcriptase confers 2-class cross resistance for RTIs | 18216099 | 0 | |
16 16RT |
0 | Case report(s) / study subset |
| Hachiya (2010) | A novel mutation, K70Q, in HIV-1 reverse transcriptase with Q151M enhances resistance to nucleoside RT inhibitors that remain active to Q151M complex | 21249155 | 0 | |
2 2RT |
0 | HIVDB |
| Hachiya (2016) | Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance | 25956162 | 0 | 599 599IN |
600 600IN |
99 | HIVDB |
| Hachiya (2016) | Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5) | Antimicrob. Agents Chemother. 45 (2), 495-501 (200 | 4.26e-145 | |
45 25PR 20RT |
0 | Case report(s) / study subset |
| Hachiya (2017) | Impact of HIV-1 integrase L74V/V75I mutations in clinical isolates on resistance to second-generation integrase strand transfer inhibitors | 28533248 | 0 | 3 3IN |
3 3IN |
100 | HIVDB |
| Hachiya (2017) | Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2013to 2015 in Japan | Unpublished | 0 | 3688 2113PR 2134RT 1553IN |
3688 2114PR 2134RT 1553IN |
100 | HIVDB |
| Haddad (2000) | EVIDENCE for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells | AIDS 14 (15), 2273-2281 (2000) | 4e-96 | |
55 55RT |
0 | Quasispecies |
| Haddad (2012) | Monogram Integrase Sequences | Unpublished | 1e-164 | |
8 8IN |
0 | ARV Rx and/or other data are N/A |
| Hahn (1990) | MOLECULAR characterization of an attenuated human immunodeficiency virus type 2 isolate | Unpublished (1990) | 6e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Haider (2021) | Molecular characterization of HIV-1 isolated in Khyber Pakhtunkhwa Pakistan | Unpublished | 3.13e-165 | |
26 25PR 26RT |
0 | Unpublished |
| Hallack (2013) | Drug Resistance Detected in a Cohort from Nairobi, Kenya | Unpublished | 9.48e-147 | |
50 50PR 50RT |
0 | ARV Rx and/or other data are N/A |
| Halvas (2021) | HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus | J Clin Invest 130 (11), 5847-5857 (2020) | 0 | |
2292 2292PR 2292RT 33IN |
0 | Proviral DNA Reservoir |
| Ham (2015) | Complete Genome Sequence of the WHO International Standard for HIV-2 RNA determined by Deep Sequencing | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Hamers (2010) | HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia | J. Acquir. Immune Defic. Syndr. 55 (1), 95-101 (20 | 0 | 548 548PR 547RT |
548 548PR 548RT |
100 | HIVDB |
| Hamers (2011) | HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study | Lancet Infect Dis 11 (10), 750-759 (2011) | 0 | 1926 1926PR 1926RT |
1926 1926PR 1926RT |
100 | HIVDB |
| Hamers (2012) | Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. | Lancet Infect Dis. 2012 Apr; | 0 | 142 142PR 142RT |
142 142PR 142RT |
100 | HIVDB |
| Hamers (2012) | Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies | Clin. Infect. Dis. (2012) In press | 0 | 142 142PR 142RT |
142 142PR 142RT |
100 | HIVDB |
| Hamilton (2010) | Analysis of Protease and Reverse Transcriptase Genes of HIV for Antiretroviral Drug Resistance in Jamaican Adults | AIDS Res. Hum. Retroviruses 28 (8), 923-927 (2012) | 0 | 102 102PR 102RT |
102 102PR 102RT |
100 | HIVDB |
| Hamkar (2010) | Detection of HIV drug resistant mutants in under therapy patients referring to Iranian AIDS research center | 20610954 | 2.48e-83 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Hamkar (2010) | Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients | AIDS 24 SUPPL 2, S85-S91 (2010) | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Han (2004) | Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. | ARHR | 1e-170 | 142 142PR 126RT |
142 142PR 126RT |
100 | HIVDB |
| Han (2015) | Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China | PLoS ONE 10 (5), E0127696 (2015) | 0 | 28 25PR 27RT 27IN |
29 29PR 29RT 29IN |
96 | HIVDB |
| Han (2019) | Genetic characterization of a novel HIV-1 CRF07_BC/CRF55_01B #Recombinant Form Identified in Jiangmen, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Han (2025) | Direct Submission | Submitted (20-AUG-2024) NHC Key Laboratory of AIDS | 0 | |
3 3PR 3RT 3IN |
0 | Unpublished |
| Han (2020) | Comparative circulation dynamics of the five main HIV subtypes in China | 32938762 | 0 | 1960 1959PR 1960RT |
1960 1960PR 1960RT |
100 | HIVDB |
| Han (2024) | Optimization of genetic distance threshold for inferring the CRF01_AE molecular network based on next-generation sequencing | 38846352 | 5.37e-173 | |
1187 961PR 1187RT |
0 | Quasispecies |
| Han (2012) | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form CRFxx_01B Disseminating among Men-who-have-sex-with-men in China | 23405298 | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Han (2013) | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men Who Have Sex with Men in Northeastern China. | Genome Announc. 2013 Jun 27;1(3). | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Han (2013) | High Prevalence of HIV-1 Intersubtype B'/C Recombinants among Injecting Drug Users in Dehong, China | PLoS ONE 8 (5), E65337 (2013) | 0 | 95 95PR 95RT |
136 133PR 133RT 41IN |
69 | HIVDB |
| Han (2014) | Identification of 3 distinct HIV-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 Chinese cities | J. Acquir. Immune Defic. Syndr. 64 (1), 16-24 (201 | 1.25e-173 | 544 544PR 544RT |
544 544PR 544RT |
100 | HIVDB |
| Han (2009) | Epidemiologic and Genetic Characterization of Human Immunodeficiency Virus Type I Infection In Liaoning Province, China | J Acquir Immune Defic Syndr. 2010 Feb;53 Suppl 1:S27-33. | 0 | 84 68PR 69RT |
86 78PR 69RT |
97 | HIVDB |
| Han (2018) | Identification and the Evolutionary Characters of a New CRF01_AE/CRF07_BC Lineage among Men Who Have Sex With Men in Northeastern China | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Han (2016) | Molecular Epidemiology of HIV in Liaoning Province, Northeastern China: Complex Findings in a Low Prevalence Area | 17411368 | 9.8e-56 | 3 3PR |
4 4PR |
75 | HIVDB |
| Han (2014) | A Large-scale Survey of CRF55_01B from Men-Who-Have-Sex-with-Men in China: implying the Evolutionary History and Public Health Impact. | Sci Rep. 2015 Dec 15;5:18147. | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Han (2020) | Direct Submission | Submitted (06-SEP-2019) School of Public Health, S | 0 | 1693 1693PR 1693RT |
3035 3035PR 3035RT |
55 | HIVDB |
| Han (2009) | Molecular analyses confirmed a HIV-1 heterosexual transmission chain in Guangzhou, China | 19778458 | 0 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Handema (2002) | PREVALENCE of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1 | AIDS Res. Hum. Retroviruses 19 (2), 151-160 (2003) | 3e-88 | 53 25PR 28RT |
53 25PR 28RT |
100 | HIVDB |
| Hanke (2019) | Genetic history of HIV-1 subtype A reveals at least two independent introductions into Germany and an accelerating spread among German men having sex with men | 30944175 | 3.9e-175 | 183 183PR 183RT |
183 183PR 183RT |
100 | HIVDB |
| Hanke (2019) | A Recent HIV Outbreak Among People Who Inject Drugs in Munich, Germany, is Associated with Consumption of Synthetic Cathinones | Unpublished | 1.56e-175 | 244 244PR 244RT |
244 244PR 244RT |
100 | HIVDB |
| Hanna (2000) | PATTERNS of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine | J. Infect. Dis. 181 (3), 904-911 (2000) | 1e-130 | |
14 14PR 14RT |
0 | ARV Rx and/or other data are N/A |
| Hanna (2002) | DRUG-SELECTED resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection | J. Infect. Dis. 188 (7), 986-991 (2003) | 1e-126 | 176 88PR 88RT |
176 88PR 88RT |
100 | HIVDB |
| Hanna (2013) | Phylogenetic characterization of six full-length HIV-1 subtype C molecular clones from three patients: identification of rare subtype C strains containing two NF-κB motifs in the long terminal repeat. | AIDS Res Hum Retroviruses. 2014 Jun;30(6):586-91. | 0 | |
6 6PR 6RT 6IN |
0 | Laboratory/experimental isolate |
| Hao (2019) | Characterization of a Novel HIV-1 Second-Generation Recombinant Form Originated from HIV-1 CRF01_AE/CRF07_BC in MSM Population from Beijing, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Hao (2017) | Low Rates of Transmitted Drug Resistances Among Treatment-Naive HIV-1-infected Students in Beijing, China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 237 237PR 237RT |
237 237PR 237RT |
100 | HIVDB |
| Hardy (2025) | Aberrant strand transfer events across multiple stages of reverse transcription shape the heterogeneous landscape of the HIV-1 reservoir | Unpublished | 0 | |
52 43PR 43RT 37IN |
0 | Proviral DNA Reservoir |
| Hariharan (2025) | Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1 | Unpublished | 0 | |
315 314PR 315RT 130IN |
0 | Proviral DNA Reservoir |
| Harrigan (2007) | A 21-Base Pair Insertion/Duplication at Codon 69 of the HIV Type 1 Reverse Transcriptase in a Patient Undergoing Multiple Nucleoside Therapy | AIDS Res. Hum. Retroviruses 23 (7), 895-899 (2007) | 0 | |
12 12RT |
0 | Case report(s) / study subset |
| Harrigan (2023) | Nano-ReCall: Seamless and accurate HIV-1 drug resistance interpretation of Oxford Nanopore sequence data | 36599816 | 0 | |
134 92PR 92RT 42IN |
0 | Pending |
| Harris (2005) | GENOMIC Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany | AIDS Res. Hum. Retroviruses 21 (7), 654-660 (2005) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Harris (2002) | AMONG 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate | AIDS Res. Hum. Retroviruses 18 (17), 1281-1290 (2002) | 1e-166 | 2 2PR 2RT 2IN |
45 45PR 45RT 45IN |
4 | HIVDB |
| Harris (2003) | A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions | AIDS Res. Hum. Retroviruses 19 (12), 1125-1133 (2003) | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Hartana (2022) | Immune correlates of HIV-1 reservoir cell decline in early-treated infants | Cell Rep 40 (3), 111126 (2022) | 0 | |
302 297PR 298RT 282IN |
0 | Proviral DNA Reservoir |
| Hase (2010) | The different trend in epidemiology of HIV-1 in a local cohort within Japan | Unpublished | 0 | |
101 101PR 101RT |
0 | ARV Rx and/or other data are N/A |
| Hasegawa (1989) | GENOMIC divergence of HIV-2 from Ghana | AIDS Res. Hum. Retroviruses 5 (6), 593-604 (1989) | 1e-100 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Hassan (2012) | Low Prevalence of Transmitted HIV Type 1 Drug Resistance Among Antiretroviral-Naive Adults in a Rural HIV Clinic in Kenya | AIDS Res. Hum. Retroviruses 29 (1), 129-135 (2013) | 0 | 91 91PR 91RT |
91 91PR 91RT |
100 | HIVDB |
| Hassan (2013) | HIV-1 virological failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya | 24456757 | 0 | 55 55PR 55RT |
55 55PR 55RT |
100 | HIVDB |
| Hassan (2018) | Presence, Persistence and Effects of Pre-treatment HIV-1 Drug Resistance Variants Detected at a Low Frequency using Next Generation Sequencing: A Retrospective Longitudinal Study from Rural Coastal Kenya | 30759103 | 0 | 79 79PR 79RT |
80 80PR 80RT |
98 | HIVDB |
| Hassan (2019) | HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya | PLoS ONE 13 (12), e0206177 (2018) | 0 | 97 97PR 97RT |
97 97PR 97RT |
100 | HIVDB |
| Hasson (2025) | Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy | Unpublished | 0 | |
563 537PR 482RT 324IN |
0 | Proviral DNA Reservoir |
| Hatano (2009) | Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy | J. Acquir. Immune Defic. Syndr. (2010) | 1e-167 | 135 135IN |
142 142IN |
95 | HIVDB |
| Hattori (2019) | Halogen bond interactions of novel HIV-1 protease inhibitors (PI)(GRL-001-15 and GRL-003-15) with the flap of protease are critical for their potent activity against wild-type and multi-PI-resistant HIV-1 variants | Antimicrob. Agents Chemother. (2019) In press | 2.02e-60 | |
3 3PR |
0 | Case report(s) / study subset |
| Hatziioannou (2014) | HIV-1-induced AIDS in monkeys | Science 344 (6190), 1401-1405 (2014) | 0 | |
8 8PR 8RT 8IN |
0 | Laboratory/experimental isolate |
| Hauser (2018) | Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies | J. Virol. Methods (2018) In press | 1.64e-179 | |
24 24PR 24RT |
0 | Case report(s) / study subset |
| Hauser (2018) | Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses | PLoS ONE 13 (11), e0206234 (2018) | 5.37e-180 | 8 8PR 8RT |
245 245PR 245RT |
3 | HIVDB |
| Hawke (2013) | HIV Non-B Subtype Distribution: Emerging Trends and Risk Factors for Imported and Local Infections Newly Diagnosed in South Australia | AIDS Res. Hum. Retroviruses 29 (2), 311-317 (2013) | 0 | 425 424PR 421RT |
425 424PR 425RT |
100 | HIVDB |
| Hawkins (2009) | Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first line antiretroviral therapy in Nigeria | J. Acquir. Immune Defic. Syndr. 52, 2 (2010) | 0 | 336 336PR 336RT |
336 336PR 336RT |
100 | HIVDB |
| Hayashida (2024) | Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam | AIDS Res Hum Retroviruses (2024) In press | 0 | |
12 12PR 12RT 12IN |
0 | Case report(s) / study subset |
| Hayashida (2024) | Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the origin | Glob Health Med 6 (5), 345-351 (2024) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| He (2017) | Near Full-Length Genome Sequence of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Detected among Blood Donors in North China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Hebberecht (2019) | Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach | J. Virol. Methods 274, 113737 (2019) | 0 | 77 77PR 77RT 77IN |
77 77PR 77RT 77IN |
100 | HIVDB |
| Hebberecht (2020) | Characterizing viruses involved in local HIV transmission using near full-length genome sequencing | Unpublished | 0 | 40 40PR 40RT 40IN |
40 40PR 40RT 40IN |
100 | HIVDB |
| Heipertz (2013) | Molecular epidemiology of early and acute HIV type 1 infections in the United States Navy and Marine Corps, 2005-2010. | AIDS Res Hum Retroviruses. 2013 Oct;29(10):1310-20. | 0 | 40 40PR 40RT |
46 46PR 46RT 6IN |
86 | HIVDB |
| Heipertz (2016) | Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG | Medicine (Baltimore) 95 (32), E4346 (2016) | 0 | 42 42PR 42RT 42IN |
42 42PR 42RT 42IN |
100 | HIVDB |
| Held (2007) | CROSS-CLADE inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers | J. Virol. 81 (10), 5375-5384 (2007) | 0 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Henerico (2020) | Direct Submission | Submitted (30-APR-2020) Molecular Biology Laborato | 9.77e-170 | |
57 57PR 57RT |
0 | Unpublished |
| Henerico (2022) | Primary Resistance Against Integrase Strand Transfer Inhibitors in Dolutegravir Naive Patients Failing First- and Second-Line ART in Tanzania | Unpublished | 0 | 49 49IN |
49 49IN |
100 | HIVDB |
| Henerico (2023) | HIV drug resistance testing in children, adolescents and adults failing first-line ART in Tanzania | 39197654 | 9.63e-140 | |
145 145PR 145RT |
0 | Pending |
| Henn (2012) | Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection | PLoS Pathog. 8 (3), E1002529 (2012) | 0 | |
93 86PR 89RT 93IN |
0 | Pending |
| Henrich (2017) | Direct Submission | Submitted (20-SEP-2017) Division of Experimental M | 0 | |
55 55PR 55RT |
0 | Case report(s) / study subset |
| Henry (2005) | FACTORS Associated with Time to CD4 Count < 350 cells/mm3 After Treatment Interruption Following Effective Antiretroviral Therapy (ART) +/- Interleukin-2 (IL-2): Results of a Pilot Study (ACTG A5102) | 16760795 | 0 | |
55 55PR 55RT |
0 | Case report(s) / study subset |
| Herbeck (2012) | Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes | J. Virol. 85 (15), 7523-7534 (2011) | 0 | |
474 474PR 474RT 474IN |
0 | Quasispecies |
| Heredia (1997) | EVIDENCE of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus | AIDS Res. Hum. Retroviruses 13, 437-439 (1997) | 4.2 | 1 1RT |
1 1RT |
100 | HIVDB |
| Heredia (2001) | GENETIC analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS | AIDS Res. Hum. Retroviruses 13 (10), 899-900 (1997) | 2e-86 | 1 1RT |
1 1RT |
100 | HIVDB |
| Hermankova (2001) | HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy | JAMA 286 (2), 196-207 (2001) | 1e-126 | |
47 47PR 47RT |
0 | Quasispecies |
| Hermans LE (2022) | Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART | J Int AIDS Soc 23 (6), e25501 (2020) | 0 | 835 835PR 835RT |
845 845PR 845RT |
98 | HIVDB |
| Hernandez-Sanchez (2011) | Genomic Characterization of Mexican Human Immunodeficiency Virus type 1 (HIV-1) isolates | 29620931 | 0 | 1 1PR 1RT 1IN |
11 11PR 11RT 5IN |
9 | HIVDB |
| Hernandez-Sanchez (2016) | Characterization of Resistance Associated Mutations in Treatment Naive Patients from San Luis Potosi, Mexico | 29620931 | 0 | 51 50PR 47RT 47IN |
51 50PR 47RT 47IN |
100 | HIVDB |
| Herrera-Castillo (2022) | Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection | 35508579 | 6.42e-180 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Herring (2001) | NATURAL Variation in HIV-1 Integrase | Unpublished | 1e-165 | 81 81IN |
81 81IN |
100 | HIVDB |
| Herring (2005) | POTENTIAL drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A | AIDS Res. Hum. Retroviruses 20 (9), 1010-1014 (2004) | 1e-162 | |
8 8IN |
0 | Case report(s) / study subset |
| Hertz (2015) | Breakthrough infections in the HVTN 503/Phambili Phase 2b HIV-1 vaccine efficacy trial | 27756485 | 0 | |
280 280PR 280RT 280IN |
0 | Quasispecies |
| Heuverswyn (2007) | GENETIC diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon | Virology 368 (1), 155-171 (2007) | 0 | |
10 2PR 10RT 10IN |
0 | NHPL/SIV |
| Hey-Nguyen (2018) | HIV-1 DNA is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure | AIDS Res. Hum. Retroviruses (2019) In press | 0 | |
158 158PR 158RT |
0 | Proviral DNA Reservoir |
| Hiener (2017) | Next-Generation Sequencing of Single Full-Length HIV-1 Proviruses Identifies Intact Genomes | 29045846 | 0 | |
346 335PR 332RT 303IN |
0 | Proviral DNA Reservoir |
| Hierholzer (2002) | HIV type 1 strains from East and West Africa are intermixed in Sudan | AIDS Res. Hum. Retroviruses 18 (15), 1163-1166 (2002) | 1e-130 | 30 30PR 30RT |
30 30PR 30RT |
100 | HIVDB |
| Hierholzer (2003) | MOLECULAR Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina | AIDS Res. Hum. Retroviruses 18 (18), 1339-1350 (2002) | 1e-164 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Hightower (2013) | HIV-1 Clade B pol Evolution following Primary Infection | PLoS ONE 8 (6), E68188 (2013) | 0 | 354 354PR 354RT |
361 361PR 361RT |
98 | HIVDB |
| Hill (2022) | The origin and phylodynamics of HIV-1 CRF47_BF | Front Microbiol (2022) In press | 0 | |
80 80PR 80RT |
0 | Quasispecies |
| Hinay (2022) | Antiviral activity of currently available drugs against primary HIV isolates with high growth capability in vitro | 36499705 | 0 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Hingankar (2012) | Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India | Clin. Infect. Dis. 54, S348-S354 (2012) | 0 | 96 96PR 96RT |
105 105PR 105RT |
91 | HIVDB |
| Hirano (2010) | Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones | Unpublished | 0 | |
21 21PR 21RT 21IN |
0 | Laboratory/experimental isolate |
| Hirigoyen (2005) | USE of Sequence Data Generated in the Bayer TruGene Genotyping Assay To Recognize and Characterize Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains | J. Clin. Microbiol. 43 (10), 5263-5271 (2005) | 1e-144 | |
29 29PR 29RT |
0 | ARV Rx and/or other data are N/A |
| Hirsch (1993) | An African primate lentivirus (SIVsm) closely related to HIV-2. | Nature | 1e-100 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Hirsch (1997) | A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3 | J. Virol. 71 (2), 1608-1620 (1997) | 1e-100 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Hirsch (1993) | A distinct African lentivirus from Sykes' monkeys | J. Virol. 67 (3), 1517-1528 (1993) | 3e-91 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Hirsch (1995) | INDUCTION of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication | J. Virol. 69 (2), 955-967 (1995) | 3.76e-122 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Hirsch (1999) | CHARACTERIZATION of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses | J. Virol. 73 (2), 1036-1045 (1999) | 4.79e-112 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Hirsch (2000) | HUMAN retrovirses, cancer and AIDS: approach to prevention and therapy | 3646094 | 1.07e-114 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Ho (2009) | Drug-Associated Changes in Amino Acid Residues in Gag p2, p7NC, and p6Gag/p6Pol in Human Immunodeficiency Virus Type 1 (HIV-1) Display a Dominant Effect on Replicative Fitness and Drug Response | 18599104 | 7e-59 | |
14 14PR |
0 | Case report(s) / study subset |
| Ho (2010) | Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor | AIDS 23 (13), 1631-1640 (2009) | 3e-60 | |
450 450PR |
0 | Quasispecies |
| Ho (2013) | Replication-competent non-induced proviruses in the latent reservoir increase barrier to HIV-1 cure | 24243014 | 0 | |
117 83PR 108RT 90IN |
0 | Quasispecies |
| Hoelscher (2001) | HIGH proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania | AIDS 15 (12), 1461-1470 (2001) | 1e-166 | 9 9PR 9RT 9IN |
9 9PR 9RT 9IN |
100 | HIVDB |
| Hoenigl (2016) | Characterization of HIV Transmission in South-East Austria | PLoS ONE 11 (3), E0151478 (2016) | 1.59e-150 | 259 259PR 258RT |
259 259PR 258RT |
100 | HIVDB |
| Hoffmann (2014) | Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa | Antivir. Ther. (Lond.) 18 (7), 915-920 (2013) | 4e-176 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Hofstra (2014) | Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients | PLoS ONE 9 (10), E110749 (2014) | 0 | |
14 14PR 14RT |
0 | Quasispecies |
| Holguin (2002) | HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe. | HIV Clin Trials | 2e-98 | 18 1PR 17RT |
18 1PR 17RT |
100 | HIVDB |
| Holguin (2000) | HIV-1 subtype J recombinant viruses in Spain | AIDS Res. Hum. Retroviruses 18 (7), 523-529 (2002) | 1e-90 | 19 5PR 14RT |
20 6PR 14RT |
95 | HIVDB |
| Holguin (2000) | PROTEASE gene analysis of HIV type 1 non-B subtypes in Spain | AIDS Res. Hum. Retroviruses 16 (14), 1395-1403 (2000) | 2e-92 | 15 15PR |
15 15PR |
100 | HIVDB |
| Holguin (2001) | PREVALENCE of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5 | J. Clin. Microbiol. 39 (5), 1850-1854 (2001) | 1e-126 | 32 32PR |
32 32PR |
100 | HIVDB |
| Holguin (2002) | HIGH prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid | AIDS 16 (8), 1163-1170 (2002) | 1e-102 | 43 43PR |
44 44PR |
97 | HIVDB |
| Holguin (2002) | HETEROGENEOUS nature of HIV-1 recombinants spreading in Spain | J. Med. Virol. 75 (3), 374-380 (2005) | 1e-123 | 75 41PR 34RT |
75 41PR 34RT |
100 | HIVDB |
| Holguin (2003) | DIFFERENCES in the Length of Gag Proteins among Different HIV Type 1 Subtypes | AIDS Res. Hum. Retroviruses 21 (10), 886-893 (2005) | 9.69e-55 | 104 104PR |
104 104PR |
100 | HIVDB |
| Holguin (2004) | IMPACT of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes | J. Clin. Virol. 31 (3), 215-220 (2004) | 3e-50 | 21 21PR |
21 21PR |
100 | HIVDB |
| Holguin (2004) | HIV-1 subtypes in Spain | HIV Med. 2005 Sep;6(5):313-20. | 8e-51 | |
14 14PR |
0 | ARV Rx and/or other data are N/A |
| Holguin (2006) | INTRODUCTION of Non-B Subtypes among Spaniards Newly Diagnosed with HIV Type 1 in the Canary Islands | AIDS Res. Hum. Retroviruses 23 (4), 498-502 (2007) | 0 | 149 148PR 148RT |
149 148PR 148RT |
100 | HIVDB |
| Holguin (2007) | NEGATIVE line immunoassay in a HIV-1 subtype D- infected patient with positive serological tests for HIV | Unpublished | 1.05e-140 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Holguin (2007) | Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain | Curr. HIV Res. 6 (4), 327-334 (2008) | 0 | 287 283PR 279RT |
288 287PR 285RT |
99 | HIVDB |
| Holguin (2008) | GENETIC characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools | J. Med. Virol. 80 (3), 383-391 (2008) | 0 | 5 5PR 4RT 1IN |
5 5PR 5RT 3IN |
100 | HIVDB |
| Holguin (2011) | Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009 | Pediatr. Infect. Dis. J. 30 (5), E82-E87 (2011) | 2.98e-167 | 75 71PR 65RT |
75 71PR 74RT |
100 | HIVDB |
| Holguin (2012) | Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America | Clin. Microbiol. Infect. 19 (12), E523-E532 (2013) | 0 | 88 70PR 88RT |
88 72PR 88RT |
100 | HIVDB |
| Holguin (2013) | HIV-1 Drug Resistance Prevalence, Drug Susceptibility and Variant Characterization in the Jacobi Medical Center Pediatric Cohort, Bronx, NY, US | 24112468 | 0 | 37 28PR 27RT |
47 37PR 47RT |
78 | HIVDB |
| Holguin (2013) | HIV-1 transmitted resistance in Madrid, Spain | Unpublished | 0 | |
820 819PR 816RT |
0 | ARV Rx and/or other data are N/A |
| Holguin (2015) | Children age, antiretroviral treatment, and CD4 count are major determinants of HIV-1B evolution in pediatric patients | 29403002 | 0 | 5 5PR 5RT |
15 15PR 15RT |
33 | HIVDB |
| Holguin (2015) | HIV-1 Variants and Drug Resistance in Pregnant Women From Equatorial Guinea: 2012-13 | 27798676 | 0 | |
70 42PR 68RT |
0 | ARV Rx and/or other data are N/A |
| Holguin (2015) | Impact of exposure to lopinavir-ritonavir in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014 | Unpublished | 0 | 3 3PR 1RT |
22 22PR 19RT |
13 | HIVDB |
| Holguin (2016) | Clinical determinants of HIV-1 genetic diversity and their association with the evolution of drug resistance in pediatric patients | 27907076 | 0 | |
7 7PR 7RT |
0 | Pending |
| Holguin (2018) | Impact of clinical parameters in the intra-host evolution of HIV-1 subtype B in pediatric patients | 29044435 | 0 | 4 4PR 4RT |
86 86PR 83RT |
4 | HIVDB |
| Holguin (2019) | Direct Submission | Submitted (29-AUG-2018) Laboratrio de Epidemiologi | 0 | 12 9PR 11RT 11IN |
58 51PR 54RT 46IN |
20 | HIVDB |
| Holguin (2020) | Direct Submission | Submitted (19-FEB-2020) Laboratrio de Epidemiologi | 0 | 8 8PR 8RT |
8 8PR 8RT |
100 | HIVDB |
| Holguin (2022) | Direct Submission | Submitted (16-NOV-2021) Laboratrio de Epidemiologi | 0 | 135 135PR 131RT 8IN |
348 312PR 315RT 175IN |
38 | HIVDB |
| Holler (1994) | HIV1 integrase expressed in Escherichia coli from a synthetic gene | Gene 136 (1-2), 323-328 (1993) | 1e-165 | |
1 1IN |
0 | Laboratory/experimental isolate |
| Holzmayer (2005) | NEAR-FULL-LENGTH genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon | AIDS Res. Hum. Retroviruses 21 (5), 414-419 (2005) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Holzmayer (2009) | Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain | AIDS Res. Hum. Retroviruses 25 (7), 721-726 (2009) | 0 | 15 1PR 1RT 15IN |
15 1PR 1RT 15IN |
100 | HIVDB |
| Hong (2023) | Direct Submission | Submitted (06-SEP-2023) Ningbo University, School | 0 | 1093 1093PR 1093RT |
1093 1093PR 1093RT |
100 | HIVDB |
| Hong (2007) | CHARACTERISTICS of a novel resistant HIV-1 strain against Tenofovir | Unpublished | 1e-144 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Honnayakanahalli Marichannegowda (2021) | Direct Submission | Submitted (06-SEP-2020) Medicine-Infectious Diseas | 0 | |
222 62PR 62RT 222IN |
0 | Unpublished |
| Hoof (2010) | Interdisciplinary analysis of HIV-specific CD8(+) T cell responses against variant epitopes reveals restricted TCR promiscuity | J. Immunol. 184 (9), 5383-5391 (2010) | 0 | |
56 27PR 56RT |
0 | Laboratory/experimental isolate |
| Hooker (1996) | AN in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine | J. Virol. 70 (11), 8010-8018 (1996) | 2e-91 | |
2 2RT |
0 | Case report(s) / study subset |
| Hora (2012) | Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL) | 27314585 | 0 | 176 176PR 176RT 176IN |
262 262PR 262RT 262IN |
67 | HIVDB |
| Hora (2017) | Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL) | Unpublished | 0 | |
47 47PR 47RT 47IN |
0 | Case report(s) / study subset |
| Hora (2020) | Characterization of near full-length genome sequences for standard panels of HIV-1 isolates established at the External Quality Assurance Program Oversight Laboratory (EQAPOL) | Unpublished | 0 | |
50 50PR 50RT 50IN |
0 | Unpublished |
| Hora (2020) | Streamlined Subpopulation, Subtype and recombination Analysis of HIV-1 Half-genome Sequences Generated by High-Throughput Sequencing | 33055255 | 2.31e-31 | |
415 415IN |
0 | Gene fragment(s) |
| Horsburgh (2019) | High levels of genetically-intact HIV in HLA-DR+ memory T-cells indicates their value for reservoir studies | 31913161 | 0 | |
91 91PR 90RT |
0 | Proviral DNA Reservoir |
| Horsburgh (2019) | Cells expressing HLA-DR contain High Levels of Genetically Intact HIV | 31913161 | 0 | |
141 136PR 133RT 128IN |
0 | Proviral DNA Reservoir |
| Horsburgh (2021) | Cellular activation, differentiation and proliferation influence the dynamics of genetically-intact proviruses over time | J Infect Dis (2021) In press | 0 | |
1000 879PR 897RT 783IN |
0 | Proviral DNA Reservoir |
| Horsburgh (2025) | Development and verification of a novel tiling PCR method for long-range HIV-1 sequencing in a diagnostic setting | Unpublished | 0 | |
90 89PR 90RT 89IN |
0 | Sequencing method |
| Horthongkham (2019) | Direct Submission | Submitted (28-AUG-2019) Microbiology, Faculty of M | 0 | |
24 24PR 24RT |
0 | Unpublished |
| Hosaka (2015) | HIV-1 CRF01_AE and subtype B transmission networks cross over: a new AE/B recombinant identified in Japan | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 17 17PR 17RT 13IN |
17 17PR 17RT 13IN |
100 | HIVDB |
| Hosseinipour (2009) | The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy | AIDS 23 (9), 1127-1134 (2009) | 1.35e-144 | 188 94PR 94RT |
188 94PR 94RT |
100 | HIVDB |
| Howard (1997) | SEQUENCE analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria | AIDS Res. Hum. Retroviruses 10 (12), 1755-1757 (1994) | 1e-164 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Hsi (2014) | Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF64_BC) Identified from Yunnan, China | AIDS Res. Hum. Retroviruses (2014) In press | 0 | 5 5PR 5RT 5IN |
6 6PR 6RT 6IN |
83 | HIVDB |
| Hsu (2013) | Exposure to MIV-150 from a high-dose intravaginal ring results in limited selection of drug resistance mutations in SHIV-RT infected rhesus macaques | 24117013 | 0 | |
644 644PR 644RT 644IN |
0 | Laboratory/experimental isolate |
| Hu (2003) | CHARACTERIZATION and Comparison of Recombinant Simian Immunodeficiency Virus from Drill (Mandrillus leucophaeus) and Mandrill (Mandrillus sphinx) Isolates | J. Virol. 77 (8), 4867-4880 (2003) | 1e-122 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Hu (2007) | VIROLOGIC characterization of human immunodeficiency virus type 1 with a codon 70 deletion in reverse transcriptase | 17496561 | 0 | |
1 1RT |
0 | HIVDB |
| Huang (2003) | SEQUENCE characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel | AIDS Res. Hum. Retroviruses 19 (4), 321-328 (2003) | 1e-130 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Huang (2009) | Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC) | AIDS Res. Hum. Retroviruses 25 (10), 1039-1043 (20 | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Huang (2016) | HIV detected in macaque monkeys | Unpublished | 5e-92 | |
3 3IN |
0 | Case report(s) / study subset |
| Huang (2006) | GENETIC characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China | Chin. Med. J. 119 (19), 1622-1628 (2006) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Huang (2006) | GENETIC Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China | AIDS Res. Hum. Retroviruses 23 (4), 569-574 (2007) | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Huang (2016) | Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa | Antivir. Ther. (Lond.) 14 (7), 975-984 (2009) | 0 | 248 238PR 248RT |
248 238PR 248RT 94IN |
100 | HIVDB |
| Huang (2013) | Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env | J. Med. Primatol. (2013) In press | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Huang (1998) | COMPLETE sequence of type B HIV-1 Taiwan strain | Unpublished | 1e-162 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Huang (2024) | Direct Submission | Submitted (21-DEC-2023) Department of Microbiology | 1.49e-92 | |
1 1RT |
0 | Case report(s) / study subset |
| Huang (2024) | Low baseline CD4 T cell count and CD4/CD8 ratio are characterized in the recently infected individuals with HIV-1 subtype CRF01_AE | Unpublished | 2.41e-170 | |
241 24PR 241RT |
0 | Unpublished |
| Huang (2025) | Molecular Epidemiology and Pretreatment Drug Resistance of HIV-1 Among Newly Diagnosed Individuals in Nanning City, Guangxi, China | Unpublished | 0 | |
1048 1046PR 1048RT |
0 | Pending |
| Huang (2021) | Genomic characterization of a new CRF01_AE/CRF07_BC case from a MSM patient in Guangdong, China | J Med Virol (2021) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Hudelson (2010) | Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration | AIDS 24 (4), 557-561 (2010) | 0 | |
60 60PR 60RT |
0 | Pending |
| Hue (2003) | HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy | AIDS 18 (5), 719-728 (2004) | 1e-130 | |
138 138PR 138RT |
0 | ARV Rx and/or other data are N/A |
| Hue (2009) | Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals | J. Virol. 83 (6), 2645-2654 (2009) | 0 | |
45 45PR 45RT |
0 | Case report(s) / study subset |
| Hue (2011) | HIV-1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination | AIDS Res. Hum. Retroviruses (2011) In press | 1e-177 | 152 152PR 152RT |
159 159PR 159RT |
95 | HIVDB |
| Hue (2004) | GENETIC analysis reveals the complex structure of HIV-1 transmission within defined risk groups | Proc. Natl. Acad. Sci. U.S.A. 102 (12), 4425-4429 (2005) | 1e-126 | |
223 223PR 223RT |
0 | ARV Rx and/or other data are N/A |
| Huet (1995) | GENETIC organization of a chimpanzee lentivirus related to HIV-1 | Nature 345 (6273), 356-359 (1990) | 1e-157 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Huet (1989) | A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot | AIDS 3 (11), 707-715 (1989) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Hughes (2009) | Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom | PLoS Pathog. 5 (9), E1000590 (2009) | 0 | |
506 506PR 506RT |
0 | Case report(s) / study subset |
| Huik (2022) | High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy | AIDS 36 (13), 1835-1840 (2022) | 0 | |
206 206IN |
0 | Case report(s) / study subset |
| Huik (2019) | The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx | PLoS ONE 14 (5), e0217048 (2019) | 4.84e-164 | 209 209PR 209RT |
209 209PR 209RT |
100 | HIVDB |
| Hunt (2017) | Low to Moderate Levels of Transmitted HIV-1 Drug Resistance across South Africa in 2012 | 30741163 | 1.03e-174 | 979 979PR 979RT |
979 979PR 979RT |
100 | HIVDB |
| Hunt (2018) | Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13 | 31526373 | 7.78e-170 | |
218 218PR 218RT |
0 | Pending |
| Hunt (2002) | CHARACTERISATION of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates | Virus Genes 26 (1), 49-56 (2003) | 1e-164 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Hunt (2013) | Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009 | Clin. Infect. Dis. 54 (SUPPL 4), S334-S338 (2012) | 0 | 345 264PR 345RT |
345 280PR 345RT |
100 | HIVDB |
| Huruy (2014) | High drug resistance and polymorphism in viral RNA and proviral DNA among treatment naive HIV-1 infected subjects in Northwest Ethiopia | 30286160 | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Huruy (2014) | Primary HIV-1 drug resistance mutations among antiretroviral treatment naive patients in northwest Ethiopia | 25649964 | 0 | 83 83PR 83RT |
83 83PR 83RT |
100 | HIVDB |
| Iamarino (2012) | BF Integrase Genes of HIV-1 Circulating in Sao Paulo, Brazil, with a Recurrent Recombination Region | PLoS ONE 7 (4), E34324 (2012) | 1e-167 | 157 157IN |
157 157IN |
100 | HIVDB |
| Ibanez (2000) | HUMAN immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies | J. Gen. Virol. 81 (Pt 1), 85-95 (2000) | 1e-121 | |
86 86PR |
0 | Quasispecies |
| Ibe (2008) | TREND of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006 | AIDS Res. Hum. Retroviruses 24 (1), 7-14 (2008) | 1.38e-167 | 402 402PR 402RT |
402 402PR 402RT |
100 | HIVDB |
| Ibe (2008) | ANALYSIS of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity | AIDS Res. Hum. Retroviruses 24 (8), 1121-1125 (2008) | 0 | 12 12PR 12RT 12IN |
12 12PR 12RT 12IN |
100 | HIVDB |
| Ibe (2010) | HIV-2 CRF01_AB: first circulating recombinant form of HIV-2 | J. Acquir. Immune Defic. Syndr. 54 (3), 241-247 (2 | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Ida (2000) | HORIZONTAL Transmission of HIV-1 from Hemophiliac Son to Father | Unpublished | 1e-133 | |
34 34RT |
0 | Case report(s) / study subset |
| Ignacio (2008) | NOVEL Protease Insertion in HIV Type-1 | AIDS Res. Hum. Retroviruses (2008) In press | 1e-178 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Imade (2013) | Transmitted HIV Drug Resistance in Antiretroviral-Naive Pregnant Women in North Central Nigeria | AIDS Res. Hum. Retroviruses (2013) In press | 0 | 34 34PR 34RT |
34 34PR 34RT |
100 | HIVDB |
| Imamichi (2001) | HUMAN immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy | J. Infect. Dis. 183 (1), 36-50 (2001) | 1e-126 | |
644 644PR |
0 | SGS |
| Imamichi (2009) | Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa | AIDS Res. Hum. Retroviruses 25 (1), 45-55 (2009) | 7.4e-147 | |
12 6PR 6RT |
0 | Case report(s) / study subset |
| Imamichi (2016) | Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy | Proc. Natl. Acad. Sci. U.S.A. 113 (31), 8783-8788 | 0 | |
158 157PR 151RT 125IN |
0 | Quasispecies |
| Imamichi (2020) | Defective HIV-1 proviruses produce viral proteins | Proc. Natl. Acad. Sci. U.S.A., 201917876 (2020) | 0 | |
29 28PR 28RT 28IN |
0 | Proviral DNA Reservoir |
| Imamichi (2022) | Associations among markers of HIV-1 transcription, protein production, and inflammation during chronic HIV-1 infection | Unpublished | 0 | |
193 187PR 193RT 192IN |
0 | Unpublished |
| Imamichi (2023) | Direct Submission | Submitted (08-AUG-2022) CMRS, LIR, NIAID, NIH, 10 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Imamichi (2025) | Tissue Distribution of Transcriptionally Active HIV-1 Proviral DNA: Clonal Expansion and Impact of Therapy | Unpublished | 0 | |
431 391PR 363RT 240IN |
0 | Proviral DNA Reservoir |
| Indriati (2018) | Appearance of drug resistance mutations among the dominant HIV-1 subtype, CRF01_AE in Maumere, Indonesia | Curr. HIV Res. (2018) In press | 1.51e-180 | 77 46PR 31RT |
77 46PR 31RT |
100 | HIVDB |
| Indriati (2021) | The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia | Acta Med Indones 52 (4), 366-374 (2020) | 3.79e-176 | 69 32PR 37RT |
69 32PR 37RT |
100 | HIVDB |
| Inzaule (2013) | Field Evaluation of a Broadly Sensitive HIV-1 In-House Genotyping Assay for Use with both Plasma and Dried Blood Spot Specimens in a Resource-Limited Country | J. Clin. Microbiol. 51 (2), 529-539 (2013) | 1.31e-169 | 59 59PR 59RT |
59 59PR 59RT |
100 | HIVDB |
| Inzaule (2015) | High prevalence of K65R drug resistance mutation in HIV-1 infected infants exposed to maternal therapy of lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk | 26953333 | 0 | 5 5PR 5RT |
5 5PR 5RT |
100 | HIVDB |
| Inzaule (2018) | Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa | J. Antimicrob. Chemother. (2018) In press | 0 | 425 425IN |
425 425IN |
100 | HIVDB |
| Inzaule (2019) | High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria | J. Acquir. Immune Defic. Syndr. 77 (1), e1-e7 (201 | 2.39e-172 | |
424 424PR 424RT |
0 | Pending |
| Iqbal (2010) | Primary HIV-1 Drug Resistance and Polymorphic Patterns Among Injecting Drug Users (IDUs) in Chennai, Southern India | J Int Assoc Physicians AIDS Care 8, 323-327 (2009) | 1.02e-156 | 91 37PR 54RT |
92 37PR 72RT |
98 | HIVDB |
| Iqbal (2016) | Drug Resistance Surveillance and Phylogenetic Analysis among Newly HIV-1 Infected Individuals Attending a Tertiary Referral Center in Chennai, India | 29045846 | 1.9e-147 | |
18 18RT |
0 | Proviral DNA Reservoir |
| Irias (2019) | HIV-1 transmitted drug resistance mutations in recently diagnosed antiretroviral-naive patients in Belem, Para, Northern of Brazil | AIDS Res. Hum. Retroviruses (2019) In press | 3.45e-158 | 81 41PR 40RT |
81 41PR 40RT |
100 | HIVDB |
| Isah (2025) | Molecular characterization of HIV-1 and drug resistance mutants among haart-treated patients in edo-north, Nigeria | Unpublished | 1.69e-60 | |
48 48PR |
0 | Unpublished |
| Isanin (2021) | [Sorption properties of cells of regenerating liver] | Tsitologiia 16 (11), 1420-1425 (1974) | 0 | |
329 157PR 157RT 172IN |
0 | ARV Rx and/or other data are N/A |
| Isarangkura-na-ayuthaya (2010) | Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients | AIDS Res. Hum. Retroviruses (2010) In press | 1e-165 | 78 78IN |
78 78IN |
100 | HIVDB |
| Ishizaki (2009) | Profile of HIV Type 1 Infection and Genotypic Resistance Mutations to Antiretroviral Drugs in Treatment-Naive HIV Type 1-Infected Individuals in Hai Phong, Viet Nam | AIDS Res. Hum. Retroviruses 25 (2), 175-182 (2009) | 0 | 294 292PR 271RT |
422 421PR 397RT |
69 | HIVDB |
| Ismael (2022) | Direct Submission | Submitted (23-MAY-2022) Plataformas Tecnologicas, | 1.46e-167 | |
118 114PR 118RT |
0 | Unpublished |
| Ismael (2024) | Direct Submission | Submitted (20-MAR-2024) Department of Technologica | 0 | 338 169PR 169RT 169IN |
535 365PR 366RT 169IN |
63 | HIVDB |
| Ivanov (2013) | Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics | PLoS ONE 8 (3), E59666 (2013) | 1e-176 | 84 84PR 83RT |
125 125PR 125RT |
67 | HIVDB |
| Iweriebor (2010) | Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa | Arch. Virol. 157 (3), 455-465 (2012) | 1e-168 | 69 29PR 40RT |
79 35PR 44RT |
87 | HIVDB |
| Iweriebor (2010) | Genetic analysis of the near full-length genome of an HIV type 1 A1/C unique recombinant form from northern South Africa. | AIDS Res Hum Retroviruses. 2011 Aug;27(8):911-5. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Iweriebor (2010) | A putative HIV-1 subtype C/CRF11_cpx unique recombinant from South Africa. | Springerplus. 2016 Mar 5;5:285. | 0 | |
2 1RT 1IN |
0 | Case report(s) / study subset |
| Iweriebor (2021) | Direct Submission | Submitted (04-JUN-2019) Biochemistry and Microbiol | 1.25e-163 | |
1 1RT |
0 | Case report(s) / study subset |
| Iyer (2017) | Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness | Proc. Natl. Acad. Sci. U.S.A. (2017) In press | 0 | |
610 303PR 303RT 610IN |
0 | Quasispecies |
| Izopet (1998) | EVOLUTION of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression | Virology 302 (2), 393-404 (2002) | 1e-129 | |
278 18PR 260RT |
0 | Proviral DNA Reservoir |
| Izopet (2000) | SHIFT in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen | AIDS 14 (15), 2247-2255 (2000) | 1e-133 | |
152 76PR 76RT |
0 | Quasispecies |
| Izopet (2002) | EVOLUTION of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype | J. Infect. Dis. 185 (10), 1506-1510 (2002) | 1e-133 | |
306 149PR 157RT |
0 | Quasispecies |
| Jabara (2011) | Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID | Proc. Natl. Acad. Sci. U.S.A. 108 (50), 20166-2017 | 1e-60 | |
4679 4679PR |
0 | Quasispecies |
| Jackson (2002) | IDENTIFICATION of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission | AIDS 14 (11), F111-F115 (2000) | 3e-22 | 15 15RT |
15 15RT |
100 | HIVDB |
| Jacobs (2007) | Complete genome sequencing of a non-syncytium-inducing HIV type 1 subtype D strain from Cape Town, South Africa. | AIDS Res Hum Retroviruses. 2007 Dec;23(12):1575-8. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Jacobs (2008) | PHYLOGENETIC Diversity and Low Level Antiretroviral Resistance Mutations in HIV Type 1 Treatment-Naive Patients from Cape Town, South Africa | AIDS Res. Hum. Retroviruses 24 (7), 1009-1012 (2008) | 0 | 140 131PR 91RT |
140 131PR 139RT |
100 | HIVDB |
| Jacobs (2012) | Construction of a High Titer Infectious HIV-1 Subtype C Proviral Clone from South Africa | Viruses 4 (9), 1830-1843 (2012) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Jacobson (2006) | EVIDENCE That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC-HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068 | J. Infect. Dis. 194 (5), 623-632 (2006) | 4.13e-146 | |
9 9PR 9RT |
0 | Case report(s) / study subset |
| Jacomini (2016) | Genotyping of human immunodeficiency virus type 1, determining the frequency of subtypes and change of resistance to inhibitors of reverse transcriptase drug naive patients in Manaus-Amazonas | Unpublished | 1.49e-126 | |
52 52RT |
0 | Gene fragment(s) |
| Jagdagsuren (2017) | The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016 | PLoS ONE 12 (12), e0189605 (2017) | 0 | 126 126PR 126RT 3IN |
126 126PR 126RT 3IN |
100 | HIVDB |
| Jagodzinski (2014) | Discrepant Amplification Results during the Development of an Assay Leads to Reclassification of Two AIDS Reagent Repository HIV-2 Isolates as HIV-1 | PLoS ONE 9 (5), E96554 (2014) | 1.46e-143 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Jahanbakhsh (2012) | Molecular epidemiology of HIV-1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use | AIDS Res. Hum. Retroviruses, DOI:10.1089/AID.2012. | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Jahanbakhsh (2013) | Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011 | PLoS ONE 8 (4), E61864 (2013) | 7.16e-170 | 94 47PR 47RT 47IN |
94 47PR 47RT 47IN |
100 | HIVDB |
| Jain (2010) | Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes | J. Infect. Dis. 203 (8), 1174-1181 (2011) | 7.06e-163 | |
534 283PR 283RT |
0 | Case report(s) / study subset |
| Jallow (2006) | VIROLOGICAL and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia | AIDS 20 (10), 1455-1458 (2006) | 1e-160 | 28 28PR 28RT |
28 28PR 28RT |
100 | HIVDB |
| Jallow (2007) | DEVELOPMENT and Evaluation of an Oligonucleotide Ligation Assay for Detection of Drug Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 2 pol Gene | J. Clin. Microbiol. 45 (5), 1565-1571 (2007) | 1e-160 | 34 28PR 34RT |
34 29PR 34RT |
100 | HIVDB |
| Jallow (2009) | Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau | Clin. Infect. Dis. 48 (12), 1790-1793 (2009) | 1e-157 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Jallow (2009) | Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants | J. Clin. Microbiol. 47 (7), 2200-2208 (2009) | 0 | 13 13PR 13RT |
13 13PR 13RT |
100 | HIVDB |
| James (2018) | Low-bias RNA sequencing of the HIV-2 genome from blood plasma | J. Virol. (2018) In press | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Janin (2009) | Low Prevalence of Drug Resistance Transmitted Virus in HIV Type 1-Infected ARV-Naive Patients in Cambodia | AIDS Res. Hum. Retroviruses 25 (5), 543-545 (2009) | 4.19e-145 | 126 59PR 67RT |
126 59PR 67RT |
100 | HIVDB |
| Janini (1996) | HORIZONTAL and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C | J. Infect. Dis. 177 (1), 227-231 (1998) | 1e-130 | |
42 42PR |
0 | Case report(s) / study subset |
| Janini (2001) | HUMAN immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells | J. Virol. 75 (17), 7973-7986 (2001) | 1e-133 | |
350 350PR |
0 | ARV Rx and/or other data are N/A |
| Janssens (1995) | DIRECT Submission | Unpublished | 3e-42 | |
1 1IN |
0 | Gene fragment(s) |
| Janssens (1995) | FURTHER evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon | AIDS 8 (7), 1012-1013 (1994) | 8e-41 | |
2 2IN |
0 | Gene fragment(s) |
| Janssens (2000) | HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants | AIDS 14 (11), 1533-1543 (2000) | 1e-162 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Janssens (2000) | NEAR full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants | AIDS Res. Hum. Retroviruses 16 (12), 1183-1189 (2000) | 1e-162 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Jarchi (2019) | Human Immunodeficiency Virus-1 Transmitted Drug Resistance Frequency in Treatment-naive Iranian HIV-1 Infected Children | Unpublished | 0 | |
15 15PR 15RT |
0 | Case report(s) / study subset |
| Javaugue (2011) | Molecular Characterization of Non-B HIV Type 1 Isolates from Patients of a Department of Infectious Diseases, University Hospital of Bordeaux, France, 1989-2009 | AIDS Res. Hum. Retroviruses 28 (9), 924-930 (2012) | 5e-170 | |
217 107PR 110RT |
0 | Pending |
| Jenkins (2016) | Complete Genome Sequence of a Reference Stock of Simian Immunodeficiency Virus RNA (SIVmac251/32H/L28) Determined by Deep Sequencing | Genome Announc 4 (3) (2016) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Jenwitheesuk (2002) | PREVALENCE of genotypic HIV-1 drug resistance in Thailand, 2002 | Ann Clin Microbiol Antimicrob 2 (1), 4 (2003) | 1e-126 | |
170 82PR 88RT |
0 | ARV Rx and/or other data are N/A |
| Jenwitheesuk (2014) | Prevalence of HIV-1 drug resistance in private hospital in Thailand | Unpublished | 3e-178 | |
500 500PR 500RT |
0 | Unpublished - Final |
| Jespersen (2018) | Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): a Randomised Controlled Trial | J. Acquir. Immune Defic. Syndr. (2018) In press | 8.05e-177 | 83 83PR 83RT |
83 83PR 83RT |
100 | HIVDB |
| Jessie (2019) | Engagement in HIV care and antiretroviral drug resistance mutations in East Africa Cross Border Areas | Unpublished | 0 | |
125 125PR 125RT |
0 | Unpublished |
| Jia (2016) | Near Full-Length Genomic Sequences of Two Novel HIV-1 Recombinant Forms identified in Shenzhen, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Jia (2019) | Two-year cross-sectional studies reveal that single, young MSMs in Shenzhen, China are at high risk for HIV infection | Virol. J. 16 (1), 83 (2019) | 0 | 409 408PR 409RT |
409 409PR 409RT |
100 | HIVDB |
| Jiamsakul (2014) | HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia | J Int AIDS Soc 17, 19053 (2014) | 0 | 210 105PR 105RT |
210 105PR 105RT |
100 | HIVDB |
| Jiamsakul (2014) | Transmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007-2010) - TASER-S. | AIDS Res Ther. 2015 Feb 13;12:3. | 0 | 28 14PR 14RT |
28 14PR 14RT |
100 | HIVDB |
| Jiamsakul (2015) | Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals | J. Med. Virol. (2015) In press | 0 | |
180 180PR 180RT |
0 | ARV Rx and/or other data are N/A |
| Jiang (2011) | Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism | J. Virol. (2011) In press | 0 | |
24 10PR 10RT 24IN |
0 | Case report(s) / study subset |
| Jiang (2019) | Genomic Characterization of a Novel HIV Type 1 strain originating from CRF07_BC and CRF01_AE by Heterosexual Transmission in the Lingshan Prefecture of Guangxi province, China | AIDS Res. Hum. Retroviruses (2019) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Jiao (2018) | Characterization of a New HIV-1 CRF01_AE/CRF07_BC Recombinant virus Form Men Who Have Sex with Men in Beijing, China | AIDS Res. Hum. Retroviruses (2018) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Jin (1994) | MOSAIC genome structure of simian immunodeficiency virus from west African green monkeys | EMBO J. 13 (12), 2935-2947 (1994) | 1e-124 | |
2 2PR 2RT 1IN |
0 | NHPL/SIV |
| Jinnopat (2009) | Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE strains on Drug Susceptibility of Virus to Protease Inhibitors | J. Acquir. Immune Defic. Syndr. (2009) In press | 9e-59 | |
8 8PR |
0 | Case report(s) / study subset |
| Joao (2024) | Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial | Lancet HIV 7 (5), e322-e331 (2020) | 0 | 682 326PR 341RT 371IN |
682 326PR 341RT 341IN |
100 | HIVDB |
| Joas (2018) | vpu and nef cooperate to allow efficient replication of HIV-1-like SIVagm chimeras in African Green Monkeys without causing disease | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Proviral DNA Reservoir |
| Johnson (2005) | Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated | J. Infect. Dis. 192 (1), 16-23 (2005) | 1.04e-85 | |
13 13RT |
0 | Gene fragment(s) |
| Johnson (1990) | SIMIAN immunodeficiency viruses from African green monkeys display unusual genetic diversity | J. Virol. 64 (3), 1086-1092 (1990) | 1e-111 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Johnson (2001) | VERTICAL transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant | J. Infect. Dis. 183 (11), 1688-1693 (2001) | 1e-112 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Johnson (2007) | DETECTION of HIV Drug Resistance at Regimen Failure during Sequential 3-Drug versus Initial 4-Drug HAART Strategies in AIDS Clinical Trials Group Protocol 384 | J. Acquir. Immune Defic. Syndr. (2007) In press | 0 | 1208 1207PR 1207RT |
1209 1208PR 1209RT |
99 | HIVDB |
| Johnston (2004) | PANEL of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations | AIDS 19 (7), 731-733 (2005) | 1e-158 | 2 2RT |
2 2RT |
100 | HIVDB |
| Johnston (2015) | Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch | J. Infect. Dis. 209 (5), 711-720 (2014) | 7.69e-152 | 127 127RT |
127 127RT |
100 | HIVDB |
| Jonassen (1997) | SEQUENCE analysis of HIV-1 group O from Norwegian patients infected in the 1960s | Virology 231 (1), 43-47 (1997) | 1e-102 | 2 1RT 1IN |
4 2PR 1RT 2IN |
50 | HIVDB |
| Jonassen (2000) | INTERSUBTYPE recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases | AIDS Res. Hum. Retroviruses 16 (1), 49-58 (2000) | 1e-162 | 1 1PR 1RT 1IN |
7 5PR 2RT 3IN |
14 | HIVDB |
| Jones (2005) | Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. | AIDS Res Hum Retroviruses. 2005 Apr;21(4):319-24. | 0 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Jones (2009) | In-depth analysis of the origins of HIV type 1 subtype C in South America | AIDS Res. Hum. Retroviruses 25 (10), 951-959 (2009 | 0 | 4 4PR 4RT |
4 4PR 4RT |
100 | HIVDB |
| Jones (2011) | Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender and age issues | AIDS Res. Hum. Retroviruses (2011) In press | 0 | 2016 2016PR 2016RT |
2016 2016PR 2016RT |
100 | HIVDB |
| Jorgensen (2000) | GENOTYPIC and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine | Antivir. Ther. (Lond.) 5 (3), 187-194 (2000) | 1e-127 | 73 37PR 36RT |
76 39PR 37RT |
96 | HIVDB |
| Jorgensen (2002) | GENOTYPIC and phenotypic resistance in cultured HIV reflect the genotype and phenotype of viral RNA in plasma | Unpublished | 1e-108 | |
34 17PR 17RT |
0 | Case report(s) / study subset |
| Jorgensen (2002) | Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. | Scand J Infect Dis | 1e-128 | 97 96PR 97RT |
97 96PR 97RT |
100 | HIVDB |
| Joseph (2022) | Deep Sequencing Analysis of HIV-1 Proviruses Reveals Frequent Asymmetric Long-Terminal Repeats And Other Novel Proviral Structures | Unpublished | 0 | |
82 75PR 77RT 62IN |
0 | Proviral DNA Reservoir |
| Joseph (2024) | The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus | PLoS Pathog 20 (2), e1011974 (2024) | 0 | |
581 26PR 26RT 581IN |
0 | Proviral DNA Reservoir |
| Jost (2002) | A patient with HIV-1 superinfection | N. Engl. J. Med. 347 (10), 731-736 (2002) | 1e-107 | |
4 2PR 2RT |
0 | Case report(s) / study subset |
| Jovanovic (2019) | Exploring Evolutionary and Transmission Dynamics of HIV Epidemic in Serbia: Bridging Socio-Demographic With Phylogenetic Approach | 30858834 | 0 | |
149 149PR 149RT |
0 | Pending |
| Jovanovic (2022) | HIV-1 Subtype B Spread Through Cross-border Clusters: a Molecular Analysis in View of Incidence Trends | 36129113 | 0 | |
151 151PR 151RT |
0 | Transmission cluster |
| Jovanovic (2022) | HIV-1 subtype B spread through cross-border clusters in the balkans: a molecular analysis in view of incidence trends | AIDS (2022) In press | 4.84e-150 | |
85 85PR 85RT |
0 | Pending |
| Jovanovic (2022) | HIV subtype B 2016-2019 | Unpublished | 6.62e-147 | |
48 48PR 48RT |
0 | Unpublished |
| Jullaksorn (2010) | Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients | Southeast Asian J. Trop. Med. Public Health 41 (2) | 0 | |
306 153PR 153RT |
0 | Pending |
| Jung (2012) | The origin and evolutionary history of HIV-1 subtype C in Senegal | 22470456 | 0 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Junqueira (2020) | NEW GENOMES FROM THE CONGO BASIN EXPAND HISTORY OF CRF01_AE ORIGIN AND DISSEMINATION | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 13 13PR 13RT 13IN |
13 13PR 13RT 13IN |
100 | HIVDB |
| K'Aluoch (2004) | HIGH Frequency of Recombinant A and D HIV-1 subtypes in a Population from Uganda | (in) 12TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFEC | 0 | 29 29PR 29RT |
29 29PR 29RT |
100 | HIVDB |
| K'Aluoch (2005) | CHARACTERIZATION of HIV-1 Subtypes and Recombinants in a Uganda Cohort by use of the gag, nef and pol Genes | Unpublished | 0 | 37 34PR 37RT |
37 36PR 37RT |
100 | HIVDB |
| Kageha (2016) | Transmitted HIV-1 Drug Resistance in Infants | Unpublished | 9.67e-155 | |
84 59PR 57RT |
0 | Pending |
| Kageha (2021) | Direct Submission | Submitted (20-MAY-2020) Virology, Kenya Medical Re | 3.31e-155 | |
120 15PR 120RT |
0 | Unpublished |
| Kalmar (2009) | Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after 6 months of therapeutic interruption | 22422687 | 0 | |
133 133PR 133RT |
0 | Case report(s) / study subset |
| Kalu (2025) | Inflammatory Responses in HIV-1 Genetic Subtypes in Relationship with Anti-Retroviral Drug Resistance in Minna, Niger State, North Central Nigeria | Unpublished | 0 | |
42 36PR 38RT |
0 | Unpublished |
| Kamori (2022) | Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on antiretroviral therapy in Tanzania: Findings from a national representative survey | 36680436 | 0 | |
262 131PR 131RT 131IN |
0 | HIVDB |
| Kandathil (2007) | A Comparison of Interpretation by Three Different HIV Type 1 Genotypic Drug Resistance Algorithms Using Sequences from Non-Clade B HIV Type 1 Strains | AIDS Res. Hum. Retroviruses 25 (3), 315-318 (2009) | 0 | 120 117PR 117RT |
129 124PR 126RT |
93 | HIVDB |
| Kang (2018) | Direct Submission | Submitted (04-JUN-2018) Division of Virology and I | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kang (2024) | Identification of two Novel HIV-1 unique recombinant forms in Shijiazhuang, Hebei | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Kanja (2018) | Flexible but conserved: a new essential motif in the C-ter domain of HIV-1 group M integrases | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Kannangai (2014) | Frequency of Transmitted Drug Resistance Mutations Among Treatment-Naive HIV-1-Infected Individuals at a Tertiary Care Centre in South India | Mol Diagn Ther 19 (5), 273-275 (2015) | 0 | 229 127PR 127RT 102IN |
340 238PR 238RT 102IN |
67 | HIVDB |
| Kantor (2002) | Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy | Antimicrob. Agents Chemother. 46 (4), 1086-1092 (2 | 1e-126 | 75 74PR 1RT |
114 114PR |
65 | HIVDB |
| Kantor (2003) | HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy | AIDS Res. Hum. Retroviruses 18 (18), 1407-1413 (2002) | 1e-87 | 20 20PR 20RT |
21 21PR 21RT |
95 | HIVDB |
| Kantor (2004) | EVOLUTION of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy | AIDS 18 (11), 1503-1511 (2004) | 1e-180 | 221 113PR 108RT |
445 227PR 218RT |
49 | HIVDB |
| Kantor (2005) | IMPACT of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration | PLoS Med 2 (4), E112 (2005) | 0 | 1088 424PR 664RT |
1292 556PR 736RT |
84 | HIVDB |
| Kantor (2014) | HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1-Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077 | PLoS ONE 9 (4), E93537 (2014) | 6.9e-166 | |
44 44PR 44RT |
0 | ARV Rx and/or other data are N/A |
| Kao (2011) | Surveillance of HIV Type 1 Recent Infection and Molecular Epidemiology Among Different Risk Behaviors Between 2007 and 2009 After the HIV Type 1 CRF07_BC Outbreak in Taiwan | AIDS Res. Hum. Retroviruses 27 (7), 745-749 (2011) | 0 | 381 381PR 378RT |
381 381PR 378RT |
100 | HIVDB |
| Kapaata (2020) | HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity | Viruses 13 (2), 171 (2021) | 0 | 48 48PR 48RT 48IN |
48 48PR 48RT 48IN |
100 | HIVDB |
| Kapoor (2016) | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients | 18221530 | 4.95e-55 | |
69 69PR |
0 | Quasispecies |
| Karad (2019) | Nucleotide sequence of protease and reverse transcriptase of HIV1 from rural part of Maharashtra, India | Unpublished | 0 | |
42 26PR 42RT |
0 | Unpublished - Final |
| Karade (2015) | Near Full-Length Genomic Characterization of a Novel CRF 01_AE/C Recombinant from Western India | AIDS Res. Hum. Retroviruses 31 (12), 1269-1273 (20 | 0 | 1 1PR 1RT |
2 2PR 2RT 1IN |
50 | HIVDB |
| Karade (2015) | Pre Treatment Drug Resistance (PDR) Among Individuals Attending Free Anti Retroviral Therapy (ART) Clinic of Pune, India | 26573132 | 7.68e-178 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Karade (2017) | Sequences from antiretroviral therapy naive individuals from Pune City | Unpublished | 3.73e-177 | |
11 11PR 11RT |
0 | Case report(s) / study subset |
| Karade (2019) | Low Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naive and Experienced Individuals from Western India | AIDS Res. Hum. Retroviruses (2019) In press | 0 | 58 58IN |
58 58IN |
100 | HIVDB |
| Karade (2016) | Virological failure at 12 months of Anti retroviral Therapy in Pune, India: Drug Resistance and Potential Implications | 27631260 | 2.87e-176 | 79 79PR 79RT |
79 79PR 79RT |
100 | HIVDB |
| Karade (2017) | Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study | PLoS ONE 12 (8), E0181889 (2017) | 9.78e-175 | 75 75PR 75RT |
75 75PR 75RT |
100 | HIVDB |
| Karamov (2018) | HIV-1 genetic diversity in recently diagnosed infections in Moscow: predominance of AFSU, frequent branching in clusters, and circulation of the Iberian subtype G variant | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 62 62PR 62RT |
62 62PR 62RT |
100 | HIVDB |
| Karchava (2006) | PREVALENCE of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State | J. Acquir. Immune Defic. Syndr. 42 (5), 614-619 (2006) | 0 | |
15 15PR 15RT |
0 | Case report(s) / study subset |
| Karkashadze (2018) | Epidemiology of HIV drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia | J. Med. Virol. (2018) In press | 3.29e-144 | 120 120PR 120RT |
122 122PR 122RT |
98 | HIVDB |
| Karlsson (2001) | RECENT origin of HIV-1 variants in resting CD4+ T-lymphocytes in untreated and suboptimally treated subjects | 11709781 | 1e-126 | |
134 134PR 133RT |
0 | Quasispecies |
| Karlsson (2007) | SEQUENTIAL Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape | PLoS ONE 2, E225 (2007) | 1e-141 | |
87 87PR 83RT |
0 | Quasispecies |
| Karlsson (2007) | ANTIRETROVIRAL drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from gag to pol | J. Virol. 81 (20), 11543-11548 (2007) | 4.42e-163 | |
24 24PR 24RT |
0 | Case report(s) / study subset |
| Karlsson (2012) | Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010 | PLoS ONE 7 (3), E33484 (2012) | 0 | 208 208PR 208RT |
208 208PR 208RT |
100 | HIVDB |
| Kasang (2010) | HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. | PLoS ONE | 0 | 86 86PR 86RT |
89 89PR 89RT |
96 | HIVDB |
| Kasang (2018) | Prevalence of pre-treatment HIV drug resistance in Mwanza, Tanzania | 30165451 | 0 | 235 235PR 235RT |
235 235PR 235RT |
100 | HIVDB |
| Kassaye (2008) | Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. | JAIDS | 7.41e-173 | 24 24PR 24RT |
24 24PR 24RT |
100 | HIVDB |
| Kassaye (2016) | Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis | AIDS Res. Hum. Retroviruses 23 (8), 1055-1061 (200 | 5.34e-147 | |
86 86RT |
0 | Pending |
| Kassaye (2016) | Envelope co-receptor tropism, drug resistance, and viral evolution among subtype C HIV-1 infected individuals receiving non-suppressive antiretroviral therapy | 19295330 | 1.37e-169 | 13 13PR 12RT |
13 13PR 13RT |
100 | HIVDB |
| Kassu (2006) | MOLECULAR epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia | AIDS Res. Hum. Retroviruses 23 (4), 564-568 (2007) | 1e-153 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| Kato (2004) | COMPARISON of genotypic assay and peripheral blood mononuclear cell-based phenotypic assay in HIV-1 antiretroviral drug resistance | Unpublished | 1e-159 | |
112 56PR 56RT |
0 | ARV Rx and/or other data are N/A |
| Katusiime (2019) | Intact HIV proviruses persist in children 7-9 years after initiation of ART in the first year of life | J. Virol. (2020) In press | 0 | |
7 7PR 7RT 7IN |
0 | Proviral DNA Reservoir |
| Katusiime (2025) | Divergent populations of HIV-infected naive and memory CD4+ T-cell clones in children on antiretroviral therapy | J Clin Invest (2025) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report (Small sample size) |
| Katzenstein (2007) | SEVENTEEN-YEAR-OLD mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns | AIDS Res. Hum. Retroviruses 24 (8), 1117-1120 (2008) | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Kaufmann (2001) | IMPACT of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs | AIDS Res. Hum. Retroviruses 17 (6), 487-497 (2001) | 1e-130 | |
42 42PR 42RT |
0 | ARV Rx and/or other data are N/A |
| Kawashima (2009) | Adaptation of HIV-1 to human leukocyte antigen class I | Nature 458 (7238), 641-645 (2009) | 0 | |
1208 298PR 985RT 375IN |
0 | Pending |
| Kaye (2001) | OBSERVATIONS of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial) | Antivir. Ther. (Lond.) (2001) In press | 9e-94 | 58 58RT |
58 58RT |
100 | HIVDB |
| Kayondo (2015) | Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors | AIDS Res. Hum. Retroviruses 31 (7), 749-756 (2015) | 0 | |
465 465PR 465RT |
0 | Quasispecies |
| Kazennova (2011) | Direct Submission | Submitted (10-AUG-2010) T-Lymphotropic Viruses Lab | 0 | 1 1PR 1RT |
86 86PR 86RT |
1 | HIVDB |
| Kazennova (2013) | HIV-1 Genetic Variants in the Russian Far East | AIDS Res. Hum. Retroviruses 30 (8), 742-752 (2014) | 0 | |
252 252PR 250RT |
0 | Pending |
| Kazennova (2014) | Analysis of genetic polymorphism of pol gene in HIV-1 strains circulating in Volga (Privolzhsky) Federal District, Russia | Unpublished | 0 | |
147 147PR 147RT |
0 | Unpublished - Final |
| Kazennova (2016) | Molecular epidemiology of HIV type 1 infection in MSM in Russia | 28443684 | 0 | 101 101PR 101RT |
107 107PR 107RT |
94 | HIVDB |
| Kazennova (2016) | Molecular epidemiological analysis of HIV infection in the northern port cities of Russia - Murmansk and Arkhangelsk | Unpublished | 0 | |
68 66PR 68RT |
0 | Unpublished - Final |
| Kazennova (2017) | Genetic variants of HIV type 1 in MSM in Russia | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 16 16PR 16RT |
16 16PR 16RT |
100 | HIVDB |
| Kazennova (2019) | The molecular epidemiological analysis of HIV infection in Altai Krai, Russia | Unpublished | 0 | |
82 82PR 82RT |
0 | Unpublished - Final |
| Ke (2014) | Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013. | PLoS One. 2014 Oct 15;9(10):e109821. | 0 | 357 357PR 357RT |
357 357PR 357RT |
100 | HIVDB |
| Ke (2014) | Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF01_ AE/07_BC Recombinant in Men Who Have Sex with Men from Shannxi, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Kearney (2009) | Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals | J. Virol. 83 (6), 2715-2727 (2009) | 0 | |
2060 2060PR 2060RT |
0 | SGS |
| Kearney (2016) | Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy | PLoS Pathog. 10 (3), E1004010 (2014) | 4.37e-164 | |
1371 1371PR 1371RT |
0 | Quasispecies |
| Kebe (2011) | High Rate Of Antiretroviral Drug Resistance Mutations in HIV Type 1-Infected Senegalese Children in Virological Failure on First-Line Treatment According to the World Health Organization Guidelines | AIDS Res. Hum. Retroviruses 29 (2), 242-249 (2013) | 0 | 52 52PR 52RT |
69 69PR 69RT |
75 | HIVDB |
| Kee (2021) | Direct Submission | Submitted (03-FEB-2020) Viral Disease Research, Ko | 0 | |
12 12PR 12RT 12IN |
0 | Unpublished |
| Keele (2019) | Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host | 31048506 | 0 | |
21 21PR 21RT 21IN |
0 | Laboratory/experimental isolate |
| Keele (2006) | CHIMPANZEE reservoirs of pandemic and nonpandemic HIV-1 | Science 313 (5786), 523-526 (2006) | 0 | 26 4PR 4RT 26IN |
30 4PR 30RT 30IN |
86 | HIVDB |
| Keele (2008) | CHARACTERIZATION of the follicular dendritic cell reservoir of human immunodeficiency virus type 1 | J. Virol. 82 (11), 5548-5561 (2008) | 1.41e-166 | |
448 401PR 448RT |
0 | Proviral DNA Reservoir |
| Keele (2009) | Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz | Nature 460 (7254), 515-519 (2009) | 2e-86 | 14 14IN |
14 11RT 14IN |
100 | HIVDB |
| Keele (2010) | Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Proc. Natl. Acad. Sci. U.S.A. 105 (21), 7552-7557 | 0 | |
1 1PR 1RT 1IN |
0 | Quasispecies |
| Keele (2016) | Generation of pathogenic transmitted/founder infectious molecular clones from the SIVsmE660 and SIVmac251 lineages | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Laboratory/experimental isolate |
| Keele (2024) | No evidence for ongoing replication on ART in SIV infected macaques | Unpublished | 0 | |
1742 1742PR 1742RT 1742IN |
0 | NHPL/SIV |
| Keita (2020) | Primary resistance to antiretroviral drugs of HIV strains in Chad: a retrospective investigation by analysis of frozen dried blood spot samples | Eur J Clin Microbiol Infect Dis (2021) In press | 0 | 24 22PR 20RT |
25 23PR 21RT |
96 | HIVDB |
| Kelentse (2020) | Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana | Medicine (Baltimore) 99 (41), e22606 (2020) | 0 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Kelentse (2023) | Direct Submission | Submitted (13-JUN-2022) Research Laboratory, Botsw | 0 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Kemal (2006) | Multidrug-resistant HIV-1 and Recombination between Variants from the Genital Tract and Plasma: A Longitudinal Analysis | 22364185 | 0 | |
166 166PR 166RT |
0 | Quasispecies |
| Kemal (2007) | HIV-1 Drug Resistance in Variants from the Female Genital Tract and Plasma | J. Infect. Dis. 195 (4), 535-545 (2007) | 0 | |
309 309PR 309RT |
0 | Quasispecies |
| Kemal (2007) | TRANSITION from Long-Term Nonprogression to HIV-1 Disease Associated with Escape from Cellular Immune Control | 18520675 | 0 | |
13 13PR 13RT 4IN |
0 | Case report(s) / study subset |
| Kemal (2013) | Molecular Epidemiology of HIV Type 1 Subtypes in Rwanda | AIDS Res. Hum. Retroviruses 29 (6), 957-962 (2013) | 0 | 30 30PR 30RT |
57 57PR 57RT |
52 | HIVDB |
| Kennedy (2023) | Comprehensive analysis of HIV reservoirs in elite controllers | J Clin Invest 133 (3), e165446 (2023) | 0 | |
86 86PR 86RT 86IN |
0 | Proviral DNA Reservoir |
| Kestler (2000) | INDUCTION of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus | 2160735 | 5e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Kfutwah (2013) | An antiretroviral drug-naive human immunodeficiency virus-1 infected woman with a persistent non-reactive proviral deoxyribonucleic acid polymerase chain reaction: a case report | J Med Case Rep 7 (1), 152 (2013) | 3e-168 | |
2 1PR 1RT |
0 | Case report(s) / study subset |
| Kfutwah (2017) | Direct Submission | Submitted (02-SEP-2014) Virology, Centre Pasteur d | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Khairunisa (2015) | Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated indonesian patients | AIDS Res. Hum. Retroviruses 31 (2), 255-259 (2015) | 6.77e-180 | 111 58PR 53RT |
111 58PR 53RT |
100 | HIVDB |
| Khairunisa (2018) | HIV-1 molecular epidemiology in Riau, Indonesia | 29589465 | 0 | 68 39PR 29RT |
68 39PR 29RT |
100 | HIVDB |
| Khairunisa (2020) | 2018-2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 87 47PR 40RT |
88 48PR 40RT |
98 | HIVDB |
| Khairunisa (2020) | Subtype Distribution and Drug Resistance of HIV-1 Circulating in Pontianak, Indonesia | 33134195 | 3.23e-175 | 24 13PR 11RT |
24 13PR 11RT |
100 | HIVDB |
| Khairunisa (2023) | Nearly full-length sequences of CRF01_AE strains prevalent in Indonesia | 38730038 | 0 | |
20 20PR 20RT 20IN |
0 | Case report(s) / study subset |
| Khairunisa (2023) | Direct Submission | Submitted (24-MAR-2022) Department of Public Healt | 0 | |
71 36PR 35RT |
0 | Unpublished |
| Khamadi (2005) | GENOMIC Diversity of HIV-1 subtypes in Northern Kenya | 16218806 | 1.09e-67 | |
152 15RT 137IN |
0 | Gene fragment(s) |
| Khamadi (2016) | Genomic Diversity of HIV-1 subtypes in Northern Kenya | Unpublished | 0.001 | |
4 2RT 2IN |
0 | Gene fragment(s) |
| Khamadi (2021) | HIV-1 Drug Resistance among infants and their mothers in a PMTCT Program in Kenya | 34955520 | 8.46e-175 | |
10 10PR 10RT |
0 | Pending |
| Khawcharoenporn (2011) | Predictors for Recombinant HIV Infection in a Thai Cohort | Sex Transm Dis 38 (11), 1046-1049 (2011) | 0 | |
4 4PR 4RT 3IN |
0 | Case report(s) / study subset |
| Khurana (2002) | SEQUENCE of HIV-1 isolate 01IN565.14 from India | Unpublished | 1e-165 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Kieffer (2004) | GENOTYPIC Analysis of HIV-1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads | J. Infect. Dis. 189 (8), 1452-1465 (2004) | 1e-124 | |
342 174PR 168RT |
0 | Quasispecies |
| Kiepiela (2005) | DOMINANT influence of HLA-B in mediating the potential co-evolution of HIV and HLA | Nature 432 (7018), 769-775 (2004) | 0 | |
230 180PR 223RT 191IN |
0 | Pending |
| Kiertiburanakul (2013) | Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients | PLoS ONE 8 (6), E62057 (2013) | 0 | 2450 1782PR 1791RT |
2450 1782PR 1793RT |
100 | HIVDB |
| Kiguoya (2017) | Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression | J. Virol. (2017) In press | 8.66e-62 | 101 101PR |
102 102PR 1RT |
99 | HIVDB |
| Kijak (2001) | RESISTANCE profiles to antiretroviral drugs in HIV-1 Drug-Naive Patients in Argentina | Antivir. Ther. (Lond.) (2001) In press | 1e-161 | 115 58PR 57RT |
115 58PR 57RT |
100 | HIVDB |
| Kijak (2001) | HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays | AIDS Res. Hum. Retroviruses 17 (15), 1415-1421 (2001) | 2e-97 | |
93 93RT |
0 | ARV Rx and/or other data are N/A |
| Kijak (2002) | ORIGIN of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure | J. Virol. 76 (14), 7000-7009 (2002) | 1e-109 | |
122 122PR 122RT |
0 | Quasispecies |
| Kijak (2003) | DEVELOPMENT and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa | AIDS Res. Hum. Retroviruses 20 (5), 521-530 (2004) | 0 | 51 51PR 51RT 51IN |
51 51PR 51RT 51IN |
100 | HIVDB |
| Kijak (2007) | DISTINGUISHING molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2 | Virology 358 (1), 178-191 (2007) | 0 | 1 1PR 1RT 1IN |
12 12PR 12RT 12IN |
8 | HIVDB |
| Kijak (2007) | VARIABLE contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells | Virology 376 (1), 101-111 (2008) | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Kijak (2012) | Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial. | J Virol. 2013 Jul;87(13):7265-81. | 0 | 42 42PR 42RT 42IN |
42 42PR 42RT 42IN |
100 | HIVDB |
| Kijak (2017) | Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection | PLoS Pathog. 13 (7), E1006510 (2017) | 0 | |
255 230PR 230RT 255IN |
0 | Quasispecies |
| Kim (2009) | Human APOBEC3G drives HIV-1 evolution and the development of drug resistance | 20660203 | 1e-172 | |
255 255RT |
0 | Quasispecies |
| Kim (2010) | Genetic Variation of the HIV-1 Integrase Region in Newly Diagnosed Antiretroviral Drug-Naive Patients with HIV/AIDS in Korea | 20946407 | 1e-168 | 75 75IN |
75 75IN |
100 | HIVDB |
| Kim (2013) | HIV Antiretroviral Resistance Mutations Among Antiretroviral Treatment-Naive and -Experienced Patients in South Korea | AIDS Res. Hum. Retroviruses 29 (12), 1617-1620 (20 | 0 | 83 83PR 81RT |
83 83PR 81RT |
100 | HIVDB |
| Kimata (1998) | A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells | J. Virol. 72 (1), 245-256 (1998) | 4.6e-115 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| King (1998) | RESISTANCE to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase | J. Virol. 72 (10), 8420-8424 (1998) | 1e-164 | |
1 1IN |
0 | Case report(s) / study subset |
| Kingoo (2021) | Direct Submission | Submitted (08-FEB-2021) Biochemistry and Biotechno | 6.68e-147 | |
140 140PR 140RT |
0 | Unpublished |
| Kinloch (2015) | Population-level Immune-mediated Adaptation in HIV-1 Polymerase during the North American Epidemic | J. Virol. (2015) In press | 0 | 608 321PR 321RT 287IN |
615 328PR 328RT 287IN |
98 | HIVDB |
| Kinloch (2018) | Direct Submission | Submitted (18-SEP-2018) Faculty of Health Sciences | 0 | 343 3PR 3RT 340IN |
347 3PR 7RT 340IN |
98 | HIVDB |
| Kinloch (2023) | HIV reservoirs are dominated by genetically younger and clonally enriched proviruses | bioRxiv (2023) | 0 | |
1732 1590PR 1646RT 1447IN |
0 | Proviral DNA Reservoir |
| Kinloch (2023) | HIV reservoirs are dominated by genetically younger and clonally enriched proviruses | mBio (2023) In press | 0 | |
70 70PR 70RT 70IN |
0 | Proviral DNA Reservoir |
| Kinomoto (2004) | HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors | Clin. Infect. Dis. 41 (2), 243-251 (2005) | 3e-50 | 38 38PR |
39 39PR |
97 | HIVDB |
| Kinyua (2017) | Antiretroviral therapy resistance among HIV-1 patients attending the comprehensive care clinic in Kenyatta National Hospital, Kenya | 30061964 | 4.48e-153 | 65 65RT |
65 65RT |
100 | HIVDB |
| Kiptoo (2008) | PREVALENCE of Nevirapine-Associated Resistance Mutations after Single Dose Prophylactic Treatment among Antenatal Clinic Attendees in North Rift Kenya | AIDS Res. Hum. Retroviruses 24 (12), 1555-1559 (2008) | 7.59e-152 | |
152 152RT |
0 | Case report(s) / study subset |
| Kiptoo (2013) | HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naive antenatal clinic attendees in rural Kenya | BMC Infect. Dis. 13 (1), 517 (2013) | 0 | 188 188PR 188RT |
188 188PR 188RT |
100 | HIVDB |
| Kirchhoff (1989) | A novel proviral clone of HIV-2: biological and phylogenetic relationship to other primate immunodeficiency viruses | Virology 177 (1), 305-311 (1990) | 4e-97 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Kireev (2018) | Phylogenetic analysis of near full-length genome sequences of HIV-1 Subtype A6 variants circulating in Russia | Unpublished | 0 | |
47 47PR 47RT 47IN |
0 | Case report(s) / study subset |
| Kireev (2024) | Features of non-structural proteins of HIV-1 in different regions of the Russian Federation | Unpublished | 0 | |
27 27PR 27RT 27IN |
0 | Unpublished |
| Kirichenko (2020) | Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs | Viruses 12 (8), 838 (2020) | 0 | 408 408IN |
408 408IN |
100 | HIVDB |
| Kirichenko (2021) | Pretreatment HIV-1 drug resistance in countries of Eastern Europe and Central Asia | 35061671 | 0 | 960 960PR 960RT |
960 960PR 960RT |
100 | HIVDB |
| Kirichenko (2022) | Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017-2018 and 2020-2021 following a WHO Survey | Viruses 14 (11), 2320 (2022) | 0 | 133 133PR 133RT |
133 133PR 133RT |
100 | HIVDB |
| Kirmaier (2010) | TRIM5 and interspecies transmission of primate immunodeficiency viruses | PLoS Biol. 2010 Aug 24;8(8). pii: e1000462. | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Kiros (2020) | Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia | Retrovirology 17 (1), 33 (2020) | 0 | 51 51PR 51RT |
51 51PR 51RT |
100 | HIVDB |
| Kiros (2022) | Low level of HIV-1C integrase strand transfer inhibitor resistance#mutations among recently diagnosed ART-naive Ethiopians | Unpublished | 0 | 46 46IN |
49 49IN |
93 | HIVDB |
| Kita (2005) | GENETIC diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo | AIDS Res. Hum. Retroviruses 20 (12), 1352-1357 (2004) | 2e-49 | |
27 27IN |
0 | Gene fragment(s) |
| Kitawi (2015) | HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy | AIDS Res. Hum. Retroviruses 31 (4), 452-455 (2015) | 1.58e-160 | |
54 40PR 54RT |
0 | Pending |
| Kitrinos (2009) | Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope | Antimicrob. Agents Chemother. 53 (3), 1124-1131 (2 | 0 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Kityo (2016) | HIV drug resistance among children initiating first-line Antiretroviral Treatment (ART) in Uganda | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 330 330PR 330RT |
331 331PR 331RT |
99 | HIVDB |
| Kityo (2017) | HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa | J. Acquir. Immune Defic. Syndr. (2017) In press | 0 | 787 787RT |
787 787RT |
100 | HIVDB |
| Kityo (2017) | Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children | J. Antimicrob. Chemother. (2017) In press | 6.27e-168 | 167 167PR 167RT |
369 369PR 369RT |
45 | HIVDB |
| Kiwelu (2014) | HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania | PLoS ONE 9 (7), E102258 (2014) | 0 | |
622 620PR 622RT |
0 | Pending |
| Klimova (2023) | Drug resistance mutations and other polymorphism detected in HIV-1 strains isolated from patients in Tumen Oblast | Unpublished | 0 | |
48 48PR 48RT |
0 | Unpublished |
| Knops (2010) | The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V | AIDS 24 (5), 779-781 (2010) | 0 | 26 26PR 26RT |
26 26PR 26RT |
100 | HIVDB |
| Knops (2010) | Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates | J. Antimicrob. Chemother. 65 (7), 1472-1476 (2010) | 0 | 21 21PR 21RT |
21 21PR 21RT |
100 | HIVDB |
| Koch (2001) | GENETIC analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant | AIDS Res. Hum. Retroviruses 17 (3), 269-273 (2001) | 2e-89 | 36 18PR 18RT |
36 18PR 18RT |
100 | HIVDB |
| Koelsch (2003) | CLADE B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus | AIDS 17 (7), F11-F16 (2003) | 1e-117 | |
9 9PR 9RT |
0 | Quasispecies |
| Koigi (2014) | HIV-1 genotypes circulating in patients failing ART in Kenya | 25487529 | 1.51e-147 | 61 61RT |
61 61RT |
100 | HIVDB |
| Koizumi (2006) | Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. | JAIDS | 1e-125 | 57 50PR 7RT |
105 50PR 7RT 48IN |
54 | HIVDB |
| Koizumi (2016) | Emergence of ART resistance associated primary mutations among drug naive HIV-1 individuals in rural western Cameroon | 16885781 | 1.68e-151 | 49 4PR 45RT |
49 4PR 45RT |
100 | HIVDB |
| Kojima (2016) | Recent diversity of human immunodeficiency virus type 1 in individuals who visited sexually transmitted infection-related clinics in Osaka, Japan | J. Infect. Chemother. 14 (1), 51-55 (2008) | 4.8e-51 | 34 34PR |
34 34PR |
100 | HIVDB |
| Kolomeets (2014) | A Unique NNRTI-Resistance Mutation in Russian Subtype A HIV-1 Viruses | 25259833 | 1.35e-178 | 193 193PR 193RT |
428 428PR 428RT |
45 | HIVDB |
| Kolpakov (2018) | HIV-1 Epidemiology and primary drug resistance in South Federal District, Russia | Unpublished | 0 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Komiyama (1989) | NUCLEOTIDE sequences of gag and env genes of a Japanese isolate of HIV-1 and their expression in bacteria | AIDS Res. Hum. Retroviruses 5 (4), 411-419 (1989) | 2e-40 | |
2 2PR |
0 | Laboratory/experimental isolate |
| Kondo (2013) | Emergence in Japan of an HIV-1 Variant Associated with Transmission among Men Who Have Sex with Men (MSM) in China: First Indication of the International Dissemination of the Chinese MSM Lineage | J. Virol. 87 (10), 5351-5361 (2013) | 0 | |
41 41PR 41RT |
0 | Case report(s) / study subset |
| Kong (2017) | Characterization of a New HIV-1 CRF01_AE/CRF07_BC Recombinant virus in Guangxi, China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kong (2018) | Identification of a novel HIV-1 unique recombinant form between B, CRF01_AE and CRF07_BC in men who have sex with men in Guangxi, China | AIDS Res. Hum. Retroviruses (2018) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kong (2022) | The HIV-1 genetic diversity and molecular clusters among persons with virological failure in Hubei province, China | Unpublished | 0 | |
72 72PR 72RT |
0 | Unpublished |
| Koning (2013) | Dynamics of HIV Type 1 Recombination Following Superinfection | AIDS Res. Hum. Retroviruses 29 (6), 963-970 (2013) | 0 | |
125 125PR 125RT |
0 | Quasispecies |
| Konings (2003) | PROTEASE mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon | AIDS Res. Hum. Retroviruses 20 (1), 105-109 (2004) | 0 | 141 129PR 12RT |
141 129PR 12RT |
100 | HIVDB |
| Konings (2006) | Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms | J. Acquir. Immune Defic. Syndr. 42 (3), 331-341 (2 | 6e-59 | |
14 14PR |
0 | Case report(s) / study subset |
| Konings (2006) | HUMAN immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G | J. Med. Virol. 78 (5), 523-534 (2006) | 0 | |
5 5RT |
0 | Case report(s) / study subset |
| Konou (2015) | Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo | AIDS 29 (18), 2527-2530 (2015) | 3.13e-180 | 173 16PR 172RT |
173 16PR 173RT |
100 | HIVDB |
| Konou (2015) | Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo | AIDS Res Ther 12, 38 (2015) | 3.31e-178 | 67 62PR 67RT |
67 62PR 67RT |
100 | HIVDB |
| Konou (2017) | Genetic diversity of HIV-1 strains among men having sex with men in Togo and significant level of mixing with strains from the general population | 27235597 | 0 | 79 68PR 76RT |
79 68PR 78RT |
100 | HIVDB |
| Koofhethile (2023) | HIV-2 proviral reservoir dominated by defective proviruses | Unpublished | 0 | |
47 47PR 47RT 46IN |
0 | Proviral DNA Reservoir |
| Korovina (2011) | Direct Submission | Submitted (18-JAN-2011) Pediatric HIV/AIDS Clinica | 0 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Kostaki (2018) | Molecular analysis of HIV-1 infected individuals in a network-based intervention (TRIP): Phylogenetics identify HIV-1 infected individuals with social links | J. Infect. Dis. (2018) In press | 6.96e-141 | 117 117PR 117RT |
117 117PR 117RT |
100 | HIVDB |
| Kostaki (2019) | Spatiotemporal characteristics of the largest HIV-1 CRF02_AG outbreak in Spain: evidence for onward transmissions | 30915040 | 1.68e-126 | 391 390PR 391RT |
391 390PR 391RT |
100 | HIVDB |
| Kotaki (2014) | High Prevalence of HIV-1 CRF01_AE Viruses among Female Commercial Sex Workers Residing in Surabaya, Indonesia | PLoS ONE 8 (12), E82645 (2013) | 4e-60 | |
22 22IN |
0 | Gene fragment(s) |
| Kotaki (2014) | Detection of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 Integrase Derived from Drug-Naive Individuals in Surabaya, Indonesia | AIDS Res. Hum. Retroviruses (2013) In press | 0 | 43 43IN |
43 43IN |
100 | HIVDB |
| Kotaki (2015) | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naive individuals in Surabaya, Indonesia | AIDS Res Ther 12, 5 (2015) | 0 | 99 52PR 47RT |
99 52PR 47RT |
100 | HIVDB |
| Kotova (2016) | Molecular genetic characterization of variants of HIV-1 prevalent in the Far Eastern Federal district of the Russian Federation | 31412174 | 0 | |
67 67PR 67RT |
0 | Pending |
| Kotova (2019) | Molecular-epidemiological characteristics of HIV-1 variants circulating in the jewish autonomous region territory | Vichinfektsiia Immunosuppr 10 (4), 130-139 (2018) | 0 | |
42 42PR 42RT |
0 | Case report(s) / study subset |
| Kotova (2019) | Molecular genetic characteristics of HIV-1 variants isolated in the territories of the Russian far East | 31412174 | 3.06e-179 | |
30 30PR 30RT |
0 | Pending |
| Kotova (2020) | Distribution of HIV-1 genovariants in the Far East of the Russian Federation | Unpublished | 8.95e-178 | |
87 87PR 87RT |
0 | Unpublished |
| Kotova (2022) | Genetic diversity of HIV-1 in the territories of the Russian Far East | 31412174 | 0 | |
44 44PR 44RT |
0 | Pending |
| Kotova (2023) | Molecular genetic characteristics of HIV-1 variants isolated in the subjects of the Russian Far East (analysis for 2021-2022) | 31412174 | 0 | |
45 45PR 45RT |
0 | ARV Rx and/or other data are N/A |
| Kotova (2023) | Genetic profile of HIV-1 in the Republic of Sakha (Yakutia) | 10.22328/2077?9828?2023?15?3?73?83 | 0 | |
64 64PR 64RT |
0 | ARV Rx and/or other data are N/A |
| Kotova (2024) | The genetic profile of HIV-1 in the territories of the Russian Far East | 31412174 | 0 | |
112 112PR 112RT |
0 | Pending |
| Kotova (2025) | The genetic profile of HIV-1 in the territories of the Russian Far East | Unpublished | 0 | |
118 118PR 118RT |
0 | Unpublished |
| Kouamou (2019) | Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy | AIDS 33 (11), 1729-1737 (2019) | 0 | 160 160PR 159RT |
160 160PR 160RT |
100 | HIVDB |
| Kouamou (2019) | Drug Resistance among Adolescents and Young Adults with Virologic Failure of 1st Line ART and Response to 2nd Line Treatment | 32138527 | 0 | 74 74PR 74RT |
74 74PR 74RT |
100 | HIVDB |
| Koulinska (2001) | A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania | AIDS Res. Hum. Retroviruses 17 (5), 423-431 (2001) | 1e-164 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Koulinska (2002) | COMMON genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania | AIDS Res. Hum. Retroviruses 18 (13), 947-956 (2002) | 1e-165 | 6 5PR 4RT 6IN |
7 6PR 7RT 6IN |
85 | HIVDB |
| Koulinska (2003) | HYPERMUTATION of HIV type 1 genomes isolated from infants soon after vertical infection | AIDS Res. Hum. Retroviruses 19 (12), 1115-1123 (2003) | 0 | |
45 3PR 45RT 3IN |
0 | Case report(s) / study subset |
| Kouri (2012) | Antiviral drug resistance and non-B subtypes in HIV-1 patients in Cuba | 22981617 | 0 | 278 278PR 278RT |
278 278PR 278RT |
100 | HIVDB |
| Kouri (2015) | CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba | EBioMedicine 2 (3), 244-254 (2015) | 0 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| Kousiappa (2008) | GENETIC analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance | AIDS Res. Hum. Retroviruses 25 (1), 23-35 (2009) | 0 | 37 37PR 37RT |
37 37PR 37RT |
100 | HIVDB |
| Kousiappa (2009) | Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection | AIDS Res Hum Retroviruses. 2009 Aug;25(8):727-40. | 0 | 77 77PR 77RT 77IN |
77 77PR 77RT 77IN |
100 | HIVDB |
| Kousiappa (2011) | Molecular Characterization of HIV-1 Strains from Newly Diagnosed Patients in Cyprus (2007 - 2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance | AIDS Res. Hum. Retroviruses (2011) In press | 0 | 74 74PR 74RT 74IN |
74 74PR 74RT 74IN |
100 | HIVDB |
| Kousiappa (2015) | HIV-1 Dissemination in Cyprus, the Eastern European Frontier: Phylogeographic and Temporal Dynamic Analyses of Viral Sequences over a Decade | 29684083 | 0 | 100 100PR 100RT |
100 100PR 100RT |
100 | HIVDB |
| Kouyos (2010) | Molecular epidemiology reveals long-term changes in HIV-1 subtype B transmission in Switzerland | J Infect Dis. 2010 May 15;201(10):1488-97. | 0 | |
570 570PR 570RT |
0 | ARV Rx and/or other data are N/A |
| Kovalenko (2023) | Phylodynamics and migration data help describe HIV transmission dynamics in internally displaced people who inject drugs in Ukraine | medRxiv (2023) In press | 4.91e-148 | |
34 34PR 34RT |
0 | Quasispecies |
| Kovalenko (2025) | VANTAGE: Van-Based Real-Time HIV Sequencing for Transmission Mapping and Drug Resistance Profiling in War-Affected Ukraine | Unpublished | 0 | |
10 10PR 10RT |
0 | Sequencing method |
| Kovarova (2018) | Ultra-long-acting removable drug delivery system for HIV treatment and prevention | 30297889 | 0 | |
47 47IN |
0 | Quasispecies |
| Koyalta (2009) | High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad | Clin. Infect. Dis. 49 (1), 155-159 (2009) | 1.48e-137 | 37 37PR 33RT |
37 37PR 33RT |
100 | HIVDB |
| Koyanagi (1996) | DUAL infection of the central nervous system by AIDS viruses with distinct cellular tropisms | Science 236 (4803), 819-822 (1987) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Kozisek (2012) | Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease | Antimicrob. Agents Chemother. (2012) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kraiselburd (2002) | PROPERTIES of virus-like particles produced by SIV-chronically infected human cell clones | Cell. Mol. Biol. (Noisy-le-grand) 41 Suppl 1, S41-S52 (1995) | 0.000000002 | |
1 1RT 1IN |
0 | Laboratory/experimental isolate |
| Krebs (2019) | Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual | Immunity (2019) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kreutz (1996) | ANALYSIS of the envelope region of the highly divergent HIV-2ALT isolate extends the known range of variability within the primate immunodeficiency viruses | AIDS Res. Hum. Retroviruses 8 (9), 1619-1629 (1992) | 1e-165 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Krisko (2016) | APOBEC3G and APOBEC3F act in concert to extinguish HIV-1 Replication | Unpublished | 0 | |
2 2RT |
0 | Laboratory/experimental isolate |
| Kristiansen (2005) | Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression. | Scand J Infect Dis. 2005;37(11-12):890-901. | 0 | |
47 47PR 47RT |
0 | ARV Rx and/or other data are N/A |
| Krogstad (2002) | MOTHER-TO-CHILD transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1 | AIDS Res. Hum. Retroviruses 18 (6), 413-417 (2002) | 5e-96 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Kroidl (2021) | High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania | Trop Med Int Health 25 (5), 579-589 (2020) | 0 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Kroon (2018) | Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand | AIDS (2018) In press | 0 | 439 433PR 438RT |
439 433PR 439RT |
100 | HIVDB |
| Kuhn (2016) | Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis | AIDS 28 (11), 1673-1678 (2014) | 0 | |
228 228PR 228RT |
0 | Pending |
| Kuhnel (2000) | Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate from a patient with neurological acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate. | PNAS | 2.93e-113 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Kuhnel (1995) | NUCLEOTIDE sequence of HIV-2D194, an isolate from a Gambian case of 'neuro-AIDS', which showed excellent growth in macrophages | Nucleic Acids Res. 18 (20), 6142 (1990) | 4e-98 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Kuo (2020) | Blood and lymph node dissemination of clonal genome-intact HIV-1 DNA sequences during suppressive antiretroviral therapy | J. Infect. Dis. (2020) In press | 0 | |
393 370PR 375RT 364IN |
0 | Proviral DNA Reservoir |
| Kuritzkes (2000) | EFFECT of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team | J. Infect. Dis. 181 (2), 491-497 (2000) | 1e-133 | |
40 40PR 40RT |
0 | Sequence quality |
| Kuritzkes (2000) | EMERGENCE of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy | J. Acquir. Immune Defic. Syndr. 23 (1), 26-34 (2000) | 9e-94 | |
6 6RT |
0 | Case report(s) / study subset |
| Kuritzkes (2004) | RATE of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens | J. Acquir. Immune Defic. Syndr. 36 (1), 600-603 (2004) | 1e-123 | 405 403PR 405RT |
405 403PR 405RT |
100 | HIVDB |
| Kurle (2017) | Direct Submission | Submitted (14-DEC-2016) HIV Drug Resistance Labora | 2.5e-179 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Kurle (2020) | Untitled | Unpublished | 0 | |
42 42PR 42RT |
0 | Unpublished |
| Kurle (2021) | HIV-1 Drug Resistance among treatment naive Transgenders from India | AIDS Res Hum Retroviruses (2021) In press | 0 | |
9 9PR 9RT |
0 | Case report(s) / study subset |
| Kurle (2024) | HIV-1 genotyping among people who inject drugs in Mizoram | Unpublished | 0 | |
118 59PR 59RT 59IN |
0 | Pending |
| Kurle (2007) | EMERGENCE of NNRTI Drug Resistance Mutations after Single-Dose Nevirapine Exposure in HIV Type 1 Subtype C-Infected Infants in India | AIDS Res. Hum. Retroviruses 23 (5), 682-685 (2007) | 0 | 32 32RT |
32 4PR 32RT |
100 | HIVDB |
| Kusagawa (2001) | ISOLATION and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02_AG, which is replication competent in a restricted host range | AIDS Res. Hum. Retroviruses 17 (7), 649-655 (2001) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Kusagawa (2002) | ISOLATION and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages | AIDS Res. Hum. Retroviruses 18 (2), 115-122 (2002) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Kusagawa (2003) | IDENTIFICATION of HIN type 2 subtype B transmission in East Africa | AIDS Res. Hum. Retroviruses 19 (11), 1045-1049 (2003) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Kusagawa (2015) | Genome Sequence of a Novel HIV-1 Recombinant Identified in a Foreign Heterosexual Resident in Japan: Relatedness to recently reported CRF69_01B detected primarily among men who have sex with men in Japan | 2602191 | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Kusagawa (2022) | Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV In Vitro Diagnostics in Japan | AIDS Res Hum Retroviruses 37 (12), 994-997 (2021) | 0 | 173 173PR 173RT |
173 173PR 173RT |
100 | HIVDB |
| Kusagawa (2022) | Isolation and biological characterization of infectious molecular clones that represent unique biological phenotypes of HIV-1 subtype B and CRF08_BC R5 viruses circulating in Yunnan, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Kuwata (2005) | Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. | J Virol. 2006 Feb;80(3):1463-75. | 0 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Kuzmichev (2022) | Ultrasensitive Digital ELISA Reveals Insights Into HIV-1 Repertoire and Growth Kinetics in Viral Outgrowth Assays | Unpublished | 4.6e-156 | |
40 40PR 40RT |
0 | Proviral DNA Reservoir |
| Kuzmichev (2023) | Application of Ultrasensitive Digital ELISA for p24 Enables Improved Evaluation of HIV-1 Reservoir Diversity and Growth Kinetics in Viral Outgrowth Assays | Unpublished | 4.75e-156 | |
128 128PR 128RT |
0 | Proviral DNA Reservoir |
| Kwon (2020) | HIV-1 Subtypes and Drug Resistance Mutations among Female Sex Workers Varied in Different Cities and Regions of the Democratic Republic of Congo | 32045455 | 0 | 93 93PR 93RT |
93 93PR 93RT |
100 | HIVDB |
| Kyeyune (2025) | Pretreatment minority and majority HIV-1 drug resistance is associated with poor virologic control in patients infected with non-B subtypes of HIV-1 | Unpublished | 0 | |
105 105PR 105RT 105IN |
0 | Unpublished |
| La Seta Catamancio (2001) | IN vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure | J. Clin. Microbiol. 39 (3), 1124-1129 (2001) | 1e-116 | |
32 16PR 16RT |
0 | Quasispecies |
| Ladnaya (2018) | Prevalence of the Transmitted Drug Resistance Mutations among HIV-1 Treatment-naive Patients in Three Administrative Regions of the Russian Federation | Unpublished | 2.99e-132 | |
195 195PR 195RT |
0 | Sequence quality |
| Laeyendecker (2005) | MOLECULAR Epidemiology of HIV-1 Subtypes in Southern China | J. Acquir. Immune Defic. Syndr. 38 (3), 356-362 (2005) | 2.03e-77 | 71 71PR |
71 71PR 71RT |
100 | HIVDB |
| Laga (2019) | Analysis of genetic polymorphism of pol gene in HIV-1 strains circulating in Russia | Unpublished | 0 | |
84 84PR 84RT |
0 | Unpublished |
| Laga (2013) | Analysis of genetic polymorphism of pol gene in HIV-1 strains circulating in Russia | 28443684 | 0 | 6 6PR 6RT |
243 221PR 223RT |
2 | HIVDB |
| Laga (2012) | Direct Submission | Submitted (20-MAR-2012) T-Lymphotropic Viruses Lab | 1e-127 | |
5 5IN |
0 | ARV Rx and/or other data are N/A |
| Laga (2012) | Molecular genetic characterization of the HIV-1 variants abundant in Kirgiziia. | Vopr Virusol. 2012 Sep-Oct;57(5):26-32. | 0 | 37 37IN |
177 72PR 64RT 46IN |
20 | HIVDB |
| Lahuerta (2007) | RAPID Spread and Genetic Diversification of HIV Type 1 Subtype C in a Rural Area of Southern Mozambique | AIDS Res. Hum. Retroviruses 24 (2), 327-335 (2008) | 3e-60 | 51 51PR |
51 51PR |
100 | HIVDB |
| Lai (2014) | Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men. | Infect Genet Evol. 2014 Apr;23:176-81. | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Lai (2019) | Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC | Front Microbiol 10, 769 (2019) | 0 | |
29 29PR 29RT |
0 | Pending |
| Lakhashe (2008) | CHARACTERIZATION of B/C Recombinants of Near Full-Length HIV Type 1 from Northeastern India with Mosaics Identical to ARE195FL But with a Different Ancestral Origin | AIDS Res. Hum. Retroviruses 24 (1), 92-99 (2008) | 0 | 15 15PR 15RT 15IN |
15 15PR 15RT 15IN |
100 | HIVDB |
| Lakhashe (2008) | EVIDENCE of a Novel B/C Recombinant Exhibiting Unique Breakpoints of Near Full-Length HIV Type 1 Genome from Northeastern India | AIDS Res. Hum. Retroviruses 24 (2), 229-234 (2008) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Lall (2008) | PROFILE of Primary Resistance in HIV-1-Infected Treatment-Naive Individuals from Western India | AIDS Res. Hum. Retroviruses 24 (7), 987-990 (2008) | 0 | 40 40PR 40RT |
40 40PR 40RT |
100 | HIVDB |
| Lam (2016) | Antiretroviral resistance following first-line antiretroviral therapy failure in diverse HIV-1 subtypes clades in the SECOND-LINE study | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 492 492PR 492RT |
492 492PR 492RT |
100 | HIVDB |
| Lambrechts (2023) | HIV-PULSE: A long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization | 36711686 | 0 | |
42 39PR 41RT 31IN |
0 | Methods paper |
| Lambrechts (2023) | HIV-PULSE: A long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization | Unpublished | 0 | |
909 653PR 768RT 786IN |
0 | Methods paper |
| Lambrechts (2025) | Blood and tissue HIV-1 reservoirs display cellular plasticity and lack of compartmentalization in virally suppressed people | Unpublished | 0 | |
1567 884PR 1173RT 1353IN |
0 | Proviral DNA Reservoir |
| Lamers (2017) | The spleen is an HIV-1 sanctuary during cART | Unpublished | 0 | |
16 16PR 16RT |
0 | Case report(s) / study subset |
| Lamers (2025) | Intrahost diversity across varied HIV-1 subtypes from the early pandemic in the Democratic Republic of the Congo | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Unpublished |
| Lan (2003) | HIV Type 1 Isolates from 200 Untreated Individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral Drugs | AIDS Res. Hum. Retroviruses 19 (10), 925-928 (2003) | 1e-145 | 347 172PR 175RT |
347 172PR 175RT |
100 | HIVDB |
| Lan (2017) | Characterization of a novel HIV-1 unique recombinant form a man in Guangdong,China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2018) | Near full length genomic analysis of a HIV-1 G subtype strain identified in Guangdong province | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2020) | Direct Submission | Submitted (30-NOV-2019) Infectious Disease Institu | 0 | |
162 162PR 162RT |
0 | Unpublished |
| Lan (2021) | Genotype diversity and distribution characteristics among HIV-1 individuals in Guangzhou, China | 33309773 | 2.48e-172 | 1388 1388PR 1388RT |
1388 1388PR 1388RT |
100 | HIVDB |
| Lan (2022) | Direct Submission | Submitted (28-MAR-2021) Department of Infectious D | 6.96e-168 | |
393 393PR 393RT |
0 | Pending |
| Lan (2022) | HIV-1 CRF56_cpx in Guangzhou | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2022) | HIV-1 CRF06_cpx in Guangzhou | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2022) | Direct Submission | Submitted (05-MAY-2022) Department of Infectious D | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Lan (2022) | The potential CRF in Guangzhou, Guangdong China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2022) | A potential CRF 07BC-01AE in Guangdong China | Unpublished | 0 | |
9 9PR 9RT 9IN |
0 | Case report(s) / study subset |
| Lan (2023) | A potential CRF 07BC-B in Guangdong China | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Lan (2024) | A potential CRF 07BC-01AE in Guangdong China | Unpublished | 4.01e-173 | |
2074 2066PR 2074RT |
0 | Unpublished |
| Lan (2020) | Genetic characteristics of CRF12_BF first identified in Guangdong Province, China | AIDS Res Hum Retroviruses (2020) In press | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Lan (2025) | Direct Submission | Submitted (05-MAR-2025) Department of Infectious D | 1.57e-148 | |
74 74PR 74RT |
0 | Unpublished |
| Lan (2021) | Near full-length genomic characterization of a novel HIV-1 B/C recombinant form identified in Guangdong Province, China | AIDS Res Hum Retroviruses (2021) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lan (2022) | Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China | J Antimicrob Chemother (2022) In press | 2.01e-156 | |
225 225PR 225RT |
0 | Pending |
| Lan (2022) | Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China | Pathogens 11 (11), 1321 (2022) | 0 | 1206 1206IN |
1208 1208IN |
99 | HIVDB |
| Lan (2023) | Direct Submission | Submitted (21-SEP-2023) Institute of Infectious Di | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Lan (2023) | A Potential CRF in Guangdong | Unpublished | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Lan (2023) | Two Potential CRF in Guangdong | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Lan (2025) | Genetic characterization of a novel HIV-1 circulating recombinant form (CRF162_cpx) involving CRF01_AE, CRF07_BC and subtype B in Guangdong, China | Virus Genes (2024) In press | 0 | |
8 8PR 8RT 8IN |
0 | Case report (Small sample size) |
| Lan (2025) | Paired cerebrospinal fluid and plasma in antiretroviral therapy (ART)-naive or -experienced patients | Unpublished | 0 | |
74 74IN |
0 | Pending |
| Lan (2025) | Potential CRF in Guangdong | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Land (2007) | FULL-LENGTH HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants | AIDS Res. Hum. Retroviruses 24 (6), 865-872 (2008) | 0 | 10 10PR 10RT 10IN |
13 13PR 13RT 13IN |
76 | HIVDB |
| Lange (2023) | Immune Reconstitution Inflammatory Syndrome Drives Emergence of HIV Drug Resistance from Multiple Anatomic Compartments In A Person Living With HIV | Nat Med (2023) In press | 3.23e-155 | |
351 350PR 351RT |
0 | Quasispecies |
| Lange (2023) | Immune Reconstitution Inflammatory Syndrome Drives Emergence of HIV Drug-Resistance from Multiple Anatomic Compartments | 37322122 | 1.06e-159 | |
355 355IN |
0 | Quasispecies |
| Laomanit (2012) | Near Full-Length Sequence Analysis of HIV CRF01_AE/B Recombinant from Thailand | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lapovok (2010) | HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries. | Curr HIV Res. | 1e-167 | 93 93IN |
130 8PR 122IN |
71 | HIVDB |
| Lapovok (2013) | HIV-1 (sample KZ038) pol (region coding protease) gene partial sequence | Unpublished | 1.8e-137 | |
15 6PR 9RT |
0 | ARV Rx and/or other data are N/A |
| Lapovok (2013) | The molecular epidemiological aspects of hiv-infection spreading in Perm region. | Zh Mikrobiol Epidemiol Immunobiol. 2007 Mar-Apr;(2):18-24. | 0 | 10 10IN |
13 13IN |
76 | HIVDB |
| Lapovok (2013) | Molecular Epidemiology of HIV-1 in Siberia and Russian Far East | 28814231 | 0 | 18 18IN |
21 21IN |
85 | HIVDB |
| Lapovok (2014) | Molecular epidemiology of HIV-infection in Volga federal district, Russia | Unpublished | 0 | |
70 70PR 70RT |
0 | HIVDB |
| Lapovok (2014) | HIV Type 1 Subtype A1 Dominates in Armenia. | Curr HIV Res. 2015;13(3):219-25. | 1.67e-165 | 17 17PR 17RT |
17 17PR 17RT |
100 | HIVDB |
| Lapovok (2014) | Analysis of HIV-1 variants circulating in Irkutsk, Russia | Unpublished | 0 | |
13 13PR 13RT |
0 | ARV Rx and/or other data are N/A |
| Lapovok (2017) | Molecular-epidemiology analysis of HIV-1 variants circulating in Russia in 1987-2015 | Unpublished | 9.13e-137 | |
9 9PR 9RT |
0 | Pending |
| Lapovok (2019) | HIV spreading and genetic characteristic of HIV variants circulated in Republic of Guinea in 2015-2017 | 10.18565/epidem.2019.9.2.44-51 | 2.84e-165 | 35 35PR 35RT |
35 35PR 35RT |
100 | HIVDB |
| Lapovok (2020) | HIV-1 variants circulated in Russia in 2006-2018 | Unpublished | 0 | 2 2PR 2RT |
561 561PR 561RT |
0 | Unpublished |
| Lapovok (2020) | Application of NGS protocol for pol gene sequencing | Unpublished | 0 | 6 6PR 6RT |
7 7PR 7RT |
85 | HIVDB |
| Lapovok (2020) | HIV-1 variants circulated in Russia in 2006-2019 | Unpublished | 0 | |
6 6PR 6RT |
0 | Unpublished |
| Lapovok (2021) | Application of NGS protocol for HIV-1 full genome sequencing | Unpublished | 0 | 9 9PR 9RT 9IN |
176 176PR 176RT 176IN |
5 | HIVDB |
| Lapovok (2021) | Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018 | Unpublished | 0 | 100 100PR 100RT |
100 100PR 100RT |
100 | HIVDB |
| Lapovok (2023) | Molecular-epidemiological analysis of genetic variants of HIV-1 circulating in Eastern European and Central Asian countries in 2010-2019 | Unpublished | 0 | |
149 149PR 149RT |
0 | ARV Rx and/or other data are N/A |
| Larrouy (2012) | Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2 Infected Patient | 23018441 | 3.33e-128 | 35 35PR |
58 42PR 16RT |
60 | HIVDB |
| Lataillade (2007) | NATURAL Polymorphism of the HIV-1 Integrase Gene and Mutations Associated with Integrase Inhibitor Resistance | Antivir. Ther. (Lond.) 12, 563-570 (2007) | 1e-168 | 66 66IN |
66 66IN |
100 | HIVDB |
| Lau (2007) | NEAR Full-Length Sequence Analysis of a Unique CRF01_AE/B Recombinant from Kuala Lumpur, Malaysia | AIDS Res. Hum. Retroviruses 23 (9), 1139-1145 (2007) | 0 | 1 1PR 1RT 1IN |
4 4PR 4RT 4IN |
25 | HIVDB |
| Lauck (2013) | Discovery and full genome characterization of two highly divergent simian immunodeficiency viruses infecting black-and-white colobus monkeys (Colobus guereza) in Kibale National Park, Uganda | Retrovirology 10 (1), 107 (2013) | 0 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Lauck (2014) | Discovery and full genome characterization of a new SIV lineage infecting red-tailed guenons (Cercopithecus ascanius schmidti) in Kibale National Park, Uganda | Retrovirology 11 (1), 55 (2014) | 0 | |
5 3PR 5RT 5IN |
0 | NHPL/SIV |
| Laukkanen (1999) | VIRTUALLY full-length sequences of HIV type 1 subtype J reference strains | AIDS Res. Hum. Retroviruses 15 (3), 293-297 (1999) | 1e-164 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Laukkanen (1999) | DIRECT Submission | Submitted (18-NOV-1998) Department of Infectious Disease Epi | 1e-164 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Laukkanen (2000) | VIRTUALLY full-length subtype F and F/D recombinant HIV-1 from Africa and South America | Virology 269 (1), 95-104 (2000) | 1e-167 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Laurent (2006) | ANTIRETROVIRAL drug resistance and routine therapy, Cameroon | Emerging Infect. Dis. 12 (6), 1001-1004 (2006) | 0 | 21 21PR 21RT |
21 21PR 21RT |
100 | HIVDB |
| Lavu (2017) | High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea | PLoS ONE 12 (2), E0170265 (2017) | 1.13e-158 | 122 122PR 122RT |
122 122PR 122RT |
100 | HIVDB |
| Lawrence (2005) | Analysis of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02-AG subtypes from drug-naive patients from Saint-Etienne, France | J. Acquir. Immune Defic. Syndr. 42 (4), 396-404 (2 | 1.38e-141 | 62 31PR 31RT |
62 31PR 31RT |
100 | HIVDB |
| Lazaro (2011) | Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159) | PLoS ONE 6 (10), E26244 (2011) | 6e-175 | 191 96PR 95RT |
191 96PR 95RT |
100 | HIVDB |
| Le Hingrat (2018) | HIV-2 primary infection in a 69-year-old French man | 30310823 | 4.06e-149 | 3 1PR 1RT 1IN |
3 1PR 1RT 1IN |
100 | HIVDB |
| Lebedev (2017) | Analysis of the pol gene variability of IDU-A HIV-1 variant in the course of HIV infection epidemic in Perm Region of Russia | 29323855 | 5.7e-148 | 75 75PR 69RT |
85 85PR 79RT |
88 | HIVDB |
| Lebedev (2019) | HIV-1 diversity in the Moscow region, Russia: phylodynamics of the most common subtypes | 30863382 | 0 | 901 901PR 901RT |
901 901PR 901RT |
100 | HIVDB |
| Ledwaba (2017) | High frequency of natural polymorphisms in HIV-1 subtype C protease-inhibitor naive sequences | 30793914 | 0 | 423 423PR 390RT |
423 423PR 390RT |
100 | HIVDB |
| Ledwaba (2017) | High prevalence of HIV-1 drug resistance mutations in Subtype C transmitting mothers detected using 454 ultra-deep sequencing | Unpublished | 0 | |
218 218PR 218RT |
0 | Unpublished |
| Lee (2009) | Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore. | HIV Med | 0 | 60 60PR 60RT |
60 60PR 60RT |
100 | HIVDB |
| Lee (2019) | Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy | Front Microbiol 10, 2214 (2019) | 6.17e-180 | |
1388 1388PR 1388RT |
0 | SGS |
| Lee (2019) | The impact of antiretroviral therapy duration on the HIV-1 infection of T-cells within anatomic sites | J. Virol. (2019) In press | 0 | |
3872 3872PR 3872RT |
0 | SGS |
| Lee (2005) | BREAST-MILK Shedding of Drug-Resistant HIV-1 Subtype C in Women Exposed to Single-Dose Nevirapine | J. Infect. Dis. 192 (7), 1260-1264 (2005) | 3e-140 | |
39 39RT |
0 | HIVDB |
| Lee (2023) | HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy | 38956017 | 0 | |
355 318PR 319RT 244IN |
0 | Proviral DNA Reservoir |
| Lee (2012) | Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 'Deep' Sequencing | PLoS ONE 7 (9), E46181 (2012) | 1e-166 | 8 8IN |
150 150IN |
5 | HIVDB |
| Lee (2014) | Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda | AIDS Res. Hum. Retroviruses 30 (9), 896-906 (2014) | 0 | 572 572PR 572RT |
572 572PR 572RT |
100 | HIVDB |
| Lee (2019) | HIV-1 DNA Sequence Diversity and Evolution during Acute Subtype C Infection | Nature (2019) In press | 0 | |
202 189PR 188RT 172IN |
0 | SGS |
| Lee (2023) | Direct Submission | Submitted (02-DEC-2022) Molecular Microbiology and | 0 | 322 322PR 322RT 322IN |
322 322PR 322RT 322IN |
100 | HIVDB |
| Lee (2023) | Direct Submission | Submitted (08-DEC-2022) Molecular Microbiology and | 0 | 36 36PR 36RT 36IN |
36 36PR 36RT 36IN |
100 | HIVDB |
| Lee (2025) | High prevalence and multiyear persistence of linked cross-class resistance to HIV nucleoside reverse transcriptase inhibitors and integrase strand transfer inhibitors: a prospective cohort study | Unpublished | 0 | |
289 289PR 289RT 289IN |
0 | ARV Rx and/or other data are N/A |
| Lee (2016) | Characterization of the Near Full-Length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant in an Injection Drug User from Southern Taiwan | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Leelamanit (2005) | IN vivo sequence variability of viral protease of HIV-1 subtype E from therapy-naive Thai patients | Unpublished | 1e-50 | |
64 64PR |
0 | Case report(s) / study subset |
| Leelamanit (2005) | IN vivo variability of viral protease from HIV-1 subtype E infected Thai patients treated with reverse transcriptase inhibitors | Unpublished | 5e-51 | |
60 60PR |
0 | Pending |
| Leelawiwat (2018) | Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection | PLoS ONE 13 (7), e0201386 (2018) | 1.25e-146 | |
15 4PR 3RT 8IN |
0 | Case report(s) / study subset |
| Leendertz (2010) | High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire | J. Virol. 84 (15), 7427-7436 (2010) | 3e-39 | |
23 2RT 21IN |
0 | Gene fragment(s) |
| Leigh Brown (2000) | REDUCED susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites | J. Virol. 74 (22), 10269-10273 (2000) | 1e-98 | 110 110RT |
110 110RT |
100 | HIVDB |
| Leigh Brown (2005) | GENETIC basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection | J. Virol. 78 (5), 2242-2246 (2004) | 9e-60 | 182 182PR |
182 182PR |
100 | HIVDB |
| Leigh Brown (2011) | Transmission Network Parameters Estimated From HIV Sequences for a Nationwide Epidemic | J. Infect. Dis. 204 (9), 1463-1469 (2011) | 0 | 1288 1288PR 1288RT |
1288 1288PR 1288RT |
100 | HIVDB |
| Leitner (1995) | BIOLOGICAL and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden | Virology 209 (1), 136-146 (1995) | 1e-68 | |
3 3RT |
0 | Case report(s) / study subset |
| Lel (2014) | HIV-1 Drug Resistance Mutations among infants born to HIV positive mothers in Busia Kenya | AIDS Res. Hum. Retroviruses (2014) In press | 9.21e-179 | |
53 53PR 53RT |
0 | Pending |
| Lemey (2002) | MAXIMUM Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Lemey (2005) | MOLECULAR footprint of drug-selective pressure in a human immunodeficiency virus transmission chain | J. Virol. 79 (18), 11981-11989 (2005) | 1e-146 | |
28 28PR 28RT |
0 | Case report(s) / study subset |
| Leoz (2008) | INTEGRASE VIH-1 group O | 18525277 | 1e-100 | 96 96IN |
96 96IN |
100 | HIVDB |
| Leoz (2012) | Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02 | AIDS 25 (11), 1371-1377 (2011) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Leoz (2013) | Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France | AIDS 27 (14), 2309-2312 (2013) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Leoz (2015) | The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon | PLoS Pathog. 11 (8), E1005029 (2015) | 1.41e-146 | |
380 190PR 190RT 190IN |
0 | Pending |
| Lepej (2016) | Phylogenetic analysis of HIV sequences obtained in a respondent-driven sampling study of men who have sex with men | AIDS Res. Hum. Retroviruses 25 (12), 1335-1338 (20 | 7.94e-149 | |
32 32PR 32RT |
0 | Case report(s) / study subset |
| Lerma (2000) | QUANTITATION of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity | J. Clin. Microbiol. 38 (1), 402-405 (2000) | 0.00000007 | |
2 2RT |
0 | Case report(s) / study subset |
| Leung (2016) | An unusual cluster of HIV-1 B/F recombinants in an Asian population | Int. J. Infect. Dis. 14, E294-E298 (2010) | 6.19e-136 | |
14 14RT |
0 | Case report(s) / study subset |
| Levy (2012) | Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases | Clin. Infect. Dis. 52 (11), 1363-1370 (2011) | 1.17e-149 | 17 17PR 17RT |
239 239PR 239RT |
7 | HIVDB |
| Lewis (2008) | EPISODIC sexual transmission of HIV revealed by molecular phylodynamics | PLoS Med. 5 (3), E50 (2008) | 0 | |
100 100PR 100RT |
0 | Case report(s) / study subset |
| Lewis (2014) | Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study. | BMC Infect Dis. 2015 Nov 20;15:538. | 0 | 51 51PR 51RT |
51 51PR 51RT |
100 | HIVDB |
| Lewis (2014) | Two Mother to Child Transmissions Within Three Generations of the Same Family | Unpublished | 0 | |
10 10PR 10RT 10IN |
0 | Case report(s) / study subset |
| Lewis (2012) | Partial Escape of HIV-1 From Cytotoxic T Lymphocytes During Chronic Infection | J. Virol. (2012) In press | 1.13e-121 | |
132 69PR 87RT 45IN |
0 | Laboratory/experimental isolate |
| Lewitus (2022) | HIV-1 infections with multiple founders associate with the development of neutralization breadth | 35303045 | 0 | |
546 359PR 360RT 546IN |
0 | ARV Rx and/or other data are N/A |
| Lewitus (2022) | HIV-1 infections with multiple founders associate with the development of neutralization breadth | Unpublished | 0 | |
143 142PR 142RT 143IN |
0 | Pending |
| Li (2006) | RAPID Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution | J. Virol. 81 (1), 193-201 (2007) | 0 | 18 18PR 18RT 18IN |
18 18PR 18RT 18IN |
100 | HIVDB |
| Li (2010) | Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers | 21124229 | 0 | |
74 74RT 74IN |
0 | Laboratory/experimental isolate |
| Li (2022) | HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China | BMC Infect Dis 22 (1), 741 (2022) | 0 | 295 295PR 295RT |
295 295PR 295RT |
100 | HIVDB |
| Li (2017) | Genome sequences of a Novel HIV-1 Circulatiing Recombinant Form Identified in China | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Li (2011) | High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men | PLoS Pathog. 6 (5), E1000890 (2010) | 0 | |
266 94PR 94RT 266IN |
0 | Quasispecies |
| Li (2025) | Identification of multiple unique HIV-1 recombinant forms in HIV-1 newly infected individuals-Anhui province, 2023 | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report (Small sample size) |
| Li (2010) | Polymorphisms for HIV-1 B pol and its potential influence on drug resistance in China | 23144802 | 0 | 737 638PR 729RT |
738 638PR 730RT |
99 | HIVDB |
| Li (2025) | Identification of Two Novel HIV-1 Unique Recombinant Forms Among Men Who Have Sex with Men in Northern China | AIDS Res Hum Retroviruses (2025) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report (Small sample size) |
| Li (2025) | Identification of a new ly emerging second-generation HIV-1 circulating recombinant form among men who have sex with men in China | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report (Small sample size) |
| Li (2022) | Identification and Characterization of two novel HIV-1 Unique Recombinant Form comprising CRF01_AE and CRF07_BC Identified among Men Who Have Sex with Men in China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2018) | HIV-1 Transmission Predominantly Derived from already Circulating Local Strains among Recently Infected Individuals in Southwest China | 30150680 | 0 | 229 229PR 229RT |
229 229PR 229RT |
100 | HIVDB |
| Li (2021) | A newly emerging HIV-1 circulating recombinant form (CRF110_BC) comprising subtype B and C among intravenous drug users in Yunnan, China | J Infect (2021) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2016) | Identification and characterization of two human immunodeficiency virus type 1 unique recombinant forms from Yunnan,China | Virol Sin 32 (2) (2016) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2016) | Direct Submission | Submitted (04-NOV-2015) Department of HIV/AIDS cli | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2017) | Direct Submission | Submitted (24-DEC-2015) Department of HIV/AIDS Cli | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2022) | Epidemiology of HIV-1 CRF103_01B in Beijing and Its Genetic Recombinant Characteristics | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Li (2025) | Direct Submission | Submitted (01-MAR-2025) Institute of Infectious Di | 0 | |
198 197PR 198RT 196IN |
0 | Unpublished |
| Li (2011) | Factors associated with viral rebound in HIV-positive subjects receiving a therapeutic HIV-1 gag vaccine | 21402549 | 0 | |
204 204RT |
0 | Quasispecies |
| Li (2012) | Characteristics and Outcomes of Initial Virologic Suppressors Following Therapeutic HIV-1 gag Vaccination | 22479542 | 0 | |
67 67RT |
0 | Case report(s) / study subset |
| Li (2019) | Direct Submission | Submitted (29-APR-2019) Chinese Center for Disease | 0 | |
391 387PR 391RT 391IN |
0 | Unpublished |
| Li (2024) | Distinct genetic clusters in HIV-1 CRF01_AE infected patients induced variable degrees of CD4+ T cell loss | 38385695 | 4.27e-174 | 24 24PR 24RT |
24 24PR 24RT |
100 | HIVDB |
| Li (2010) | Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China | AIDS Res. Hum. Retroviruses 26 (6), 711-716 (2010) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Li (2010) | Near Full-Length Sequence Analysis of a Novel HIV-1 C/CRF01_AE Recombinant Variant from Yunnan, China | AIDS Res. Hum. Retroviruses (2010) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2011) | Analysis of the near full-length genomic characterization of HIV-1 subtype G detected in Guangxi for the first time | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2012) | Recombination Form and Epidemiology of HIV-1 Unique Recombinant Strains Identified in Yunnan, China | PLoS ONE 7 (10), E46777 (2012) | 0 | 58 58PR 58RT 58IN |
58 58PR 58RT 58IN |
100 | HIVDB |
| Li (2013) | Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China | J. Med. Virol. 85 (3), 388-395 (2013) | 0 | 211 211PR 211RT 211IN |
211 211PR 211RT 211IN |
100 | HIVDB |
| Li (2012) | Genetic characterization and transmitted drug resistance of HIV-1 epidemic in men who have sex with men in Beijing, China | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 76 76PR 76RT 76IN |
76 76PR 76RT 76IN |
100 | HIVDB |
| Li (2009) | Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China | AIDS Res. Hum. Retroviruses 26 (6), 699-704 (2010) | 0 | 13 13PR 13RT 13IN |
13 13PR 13RT 13IN |
100 | HIVDB |
| Li (2011) | High genetic diversity and low drug-resistance of HIV-1 was found in men who have sex with men in Shijiazhuang, China | 21645646 | 0 | 15 15PR 15RT 15IN |
15 15PR 15RT 15IN |
100 | HIVDB |
| Li (2012) | Multiple introductions of HIV into men who have sex with men were found in Zhengzhou city, China | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 14 14PR 14RT 14IN |
14 14PR 14RT 14IN |
100 | HIVDB |
| Li (2013) | Relatively High Prevalence of Drug Resistance among Antiretroviral-Naive Patients from Henan, Central China | AIDS Res. Hum. Retroviruses (2013) In press | 0 | 98 98PR 98RT 98IN |
98 98PR 98RT 98IN |
100 | HIVDB |
| Li (2015) | HIV-1 Thai B strains has spread out of former plasma donors into general population through sexual contact in Henan, China | 26381060 | 0 | 104 104PR 104RT 104IN |
104 104PR 104RT 104IN |
100 | HIVDB |
| Li (2015) | CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan prefecture of Sichuan, China | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 284 283PR 284RT 284IN |
603 603PR 603RT 603IN |
47 | HIVDB |
| Li (2024) | Near Full-Length Genome Characterization of two Novel Unique Recombinants (CRF01_AE/CRF07_BC) in Beijing, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2024) | Genetic characterisation of a recombinant strain of HIV (CRF121_0107) | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report (Small sample size) |
| Li (2025) | Genetic characterisation of a recombinant strain of HIV (CRF121_0107) | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report (Small sample size) |
| Li (2024) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF135_0107) in Heilongjiang Province, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2024) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF135_0107) in Heilongjiang Province, China | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Li (2024) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF136_0107) in Heilongjiang Province, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Li (2018) | Drug resistance mutation profiles of the drug-naive and first-line regimen-treated HIV-1-infected population of Suzhou, China | Virol Sin 32 (4), 271-279 (2017) | 0 | 120 87PR 120RT 118IN |
120 120PR 120RT 118IN |
100 | HIVDB |
| Li (2016) | Near Full-Length Genome Sequences of Two Novel HIV-1 Recombinant Forms Detected In Henan Province, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2025) | Direct Submission | Submitted (23-APR-2025) Clinical Laboratory Center | 0 | |
1 1PR 1RT 1IN |
0 | Case report (Small sample size) |
| Li (2024) | Characterization of two HIV-1 strains with novel unique recombinant genome in Hebei, China | AIDS Res Hum Retroviruses (2024) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2013) | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF61_BC) Identified among Heterosexuals in China. | Genome Announc. 2013 Jun 27;1(3). | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Li (2013) | Near full-length genome sequence of a novel HIV type 1 second-generation recombinant form (CRF01_AE/CRF07_BC) identified among men who have sex with men in Jilin, China. | AIDS Res Hum Retroviruses. 2013 Dec;29(12):1604-8. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2014) | Near Full-length Genome Analyses of a Novel HIV-1 Circulating Recombinant Form, CRF63_01B, Identified among MSM in China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2017) | A unique second-generation recombinant form of HIV-1 was identified among MSM, in Beijing, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2025) | Tracing the epidemic history of HIV-1 CRF01_AE lineages by near full-length genome analyses | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report (Small sample size) |
| Li (2013) | Near full-length genome sequence of a novel HIV-1 recombinant form (CRF01_AE/B) detected among men who have sex with men in Jilin Province, China. | AIDS Res Hum Retroviruses. 2014 Jul;30(7):701-5. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2014) | Near full-length genome identification of a novel HIV-1 recombinant form (CRF01_AE/B/C) among heterosexuals in Jilin, China. | AIDS Res Hum Retroviruses. 2014 Jul;30(7):695-700. | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Li (2015) | HIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, China | PLoS ONE 10 (6), E0129559 (2015) | 0 | 1265 1265PR 1265RT |
1265 1265PR 1265RT |
100 | HIVDB |
| Li (2015) | Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants | PLoS ONE 9 (10), E110738 (2014) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Li (2007) | DUAL infections with multiple lineages of HIV-1 strains in unique geographical recombination 'hotspots' in Asia | Unpublished | 1e-168 | |
85 85PR 60RT |
0 | ARV Rx and/or other data are N/A |
| Li (2005) | MOLECULAR epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan Province of China suggests origin from the local IDU epidemic | AIDS Res. Hum. Retroviruses 21 (11), 977-980 (2005) | 1e-174 | 26 26PR 26RT |
52 51PR 51RT |
50 | HIVDB |
| LI (1989) | Simian immunodeficiency virus (isolate SMM-M7) | UNPUBLISHED (1989) | 5e-83 | |
1 1RT 1IN |
0 | ARV Rx and/or other data are N/A |
| Li (2023) | Untitled | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Li (2025) | High peak viremia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa | Unpublished | 0 | |
14 7PR 8RT 14IN |
0 | HIVDB |
| Li (2017) | Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF79_0107) Identified from Shanxi, China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Li (1991) | MOLECULAR characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes | J. Virol. 65 (8), 3973-3985 (1991) | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Li (2019) | Genetic Clustering Analysis for HIV Infection among Men Who Have Sex with Men in Nigeria: implications for intervention | AIDS (2019) In press | 0 | |
265 265PR 265RT |
0 | Pending |
| Li (1989) | EXTENSIVE genetic variability of simian immunodeficiency virus from African green monkeys | J. Virol. 63 (4), 1800-1802 (1989) | 9e-30 | |
1 1RT |
0 | Gene fragment(s) |
| Li (2012) | Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir | J. Virol. 86 (19), 10776-10791 (2012) | 0 | |
26 1PR 6RT 26IN |
0 | NHPL/SIV |
| Li (2025) | Direct Submission | Submitted (12-APR-2025) School of Public Health, N | 4.89e-178 | |
3 3PR 3RT |
0 | Unpublished |
| Li (2011) | High Prevalence of HIV Type 1 Subtype B' Among Heterosexuals in Western Hubei, Central China: Bridging the Epidemic into the General Population | AIDS Res. Hum. Retroviruses 27 (9), 1025-1028 (201 | 0 | 62 62PR 33RT |
62 62PR 62RT |
100 | HIVDB |
| Li (2011) | Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B | J. Acquir. Immune Defic. Syndr. 54 (2), 129-136 (2 | 0 | 17 17PR 17RT 3IN |
23 23PR 23RT 3IN |
73 | HIVDB |
| Li (2015) | Direct Submission | Submitted (11-JAN-2015) National Center for AIDS a | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Li (2012) | Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses | AIDS 26 (7), 877-884 (2012) | 0 | 33 33PR 33RT 33IN |
33 33PR 33RT 33IN |
100 | HIVDB |
| Li (2015) | Trends of HIV subtypes and phylogenetic dynamics among young men who have sex with men in China, 2009-2014 | Sci Rep 5, 16708 (2015) | 0 | 1205 1204PR 1205RT |
1205 1204PR 1205RT |
100 | HIVDB |
| Li (2014) | Genomic Characterization of Two Novel HIV-1 Second-Generation Recombinant Forms Among Men Who Have Sex with Men in Beijing, China | AIDS Res. Hum. Retroviruses 31 (3), 342-346 (2015) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Liang (2009) | A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1 | PLoS ONE 6 (10), E26745 (2011) | 8.01e-56 | |
52 52PR 52RT |
0 | Quasispecies |
| Liang (2014) | Association between Latent Proviral Characteristics and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected Adults | J. Virol. (2014) In press | 0 | |
123 123PR 123RT |
0 | Proviral DNA Reservoir |
| Liang (2020) | Direct Submission | Submitted (13-OCT-2019) School of Public Health, G | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Liang (2018) | HIV-1 genotyping and transmitted drug resistance among heterosexually infected individuals and injection drug users in antiretroviral-treatment-naive HIV patients from Lingshan County, Guangxi, China | 31018203 | 0 | 183 182PR 182RT |
183 182PR 183RT |
100 | HIVDB |
| Liang (2015) | Community-Based HIV-1 Early Diagnosis and Risk Behavior Analysis of Men Having Sex with Men in Hong Kong | PLoS ONE 10 (4), E0125715 (2015) | 2.22e-77 | |
8 8RT |
0 | Gene fragment(s) |
| Liang (2020) | The Genotype Distribution, Infection Stage and Drug Resistance Mutation Profile of Human Immunodeficiency Virus-1 among the Infected Blood Donors from Five Chinese Blood Centers, 2014-2017 | 33347449 | 6.87e-171 | 356 356PR 356RT |
356 356PR 356RT |
100 | HIVDB |
| Liang (2021) | HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China | 33557775 | 0 | 1144 1144PR 1144RT |
1144 1144PR 1144RT |
100 | HIVDB |
| Liao (2009) | Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam | Virology 391 (1), 51-56 (2009) | 0 | 33 33PR 33RT 33IN |
33 33PR 33RT 33IN |
100 | HIVDB |
| Liao (2007) | GENOTYPIC Analysis of the Protease and Reverse Transcriptase of HIV Type 1 Isolates from Recently Infected Injecting Drug Users in Western China | AIDS Res. Hum. Retroviruses 23 (8), 1062-1065 (2007) | 1e-148 | 50 25PR 25RT |
50 25PR 25RT |
100 | HIVDB |
| Librelotto (2015) | HIV-1 epidemiology and circulating subtypes in the countryside of South Brazil | Rev. Soc. Bras. Med. Trop. 48 (3), 249-257 (2015) | 0 | |
26 26PR 26RT |
0 | ARV Rx and/or other data are N/A |
| Lidstrom (2011) | Initiation of antiretroviral treatment in women after delivery can induce multi-class drug resistance in breastfeeding HIV-infected infants | 21460326 | 0 | |
186 186PR 186RT |
0 | Pending |
| Liegeois (2006) | MOLECULAR characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis) | Virology 349 (1), 55-65 (2006) | 0 | |
6 3PR 4RT 6IN |
0 | NHPL/SIV |
| Liegeois (2008) | Full-length genome characterization of a novel simian immunodeficiency virus lineage (SIVolc) from olive Colobus (Procolobus verus) and new SIVwrcPbb strains from Western Red Colobus (Piliocolobus badius badius) from the Tai Forest in Ivory Coast | J. Virol. 83 (1), 428-439 (2009) | 0 | |
3 3PR 3RT 3IN |
0 | NHPL/SIV |
| Liegeois (2011) | Full-length genome sequence of a simian immunodeficiency virus (SIVsunK08) from a wild captured sun-tailed monkey (Cercopithecus solatus) in Gabon provides evidence for a species specific monophyletic SIVsun lineage | AIDS Res. Hum. Retroviruses (2011) In press | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Liegeois (2011) | Evidence of circulating monophyletic Simian Immunodeficiency Virus strain in sun-tailed monkeys (Cercopithecus solatus) | Unpublished | 8e-65 | |
2 1RT 2IN |
0 | NHPL/SIV |
| Liegeois (2012) | First evidence of multiple retroviral infections in Non-Human Primates Bushmeat from Gabon | Unpublished | 0 | |
7 5RT 7IN |
0 | NHPL/SIV |
| Liegeois (2013) | HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains. | AIDS Res Hum Retroviruses. 2013 Jul;29(7):1085-90. | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Liegeois (2014) | Full-Length Genome Analyses of Two New Simian Immunodeficiency Virus (SIV) Strains from Mustached Monkeys (C. Cephus) in Gabon Illustrate a Complex Evolutionary History among the SIVmus/mon/gsn Lineage | Viruses 6 (7), 2880-2898 (2014) | 0 | |
2 2PR 2RT 2IN |
0 | NHPL/SIV |
| Liegler (2014) | HIV-1 Drug Resistance in the iPrEx Pre-Exposure Prophylaxis Trial | 24740633 | 2.26e-152 | 268 134PR 134RT |
268 134PR 134RT |
100 | HIVDB |
| Lihana (2006) | HIV Type 1 Subtypes among STI Patients in Nairobi: A Genotypic Study Based on Partial pol Gene Sequencing | AIDS Res. Hum. Retroviruses 22 (11), 1172-1177 (2006) | 1e-50 | |
140 140IN |
0 | Gene fragment(s) |
| Lihana (2010) | Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya | AIDS Res. Hum. Retroviruses 26 (7), 833-838 (2010) | 3e-58 | 10 10PR |
10 10PR |
100 | HIVDB |
| Lihana (2010) | HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy | AIDS Res. Hum. Retroviruses 25 (12), 1211-1217 (20 | 1.27e-151 | 51 51RT |
51 51RT |
100 | HIVDB |
| Lihana (2011) | Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy | J. Clin. Virol. 52 (2), 123-128 (2011) | 4.69e-152 | |
211 1PR 210RT |
0 | Pending |
| Lihana (2004) | HIV Recombinants and Subtypes Among Patients Attending a Sexually Transmitted Disease Clinic in Nairobi, Kenya | 19327052 | 2e-49 | |
79 79IN |
0 | Gene fragment(s) |
| Liitsola (2000) | AN AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network | AIDS Res. Hum. Retroviruses 16 (11), 1047-1053 (2000) | 1e-163 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Lillemark (2008) | Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen | J. Med. Virol. 83 (3), 377-383 (2011) | 0 | |
21 21PR 21RT |
0 | Pending |
| Lima (2020) | Direct Submission | Submitted (17-JAN-2020) Medicina Tropical, Univers | 1.34e-166 | 633 633PR 633RT |
633 633PR 633RT |
100 | HIVDB |
| Lima (2016) | Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil | PLoS ONE 11 (5), E0155854 (2016) | 3.66e-150 | 167 167PR 167RT |
167 167PR 167RT |
100 | HIVDB |
| Lima (2014) | Mother-to-child transmission and transmitted drug resistance among HIV-1 pregnant women with recent seroconversion | 27381205 | 5.79e-166 | 11 11PR 11RT |
43 43PR 43RT |
25 | HIVDB |
| Lima (2016) | HIV-1 drug resistance, genetic diversity and clinical outcomes in pregnant Brazilian women | Unpublished | 1.27e-163 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Lin (2018) | Diverse genetic characterization and low transmitted drug resistance among men have sex with men with antiretroviral therapy -naive HIV-1-infected individuals in Zhuhai, China | Unpublished | 0 | |
308 308PR 308RT |
0 | Case report(s) / study subset |
| Lin (2011) | Biological characterization and drug susceptibilities of CRF07_BC strains from treatment-naive patients in Taiwan | Unpublished | 1e-172 | |
6 6PR 6RT |
0 | ARV Rx and/or other data are N/A |
| Lin (2007) | MOLECULAR Epidemiology of HIV-1 Infection and Full-Length Genomic Analysis of Circulating Recombinant Form 07_BC Strains from Injection Drug Users in Taiwan | J. Infect. Dis. 195 (9), 1283-1293 (2007) | 0 | 269 269PR 2RT 2IN |
279 279PR 4RT 4IN |
96 | HIVDB |
| Ling (2003) | NON-INVASIVE Detection of New Simian Immunodeficiency Virus Lineages in Captive Sooty Mangabeys: Ability to Amplify Virion RNA from Fecal Samples Correlates with Plasma Viral Load | J. Virol. (2003) In press | 5e-30 | |
10 10IN |
0 | NHPL/SIV |
| Ling (2025) | Molecular characterization of a unique Recombinant form of HIV-1 subtype F2/CRF02_AG identified in Guangdong, China | Virol J 22 (1), 329 (2025) | 0 | |
1 1PR 1RT 1IN |
0 | Pending |
| Linka (2004) | Direct Submission | Submitted (24-SEP-2009) National Reference Laborat | 0 | |
1265 1265PR 1265RT |
0 | ARV Rx and/or other data are N/A |
| Lipscomb (2015) | HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences | J. Infect. Dis. 210 (11), 1827-1837 (2014) | 6.58e-126 | |
528 528RT |
0 | Quasispecies |
| Little (2008) | PERSISTENCE of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection | J. Virol. 82 (11), 5510-5518 (2008) | 0 | |
142 142PR 142RT |
0 | Case report(s) / study subset |
| Little (2008) | ANTIRETROVIRAL-DRUG resistance among patients recently infected with HIV | N. Engl. J. Med. 347 (6), 385-394 (2002) | 0 | 321 321PR 321RT |
321 321PR 321RT |
100 | HIVDB |
| Little (2014) | Using HIV Networks to Inform Real Time Prevention Interventions | PLoS ONE 9 (6), E98443 (2014) | 0 | 648 648PR 648RT |
648 648PR 648RT |
100 | HIVDB |
| Liu (2005) | Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China. | JAIDS | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Liu (1997) | HIV-1 reverse transcriptase encoding region of brain derived viral RNA. | Unpublished | 9e-94 | |
10 10RT |
0 | Case report(s) / study subset |
| Liu (2022) | Direct Submission | Submitted (06-DEC-2021) Department of Pathogen Det | 0 | |
356 356PR 356RT |
0 | Unpublished |
| Liu (2010) | Drug Resistance and HCV Coinfection in Former Blood Donors Infected with HIV Type 1 in China | AIDS Res. Hum. Retroviruses 27 (8), 925-930 (2011) | 6.78e-164 | 63 63PR 63RT |
63 63PR 63RT |
100 | HIVDB |
| Liu (2025) | HIV-1 subtype distribution and drug resistance profiles among PLWHA with detectable viremia in Henan Province, China, 2023 | Unpublished | 0 | |
804 804RT |
0 | ARV Rx and/or other data are N/A |
| Liu (2024) | Characteristics of Drug Resistance Mutations in ART-experienced HIV-1 Patients with Low-Level Viremia in Zhengzhou City, China | 38724547 | 0 | |
104 104PR 104RT |
0 | Pending |
| Liu (2025) | Transmitted drug resistance profiles among people living with HIV-1 in Henan province, China, 2024 | Unpublished | 0 | |
1227 1227PR 1227RT |
0 | HIVDB |
| Liu (2007) | POLYMORPHISMS and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China | Arch. Virol. 152 (10), 1799-1805 (2007) | 2.59e-135 | 66 66PR 66RT |
66 66PR 66RT |
100 | HIVDB |
| Liu (2022) | Prevalence of transmitted drug resistance mutations among patients infected with human immunodeficiency virus type 1 (HIV-1) in Henan Province, China | 36573735 | 0 | 1228 1227PR 1228RT |
1228 1227PR 1228RT |
100 | HIVDB |
| Liu (2007) | POLYMORPHISM and antiretroviral drug resistance patterns in the protease gene of HIV-1 subtypes infecting PI naive Chinese patients | Unpublished | 1e-59 | 70 70PR |
81 81PR |
86 | HIVDB |
| Liu (2012) | HIV-1 pol gene from CNS and blood in Chinese settings | 23325676 | 0 | |
68 68PR 68RT |
0 | Pending |
| Liu (2023) | Near Full-Length Genomic Characterization of Two Novel HIV Type 1 Second-generation Recombinant Form (CRF01_AE/CRF07_BC) from Guangxi, China | AIDS Res Hum Retroviruses (2023) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Liu (2013) | Vertical T cell immunodominance and epitope entropy determine HIV-1 escape | J. Clin. Invest. 123 (1), 380-393 (2013) | 0 | |
1228 1031PR 1031RT 1227IN |
0 | Quasispecies |
| Liu (2008) | MOLECULAR epidemiology of human immunodeficiency virus type 1 and hepatitis C virus in former blood donors in central china | AIDS Res. Hum. Retroviruses 24 (1), 1-6 (2008) | 0 | |
55 55PR 55RT 2IN |
0 | Pending |
| Liu (2012) | Genetic diversity and drug resistance of HIV type 1 in international travels in Shenzhen City of China | Unpublished | 0 | |
68 61PR 68RT |
0 | Unpublished - Final |
| Liu (2018) | Direct Submission | Submitted (22-MAY-2018) Division of Virology and I | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Liu (2010) | Identification and characterization of two new HIV type 1 unique (B/C) recombinant forms in China | 20977352 | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Liu (2013) | Characterization of near full-length genomes of HIV-1 in Yunnan, China: dominance of multiple circulating recombinant forms and unique recombinant forms | Unpublished | 0 | |
55 55PR 55RT 55IN |
0 | Unpublished - Final |
| Liu (2025) | Direct Submission | Submitted (23-FEB-2025) Ningxia Medical University | 7.32e-173 | |
95 95PR 95RT |
0 | Unpublished |
| Liu (2016) | Phylogenetic analysis of HIV-1 CRF65_CPX reveals Yunnan province is still a source contributing to the spread of HIV-1 in China | J. Acquir. Immune Defic. Syndr. (2015) In press | 0 | 6 6PR 6RT |
6 6PR 6RT |
100 | HIVDB |
| Liu (2006) | SELECTION on the human immunodeficiency virus type 1 proteome following primary infection | J. Virol. 80 (19), 9519-9529 (2006) | 0 | |
174 40PR 174RT 40IN |
0 | Quasispecies |
| Liu (2009) | Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners | J. Virol. 83 (20), 10821-10829 (2009) | 0 | |
65 34PR 65RT 31IN |
0 | Case report(s) / study subset |
| Liu (2025) | Rapid Circulation of HIV-1 CRF85_BC in Southwest China: its geographic origins and molecular transmission networks analysis | Unpublished | 0 | |
496 496PR 496RT 47IN |
0 | HIVDB |
| Lloyd (2007) | PREVALENCE of Resistance Mutations in HIV-1-Infected Hondurans at the Beginning of the National Antiretroviral Therapy Program | AIDS Res. Hum. Retroviruses 24 (4), 529-535 (2008) | 0 | 336 336PR 336RT |
336 336PR 336RT |
100 | HIVDB |
| Lo Presti (2019) | Characterization of HIV-1 subtypes among South Sudanese patients | AIDS Res. Hum. Retroviruses (2019) In press | 0 | |
5 3PR 5RT |
0 | Case report(s) / study subset |
| Locatelli (2016) | Full molecular characterization of a simian immunodeficiency virus, SIVwrcpbt from Temminck's red colobus (Piliocolobus badius temminckii) from Abuko Nature Reserve, The Gambia | Virology 376 (1), 90-100 (2008) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Locatelli (2016) | Prevalence and genetic diversity of simian immunodeficiency virus infection in wild-living red colobus monkeys (Piliocolobus badius badius) from the Tai forest, Cote d'Ivoire SIVwrc in wild-living western red colobus monkeys | Infect. Genet. Evol. 8 (1), 1-14 (2008) | 9.16e-51 | |
9 9RT 9IN |
0 | NHPL/SIV |
| Loemba (2002) | GENETIC divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT | Antimicrob. Agents Chemother. 46 (7), 2087-2094 (2002) | 0 | |
28 14PR 15RT 1IN |
0 | Gene fragment(s) |
| Loffredo (2008) | PATTERNS of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication | J. Virol. 82 (4), 1723-1738 (2008) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Lole (1999) | FULL-LENGTH human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination | J. Virol. 73 (1), 152-160 (1999) | 1e-165 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Long (2019) | Intactness of persistent SIVmac239 in acutely and chronically treated macaques | Unpublished | 0 | |
327 326PR 326RT 325IN |
0 | NHPL/SIV |
| Long (2019) | Direct Submission | Submitted (10-SEP-2019) AIDS and Cancer Virus Prog | 0 | |
45 45PR 45RT 44IN |
0 | NHPL/SIV |
| Longo (2008) | HIV-1 diversity among inmates of Italian prisons | J. Med. Virol. 80 (10), 1689-1694 (2008) | 0 | |
9 9PR 9RT |
0 | Case report(s) / study subset |
| Loosli (2023) | HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis | Lancet HIV (2023) In press | 0 | 92 90PR 90RT 92IN |
92 90PR 90RT 92IN |
100 | HIVDB |
| Loosli (2023) | Direct Submission | Submitted (09-SEP-2023) Department of Infectious D | 0 | 368 323PR 322RT 368IN |
368 320PR 322RT 368IN |
100 | HIVDB |
| Loosli (2025) | Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study | Clin Infect Dis (2025) In press | 0 | 444 217PR 217RT 227IN |
444 217PR 217RT 227IN |
100 | HIVDB |
| Lopez (2012) | The genetic diversity and evolution of B-clade (subtype) HIV-1 in Puerto Rico | 26703695 | 8.51e-149 | 1071 1069PR 1071RT |
1721 1291PR 1501RT |
62 | HIVDB |
| Lopez (2018) | Molecular Epidemiology of HIV-1 virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D and CRF-24BG | AIDS Res. Hum. Retroviruses (2018) In press | 3.58e-148 | 846 846PR 846RT |
846 846PR 846RT |
100 | HIVDB |
| Lopez-Galindez (2010) | Initial fitness recovery of HIV-1 is driven by quasispecies heterogeneity and can occur without mutations in the consensus sequence | PLoS One. 2010 Apr 26;5(4):e10319. | 0 | |
22 22PR 22RT 22IN |
0 | Laboratory/experimental isolate |
| Lopez-Ortiz (2025) | Characterization of HIV genetic transmission networks in Mexico City, Chiapas and Quintana Roo 2019-2021: a cross sectional study | Unpublished | 1.06e-180 | |
8820 8820PR 8820RT |
0 | Unpublished |
| Lopker (2012) | Transmitted/Founder Viruses from the SIVsmE660 and SIVmac251 Lineages are Infectious and Replication Competent In-Vivo | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Lopker (2016) | Derivation and characterization of pathogenic transmitted/founder molecular clones from SIVsmE660 and SIVmac251 following mucosal infection | J. Virol. (2016) In press | 0 | |
426 194PR 214RT 426IN |
0 | Laboratory/experimental isolate |
| Lorenzin (2020) | Prevalence of Non-B HIV-1 Subtypes in North Italy and Analysis of Transmission Clusters Based on Sequence Data Analysis | Microorganisms 8 (1), 36 (2019) | 6.74e-170 | |
30 30PR 30RT |
0 | Case report(s) / study subset |
| Lorenzo-Redondo (2011) | Dynamics of in vitro fitness recovery of HIV-1 | J. Virol. 85 (4), 1861-1870 (2011) | 0 | |
12 12PR 12RT 12IN |
0 | Laboratory/experimental isolate |
| Lorenzo-Redondo (2016) | Persistent HIV-1 replication maintains the tissue reservoir during therapy | Nature 530 (7588), 51-56 (2016) | 5.02e-101 | |
1030 592PR 1030RT |
0 | Proviral DNA Reservoir |
| Loubet (2014) | Prevalence of HIV-1 Transmitted Drug Resistance in Liberia | AIDS Res. Hum. Retroviruses 30 (9), 863-866 (2014) | 0 | 211 109PR 102RT |
211 109PR 102RT |
100 | HIVDB |
| Low (2009) | Natural Genotypic Polymorphisms of the HIV-1 Integrase Gene and Associated Drug Susceptibilities to a Panel of Diverse Integrase Strand Transfer Inhibitors | Antimicrob Agents Chemother. 2009 | 1e-168 | 133 133IN |
133 133IN |
100 | HIVDB |
| Loxton (2004) | SEQUENCE Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986 | AIDS Res. Hum. Retroviruses 21 (5), 410-413 (2005) | 0 | |
4 4PR 4RT 4IN |
0 | Sequence quality |
| Lu (2025) | Direct Submission | Submitted (25-JAN-2025) Public Health, Hainan Medi | 2.92e-180 | |
36 36PR 36RT |
0 | Unpublished |
| Lu (2019) | Relationship between intact HIV-1 proviruses in circulating CD4(+) T cells and rebound viruses emerging during treatment interruption | Proc. Natl. Acad. Sci. U.S.A. 115 (48), E11341-E11 | 0 | |
1590 1590PR 1590RT 1590IN |
0 | SGS |
| Lu (2017) | HIV-1 genetic evolution and recombinant patterns among the newly diagnosed HIV-1 individuals in Hebei Province, China | Unpublished | 0 | |
20 20PR 14RT 4IN |
0 | Case report(s) / study subset |
| Lu (2021) | Genome mosaic structure of two novel HIV-1 recombinant forms (CRF01_AE/B) among the recently infected men who have sex with men in Hebei, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Lu (2022) | Novel recombinant forms | Unpublished | 0 | |
3 2PR 3RT 3IN |
0 | Case report(s) / study subset |
| Lu (2022) | Identification of two novel HIV-1 recombinant forms originated from CRF01_AE and subtype B in Hebei, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Lu (2023) | CRF01_AE/CRF07_BC recombinant forms | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Lu (2023) | Identification of a new HIV-1 recombinant forms (CRF68_01B/A1) among the recently infected men who have sex with men in Hebei, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lu (2023) | Identification of CRF01_AE/C recombinant forms | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lu (2023) | Near-full-length genome analysis of a HIV-1 CRF01_AE/B recombinant strain among men who have sex with men in Chengde City, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Lu (2015) | HIV-1 Genetic Diversity and Transmitted Drug Resistance Among Recently Infected Individuals at Men Who Have Sex with Men Sentinel Surveillance Points in Hebei Province, China | AIDS Res. Hum. Retroviruses 31 (10), 1038-1045 (20 | 0 | 48 48PR 48RT |
48 48PR 48RT |
100 | HIVDB |
| Lu (2016) | Surveillance of Transmitted Drug Resistance in HIV-1-Infected Youths Aged 16 to 25 Years, a Decade After Scale-up of Antiretroviral Therapy in Hebei, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 145 145PR 145RT 1IN |
145 145PR 145RT 1IN |
100 | HIVDB |
| Lu (2017) | Regional transmission pattern of HIV-1 Non-CRF01_AE strains circulating in Hebei province, China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 317 317PR 317RT |
317 317PR 317RT |
100 | HIVDB |
| Lu (2016) | Recombinant patterns of nine novel HIV-1 recombinant strains identified in Hebei province, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 9 9PR 9RT |
9 9PR 9RT |
100 | HIVDB |
| Lu (2023) | Changes of viral load, drug resistance, and CD4 cell count in HIV-1-infected patients receiving antiretroviral therapy in Hebei Province, China, 2003 - 2019 | AIDS Res Hum Retroviruses (2023) In press | 0 | |
115 105PR 115RT |
0 | Pending |
| Lu (2019) | Large transmission clusters of HIV-1 main genotypes among HIV-1 individuals before antiretroviral therapy in the Hebei province, China | AIDS Res. Hum. Retroviruses (2019) In press | 1.28e-177 | 138 138PR 138RT |
138 138PR 138RT |
100 | HIVDB |
| Luk (2008) | NEAR Full-Length Genome Characterization of an HIV Type 1 CRF25_cpx Strain from Cameroon | AIDS Res. Hum. Retroviruses 24 (10), 1309-1314 (2008) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Luk (2015) | Utility of Unbiased Next-Generation Sequencing for HIV Surveillance | 26599538 | 0 | 25 25PR 25RT 25IN |
34 33PR 34RT 34IN |
73 | HIVDB |
| Luk (2001) | NATURALLY Occurring Sequence Polymorphisms within HIV Type 1 Group O Protease | AIDS Res. Hum. Retroviruses 17 (16), 1555-1561 (2001) | 0.0000000005 | 28 28PR |
28 28PR |
100 | HIVDB |
| Luk (2007) | NEAR Full-Length Genome Characterization of Three Additional HIV Type 1 CRF13_cpx Strains from Cameroon | AIDS Res. Hum. Retroviruses 23 (2), 297-302 (2007) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Lukashov (2001) | SELECTION by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs | AIDS Res. Hum. Retroviruses 17 (9), 807-818 (2001) | 4e-96 | |
231 231RT |
0 | Quasispecies |
| Lukashov (2012) | Transmission of risk-group specific HIV-1 strains among Dutch drug users for over 20 years and their rapid replacement by non-specific strains after switching to low harm drug practices | 23117501 | 0 | |
317 317PR 317RT |
0 | ARV Rx and/or other data are N/A |
| Lunar (2013) | Short Communication: Prevalence of HIV Type 1 Transmitted Drug Resistance in Slovenia: 2005-2010 | AIDS Res. Hum. Retroviruses 29 (2), 343-349 (2013) | 6e-172 | 120 120PR 120RT |
120 120PR 120RT |
100 | HIVDB |
| Lunar (2014) | Prevalence of HIV-1 transmitted drug resistance among patients diagnosed in 2011-2012 in Slovenia | 25970253 | 1.32e-171 | 53 53PR 53RT |
53 53PR 53RT |
100 | HIVDB |
| Lunar (2017) | Sequence ambiguity determined from routine pol sequencing is a decent indicator of incident HIV infections: a nation-wide study | 30682549 | 1.83e-170 | 63 63PR 63RT |
63 63PR 63RT |
100 | HIVDB |
| Lunar (2017) | HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update | 29698470 | 5.85e-172 | 28 28PR 28RT |
28 28PR 28RT |
100 | HIVDB |
| Lunar (2020) | HIV-1 Unique Recombinant Forms Identified in Slovenia and Their Characterization by Near Full-Length Genome Sequencing | Viruses 12 (1), E63 (2020) | 0 | 14 14PR 14RT 13IN |
14 14PR 14RT 13IN |
100 | HIVDB |
| Lungu (2017) | Genome characterization of HIV-2 biological clones with divergent replication capacities | Unpublished | 0 | |
13 13PR 13RT 13IN |
0 | Case report(s) / study subset |
| Lunkuse (2025) | Diagnostic accuracy of next generation sequencing: Prevalence of HIV-1 drug resistance and associated factors among adults on integrase inhibitors with virologic failure | Unpublished | 0 | |
174 174IN |
0 | HIVDB |
| Luo (2009) | Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China | J. Acquir. Immune Defic. Syndr. 50 (1), 1-8 (2009) | 0 | 152 152PR 152RT |
152 152PR 152RT |
100 | HIVDB |
| Luo (2024) | Direct Submission | Submitted (04-APR-2024) School of Public Health, G | 0 | |
331 331PR 331RT |
0 | Unpublished |
| Luthuli (2023) | Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses | Virology 583, 14-26 (2023) | 0 | |
21 21PR 21RT 21IN |
0 | Pending |
| Luu (2012) | HIV-1 Coreceptor Tropism, CCR5 Genotype and Integrase Inhibitor Resistance Profiles in Vietnam - Implications for the Introduction of New Antiretroviral Regimens | AIDS Res. Hum. Retroviruses (2012) In press | 1e-163 | 54 54IN |
54 54IN |
100 | HIVDB |
| Luvai (2015) | Evaluation of antiretroviral therapy treatment failure in a cohort of HIV positive patients in Nairobi, Kenya | Unpublished | 4.72e-150 | |
52 52RT |
0 | ARV Rx and/or other data are N/A |
| Luz (2025) | Molecular characteristics and antiretroviral resistance of HIV-1 subtypes b and f vertically transmitted between mothers and children | Unpublished | 3.27e-180 | |
30 30PR 30RT |
0 | Pending |
| Lwembe (2016) | Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure | J. Med. Virol. 79 (7), 865-872 (2007) | 3.39e-153 | 212 212RT |
213 213RT |
99 | HIVDB |
| Lwembe (2011) | Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers | Unpublished | 0 | |
4 4RT 4IN |
0 | ARV Rx and/or other data are N/A |
| Ly (2007) | REVERSE transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV type 1 perinatal transmission | AIDS Res. Hum. Retroviruses 23 (12), 1563-1567 (2007) | 3.91e-162 | 134 134RT |
134 134RT |
100 | HIVDB |
| Ly (2005) | CHARACTERIZATION of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs | AIDS Res. Hum. Retroviruses 21 (11), 971-976 (2005) | 1e-142 | 280 136PR 144RT |
283 139PR 144RT |
98 | HIVDB |
| Ma (2024) | Identification of three a Novel HIV-1 Recombinant Form comprising CRF01_AE and C among men who have sex with men in Hebei province, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Ma (2012) | SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations. | PLoS Pathog. 2013 Jan;9(1):e1003011. | 2e-68 | |
89 89IN |
0 | Gene fragment(s) |
| Ma (2014) | Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild | J. Virol. 88 (10), 5687-5705 (2014) | 8e-109 | |
47 46RT 47IN |
0 | NHPL/SIV |
| Ma (2023) | Direct Submission | Submitted (25-AUG-2022) Center for Translational M | 0 | 222 222PR 222RT |
222 222PR 222RT |
100 | HIVDB |
| Ma (2023) | Assessment of consistency of drug resistance mutations in plasma and peripheral blood mononuclear cells in treatment-naive and treatment-experienced HIV-1 patients | 38179423 | 0 | 66 66PR 66RT |
66 66PR 66RT |
100 | HIVDB |
| Ma (2025) | Direct Submission | Submitted (24-APR-2025) Center for Translational M | 0 | |
149 149PR 149RT |
0 | Unpublished |
| Ma (2024) | Direct Submission | Submitted (17-JUN-2023) Shanghai Public Health Cli | 0 | 1515 1508PR 1515RT |
1515 1458PR 1515RT |
100 | HIVDB |
| Mabeya (2019) | Analyses of HIV-1 integrase sequences prior to roll out of integrase inhibitors by Kenyan national HIV-treatment program in Kisii County, Kenya | 32116431 | 1.79e-70 | |
33 33IN |
0 | Sequence quality |
| Mabeya (2019) | Prevalence of acquired HIV drug resistance among drug experienced patients in Kisii County, Kenya | Unpublished | 1.81e-162 | |
51 5PR 51RT |
0 | Unpublished |
| Machado Zaldivar (2011) | Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 153 153PR 153RT |
153 153PR 153RT |
100 | HIVDB |
| Machado (2002) | USE of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors | AIDS 16 (1), 113-119 (2002) | 1e-135 | 31 30PR 31RT |
31 30PR 31RT |
100 | HIVDB |
| Machado (2003) | GENOTYPIC resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy | J. Clin. Virol. 30 (1), 24-31 (2004) | 1e-110 | 149 74PR 75RT |
149 74PR 75RT |
100 | HIVDB |
| Machado (2004) | ALTERNATIVE, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy | Pediatr. Infect. Dis. J. 23 (11), 1057-1059 (2004) | 1e-108 | 11 8PR 3RT |
11 8PR 3RT |
100 | HIVDB |
| Machado (2004) | OVERVIEW of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil | An. Acad. Bras. Cienc. 76 (4), 727-741 (2004) | 1e-116 | 141 73PR 68RT |
141 73PR 68RT |
100 | HIVDB |
| Machado (2009) | Molecular epidemiology of HIV-1 in Northern Brazil: identification of subtypes C and D and the introduction of CRF02_AG in the Amazon Region of Brazil | Aids Research and Human Retrovirology 1 (1) (2009) | 7.97e-57 | 66 66PR |
71 71PR |
92 | HIVDB |
| Machado (2012) | HIV Type 1 Genetic Diversity in Newly Diagnosed Cuban Patients | AIDS Res. Hum. Retroviruses 28 (8), 956-960 (2012) | 5e-172 | 46 46PR 46RT |
47 47PR 47RT |
97 | HIVDB |
| Machado (2014) | Transmitted drug resistance from Cuban HIV-1 patients in 2012 | Unpublished | 0 | |
28 28PR 28RT |
0 | Case report(s) / study subset |
| Machado (2016) | Molecular epidemiology of Human immunodeficiency virus type 1 (HIV-1) from Northern Brazil | Unpublished | 6.1e-56 | |
10 10PR |
0 | ARV Rx and/or other data are N/A |
| Machado (2016) | Serological and molecular typing of HIV type 1 infection in the Tiriyo tribe, a native Indian community of the Amazon region of Brazil | AIDS Res. Hum. Retroviruses 22 (12), 1267-1270 (20 | 1.06e-53 | |
1 1PR |
0 | Case report(s) / study subset |
| Machado (2019) | National survey of pre-treatment HIV drug resistance in Cuban patients | 31479466 | 0 | 141 141PR 141RT |
141 141PR 141RT |
100 | HIVDB |
| Macharia (2018) | Transmitted HIV-1 Drug resistance and the Role of Herpes Simplex Virus-2 Coinfection among Fishermen along the Shores of Lake Victoria, Kisumu, Kenya | J HIV Retro Virus 2 (3), 26 (2016) | 6.37e-156 | 59 59RT |
59 59RT |
100 | HIVDB |
| Machuca (2004) | UNKNOWN co-receptor usage in HIV isolates from patients undergoing long-term antiretroviral therapy | Unpublished | 1e-114 | |
40 19PR 21RT |
0 | Case report(s) / study subset |
| Mack (2017) | Efficient Vpu-mediated tetherin antagonism by an HIV-1 group O strain | J. Virol. (2017) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Madsen (2006) | INTRODUCTION of HIV Type 1 into an Isolated Population: Molecular Epidemiologic Study from Greenland | AIDS Res. Hum. Retroviruses 23 (5), 675-681 (2007) | 0 | 75 75PR 75RT |
75 75PR 75RT |
100 | HIVDB |
| Madsen (2007) | REAPPEARANCE of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption | Scand. J. Infect. Dis. 40 (2), 174-182 (2008) | 0 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Madsen (2008) | SHORT communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naive patients in Greenland | AIDS Res. Hum. Retroviruses 24 (8), 1073-1077 (2008) | 0 | |
14 14PR 14RT |
0 | Case report(s) / study subset |
| Magiorkinis (2011) | Appearance of a Single Amino Acid Insertion at Position 33 in HIV Type 1 Protease Under a Lopinavir-Containing Regimen, Associated with Reduced Protease Inhibitor Susceptibility | AIDS Res. Hum. Retroviruses 27 (11), 1223-1229 (20 | 2e-57 | |
14 14PR |
0 | Pending |
| Magomere (2019) | Performance Characteristics of a Modified HIV-1 Drug Resistance Genotyping Method for use in Resource Limited Settings | 31656591 | 4.56e-165 | |
24 24PR 24RT |
0 | ARV Rx and/or other data are N/A |
| Mahalanabis (2001) | IMPROVED detection of HIV-1 drug resistance mutations by an oligoligase assay compared to consensus sequencing | 15297515 | 1e-128 | |
149 149PR 149RT |
0 | ARV Rx and/or other data are N/A |
| Mahasha (2014) | Differential Distribution and Evolution of HIV-1 RNA Variants in the Gastrointestinal Tract of Antiretroviral Naive African AIDS Patients with Diarrhea and (or) Weight Loss | Unpublished | 0 | |
45 45PR 45RT |
0 | ARV Rx and/or other data are N/A |
| Maia Teixeira (2006) | Trends in drug resistance mutations in antiretroviral-naive intravenous drug users of Rio de Janeiro. | J Med Virol | 7.72e-144 | 65 65PR 65RT |
65 65PR 65RT |
100 | HIVDB |
| Maier (1998) | MIXED reconstitution of mutated subunits of HIV-1 RT co-expressed in E. coli- two tags tie it up | Unpublished | 9e-94 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Maksimenko (2022) | Circulation of multiple HIV-1 unique recombinant forms A/B in Krasnoyarsk Region, Russia | Unpublished | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Maksimenko (2024) | Expanding HIV-1 diversity in Russia: novel circulating recombinant form between subtypes a6 and b (crf147_a6b) | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Makuwa (2011) | New strain of simian immunodeficiency virus identified in wild-born chimpanzees from central Africa. | PLoS One. 2012;7(9):e44298. | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Makwaga (2020) | Direct Submission | Submitted (01-JUL-2020) Research, KEMRI, P.O. Box | 1.78e-166 | 34 34PR 34RT |
37 37PR 37RT |
91 | HIVDB |
| Makwaga (2021) | Direct Submission | Submitted (01-SEP-2020) Research, KEMRI, P.O. Box | 8.88e-167 | 16 16PR 16RT |
17 17PR 17RT |
94 | HIVDB |
| Malboeuf (2012) | Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification | Nucleic Acids Res. (2012) In press | 0 | |
13 13PR 13RT 13IN |
0 | Case report(s) / study subset |
| Maldarelli (2013) | HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion | J. Virol. 87 (18), 10313-10323 (2013) | 0 | |
1387 1387PR 1387RT |
0 | SGS |
| Maldarelli (2016) | HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells | Science 345 (6193), 179-183 (2014) | 0 | |
206 206PR 206RT |
0 | Proviral DNA Reservoir |
| Malet (2009) | Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients | J. Antimicrob. Chemother. 63 (4), 795-804 (2009) | 1e-166 | 22 22IN |
22 22IN |
100 | HIVDB |
| Maljkovic (2003) | LIMITED Transmission of Drug-Resistant HIV Type 1 in 100 Swedish Newly Detected and Drug-Naive Patients Infected with Subtypes A, B, C, D, G, U, and CRF01_AE | AIDS Res. Hum. Retroviruses 19 (11), 989-997 (2003) | 0 | 100 100PR 100RT |
100 100PR 100RT |
100 | HIVDB |
| Mamadou (2003) | EMERGENCE of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa | AIDS Res. Hum. Retroviruses 19 (1), 77-82 (2003) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Mamatkulov (2017) | Monitoring of HIV drug resistance in Uzbekistan | Unpublished | 0 | 388 388PR 338RT |
388 388PR 338RT |
100 | HIVDB |
| Mampe (2022) | Direct Submission | Submitted (15-NOV-2021) Infectious Disease, Univer | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Manak (2011) | Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity | AIDS Res. Hum. Retroviruses (2011) In press | 0 | |
160 77PR 76RT 159IN |
0 | Pending |
| Manasa (2012) | Primary Drug Resistance in South Africa: Data from 10 Years of Surveys | AIDS Res. Hum. Retroviruses 28 (6), 558-565 (2012) | 0 | 71 71PR 71RT |
72 72PR 72RT |
98 | HIVDB |
| Manasa (2013) | High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa | PLoS ONE 8 (8), E72152 (2013) | 0 | 222 219PR 222RT |
222 220PR 222RT |
100 | HIVDB |
| Manasa (2018) | Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors | Sci Rep 7 (1), 11559 (2017) | 0 | 100 101PR 101RT |
101 101PR 101RT |
99 | HIVDB |
| Mandust (2024) | Direct Submission | Submitted (29-JAN-2024) Virology, Hamadan Universi | 1.94e-62 | |
44 44PR |
0 | Unpublished |
| Mani (2014) | Emergence of HIV-1 drug resistant variants in women following antiretroviral prophylaxis for the prevention of mother to child transmission of HIV | 25865972 | 0 | |
38 38PR 38RT |
0 | Pending |
| Manickam (2016) | Near full length HIV-1 genome sequences from India | Unpublished | 0 | |
10 10PR 10RT 10IN |
0 | Case report(s) / study subset |
| Manolescu (2016) | Resistance profile of HIV-1 subtype F1 heavily treated Romanian patients | 22180722 | 1.27e-144 | 27 27RT |
28 28RT |
96 | HIVDB |
| Manyana (2022) | Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings | 36759801 | 0 | |
170 85PR 85RT 85IN |
0 | Pending |
| Maponga (2025) | Looking for a needle in a haystack: Nanopore sequencing of a full-length Simian immunodeficiency virus (SIV) from a chacma baboon (Papio ursinus) | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Marconi (2008) | Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa | Clin. Infect. Dis. 46 (10), 1589-1597 (2008) | 1.69e-143 | 115 114PR 115RT |
115 114PR 115RT |
100 | HIVDB |
| Marechal (2006) | INCREASING HIV Type 1 Polymorphic Diversity But No Resistance to Antiretroviral Drugs in Untreated Patients from Central African Republic: A 2005 Study | AIDS Res. Hum. Retroviruses 22 (10), 1036-1044 (2006) | 1.07e-148 | 170 96PR 74RT |
170 96PR 74RT |
100 | HIVDB |
| Margot (2010) | Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat | Antimicrob. Agents Chemother. 54 (6), 2345-2353 (2 | 1.76e-56 | 31 31PR |
31 31PR |
100 | HIVDB |
| Margot (2019) | Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naive individuals | J. Med. Virol. (2019) In press | 0 | 1819 1819IN |
1819 1819IN |
100 | HIVDB |
| Marjani (2019) | HIV-1 Integrase Mutations for Drug-Resistance Surveillance in Iranian Treatment Experienced HIV-infected Patients | 31741096 | 0 | 62 62IN |
62 13RT 62IN |
100 | HIVDB |
| Markham (2007) | RELATIONSHIP of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 Pol Gene | 19214121 | 2.87e-159 | |
1100 1100PR 1100RT |
0 | Pending |
| Markowitz (2018) | Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis | J. Acquir. Immune Defic. Syndr. 76 (4), e104-e106 | 0 | |
26 9PR 12RT 5IN |
0 | Case report(s) / study subset |
| Marques (2018) | Potential overestimation of HIV-1 sub-subtype F1 circulation in Rio de Janeiro, Brazil | Mem. Inst. Oswaldo Cruz 113 (8), e170483 (2018) | 0 | |
79 42PR 42RT 48IN |
0 | Pending |
| Martin (2021) | Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes | J Infect Dis (2021) In press | 7.64e-117 | |
331 331RT |
0 | Proviral DNA Reservoir |
| Martin (2014) | Early immune adaptation in HIV-1 revealed by population-level approaches | Retrovirology 11 (1), 64 (2014) | 0 | 242 116PR 116RT 126IN |
242 116PR 116RT 126IN |
100 | HIVDB |
| Martin (2018) | Coevolved multidrug-resistant HIV-1 protease and reverse transcriptase influences integrase drug susceptibility and replication fitness | 34578103 | 0 | |
179 179PR 179RT 179IN |
0 | Case report(s) / study subset |
| Martin (2016) | A microarray-based genotyping platform for the identification of drug-resistance mutations in majority and minority subpopulations of HIV-1 quasispecies | 27959928 | 0 | |
2270 1172PR 1109RT |
0 | Quasispecies |
| Martinez (1999) | HUMAN immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia | Virology 256 (2), 180-187 (1999) | 9e-94 | |
60 60RT |
0 | Proviral DNA Reservoir |
| Martinez-Cajas (2012) | The Role of Polymorphisms at Position 89 in the HIV-1 Protease Gene on the Development of Drug Resistance to HIV-1 Protease Inhibitors | J Antimicrob Chemother. 2012 Apr | 0 | |
3 3PR 3RT |
0 | HIVDB |
| Martinez-Picado (2000) | ANTIRETROVIRAL resistance during successful therapy of HIV type 1 infection | Proc. Natl. Acad. Sci. U.S.A. 97 (20), 10948-10953 (2000) | 0 | |
137 120PR 133RT |
0 | Quasispecies |
| Martins (2016) | High level of resistance mutations to protease inhibitors in proviral DNA of HIV-2 infected patients in Portugal | Unpublished | 1.68e-31 | 180 180PR |
180 180PR |
100 | HIVDB |
| Martinson (2008) | Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. | JAIDS | 0 | 64 64PR 64RT |
64 64PR 64RT |
100 | HIVDB |
| Maruapula (2020) | Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naive HIV-1 Subtype C-infected patients in Botswana | Unpublished | 0 | 101 91PR 94RT |
103 94PR 103RT |
98 | HIVDB |
| Maruapula (2021) | Low-frequency HIV-1 drug resistance mutations in antiretroviral naive individuals in Botswana | Unpublished | 0 | 90 90PR 90RT |
90 90PR 90RT |
100 | HIVDB |
| Marx (1991) | ISOLATION of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey | J. Virol. 65 (8), 4480-4485 (1991) | 3e-84 | |
1 1RT 1IN |
0 | NHPL/SIV |
| Marzinke (2023) | Extended characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083 | 36995219 | 0 | 52 52IN |
52 52IN |
100 | HIVDB |
| Marzinke (2025) | Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 | J Infect Dis 224 (9), 1581-1592 (2021) | 0 | 63 63PR 63RT 63IN |
63 63PR 63RT 63IN |
100 | HIVDB |
| Marzinke (2025) | Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 | Antimicrob Agents Chemother (Bethesda) 67 (4), e00 | 0 | 59 59PR 59RT 59IN |
59 59PR 59RT 59IN |
100 | HIVDB |
| Mas (1999) | Report of the first 2 cases of HIV-1 group O infection in Spain. | Med Clin (Barc). 1996 Oct 5;107(11):418-21. | 0.000000000005 | |
5 5RT |
0 | Case report(s) / study subset |
| Mas (2001) | Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance | EMBO J. 19 (21), 5752-5761 (2000) | 0 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Masciotra (2000) | EVIDENCE of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina | AIDS Res. Hum. Retroviruses 16 (10), 1007-1014 (2000) | 1e-128 | 42 42PR |
42 42PR |
100 | HIVDB |
| Masciotra (2002) | DETECTION of Simian Immunodeficiency Virus in Diverse Species and of Human Immunodeficiency Virus Type 2 by Using Consensus Primers within the pol Region | J. Clin. Microbiol. 40 (9), 3167-3171 (2002) | 8e-80 | |
26 26IN |
0 | Gene fragment(s) |
| Masciotra (2007) | HIGH Concordance between HIV-1 Drug Resistance Genotypes Generated from Plasma and Dried Blood Spots in Treated Persons | 18025887 | 0 | |
66 66PR 66RT |
0 | Pending |
| Masharsky (2002) | MOLECULAR cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union | AIDS Res. Hum. Retroviruses 19 (10), 933-939 (2003) | 1e-163 | 2 2PR 2RT 2IN |
15 8PR 15RT 9IN |
13 | HIVDB |
| Masimba (2013) | Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural Tanzania. | AIDS Res Hum Retroviruses. 2013 Sep;29(9):1229-36. | 0 | 226 13PR 226RT |
226 13PR 226RT |
100 | HIVDB |
| Maslin (2005) | ANTIRETROVIRAL Drug Resistance Among Drug-Naive HIV-1 Infected Patients in Djibouti (Horn of Africa) | AIDS (2005) In press | 8.94e-56 | |
25 25PR 8RT |
0 | Case report(s) / study subset |
| Maslin (2016) | Epidemiology and Genetic Characterization of HIV-1 Isolates in the General Population of Djibouti (Horn of Africa) | J. Acquir. Immune Defic. Syndr. 39 (2), 129-132 (2 | 4.19e-139 | |
34 34RT |
0 | Gene fragment(s) |
| Mason (2016) | Targeted Isolation of Antibodies Directed against Major Sites of SIV env Vulnerability | PLoS Pathog. 12 (4), E1005537 (2016) | 0 | |
5 5PR 5RT 5IN |
0 | NHPL/SIV |
| Masoud (2020) | Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring | Unpublished | 0 | 159 159IN |
159 159IN |
100 | HIVDB |
| Masquelier (1999) | ZIDOVUDINE resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study | Antivir. Ther. (Lond.) 4 (2), 69-77 (1999) | 2e-91 | 48 48RT |
50 50RT |
96 | HIVDB |
| Masquelier (2000) | GENOTYPIC and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors | Antimicrob. Agents Chemother. 45 (6), 1836-1842 (2001) | 1e-123 | 48 48RT |
197 79PR 118RT |
24 | HIVDB |
| Masquelier (2001) | ZIDOVUDINE genotypic resistance in HIV-1-infected newborns in the French perinatal cohort | J. Acquir. Immune Defic. Syndr. 27 (2), 99-104 (2001) | 9e-94 | |
34 34RT |
0 | ARV Rx and/or other data are N/A |
| Masquelier (2002) | MECHANISMS of Early Virologic Failure in Antiretroviral-Naive Patients Starting Protease Inhibitor-Containing Regimens: The APROVIR Study | J. Infect. Dis. 186 (10), 1503-1507 (2002) | 1e-122 | 47 24PR 23RT |
47 24PR 24RT |
100 | HIVDB |
| Massanella (2024) | Inducibility and distribution of HIV proviruses in early treated Thai children on suppressive ART | Unpublished | 0 | |
626 596PR 596RT 443IN |
0 | Unpublished |
| Massanella (2025) | Inducibility and distribution of HIV proviruses in early treated Thai children on suppressive ART | Unpublished | 0 | |
137 132PR 123RT 78IN |
0 | Unpublished |
| Masyeni (2018) | Clinical and genotypic characteristics of Human immunodeficiency virus type 1 isolated in Bali, Indonesia | Unpublished | 1.09e-176 | 68 31PR 37RT |
68 31PR 37RT |
100 | HIVDB |
| Matsuda (2014) | An HIV-1 Transmission Case Possibly Associated with Manicure Care | AIDS Res. Hum. Retroviruses 30 (11), 1150-1153 (20 | 1.77e-110 | |
33 33PR 33RT |
0 | Case report(s) / study subset |
| Matsuda (2017) | Unrecognized acute HIV infection identified through RNA testing of pooled serum obtained during dengue outbreak in Sao Paulo, Brazil | Unpublished | 6.4e-169 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Matsuda (2017) | High prevalence of drug resistance mutations among patients failing first-line antiretroviral therapy and predictors of virological response 24 weeks after switch to second-line therapy in Sao Paulo State, Brazil | AIDS Res. Hum. Retroviruses (2017) In press | 1.36e-159 | 320 319PR 320RT |
320 319PR 320RT |
100 | HIVDB |
| Matsuda (2017) | SIVsm804E-CL757 molecular clone sequence | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Matsuoka (2011) | Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type | Retrovirology 6, 21 (2009) | 1.23e-55 | |
3 3PR |
0 | Laboratory/experimental isolate |
| Matsuoka-Aizawa (2003) | ISOLATION and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication | J. Virol. 77 (1), 318-327 (2003) | 1e-108 | |
4 4PR |
0 | Case report(s) / study subset |
| Matteoli (2009) | Direct Submission | Submitted (27-MAY-2009) Department of Experimental | 0 | |
34 21PR 21RT |
0 | ARV Rx and/or other data are N/A |
| Matthews (2008) | CENTRAL role of reverting mutations in HLA associations with human immunodeficiency virus set point | J. Virol. 82 (17), 8548-8559 (2008) | 0 | 461 406PR 428RT 268IN |
461 408PR 460RT 276IN |
100 | HIVDB |
| Matthews (2016) | Adaptation of HIV-1 to HLA I | Unpublished | 0.001 | |
1 1PR |
0 | Gene fragment(s) |
| Maureen (2018) | Selective resistance profiles emerging in patient-derived clinical isolates passaged in cabotegravir, bictegravir, dolutegravir and elvitegravir | 30119633 | 0 | 8 8IN |
10 10IN |
80 | HIVDB |
| Maureen (2018) | Ex vivo selected resistance to newer integrase inhibitors by b & non-b subtype viruses | 30119633 | 0 | 5 5IN |
6 6IN |
83 | HIVDB |
| Mayers (1993) | CHARACTERIZATION of HIV isolates arising after prolonged zidovudine therapy | J. Acquir. Immune Defic. Syndr. 5 (8), 749-759 (1992) | 2e-60 | |
9 9RT |
0 | Case report(s) / study subset |
| Mayini (2025) | HIV-1 Drug Resistance Patterns and Factors Associated with Major PI Drug Resistance Mutations among People Failing Second-Line PI-Based ART in Zimbabwe | Unpublished | 8.25e-177 | |
297 297PR 297RT |
0 | Unpublished |
| Mbisa (2011) | Identification of mutations in all domains of non-B subtype HIV-1 reverse transcriptase linked to the development of Q151M multi-drug resistance: implications for drug susceptibility and replicative fitness | 21569325 | 0 | |
145 145PR 145RT |
0 | Quasispecies |
| Mbisa (2012) | Phylodynamic and Phylogeographic Patterns of the HIV-1 Subtype F1 Parenteral Epidemic in Romania | AIDS Res. Hum. Retroviruses (2012) In press | 1e-176 | |
58 58PR 58RT |
0 | ARV Rx and/or other data are N/A |
| Mbisa (2018) | Determining the source of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction | 30534981 | 0 | |
80 80PR 80RT |
0 | Case report(s) / study subset |
| Mbisa (2020) | Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK | 32728703 | 0 | 962 619PR 619RT 652IN |
962 619PR 619RT 652IN |
100 | HIVDB |
| Mboudjeka (1999) | THE pol and env-based phylogenetic analysis of HIV-1 among the Muslim in the northern part of Cameroon | Unpublished | 6e-43 | |
1 1IN |
0 | Gene fragment(s) |
| Mboudjeka (2000) | GENETIC diversity of HIV-1 group M from Cameroon and Republic of Congo | Arch. Virol. 144 (12), 2291-2311 (1999) | 1e-48 | |
35 35IN |
0 | Gene fragment(s) |
| Mboumba Bouassa (2016) | High levels of virological failure with major genotypic rsitance mutations in HIV-1-infected chilidren after 5 years of WHO-recommended first-line and second line antiretroviral regimens in the Central African Republic: a cross-sectional study | 28272247 | 0 | 48 36PR 48RT |
159 159PR 159RT |
30 | HIVDB |
| McCarthy (2016) | Phylogeny and History of the Lost SIV from Crab-Eating Macaques: SIVmfa | PLoS ONE 11 (7), E0159281 (2016) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Mccluskey (2021) | Direct Submission | Submitted (07-DEC-2020) Department of Medicine, Di | 0 | 184 184IN |
184 184IN |
100 | HIVDB |
| McClutchan (2003) | PRECISE mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China | AIDS Res. Hum. Retroviruses 18 (15), 1135-1140 (2002) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| McConnell (2007) | MOLECULAR epidemiology of HIV type 1 in newly diagnosed patients in southern Spain | AIDS Res. Hum. Retroviruses 24 (6), 881-887 (2008) | 3.23e-149 | 72 72PR 72RT |
72 72PR 72RT |
100 | HIVDB |
| McCormick (2020) | Discordance between Etravirine Phenotype and Genotype-based Predicted Phenotype for Subtype C HIV-1 from First-line Antiretroviral Therapy Failures in South Africa | Antimicrob. Agents Chemother. (2020) In press | 0 | 112 112RT |
112 112RT |
100 | HIVDB |
| McCutchan (2003) | HIV Type 1 Circulating Recombinant Form CRF09_cpx from West Africa Combines Subtypes A, F, G, and May Share Ancestors with CRF02_AG and Z321 | AIDS Res. Hum. Retroviruses 20 (8), 819-826 (2004) | 1e-165 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| McCutchan (2005) | IN-DEPTH analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection | J. Virol. 79 (18), 11693-11704 (2005) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| McFaul (2016) | Direct Submission | Submitted (31-OCT-2016) Centre for Immunology and | 1.44e-25 | |
1 1IN |
0 | Gene fragment(s) |
| McInally (2025) | Comparison of viral phenotype and inflammatory biomarker responses in HIV-1 acute subtype A and C infections | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report (Small sample size) |
| McIntosh (2000) | NUCLEOTIDE sequence of a Cambridge isolate of human immunodeficiency virus type 1 | Unpublished | 1e-163 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| McLaughlin (2004) | SEQUENCE Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network | Unpublished | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| McManus (2019) | HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy | J. Clin. Invest. 130, 126714 (2019) | 0 | |
3334 3120PR 3120RT 214IN |
0 | Pending |
| McNulty (2006) | EVALUATION of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing | J. Clin. Microbiol. 45 (2), 517-521 (2007) | 5.44e-151 | 48 48PR 48RT |
48 48PR 48RT |
100 | HIVDB |
| Medrano (1999) | SEQUENCE analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands | Virus Genes 18 (3), 203-210 (1999) | 1e-161 | |
69 69RT |
0 | Quasispecies |
| Meeme (2013) | Drug resistance mutations among antiretroviral-treated female sex workers in Nairobi, Kenya | Afr J Health Sci 26, 291-301 (2013) | 3.5e-151 | 60 60RT |
60 60RT |
100 | HIVDB |
| Meersseman (2006) | FATAL brain necrosis in primary HIV infection | Lancet 366 (9488), 866 (2005) | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Megasari (2019) | Genotypic Characterization of Human Immunodeficiency Virus Type 1 Isolated from Antiretroviral Treatment-Experienced Individuals in Buleleng Regency, Bali, Indonesia | AIDS Res. Hum. Retroviruses (2019) In press | 0 | 83 43PR 40RT |
83 43PR 40RT |
100 | HIVDB |
| Megasari (2019) | The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia | Acta Med Indones 51 (3), 197-204 (2019) | 0 | 58 28PR 30RT |
58 28PR 30RT |
100 | HIVDB |
| Megens (2014) | Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits | Virology 456-457, 310-318 (2014) | 0 | |
6 6PR 6RT 2IN |
0 | Case report(s) / study subset |
| Mehta (2016) | The Relatedness of HIV Epidemics in the United States-Mexico Border Region | AIDS Res. Hum. Retroviruses 26 (12), 1273-1277 (20 | 1.41e-114 | |
25 25RT |
0 | Case report(s) / study subset |
| Meini (2014) | Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania | AIDS Res. Hum. Retroviruses 31 (4), 448-451 (2015) | 1.08e-172 | 81 81PR 79RT |
81 81PR 79RT |
100 | HIVDB |
| Meixenberger (2014) | Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker to identify recent infections in HIV-1 incidence studies | J. Clin. Microbiol. 52 (8) (2014) In press | 0 | 2203 2203PR 2203RT |
2203 2203PR 2203RT |
100 | HIVDB |
| Meixenberger (2016) | Molecular evolution of the HIV-1 integrase at population level in Germany during 1986-2006 prior to the approval of integrase inhibitors | 25397491 | 0 | 337 337IN |
337 337IN |
100 | HIVDB |
| Meixenberger (2018) | Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort | 30650082 | 0 | 2052 2052PR 2052RT |
2052 2052PR 2052RT |
100 | HIVDB |
| Mekue (2014) | Performance of ViroSeq sequencing primers for HIV 1 subtypes | Unpublished | 0 | |
37 37PR 37RT |
0 | Case report(s) / study subset |
| Melo (2012) | Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil. | AIDS Res Hum Retroviruses. 2012 Sep;28(9):1082-8. | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Meloni (2004) | DISTINCT Human Immunodeficiency Virus Type 1 Subtype A Virus Circulating in West Africa: Sub-Subtype A3 | J. Virol. 78 (22), 12438-12445 (2004) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Memarnejadian (2014) | Characterization of Integrase Region Polymorphisms in HIV-1 CRF35_AD Viruses from Treatment-Naive Patients | 25962088 | 0 | 6 6PR 6RT |
65 6PR 6RT 59IN |
9 | HIVDB |
| Memarnejadian (2015) | Transmitted Drug Resistance Mutations in Antiretroviral-Naive Injection Drug Users with Chronic HIV-1 Infection in Iran | PLoS ONE 10 (5), E0126955 (2015) | 2.91e-167 | 34 34PR 34RT |
34 34PR 34RT |
100 | HIVDB |
| Mendes Da Silva (2021) | Genetic Characterization of a New HIV-1 Sub-Subtype A in Cabo Verde, Denominated A8 | Viruses 13 (6), 1093 (2021) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Mendez Ortega (2011) | An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1 | Virol. J. 7 (1), 369 (2010) | 6.89e-150 | |
35 35PR 35RT |
0 | Quasispecies |
| Mendoza (2020) | Antigen responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir | J. Exp. Med. (2020) In press | 0 | |
1643 1633PR 1621RT 1143IN |
0 | Proviral DNA Reservoir |
| Mendoza (2014) | Molecular Epidemiology of HIV-1 in Panama: Origin of Non-B Subtypes in Samples Collected from 2007 to 2013 | PLoS ONE 9 (1), E85153 (2014) | 2.88e-171 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Mendoza (2016) | Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven by Dissemination of Country-Specific Clades | PLoS ONE 9 (4), E95360 (2014) | 2.22e-174 | 630 630PR 630RT |
648 648PR 648RT |
97 | HIVDB |
| Meng (2008) | CONSTRUCTION and Characterization of an Infectious Molecular Clone of HIV Type 1 CRF07_BC | AIDS Res. Hum. Retroviruses 24 (2), 259-264 (2008) | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Meng (2007) | GENETIC Characterization of Three Newly Isolated CRF07_BC Near Full-Length Genomes in China | AIDS Res. Hum. Retroviruses 23 (8), 1049-1054 (2007) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Meng (2012) | Five new CRF07_BC near full-length sequences isolated from Sichuan, China | 22931113 | 0 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Mens (2022) | Direct Submission | Submitted (31-MAY-2022) Virus & Microbiological Sp | 0 | 2 1PR 1RT 1IN |
2 1PR 1RT 1IN |
100 | HIVDB |
| Mens (2022) | Emergence of the G118R pan-integrase resistance mutation as a result of low compliance to a dolutegravir based cART | Unpublished | 0 | 2 1PR 1RT 1IN |
2 1PR 1RT 1IN |
100 | HIVDB |
| Mens (2011) | HIV-1 Continues to Replicate and Evolve in Patients with Natural Control of HIV infection | J. Virol. (2010) In press | 6.16e-163 | |
189 189PR 189RT |
0 | Quasispecies |
| Merati (2022) | Prevalence of HIV Infection and Resistance Mutations in Patients Hospitalized for Febrile Illness in Indonesia | Am J Trop Med Hyg 105 (4), 960-965 (2021) | 0 | 30 30RT |
30 30RT |
100 | HIVDB |
| Metsky (2019) | Capturing diverse microbial sequence with comprehensive and scalable probe design | Unpublished | 0 | |
2 1PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Metzker (2002) | MOLECULAR Evidence of HIV-1 Transmission in a Criminal Case | Proc. Natl. Acad. Sci. U.S.A. 99, 14292-14297 (2002) | 9e-94 | |
42 8PR 42RT |
0 | Case report(s) / study subset |
| Mezei (2011) | Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV-1 infected, untreated patients in Hungary | AIDS Res. Hum. Retroviruses (2011) In press | 4e-170 | 59 29PR 30RT |
60 30PR 34RT |
98 | HIVDB |
| Miao (2018) | Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF01_AE/B'/C (CRF96_cpx), in Yunnan, China | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Miao (2010) | Sequence and characterization of full-length genome of two HIV-1 strains isolated from two infected patients in China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Micek (2015) | Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique | J. Infect. Dis. 210 (4), 641-645 (2014) | 1.35e-148 | |
33 33RT |
0 | Case report(s) / study subset |
| Michael (1995) | DEFECTIVE accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus | J. Virol. 69 (7), 4228-4236 (1995) | 1e-16 | |
22 22IN |
0 | Gene fragment(s) |
| Middleton (2002) | EVIDENCE for transmission of two different circular recombinant form-AE strains in HIV intravenous users in Australia | Unpublished | 7.89e-158 | |
24 24PR 24RT |
0 | Case report(s) / study subset |
| Mikasi (2019) | HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms among Integrase strand transfer Inhibitor-Naive HIV-1 Patients from Cameroon | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 41 41IN |
44 44IN |
93 | HIVDB |
| Mikasi (2020) | Investigation of the HIV-1 diversity in the Cape Wine-lands district of the Western Cape Province of South Africa | Unpublished | 3.85e-147 | 73 73IN |
73 73IN |
100 | HIVDB |
| Mikhail (2006) | FULL length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort | 15989463 | 0 | |
34 34PR 34RT 34IN |
0 | Case report(s) / study subset |
| Milazzo (2000) | EVIDENCE of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 22 (1), 101 | 4e-96 | 40 40RT |
40 40RT |
100 | HIVDB |
| Milne (2019) | Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women | AIDS (2019) In press | 1.85e-177 | 170 3PR 170RT |
177 7PR 177RT |
96 | HIVDB |
| Mintsa-Ndong (2008) | High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa | AIDS Res. Hum. Retroviruses 25 (4), 411-418 (2009) | 3.24e-176 | 17 16PR 15RT |
17 16PR 15RT |
100 | HIVDB |
| Miri (2011) | Characterization of Protease Resistance-Associated Mutations in HIV Type 1 Drug-Naive Patients Following the Increasing Prevalence of the CRF02_AG Strain in Morocco | AIDS Res. Hum. Retroviruses 28 (6), 571-577 (2012) | 1e-60 | 162 162PR |
162 162PR |
100 | HIVDB |
| Misbah (2013) | Direct Submission | Submitted (19-AUG-2013) Biotechnology, Jamia Milli | 9e-54 | |
105 105IN |
0 | Gene fragment(s) |
| Misbah (2013) | Evaluation of mutation profile of protease gene in confirmed HIV-1 infected patients Presenting with antiretroviral drug resistance | Unpublished | 2e-60 | 90 90PR |
90 90PR 90RT |
100 | HIVDB |
| Misbah (2013) | Genetic Diversity in reverse transcriptase gene from HIV-1 naive and ART non-responsding patients | 26801790 | 2.83e-152 | 64 64RT |
67 67RT |
95 | HIVDB |
| Misbah (2014) | Genetic Diversity in reverse transcriptase gene of HIV-1 from ART patients | 26801790 | 1.62e-151 | 38 38RT |
38 38RT |
100 | HIVDB |
| Mitsuya (2006) | N88D Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug Resistance in HIV Type 1 Protease following Nelfinavir Treatment Failure | AIDS Res. Hum. Retroviruses 22 (12), 1300-1305 (2006) | 4e-58 | 25 25PR |
27 27PR |
92 | HIVDB |
| Miura (2004) | Increased Virus Replication and Cytotoxicity of Non-pathogenic Simian Human Immuno Deficiency Viruses-NM-3rN After Serial Passage in a Monkey-Derived Cell Line. | Ann Med Health Sci Res. 2013 Jan;3(1):55-61. | 0 | |
1 1RT 1IN |
0 | Laboratory/experimental isolate |
| Miura (2010) | Impaired fitness of acute/early viruses in persons who become HIV controllers | J Virol. 2010 Aug;84(15):7581-91. Epub 2010 May 26. | 0 | |
23 23PR 23RT 23IN |
0 | Case report(s) / study subset |
| Miura (2010) | Long-term successful control of super-multi-drug resistant HIV-1 by a combination therapy of Lamivdine, Raltegravir, boosted-Darunavir and Etravirin | 20585968 | 1e-152 | |
7 4PR 3RT |
0 | Case report(s) / study subset |
| Miura (2011) | Coordinately linked sites in HIV evolution reveal regions of immunologic vulnerability | 21690407 | 0.0000000158 | |
1 1PR |
0 | Gene fragment(s) |
| Miura (2008) | GENETIC characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes | J. Virol. 82 (17), 8422-8430 (2008) | 0 | 121 41PR 41RT 39IN |
151 41PR 41RT 69IN |
80 | HIVDB |
| Miura (2008) | HLA-ASSOCIATED Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 | J. Virol. 83 (1), 140-149 (2009) | 1e-52 | |
32 32PR |
0 | Case report(s) / study subset |
| Mlakar (2014) | Molecular epidemiology of non-B HIV-1 subtypes in Slovenia | 29698470 | 0 | 39 39PR 39RT |
109 109PR 109RT |
35 | HIVDB |
| Mochizuki (1999) | AN infectious DNA clone of HIV type 1 subtype C | AIDS Res. Hum. Retroviruses 15 (14), 1321-1324 (1999) | 1e-165 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Modise (2018) | Human immunodeficiency virus type 1 (HIV-1) genotyping in Mahikeng, South Africa: assessing antiretroviral drug-resistance associated mutations in an HIV type-1 infected pregnant women cohort | Unpublished | 9.25e-174 | |
7 7PR 7RT |
0 | Unpublished |
| Mohammadi (2024) | Viral and host mediators of non-suppressible HIV-1 viremia | Nat Med 29 (12), 3212-3223 (2023) | 0 | |
714 711PR 714RT 672IN |
0 | Proviral DNA Reservoir |
| Mohammadikhah (2024) | Direct Submission | Submitted (01-SEP-2024) Medical Virology, Ahwaz Ju | 8.2e-156 | |
58 20PR 38RT |
0 | Unpublished |
| Mohammadikhah (2024) | Direct Submission | Submitted (06-OCT-2024) Medical Virology, Ahwaz Ju | 0 | |
15 10PR 5IN |
0 | Unpublished |
| Mohd Zain (2015) | Drug resistance mutations among virological failure HIV-1 infected patients in Malaysia | Unpublished | 0 | 100 100PR 100RT |
100 100PR 100RT |
100 | HIVDB |
| Mohd Zain (2016) | Drug Resistance Mutations among HIV-1 Naive Patients in Malaysia | 28107870 | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Mohri (2015) | The Viral Envelope is a Major Determinant of Enhanced Fitness of a Multidrug-Resistant HIV-1 Variant | J. Acquir. Immune Defic. Syndr. (2015) In press | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Moisan (2019) | In vivo emergence of an HIV-1/MO recombinant revealed undiagnosed HIV-1/M+O co-infection | Clin. Microbiol. Infect. (2020) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Mokgethi (2023) | High Prevalence of Pre-treatment and Acquired HIV-1 Drug Resistance Mutations Among Non-Citizens Living with HIV In Botswana | 38476948 | 0 | 37 37PR 37RT |
37 37PR 37RT |
100 | HIVDB |
| Mokili (2002) | IDENTIFICATION of a novel clade of human immunodeficiency virus type 1 in democratic republic of congo | AIDS Res. Hum. Retroviruses 18 (11), 817-823 (2002) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Molla (2021) | Direct Submission | Submitted (21-DEC-2020) Department of Virology, Ba | 4.92e-117 | |
30 30RT |
0 | Unpublished |
| Monie (2005) | A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+ T Cells of Viremic Patients | 15795302 | 2.42e-141 | |
415 331PR 348RT |
0 | Proviral DNA Reservoir |
| Monleau (2012) | Drug resistance mutations of HIV-1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-Saharan countries and discordant interpretations | AIDS Res. Hum. Retroviruses (2012) In press | 1e-164 | 97 97IN |
97 97IN |
100 | HIVDB |
| Monleau (2013) | Antiretroviral drug resistance in HIV-1 infected patients receiving antiretroviral treatment in routine clinics in Cotonou, Benin | J AIDS HIV Res 3 (6), 114-120 (2011) | 0 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Monno (2003) | MUTATIONAL patterns of paired blood and rectal biopsies in HIV-infected patients on HAART | J. Med. Virol. 70 (1), 1-9 (2003) | 1e-178 | 17 17PR 17RT |
32 30PR 32RT |
53 | HIVDB |
| Monno (2003) | HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy | J. Med. Virol. 75 (4), 483-490 (2005) | 0 | 44 43PR 44RT |
60 59PR 60RT |
73 | HIVDB |
| Monno (2007) | A multidrug-resistant (MDR) HIV-1 infection in a homosexual man and identified source patient | 17961118 | 1e-177 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Monno (2012) | An outbreak of HIV-1 BC recombinants in Southern Italy | 22981618 | 0 | |
22 22PR 22RT |
0 | Case report(s) / study subset |
| Montavon (2000) | MOST env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG | J. Acquir. Immune Defic. Syndr. 23 (5), 363-374 (2000) | 0 | 13 13PR 13RT 3IN |
13 13PR 13RT 3IN |
100 | HIVDB |
| Montavon (2001) | CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. | J. Acquir. Immune Defic. Syndr. 2002 Apr 15;29(5):522-30. | 1e-165 | 2 2PR 2RT 2IN |
9 9PR 9RT 2IN |
22 | HIVDB |
| Montavon (2001) | THE identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries | AIDS Res. Hum. Retroviruses 15 (18), 1707-1712 (1999) | 0 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Montavon (2002) | IDENTIFICATION of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa | AIDS Res. Hum. Retroviruses 18 (3), 231-236 (2002) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Monteiro-Cunha (2016) | Lack of High-Level Resistance Mutations in HIV Type 1 BF Recombinant Strains Circulating in Northeast Brazil | AIDS Res. Hum. Retroviruses 27 (6), 623-631 (2011) | 1.87e-142 | 58 58PR 58RT |
58 58PR 58RT |
100 | HIVDB |
| Monteiro-Cunha (2017) | Significant difference of transmitted drug resistance prevalence found among an HIV-1 infected population in Northeast Brazil based on the calibrated population resistance tool and the Stanford algorithm | 28591401 | 3.26e-143 | 97 97PR 97RT |
97 97PR 97RT |
100 | HIVDB |
| Montes (2003) | COMPARISON of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B | J. Acquir. Immune Defic. Syndr. 35 (4), 329-336 (2004) | 1e-149 | 184 153PR 184RT |
186 155PR 186RT |
98 | HIVDB |
| Moore (2006) | EVIDENCE of HIV-1 adaptation to HLA-restricted immune responses at a population level | Science 296 (5572), 1439-1443 (2002) | 1.66e-150 | |
473 473RT |
0 | Case report(s) / study subset |
| Moore (2024) | Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase | 38727213 | 0 | |
380 190PR 190RT 190IN |
0 | Pending |
| Moore (2025) | Viral suppression with dolutegravir-based HIV treatment in a person with transmitted dolutegravir resistance and pre-treatment resistance to lamivudine: a case report from HPTN 083 | Unpublished | 0 | |
72 1PR 1RT 71IN |
0 | Case report (Small sample size) |
| Moorthy (2009) | Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants | PLoS ONE 4 (1), E4096 (2009) | 1.08e-167 | |
4063 4063RT |
0 | Quasispecies |
| Moranguinho (2019) | Genotypic resistance profiles of HIV-2 infected patients in Cape Verde failing first-line antiretroviral therapy | Unpublished | 5.37e-123 | 23 23PR 23RT |
23 23PR 23RT |
100 | HIVDB |
| Morcilla (2021) | HIV-1 Genomes Are Enriched in Memory CD4(+) T-Cells with Short Half-Lives | mBio, e0244721 (2021) In press | 0 | |
366 355PR 353RT 269IN |
0 | Proviral DNA Reservoir |
| Moreno (2024) | Direct Submission | Submitted (25-OCT-2022) Genomics and Proteomics, G | 0 | |
80 80PR 80RT 58IN |
0 | Unpublished |
| Mori (2015) | A cluster of rapid disease progressors with acute HIV-1 infection shared novel HIV-1 variants characterized by genetic signatures in p6gag/pol and pol/vif genes | Unpublished | 0 | |
17 17IN |
0 | Case report(s) / study subset |
| Moriyama (1998) | HIV-1 in Ghana | Unpublished | 1e-129 | |
1 1IN |
0 | Case report(s) / study subset |
| Moriyama (1998) | HIV-1 in Congo | 10791871 | 1e-128 | |
1 1IN |
0 | Case report(s) / study subset |
| Morris (1999) | MOSAIC structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations | J. Virol. 73 (10), 8720-8731 (1999) | 9e-94 | |
11 11RT |
0 | Quasispecies |
| Mortier (2022) | Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019 | Open Forum Infect Dis 9 (7), ofac195 (2022) | 3.56e-140 | 634 633PR 631RT |
635 635PR 634RT |
99 | HIVDB |
| Moscona (2025) | Newly designed amplicons-based Method for Near-Full-Length Genome (NFLG) Sequencing of HIV-1 Group M Recombinant Forms | Unpublished | 0 | |
35 35PR 35RT 35IN |
0 | Case report (Small sample size) |
| Mosha (2012) | Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania | AIDS Res. Hum. Retroviruses 27 (4), 377-382 (2011) | 0 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Moskaleychik (2016) | [Rapid spread of the HIV-1 circular recombinant CRF02-AG in Russia and neighboring countries] | Vopr. Virusol. 60 (6), 14-19 (2015) | 0 | 15 15PR 15RT 4IN |
15 15PR 15RT 4IN |
100 | HIVDB |
| Mota (2016) | Prevalence of gb virus c infection in patients with different HIV-1 subtypes in southern Brazil | 27171504 | 8.55e-134 | |
53 9PR 50RT |
0 | Gene fragment(s) |
| Mouinga-Ondeme (2012) | Novel SIVs from central African nonhuman primates bush meat and pets and the potential risks of cross-species transmission to humans | Unpublished | 8e-87 | |
10 2RT 10IN |
0 | NHPL/SIV |
| Moura (2014) | Transmitted drug resistance and HIV-1 genetic diversity among patients from Piaui State, northeast, Brazil | 25649362 | 8.91e-170 | 89 89PR 89RT |
89 89PR 89RT |
100 | HIVDB |
| Moura (2015) | Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in maranhao state, northeast Brazil | AIDS Res. Hum. Retroviruses 31 (2), 250-254 (2015) | 1e-168 | 106 106PR 106RT |
106 106PR 106RT |
100 | HIVDB |
| Mouroux (2001) | LOW rate of emergence of TAMs | 11808752 | 1e-98 | |
5 5RT |
0 | Case report(s) / study subset |
| Moussa (2022) | First description of of HIV-1 group O in Central African Republic (CAR) and HIV type 2 strains over the years 2003 to 2014 | 39370672 | 3.98e-154 | |
6 4PR 5RT |
0 | Pending |
| Moussa (2010) | First Data on HIV-1 Resistance Mutations to Antiretroviral Drugs in Central African Republic | AIDS Res. Hum. Retroviruses 26 (11), 1247-1248 (20 | 2.17e-167 | 43 22PR 21RT |
43 22PR 21RT |
100 | HIVDB |
| Moussa (2021) | High efficency of WHO option B+ strategy for prevention of mother-to-child transmission of HIV-1 in breastfeeding mothers living in the Central African Republic : a prospective STROBE-compliant study | Unpublished | 8.19e-180 | |
47 23PR 24RT |
0 | Unpublished |
| Moyo (2020) | Direct Submission | Submitted (31-AUG-2020) Centre for HIV and STIs, N | 2.76e-167 | 674 674PR 674RT |
674 674PR 674RT |
100 | HIVDB |
| Msimanga (2015) | HIV-1 diversity in an antiretroviral treatment naive cohort from Bushbuckridge, Mpumalanga Province, South Africa | Virol. J. 12, 24 (2015) | 0 | 13 13PR 12RT |
32 13PR 13RT 19IN |
40 | HIVDB |
| Mueller (2007) | DUAL Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease | J. Virol. 81 (6), 2887-2898 (2007) | 7e-59 | 94 94PR |
94 94PR |
100 | HIVDB |
| Muenchhoff (2019) | Direct Submission | Submitted (19-AUG-2019) Virology, Pettenkofer Inst | 4.16e-137 | |
75 25PR 49RT 25IN |
0 | Unpublished |
| Muenchhoff (2019) | HIV-1-o | Unpublished | 2.76e-42 | |
1 1IN |
0 | Case report(s) / study subset |
| Mukesh (2012) | Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India. | AIDS Res Hum Retroviruses. 2014 Mar;30(3):294-8. | 0 | 27 27PR 27RT |
27 27PR 27RT |
100 | HIVDB |
| Mulato (2024) | Preclinical Characterization of a Non-peptidomimetic HIV Protease Inhibitor with Improved Metabolic Stability | Unpublished | 5.28e-65 | |
3 3PR |
0 | Case report(s) / study subset |
| Mullins (2013) | HIV-1 superinfection with a triple class drug resistant strain in a patient successfully controlled with antiretroviral treatment | Unpublished | 0 | |
35 35PR 23RT 23IN |
0 | Case report(s) / study subset |
| Mullins (2025) | Early Evolutionary Dynamics of HIV infection | Unpublished | 0 | |
43063 42352PR 43057RT |
0 | Pending |
| Mulu (2013) | Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia | BMC Infect. Dis. 14 (1), 158 (2014) | 0 | 161 149PR 154RT |
162 150PR 154RT |
99 | HIVDB |
| Mulu (2014) | Lack of integrase inhibitors-associated resistance mutation among HIV-1 subtype C isolates | 26626277 | 0 | 43 43IN |
45 45IN |
95 | HIVDB |
| Mulu (2015) | Low incidence of HIV-1C acquired drug resistance 10 years after roll-out of antiretroviral therapy in Ethiopia: A prospective cohort study | 26512902 | 0 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Munoz-Nieto (2008) | HIV Type 1 Intersubtype Recombinants during the Evolution of a Dual Infection with Subtypes B and G | AIDS Res. Hum. Retroviruses 24 (2), 337-343 (2008) | 0 | |
12 11PR 12RT 12IN |
0 | Case report(s) / study subset |
| Murakoshi (2018) | Broad recognition of circulating HIV-1 by HIV-1-specific CTLs with strong ability to suppress HIV-1 replication | Unpublished | 0 | |
1 1RT |
0 | Case report(s) / study subset |
| Murillo (2009) | Prevalence of drug resistance and importance of virus load measurements in Honduran HIV patients failing antiretroviral treatment | HIV Med. 2010 Feb;11(2):95-103. Epub 2009 Aug 3. | 0 | 138 138PR 138RT |
140 140PR 140RT |
98 | HIVDB |
| Murillo (2013) | Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America | J. Med. Virol. 84 (10), 1514-1521 (2012) | 0 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Murzakova (2018) | Characterization of HIV-1 subtype G caused nosocomial outbreak in the south of USSR in 1988-1990 and currently circulating in the Russian Federation | 30995717 | 0 | 10 10PR 10RT 10IN |
11 11PR 11RT 11IN |
90 | HIVDB |
| Musick (2019) | A Majority of Clonally-Expanded CD4+ T Cells Containing Replication-Competent Provirus are Transcriptionally Silent and Can Be Found in the Effector Memory Subset | 31632364 | 0 | |
3729 3729PR 3729RT |
0 | Proviral DNA Reservoir |
| Musyoki (2011) | Genetic Characterization of HIV Before Widespread Testing of HIV Vaccine Candidates at a Clinical Trial Site in Pretoria, South Africa | AIDS Res. Hum. Retroviruses 28 (9), 931-938 (2012) | 0 | 25 25PR 25RT |
25 25PR 25RT |
100 | HIVDB |
| Musyoki (2014) | Identification and genetic characterisation of unique HIV-1 A1/C recombinant strain in South Africa | 25517728 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Mutsvangwa (2015) | Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C | J. Virol. Methods 210C, 36-39 (2014) | 5.2e-157 | |
38 38RT |
0 | Case report(s) / study subset |
| Mwaengo (1998) | MOLECULAR cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections | J. Virol. 72 (11), 8976-8987 (1998) | 1e-165 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Mwangi (2016) | HIV subtypes in Kenya current status | Unpublished | 1.06e-110 | |
114 114RT |
0 | Sequence quality |
| Mwangi (2006) | VIREMIC sero-negative donations and genetic diversity of viral infections among blood donors in Kenya: implications on blood safety | Unpublished | 5e-48 | |
17 17IN |
0 | Gene fragment(s) |
| Myers (2011) | Transmitted Drug Resistance Among Antiretroviral-Naive Patients with Established HIV Type 1 Infection in Santo Domingo, Dominican Republic and Review of the Latin American and Caribbean Literature | AIDS Res. Hum. Retroviruses (2011) In press | 1e-172 | 143 143PR 143RT |
143 143PR 143RT |
100 | HIVDB |
| Mziray (2020) | Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania | PLoS ONE (2020) In press | 1.55e-173 | 25 25PR 25RT |
25 25PR 25RT |
100 | HIVDB |
| Nabatov (2001) | STUDY of distribution of AZT-resistant subtype B HIV-1 during the second stage of HIV epidemic in former Soviet Union countries | Unpublished | 9e-94 | |
3 3RT |
0 | Case report(s) / study subset |
| Nadai (2008) | HIV-1 epidemic in the Caribbean is dominated by subtype B | PLoS ONE 4 (3), E4814 (2009) | 0 | 67 67PR 67RT 15IN |
81 81PR 81RT 15IN |
82 | HIVDB |
| Nadji (2013) | HIV-1 RT gene region sequences from Iranian patients admitted to VRC-NRITLD, Tehran-Iran | Unpublished | 0 | |
55 55RT |
0 | ARV Rx and/or other data are N/A |
| Nagai (2011) | Construction and characterization of infectious molecular clones derived from japanese blood donors | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Nagai (2012) | Construction and characterization of infectious molecular clones deriver from HIV-1, URF between subtype B and CRF01_AE, underestimated by Cobas TaqMan version 1 HIV-1 RNA quantification assay | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Nagai (2012) | Molecular characterization of infectious molecular clones derived from HIV-1 CRF08_BC isolates in Yunnan, China | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Laboratory/experimental isolate |
| Nagarajan (2024) | Spectrum of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living With HIV-1 Receiving Rilpivirine | Unpublished | 0 | 312 312RT |
312 312RT |
100 | HIVDB |
| Najera (1995) | POL gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy | J. Virol. 69 (1), 23-31 (1995) | 9e-97 | |
175 175RT |
0 | Quasispecies |
| Nakano (1997) | CLONAL selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis | AIDS Res. Hum. Retroviruses 13 (7), 563-573 (1997) | 1e-98 | |
51 51RT |
0 | Case report(s) / study subset |
| Nanfack (2015) | Direct Submission | Submitted (08-JUL-2015) Molecular Biology, CIRCB, | 0 | |
31 31IN |
0 | Unpublished - Final |
| Nanfack (2017) | Multimethod Longitudinal HIV Drug Resistance Analysis in ART Naive Patients | J. Clin. Microbiol. (2017) In press | 9.84e-114 | 61 61RT |
130 130RT |
46 | HIVDB |
| Nankya (2025) | Direct Submission | Submitted (03-NOV-2025) Molecular Biology, Case We | 3.74e-139 | |
387 387RT |
0 | Unpublished |
| Nankya (2025) | Direct Submission | Submitted (04-NOV-2025) Molecular Biology, Case We | 1.12e-156 | |
144 144IN |
0 | Unpublished |
| Nasioulas (1999) | MOLECULAR analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination | AIDS Res. Hum. Retroviruses 15 (8), 745-758 (1999) | 1e-163 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Nasiri Tajabadi (2020) | A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients | Arch Clin Infect Dis 13 (6), e69153 (2018) | 5.87e-62 | 16 16PR |
16 16PR 10RT |
100 | HIVDB |
| Naugler (2002) | T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. | J Infect Dis | 4e-96 | 50 50RT |
50 50RT |
100 | HIVDB |
| Naziri (2016) | Antiretroviral drug resistance mutations among naive and experienced patients in Shiraz, Iran, 2014 | 27368990 | 2.47e-141 | 101 51PR 50RT |
101 51PR 50RT |
100 | HIVDB |
| Nazziwa (2012) | HIV Type 1 Transmitted Drug Resistance and Evidence of Transmission Clusters Among Recently Infected Antiretroviral-Naive Individuals from Ugandan Fishing Communities of Lake Victoria | AIDS Res. Hum. Retroviruses 29 (5), 788-795 (2013) | 0 | 48 48PR 46RT |
48 48PR 46RT |
100 | HIVDB |
| Ndahimana (2015) | HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda | Antivir. Ther. (Lond.) (2015) In press | 0 | 51 31PR 31RT |
51 31PR 31RT |
100 | HIVDB |
| Ndahimana (2016) | Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virologic failure in Rwanda | Trop. Med. Int. Health (2016) In press | 3.14e-148 | 140 70PR 70RT |
140 70PR 70RT |
100 | HIVDB |
| Ndashimye (2018) | Absence of HIV-1 drug resistance mutations supports the use of dolutegravir in Uganda | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 698 179PR 316RT 381IN |
699 179PR 317RT 382IN |
99 | HIVDB |
| Ndembi (2003) | HIV type 1 infection in Pygmy hunter gatherers is from contact with Bantu rather than from nonhuman primates | AIDS Res. Hum. Retroviruses 19 (5), 435-439 (2003) | 1e-48 | |
10 10IN |
0 | Gene fragment(s) |
| Ndembi (2004) | GENETIC Diversity of HIV Type 1 in Rural Eastern Cameroon | J. Acquir. Immune Defic. Syndr. 37 (5), 1641-1650 (2004) | 1e-48 | |
20 20IN |
0 | Gene fragment(s) |
| Ndembi (2007) | Analysis of resistance transmission over time of chronically and acutely infected HIV patients | Unpublished | 9e-58 | |
30 30PR |
0 | ARV Rx and/or other data are N/A |
| Ndembi (2008) | TRANSMITTED Antiretroviral Drug Resistance Surveillance among Newly HIV Type 1-Diagnosed Women Attending an Antenatal Clinic in Entebbe, Uganda | AIDS Res. Hum. Retroviruses 24 (6), 889-895 (2008) | 1.23e-170 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Ndembi (2009) | Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between Combivir/nevirapine and Combivir/abacavir | J Infect Dis. 2010 Jan 1;201(1):106-13. | 1.6e-169 | 90 87PR 90RT |
90 87PR 90RT |
100 | HIVDB |
| Ndembi (2011) | Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala, Uganda | AIDS (2011) In press | 4.41e-170 | 70 70PR 70RT |
70 70PR 70RT |
100 | HIVDB |
| Ndembi (2011) | High Frequency of HIV-1 Dual Infections in Cameroon, West Central Africa | J. Acquir. Immune Defic. Syndr. 57 (2), E25-E27 (2 | 2e-49 | |
54 54IN |
0 | Gene fragment(s) |
| Ndembi (2016) | Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B | J. Clin. Microbiol. 46 (1), 177-184 (2008) | 4.14e-158 | 77 73PR 77RT |
77 77PR 77RT |
100 | HIVDB |
| Ndiaye (2013) | HIV Type 1 Subtype C Remains the Predominant Subtype in Men Having Sex with Men in Senegal | AIDS Res. Hum. Retroviruses 29 (9), 1265-1272 (201 | 0 | 60 60PR 60RT |
60 60PR 60RT |
100 | HIVDB |
| Ndjolo Ada (2025) | Low rates of virological failure and acquired drug resistance among children in Cameroon: evidence following transition to dolutegravir-based regimens in paediatrics | Unpublished | 7.51e-173 | |
3 3PR 3RT |
0 | Case report (Small sample size) |
| Ndongmo (2006) | HIV Genetic Diversity in Cameroon: Possible Public Health Importance | AIDS Res. Hum. Retroviruses 22 (8), 812-816 (2006) | 5e-59 | 70 70PR |
70 70PR |
100 | HIVDB |
| Ndung'u (2000) | MOLECULAR cloning and biological characterization of full-length HIV-1 subtype C from Botswana | Virology 278 (2), 390-399 (2000) | 1e-162 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Ndung'u (2001) | CONSTRUCTION and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone | J. Virol. 75 (11), 4964-4972 (2001) | 1e-162 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Nduva (2020) | Direct Submission | Submitted (19-FEB-2020) Systems Virology, Lund Uni | 3.16e-165 | 163 163PR 163RT |
163 163PR 163RT |
100 | HIVDB |
| Nduva (2022) | Direct Submission | Submitted (01-JAN-2022) Systems Virology, Lund Uni | 5.98e-175 | |
588 587PR 588RT |
0 | Evolutionary study |
| Neel (2010) | Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas | J. Virol. 84 (3), 1464-1476 (2010) | 1e-53 | |
24 24IN |
0 | Gene fragment(s) |
| Negedu-momoh (2011) | Evaluation of antiretroviral drug resistant variants among HIV art experienced and naive patients in nigeria | Unpublished | 3e-173 | |
40 40PR 40RT |
0 | ARV Rx and/or other data are N/A |
| Negi (2018) | Genotypic characterization of Human immunodeficiency virus type 1 derived from Nepalese on antiretroviral therapy | 28298145 | 0 | 61 29PR 32RT |
61 29PR 32RT |
100 | HIVDB |
| Neilson (1999) | SUBTYPES of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya | J. Virol. 73 (5), 4393-4403 (1999) | 1e-165 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Nelson (2015) | Direct Submission | Submitted (27-APR-2015) Microbiology and Immunolog | 4.42e-150 | |
42 21PR 21RT |
0 | ARV Rx and/or other data are N/A |
| Nelson (2015) | Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis: results of the Breastfeeding, Antiretrovirals and Nutrition study | AIDS (2015) In press | 1.96e-172 | |
110 110RT |
0 | Pending |
| Neogi (2015) | Near full-length genome sequencing from Sweden | 26115688 | 0 | 24 24PR 24RT 24IN |
24 24PR 24RT 24IN |
100 | HIVDB |
| Neogi (2011) | Characterization of HIV Type 1 Subtype C protease Gene: Selection of L63P Mutation in Protease Inhibitor-Naive Indian Patients | AIDS Res. Hum. Retroviruses (2011) In press | 6e-60 | 39 39PR |
39 39PR |
100 | HIVDB |
| Neogi (2013) | Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals | J Int AIDS Soc 16, 18472 (2013) | 8.92e-152 | 88 88RT |
176 176RT |
50 | HIVDB |
| Neogi (2015) | HIV-1 protease and reverse transcriptase from therapy naive individuals from India | 24699043 | 1.5e-164 | 297 297PR 297RT |
297 297PR 297RT |
100 | HIVDB |
| Neogi (2015) | Mutational heterogeneity in p6 Gag late assembly (L) domains in HIV-1 subtype C viruses from South Africa | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 388 388PR 388RT |
845 845PR 845RT |
45 | HIVDB |
| Neogi (2016) | Naturally Occurring Polymorphisms and Primary Drug Resistance Profile Among Antiretroviral-Naive Individuals in Bangalore, India | AIDS Res. Hum. Retroviruses 26 (10), 1097-1101 (20 | 6.97e-154 | 21 21RT |
21 21RT |
100 | HIVDB |
| Neogi (2017) | Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden | Sci Rep 7 (1), 6371 (2017) | 0 | 83 83PR 83RT 83IN |
83 83PR 83RT 83IN |
100 | HIVDB |
| Nerrienet (1997) | Genetic diversity of SIVs and STLVs in naturally infected Mandrills (Mandrillus sphinx) | 9643378 | 2.01e-37 | |
43 43RT |
0 | NHPL/SIV |
| Nerrienet (2003) | Simian immunodeficiency virus infection in wild-caught chimpanzees from cameroon. | J Virol. 2005 Jan;79(2):1312-9. | 0 | 1 1PR 1RT 1IN |
2 1PR 2RT 1IN |
50 | HIVDB |
| Nerrienet (2013) | HIV-1 Protease Inhibitors Resistance Profiles in Patients with Virological Failure on LPV/r-based 2nd Line Regimen in Cambodia | J AIDS Clin Res 3, S5 (2013) | 1e-163 | 178 71PR 83RT 24IN |
178 71PR 83RT 24IN |
100 | HIVDB |
| Nesakumar (2019) | Transmitted HIV-1 drug resistance in a treatment naive cohort of recently infected individuals from Chennai, India | AIDS Res. Hum. Retroviruses (2019) In press | 1.04e-180 | 52 48PR 47RT |
53 49PR 53RT |
98 | HIVDB |
| Neshumaev (2019) | Molecular Surveillance of HIV-1 infection in Krasnoyarsk Region, Russia: Epidemiology, Phylodynamics and Phylogeography | Curr. HIV Res. (2019) In press | 0 | |
281 281PR 281RT |
0 | Pending |
| Neumann (1995) | RESTRICTION of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function | J. Virol. 69 (4), 2159-2167 (1995) | 1e-165 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Ng'Ong'A (2020) | Assessing HIV-1 drug resistance profiles in Kenya by sequencing the pole protein encoding gene | Unpublished | 0 | |
40 6PR 40RT |
0 | Unpublished |
| Ng (2011) | Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms. | ARHR | 9e-60 | 199 199PR |
199 199PR 194RT |
100 | HIVDB |
| Ng (2011) | Identification of New CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. | ARHR | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Ng (2015) | Co-infections and transmission networks of HCV, HIV-1 and HPgV among individuals with intravenous drug exposures | 26459957 | 0 | |
21 21PR 21RT |
0 | Case report(s) / study subset |
| Ng (2017) | Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF) 77_cpx from Malaysia | 28663289 | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Ng (2012) | Genome Sequence of a Novel HIV-1 Circulating Recombinant Form 54_01B from Malaysia | J. Virol. 86 (20), 11405-11406 (2012) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Ng (2013) | Evolutionary History of HIV-1 Subtype B and CRF01_AE Transmission Clusters among Men Who Have Sex with Men (MSM) in Kuala Lumpur, Malaysia | PLoS ONE 8 (6), E67286 (2013) | 4e-179 | 34 34PR 34RT |
87 87PR 87RT |
39 | HIVDB |
| Ngo-Giang-Huong (2012) | Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis | PLoS ONE 6 (11), E27427 (2011) | 0 | 121 32PR 121RT |
121 32PR 121RT |
100 | HIVDB |
| Ngo-Giang-Huong (2018) | Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries | J. Antimicrob. Chemother. (2018) In press | 0 | 1024 997PR 1019RT |
1024 1002PR 1022RT |
100 | HIVDB |
| Ngo-Malabo (2017) | HIV Drug Resistance Testing in a Resource Limited Setting with high Viral Diversity: The first Twenty Eight Months Experience | Curr. HIV Res. (2017) In press | 6.27e-175 | 167 167PR 166RT |
167 167PR 166RT |
100 | HIVDB |
| Nguyen (2011) | Cloning and expression of protease-encoding gene of HIV type 1 isolated from Vietnam | Tap Chi Cong Nghe Sinh Hoc (2011) In press | 4e-49 | |
1 1PR |
0 | Laboratory/experimental isolate |
| Nguyen (2018) | Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing | J. Antimicrob. Chemother. (2018) In press | 0 | 122 122IN |
122 122IN |
100 | HIVDB |
| Nguyen (2022) | Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection | J Virol (2022) In press | 8.6e-106 | |
11 11PR 11RT |
0 | Case report(s) / study subset |
| Niama (2009) | CRF45_AKU, a Circulating Recombinant from Central Africa, Is Probably the Common Ancestor of HIV Type 1 MAL and HIV Type 1 NOGIL | AIDS Res. Hum. Retroviruses 25 (12), 1345-1353 (20 | 0 | 4 4PR 4RT 4IN |
6 4PR 4RT 6IN |
66 | HIVDB |
| Niama (2016) | HIV-1 pol gene diversity and complex recombinant structure of HIV-1 strains circulating in the Republic of Congo | 16473564 | 0 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Nicolae (2025) | Direct Submission | Submitted (01-OCT-2025) Molecular Diagnostics Labo | 0 | |
114 114PR 114RT |
0 | Unpublished |
| Nicolas (2022) | Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients | Microbiol Spectr, e0078422 (2022) In press | 0 | |
60 56PR 60RT 60IN |
0 | Proviral DNA Reservoir |
| Nielsen (2003) | THE CATCH study - Combined Analysis of Resistance Transmission over time of Chronically and acute infected HIV patients | Unpublished | 1e-174 | |
33 33PR 33RT |
0 | ARV Rx and/or other data are N/A |
| Nii-Trebi (2013) | HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naive Patients after the Implementation of Antiretroviral Therapy in Ghana | PLoS ONE 8 (8), E71972 (2013) | 0 | 101 101PR 101RT |
101 101PR 101RT |
100 | HIVDB |
| Nii-Trebi (2017) | Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana | J. Med. Microbiol. (2017) In press | 0 | 24 21PR 24RT |
24 21PR 24RT |
100 | HIVDB |
| Ning (2013) | Near Full-length Genome Identification of a Novel HIV-1 B'/C Recombinant Isolate JL100091 in Jilin, China | AIDS Res. Hum. Retroviruses (2013) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Nishizawa (2015) | Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy | PLoS ONE 10 (9), E0135941 (2015) | 0 | |
181 181RT |
0 | Quasispecies |
| Njagi (2016) | Genetic diverstiy of HIV-1 isolates and anti-retroviral drug resistance from patients in Kirinyaga County, Kenya | Unpublished | 4.03e-157 | |
33 33RT |
0 | Case report(s) / study subset |
| Njai (2007) | THE predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness | Retrovirology 3, 40 (2006) | 0 | 27 27PR 27RT 27IN |
27 27PR 27RT 27IN |
100 | HIVDB |
| Njai (2013) | Deciphering the Complex Distribution of Human Immunodeficiency Virus Type 1 Subtypes among Different Cohorts in Northern Tanzania | PLoS ONE 8 (12), E81848 (2013) | 2.72e-118 | |
136 136RT |
0 | Gene fragment(s) |
| Njouom (2003) | ASSESSMENT of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences | J. Virol. Methods 110 (1), 1-8 (2003) | 9e-95 | 40 23PR 30RT |
40 23PR 30RT |
100 | HIVDB |
| Nkengasong (2001) | DISTRIBUTION of HIV-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire | J. Acquir. Immune Defic. Syndr. 23 (5), 430-436 (2000) | 1e-108 | 12 12PR |
12 12PR |
100 | HIVDB |
| Nkone (2021) | Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages | 35346259 | 0 | 88 88PR 88RT 88IN |
88 88PR 88RT 88IN |
100 | HIVDB |
| Noel (2016) | Molecular epidemiology of HIV-1 in the Caribbean - Puerto Rico, Dominican Republic and the French Caribbean | Unpublished | 8.82e-136 | |
1762 1762RT |
0 | Unpublished - Final |
| Noel (2003) | PHYLOGENETIC relationships between Puerto Rico and Continental USA HIV-1 pol sequences: a shared HIV-1 infection in USA and PR. | 14983986 | 1e-122 | |
584 287PR 297RT |
0 | Pending |
| Nomura (2012) | Significant Reductions in Gag-Protease-Mediated HIV-1 Replication Capacity during the Course of the Epidemic in Japan | J. Virol. 87 (3), 1465-1476 (2013) | 5e-61 | 140 140PR |
140 140PR |
100 | HIVDB |
| Nosik (2023) | Direct Submission | Submitted (10-MAY-2023) HIV diagnostic and molecul | 0 | |
9 9PR 9RT 9IN |
0 | Unpublished |
| Nouhin (2010) | Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naive individuals in Cambodia, Thailand and Vietnam: An ANRS AC12 working group study | Infect. Genet. Evol. 11 (1), 38-43 (2011) | 1e-164 | 50 50IN |
87 87IN |
57 | HIVDB |
| Nouhin (2013) | Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia | PLoS ONE 8 (8), E73744 (2013) | 2.04e-158 | 520 520RT |
520 520RT |
100 | HIVDB |
| Novelli (2002) | CONSTRUCTION and characterization of a full-length HIV-1(92UG001) subtype D infectious molecular clone | AIDS Res. Hum. Retroviruses 18 (1), 85-88 (2002) | 1e-162 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Novembre (1992) | SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus | Virology 186 (2), 783-787 (1992) | 1e-100 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Novembre (1993) | MULTIPLE viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant | J. Virol. 67 (5), 2466-2474 (1993) | 1e-100 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Novembre (1998) | ISOLATION and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey | J. Virol. 72 (11), 8841-8851 (1998) | 1e-100 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Novembre (2010) | Neuropathogenic SIVsmmFGb Genetic Diversity and Selection-Induced Tissue-Specific Compartmentalization During Asymptomatic Infection and Temporal Evolution of Viral Genes in Lymphoid and Central Nervous System Tissues | Unpublished | 1e-101 | |
857 857RT 857IN |
0 | Quasispecies |
| Novitsky (1999) | MOLECULAR cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana | J. Virol. 73 (5), 4427-4432 (1999) | 1e-165 | 23 23PR 23RT 23IN |
23 23PR 23RT 23IN |
100 | HIVDB |
| Novitsky (2000) | HIV type 1 A/J recombinant with a pronounced pol gene mosaicism | AIDS Res. Hum. Retroviruses 16 (10), 1015-1020 (2000) | 1e-164 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Novitsky (2002) | HUMAN immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? | J. Virol. 76 (11), 5435-5451 (2002) | 1e-165 | 42 42PR 42RT 42IN |
42 42PR 42RT 42IN |
100 | HIVDB |
| Novitsky (2002) | HIV-1 subtype C/Denv/C recombinant from Botswana | Unpublished | 1e-102 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Novitsky (2007) | THE Reverse Transcriptase 67N 70R 215Y Genotype Is the Predominant TAM Pathway Associated with Virologic Failure among HIV Type 1C-Infected Adults Treated with ZDV/ddI-Containing HAART in Southern Africa | AIDS Res. Hum. Retroviruses 23 (7), 868-878 (2007) | 0 | 61 61PR 61RT |
63 63PR 63RT |
96 | HIVDB |
| Novitsky (2015) | Long-range HIV genotyping using viral RNA and proviral DNA for analysis of HIV drug-resistance and HIV clustering | J. Clin. Microbiol. (2015) In press | 0 | 648 625PR 606RT 647IN |
649 649PR 649RT 649IN |
99 | HIVDB |
| Ntamatungiro (2016) | Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression | 28387865 | 0 | 20 20PR 20RT |
20 20PR 20RT |
100 | HIVDB |
| Ntamatungiro (2023) | Direct Submission | Submitted (23-MAR-2023) Interventions and Clinical | 0 | |
16 16PR 16RT |
0 | Pending |
| Ntamatungiro (2023) | Transitioning to dolutegravir in a programmatic setting: Virological outcomes and associated factors in the Kilombero and Ulanga antiretroviral cohort in rural Tanzania | 37520425 | 0 | |
17 17PR 17RT |
0 | Pending |
| Ntemgwa (2007) | VARIATIONS in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine | Antimicrob. Agents Chemother. 51 (11), 3861-3869 (2007) | 0 | |
90 41PR 90RT |
0 | Pending |
| Ntemgwa (2007) | NEAR Full-Length Genomic Analysis of a Novel Subtype A1/C Recombinant HIV Type 1 Isolate from Canada | AIDS Res. Hum. Retroviruses 24 (4), 655-659 (2008) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Ntemgwa (2008) | DISCREPANCIES in Assignment of Subtype/Recombinant Forms by Genotyping Programs for HIV Type 1 Drug Resistance Testing May Falsely Predict Superinfection | AIDS Res. Hum. Retroviruses 24 (7), 995-1002 (2008) | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Ntemgwa (2009) | Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2 | Antimicrob. Agents Chemother. 53 (2), 708-715 (200 | 9e-171 | |
6 6RT |
0 | Case report(s) / study subset |
| Ntemgwa (2016) | Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors | Antimicrob. Agents Chemother. 51 (2), 604-610 (200 | 1.58e-29 | |
3 3PR |
0 | HIVDB |
| Nukoolkarn (2005) | SEQUENCE variability of the HIV type 1 protease gene in thai patients experienced with antiretroviral therapy | AIDS Res. Hum. Retroviruses 20 (12), 1368-1372 (2004) | 1.31e-57 | 66 66PR |
66 66PR |
100 | HIVDB |
| Nunberg (1991) | VIRAL resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors | J. Virol. 65 (9), 4887-4892 (1991) | 1e-98 | |
2 2RT |
0 | Laboratory/experimental isolate |
| Nunes (2022) | Insights about HIV-1 genetic diversity and transmitted drug resistance to integrase strand transfer inhibitors among recently diagnosed adults in Porto Alegre, Southern Brazil | 36272141 | 0 | 42 42IN |
42 42IN |
100 | HIVDB |
| Nunes (2014) | Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in Sao Paulo and Santos, Brazil | PLoS ONE 9 (1), E84066 (2014) | 6.89e-51 | |
100 100PR |
0 | Gene fragment(s) |
| Nwobegahay (2009) | Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. | S Afr Med J | 0 | 91 45PR 46RT |
91 45PR 46RT |
100 | HIVDB |
| Nwobegahay (2009) | Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naive patients entering antiretroviral treatment programs at two sites in northern South Africa | J. Med. Virol. 84 (12), 1839-1843 (2012) | 0 | 160 80PR 80RT |
160 80PR 80RT |
100 | HIVDB |
| Nwobegahay (2010) | Prevalence of antiretroviral drug resistance mutations among drug-naive HIV-1-infected persons attending Mankweng Hospital, South Africa | 21957668 | 1e-168 | 61 43PR 18RT |
61 43PR 18RT |
100 | HIVDB |
| Nwobegahay (2010) | Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa. | J Health Popul Nutr | 0 | 47 11PR 36RT |
47 11PR 36RT |
100 | HIVDB |
| Nwobegahay (2016) | Prevalence of drug resistance mutations among drug-naive HIV-1 infected individuals in a treatment site in the Waterberg District of South Africa | 21837878 | 4.84e-165 | 21 12PR 9RT |
21 12PR 9RT |
100 | HIVDB |
| Nyamache (2011) | HIV Type 1 Genetic Diversity and Naturally Occurring Polymorphisms in HIV Type 1 Kenyan Isolates: Implications for Integrase Inhibitors | AIDS Res. Hum. Retroviruses 28 (8), 933-936 (2012) | 2e-47 | |
41 41IN |
0 | Gene fragment(s) |
| Nyamache (2022) | Direct Submission | Submitted (21-APR-2022) Biological Sciences, Unive | 2.95e-159 | |
69 41RT 28IN |
0 | Unpublished |
| Nyamota (2019) | Prevalence and genetic diversity of SIVagm infecting urban-restricted Africa green monkeys and olive baboons in Kenya | Unpublished | 6.76e-92 | |
14 1RT 14IN |
0 | NHPL/SIV |
| Nyombi (2007) | DIVERSITY of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania | AIDS Res. Hum. Retroviruses 24 (6), 761-769 (2008) | 0 | 167 166PR 167RT |
167 167PR 167RT |
100 | HIVDB |
| Nzeyimana (2013) | Monitoring of HIV-1 drug resistance and associated programmatic factors in patients initiating antiretroviral therapy at two ART sites in Bujumbura, Burundi | Antivir. Ther. 15, A153-A153 (2010) | 0 | 244 244PR 244RT |
244 244PR 244RT |
100 | HIVDB |
| O'Brien (1996) | HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain | Nature 348 (6296), 69-73 (1990) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| O'Connell (2010) | Prolonged control of an HIV-1 escape variant following treatment interruption in an HLA-B*27 positive patient | 20854198 | 0 | |
2 2PR 2RT 1IN |
0 | Case report(s) / study subset |
| O'Connell (2011) | Sustained Elite Suppression of Replication Competent HIV-1 in a Patient Treated with Rituximab Based Chemotherapy | 21550842 | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| O'Connor (2004) | A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation | J. Virol. 78 (24), 14012-14022 (2004) | 0 | |
26 26PR 26RT 26IN |
0 | Laboratory/experimental isolate |
| Obeng (2019) | Direct Submission | Submitted (07-AUG-2019) Microbiology, University o | 0 | |
32 20PR 25RT |
0 | Case report (Small sample size) |
| Ochoa de Echaguen (2005) | Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir. | AIDS | 0 | 25 25PR 25RT |
26 26PR 26RT |
96 | HIVDB |
| Ochsenbauer (2012) | Generation and Biological Characterization of Infectious Molecular Clones of Transmitted/Founder HIV-1 genomes | J Virol (2012) | 0 | |
43 43PR 43RT 43IN |
0 | Laboratory/experimental isolate |
| Odhiambo (2019) | Correlation between lamivudine plasma concentrations and clinical outcomes among patients on antiretroviral therapy in Nairobi, Kenya | Unpublished | 5.49e-148 | |
42 42RT |
0 | Unpublished |
| Oelrichs (1999) | Genomic sequence of HIV type 1 from four members of the Sydney blood bank cohort of long-term nonprogressors. | ARHR | 1e-163 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Oelrichs (1999) | FULL-LENGTH genomic sequence of an HIV type 1 subtype G from Kinshasa | AIDS Res. Hum. Retroviruses 15 (6), 585-589 (1999) | 1e-165 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Oelrichs (1999) | SEQUENCE of HIV-1 subtype A/E polymerase gene | Unpublished | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Oelrichs (1999) | SEQUENCE of HIV-1 subtype B gag gene poorly detected by both RT-PCR and P24 monoclonal during symptomatic seroconversion | Unpublished | 1e-114 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Oelrichs (2000) | RAPID full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates | J. Biomed. Sci. 7 (2), 128-135 (2000) | 1e-164 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Oelrichs (2000) | NEAR full-length proviral sequence of HIV-1 from an individual homozygous for the delta-32 CCR5 allele | 10199243 | 1e-155 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Oelrichs (2001) | A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso | AIDS Res. Hum. Retroviruses 14 (16), 1495-1500 (1998) | 1e-164 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Ogawa (2019) | A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis | AIDS Res. Hum. Retroviruses 32 (3), 284-289 (2016) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Oguzie (2023) | Metagenomics identifies emerging and re-emerging viruses in Nigerian cohorts with acute febrile illnesses, including pathogens of global concern | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Ojesina (2006) | SUBTYPE-SPECIFIC Patterns in HIV Type 1 Reverse Transcriptase and Protease in Oyo State, Nigeria: Implications for Drug Resistance and Host Response | AIDS Res. Hum. Retroviruses 22 (8), 770-779 (2006) | 0 | 78 43PR 35RT |
78 43PR 35RT |
100 | HIVDB |
| Ojesina (2008) | CHARACTERIZATION of HIV Type 1 Reverse Transcriptase Mutations in Infants Infected by Mothers Who Received Peripartum Nevirapine Prophylaxis in Jos, Nigeria | AIDS Res. Hum. Retroviruses 23 (12), 1587-1592 (2007) | 0 | 14 14RT |
14 14RT |
100 | HIVDB |
| Ojwach (2018) | Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection | J. Virol. (2018) In press | 0 | 487 487RT 487IN |
487 487RT 487IN |
100 | HIVDB |
| Oka (2020) | Direct Submission | Submitted (05-FEB-2019) Department of Public Healt | 0 | |
5 5PR 5RT 5IN |
0 | Unpublished |
| Oke (2020) | Direct Submission | Submitted (19-APR-2020) Centre for Human and Zoono | 1.44e-54 | |
1 1PR |
0 | Unpublished |
| Okonko (2021) | HIV-1 genetic diversity, coreceptor usage and drug resistance mutations in art-naive HIV-infected individuals in south-south region, Nigeria | Unpublished | 4.31e-103 | |
31 31RT |
0 | Case report(s) / study subset |
| Olivares (1998) | COMPLETE sequence of an infectious molecular clone derived from a Spanish HIV type I isolate | AIDS Res. Hum. Retroviruses 14 (18), 1649-1651 (1998) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Oliveira (2012) | Genetic Diversity and Naturally Polymorphisms in HIV-1 Integrase Isolates from Maputo, Mozambique: Implications for Integrase Inhibitors | AIDS Res. Hum. Retroviruses (2012) In press | 1e-164 | 57 57IN |
57 57IN |
100 | HIVDB |
| Oliveira (2023) | Molecular and phylogenetic analysis of HIV-1 subtype C in Bahia state, northeastern Brazil | 37312563 | 0 | |
5 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Oliveira (2023) | Direct Submission | Submitted (11-JUL-2023) Biochemistry and Biophisic | 0 | |
1 1IN |
0 | Case report(s) / study subset |
| Oliveira (2011) | Genetic Diversity and Drug Resistance Profiles in HIV Type 1- and HIV Type 2-Infected Patients from Cape Verde Islands | AIDS Res. Hum. Retroviruses 28 (5), 510-522 (2012) | 1e-174 | 67 40PR 27RT |
67 40PR 52RT |
100 | HIVDB |
| Oliveira-Filho (2021) | High genetic diversity and antiretroviral drug resistance in people who used illicit drugs in the Amazon region: public health alert in two Brazilian states | Unpublished | 6.47e-167 | |
177 177PR 177RT |
0 | Unpublished |
| Olusola (2017) | Early HIV infection among persons referred for malaria parasite testing in Nigeria | Arch. Virol. (2017) In press | 0.000155 | |
4 4PR |
0 | Case report(s) / study subset |
| Olusola (2020) | Direct Submission | Submitted (04-FEB-2020) Virology, University of Ib | 2.31e-132 | |
12 3PR 12RT |
0 | Unpublished |
| Omondi (2025) | Prolonged non-suppressible viremia sustained by a clonally-expanded, genomically-defective provirus with an immune evasive HIV protein expression profile | Unpublished | 0 | |
15 15PR 15RT 15IN |
0 | Proviral DNA Reservoir |
| Omondi (2025) | Prolonged non-suppressible viremia sustained by a clonally-expanded, genomically-defective provirus with an immune evasive HIV protein expression profile | Unpublished | 1.03e-163 | |
14 14PR 14RT |
0 | Proviral DNA Reservoir |
| Omondi (2025) | Prolonged non-suppressible viremia sustained by a clonally-expanded, genomically-defective provirus with an immune evasive HIV protein expression profile | Unpublished | 0 | |
249 230PR 244RT 134IN |
0 | Proviral DNA Reservoir |
| Omooja (2019) | Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda | J. Antimicrob. Chemother. (2019) In press | 0 | 97 97PR 97RT |
97 97PR 97RT |
100 | HIVDB |
| Onanga (2006) | SIVSUN natural history in Cercopithecus solatus and Macaca fascicularis: Evidence of a common ''Evolution Profile'' in african monkeys related to the lack of pathogeny of SIVs in natural host | Unpublished | 3e-87 | |
1 1IN |
0 | NHPL/SIV |
| Ong (2013) | Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naive patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia | J. Med. Virol. (2013) In press | 4e-179 | 66 66PR 66RT |
66 66PR 66RT |
100 | HIVDB |
| Onsongo (2014) | Increasing Patterns of Transmitted HIV-1 Drug Resistance in Kenyan Urban and Suburban Populations | 26401720 | 3.8e-139 | 63 63PR |
130 65PR 65RT |
48 | HIVDB |
| Onwong'a (2022) | A Low-cost In-house HIV Integrase Strand-Transfer Inhibitor Drug Resistance Test for Resource-limited Settings | Unpublished | 0 | |
70 70IN |
0 | Unpublished - Final |
| Onwuamah (2018) | HIV Drug Resistance: Implications for optimizing antiretroviral therapy (U2G GH000770) | 29255731 | 0 | 576 576PR 576RT |
576 576PR 576RT |
100 | HIVDB |
| Onywera (2016) | Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naive persons in rural western Kenya | 28178281 | 4.29e-176 | 87 87PR 87RT |
87 87PR 87RT |
100 | HIVDB |
| Op de Coul (2000) | INDEPENDENT introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands | Virology 270 (2), 267-277 (2000) | 1e-114 | 6 6PR 6RT |
6 6PR 6RT |
100 | HIVDB |
| Op De Coul (2000) | GENETIC evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children | AIDS Res. Hum. Retroviruses 16 (4), 327-336 (2000) | 7e-86 | 14 14PR 14RT |
14 14PR 14RT |
100 | HIVDB |
| Opiyo (2023) | HIV Drug Resistance associated Mutations among ART naive Female Sex Workers in Nairobi, Kenya | Unpublished | 8.51e-176 | |
64 64PR 64RT |
0 | Pending |
| Oram (1990) | NUCLEOTIDE sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates | AIDS Res. Hum. Retroviruses 6 (9), 1073-1078 (1990) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ordonez Suarez (2012) | Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives. | Antimicrob Agents Chemother. 2012 May;56(5):2581-9. | 0 | |
3 3RT |
0 | Laboratory/experimental isolate |
| Orlandi (1999) | ANALYSIS of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (3), 230 | 3e-93 | 51 51RT |
52 52RT |
98 | HIVDB |
| Oroz (2019) | Direct Submission | Submitted (04-JUL-2019) Laboratory for Molecular D | 0 | 503 403PR 403RT 100IN |
503 403PR 403RT 100IN |
100 | HIVDB |
| Orta-Resendiz (2017) | Resistance and cross-resistance to integrase inhibitors in a cohort of multi-experienced HIV-1-infected Mexican patients failing to raltegravir | 32041622 | 0 | 25 25IN |
25 25IN |
100 | HIVDB |
| Orta-Resendiz (2019) | Direct Submission | Submitted (13-NOV-2018) Laboratorio de Virologia M | 0 | |
14 14IN |
0 | Unpublished - Final |
| Osborne (2013) | The impact of antiretroviral therapy duration and intensification on isolated semen HIV-1 RNA shedding | J. Infect. Dis. (2013) In press | 0 | |
12 5PR 12RT 7IN |
0 | Quasispecies |
| Osman (2013) | Diversity of HIV Type 1 and Drug Resistance Mutations Among Injecting Drug Users in Kenya | AIDS Res. Hum. Retroviruses 29 (1), 187-190 (2013) | 5.96e-149 | |
59 59RT |
0 | ARV Rx and/or other data are N/A |
| Ostankova (2019) | Molecular epidemiology and pharmaco-resistance of HIV-1 in patients with virologic inefficiency of antiretroviral therapy in Arkhangelsk district | 36010172 | 0 | 64 64PR 64RT |
64 64PR 64RT |
100 | HIVDB |
| Ostankova (2019) | HIV molecular epidemiology and pharmaco-resistance in patients with antiretroviral therapy failure in Arkhangelsk district | Vichinfektsiia Immunosuppr (2019) In press | 0 | 12 12PR 12RT |
12 12PR 12RT |
100 | HIVDB |
| Ostankova (2020) | Direct Submission | Submitted (21-AUG-2020) Immunology and Viroligy of | 0 | |
58 58PR 58RT |
0 | Unpublished |
| Ostankova (2023) | Direct Submission | Submitted (08-JAN-2023) Immunology and Viroligy of | 0 | |
61 61PR 61RT |
0 | Pending |
| Ostankova (2024) | Direct Submission | Submitted (08-FEB-2024) Immunology and Virology of | 0 | |
120 120PR 120RT |
0 | Unpublished |
| Osterhaus (1999) | ISOLATION and partial characterization of a lentivirus from talapoin monkeys (Myopithecus talapoin) | Virology 260 (1), 116-124 (1999) | 1.09e-35 | |
2 1PR 2RT |
0 | Gene fragment(s) |
| Otecko (2016) | Viral and Host Characteristics of Recent and Established HIV-1 Infections in Kisumu: Secondary Analysis of the Kisumu Incidence Cohort Study (KICoS) | 27897226 | 9.76e-174 | 100 100PR 100RT |
100 100PR 100RT |
100 | HIVDB |
| Otiong (2025) | Acquired HIV-1 drug resistance mutation mapping: Insights for effective drug therapy | Unpublished | 0 | |
100 100PR 100RT |
0 | Unpublished |
| Ou (2018) | Direct Submission | Submitted (22-MAY-2018) Division of Virology and I | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ou (2018) | Characterization of a New HIV-1 CRF01_AE/ B Recombinant Virus Form Among Men Who Have Sex with Men in Shanghai, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Oyomopito (2013) | Risk group characteristics and viral transmission clusters in Asian patients infected with HIV-1 circulating recombinant form (CRF)01_AE and subtype B | 23138836 | 0 | |
31 20PR 20RT |
0 | Case report(s) / study subset |
| Ozhmegova (2019) | Analysis of the local HIV-1 epidemic in Vologda region, Russia: Predominance of CRF03_AB and rapid expansion of URFs | Unpublished | 0 | |
77 77PR 77RT |
0 | Pending |
| Ozhmegova (2021) | Direct Submission | Submitted (13-OCT-2020) Laboratory of T-Lymphotrop | 0 | |
95 95PR 95RT |
0 | Unpublished |
| Pablo (2019) | Genetic Variation of the HIV-1 Integrase Region in Puerto Rico: 2015-2018 | Unpublished | 0 | |
132 132IN |
0 | Unpublished |
| Pace (2007) | POPULATION level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation | J. Virol. 80 (18), 9259-9269 (2006) | 0 | |
133 123PR 132RT 125IN |
0 | Pending |
| Pacold (2016) | Comparison of methods to detect HIV dual infection | AIDS Res. Hum. Retroviruses 26 (12), 1291-1298 (20 | 7.09e-113 | |
248 248RT |
0 | SGS |
| Padua (2025) | Direct Submission | Submitted (06-MAR-2025) Infectious Diseases, Natio | 6.69e-138 | |
80 45RT 35IN |
0 | Unpublished |
| Palacios-Saucedo (2011) | Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children | Curr. HIV Res. 9 (3), 154-159 (2011) | 0 | |
10 5PR 10RT |
0 | Case report(s) / study subset |
| Palladino (2017) | Early infant diagnosis of HIV-1 infection in Luanda using a new DNA PCR test and dried blood spots | Unpublished | 0 | |
9 9IN |
0 | Case report(s) / study subset |
| Palm (2015) | Co-circulation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing | AIDS Res. Hum. Retroviruses (2015) In press | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Palmer (2002) | REVERSE transcriptase and protease sequence evolution in two HIV-1-infected couples | J. Acquir. Immune Defic. Syndr. 31 (3), 285-290 (2002) | 1e-121 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Palumbo (2001) | ANTIRETROVIRAL resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades | J. Infect. Dis. 184 (9), 1120-1126 (2001) | 2e-85 | |
6 6RT |
0 | Case report(s) / study subset |
| Palumbo (2018) | Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052 | J. Acquir. Immune Defic. Syndr. (2018) In press | 0 | 242 242PR 242RT |
242 242PR 242RT |
100 | HIVDB |
| Palumbo (2019) | HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074 | PLoS ONE 14 (10), e0223829 (2019) | 0 | 449 449PR 449RT |
488 488PR 488RT |
92 | HIVDB |
| Palumbo (2022) | Multiple infection and HIV superinfection among persons who inject drugs in Indonesia and Ukraine | J Infect Dis (2022) In press | 0 | 79 79PR 79RT |
79 79PR 79RT |
100 | HIVDB |
| Pan (2022) | Direct Submission | Submitted (04-MAY-2022) HIV Prevention, Anhui Prov | 0 | |
166 166PR 166RT |
0 | Unpublished |
| Pandey (2013) | Molecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India. | AIDS Res Hum Retroviruses. 2013 Sep;29(9):1245-53. | 0 | |
10 10PR 10RT 2IN |
0 | HIVDB |
| Pandey (2015) | Genetic characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1 | 26756665 | 0 | 4 4PR 4RT 4IN |
9 9PR 9RT 9IN |
44 | HIVDB |
| Pandey (2015) | Novel intersubtype HIV-1 CRF01_AE/C and A1/C recombinants from India | 26294622 | 0 | 3 3PR 3RT 3IN |
14 14PR 14RT 14IN |
21 | HIVDB |
| Pando (2006) | First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. | Retrovirology | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Pando (2007) | HIGH Genetic Variability in Female Sex Workers (FSWs) from Argentina | 17697319 | 1e-145 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Pandrea (2001) | HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova | AIDS Res. Hum. Retroviruses 17 (13), 1297-1304 (2001) | 7e-86 | 6 6PR 6RT |
6 6PR 6RT |
100 | HIVDB |
| Pandrea (2002) | ANALYSIS of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon | AIDS Res. Hum. Retroviruses 18 (15), 1103-1116 (2002) | 1e-102 | 37 30PR 36RT |
37 36PR 37RT |
100 | HIVDB |
| Pang (2012) | Extensive and complex HIV-1 recombination between B', C and CRF01_AE among IDUs in south-east Asia | AIDS 26 (9), 1121-1129 (2012) | 0 | 69 69PR 69RT |
69 69PR 69RT |
100 | HIVDB |
| Pang (2025) | Low-Level Viremia: A Predictor of Drug Resistance and Virologic Failure Among People Living with HIV-1 in Southwest China | Unpublished | 0 | |
753 753PR 753RT |
0 | Unpublished |
| Panpradist (2019) | Development and evaluation of OLA-Simple 1.0: a software-guided test kit for low-resource laboratories to detect drug resistance in HIV-1 subtypes A, B, C, D and AE | Unpublished | 3.77e-155 | |
57 57RT |
0 | Methods paper |
| Panpradist (2020) | Direct Submission | Submitted (12-FEB-2020) Bioengineering, U of Washi | 2.36e-177 | |
17 17PR 17RT |
0 | Unpublished |
| Panpradist (2020) | Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort | AIDS (2020) In press | 0 | |
43 43PR 43RT 31IN |
0 | Case report(s) / study subset |
| Paolucci (2014) | Phylogenetic Analysis of HIV Type 1 CRF02_AG in Multiple Genes in Italian and African Patients Living in Italy | AIDS Res. Hum. Retroviruses 30 (8), 812-818 (2014) | 0 | 61 61IN |
95 95IN |
64 | HIVDB |
| Paolucci (2016) | Uncovering HIV-2 diffusion patterns using Bayesian phylogeographic analysis | Unpublished | 4.69e-108 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Papa (2002) | HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece | Virus Res. 85 (1), 85-93 (2002) | 5e-92 | 50 50RT |
50 50RT |
100 | HIVDB |
| Papa (2002) | GENETIC Variation of the Protease and Reverse Transcriptase Genes in HIV-1 CRF04_cpx Strains | AIDS Res. Hum. Retroviruses 18 (9), 677-680 (2002) | 7e-80 | 10 7PR 3RT |
10 7PR 3RT |
100 | HIVDB |
| Papathanasopoulos (2002) | FULL-LENGTH Genome Analysis of HIV-1 Subtype C Utilizing CXCR4 and Intersubtype Recombinants Isolated in South Africa | AIDS Res. Hum. Retroviruses 18 (12), 879-886 (2002) | 1e-165 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Papathanasopoulos (2003) | FULL-LENGTH Genome Characterization of HIV Type 1 Subtype C Isolates from Two Slow-Progressing Perinatally Infected Siblings in South Africa | AIDS Res. Hum. Retroviruses 19 (11), 1033-1037 (2003) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Papathanasopoulos (2010) | Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study | AIDS Res. Hum. Retroviruses 26 (6), 705-709 (2010) | 1e-168 | 67 35PR 35RT 32IN |
67 35PR 35RT 32IN |
100 | HIVDB |
| Papuashvili (2005) | CHARACTERISTICS of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe | Infect. Genet. Evol. 5 (1), 45-53 (2005) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Paraschiv (2007) | Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania | Int. J. Infect. Dis. 13 (1), 81-89 (2009) | 0 | 335 335RT |
351 351RT |
95 | HIVDB |
| Paraschiv (2010) | Diversity of HIV-1 subtype C strains isolated in Romania | Infect. Genet. Evol. (2010) In press | 1e-179 | |
57 57PR 57RT |
0 | Case report(s) / study subset |
| Paraschiv (2012) | Molecular typing of the recently expanding subtype B HIV-1 epidemic in Romania: Evidence for local spread among MSMs in Bucharest area | Infect. Genet. Evol. 12 (5), 1052-1057 (2012) | 0 | |
71 71PR 71RT |
0 | Case report(s) / study subset |
| Paraschiv (2012) | Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains | Int. J. Infect. Dis. 11 (2), 123-128 (2007) | 0 | 29 29PR 29RT |
29 29PR 29RT |
100 | HIVDB |
| Paraschiv (2014) | Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains. | AIDS Res Hum Retroviruses. 2015 May;31(5):488-95. | 0 | 139 139PR 139RT |
196 196PR 196RT |
70 | HIVDB |
| Paraschiv (2017) | The molecular epidemiology of HCV and HIV in co-infected intravenous drug users in Romania revealed different time points of HIV and HCV infection | 29016621 | 0 | 86 86PR 86RT |
86 86PR 86RT |
100 | HIVDB |
| Paraschiv (2024) | Direct Submission | Submitted (25-OCT-2024) Molecular Diagnostics Labo | 0 | 312 309PR 312RT |
333 326PR 333RT |
93 | HIVDB |
| Paraskevis (2000) | MOLECULAR characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences | AIDS Res. Hum. Retroviruses 16 (9), 845-855 (2000) | 1e-160 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Paraskevis (2001) | MOLECULAR characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype | J. Gen. Virol. 82 (Pt 10), 2509-2514 (2001) | 1e-158 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Paraskevis (2005) | PREVALENCE of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece | Virus Res. 112 (1-2), 115-122 (2005) | 3.88e-142 | 101 101RT |
202 101PR 101RT |
50 | HIVDB |
| Paraskevis (2007) | INCREASING Prevalence of HIV-1 Subtype A in Greece: Estimating Epidemic History and Origin | J. Infect. Dis. 196 (8), 1167-1176 (2007) | 0 | 2001 983PR 1019RT |
2068 1025PR 1046RT |
96 | HIVDB |
| Paraskevis (2014) | Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study | PLoS ONE 8 (11), E78941 (2013) | 1.05e-140 | |
56 56PR 56RT |
0 | Pending |
| Parbie (2022) | High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana | 36090108 | 0 | |
69 32PR 34RT 33IN |
0 | Pending |
| Parboosing (2011) | Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa | J. Med. Virol. 83 (9), 1508-1513 (2011) | 0 | 56 56PR 56RT |
56 56PR 56RT |
100 | HIVDB |
| Parczewski (2010) | Characteristics of HIV-1 non-B subtype infections in Northwest Poland | J. Med. Virol. 82 (8), 1306-1313 (2010) | 0 | 10 10PR 10RT |
21 21PR 21RT |
47 | HIVDB |
| Parczewski (2011) | HIV-1 subtype D infections among Caucasians from Northwestern Poland - phylogenetic and clinical analysis | 25248322 | 0 | 42 19PR 19RT 23IN |
43 19PR 19RT 24IN |
97 | HIVDB |
| Parczewski (2013) | HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland | BMC Infect. Dis. 12 (1), 368 (2012) | 1e-166 | 89 89IN |
89 89IN |
100 | HIVDB |
| Parczewski (2014) | Phylogeographic analysis on the travel-related introduction of HIV-1 non-B subtypes to Northern Poland | Infect. Genet. Evol. (2014) In press | 0 | 19 19PR 19RT |
48 48PR 48RT |
39 | HIVDB |
| Parczewski (2014) | Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype | J. Antimicrob. Chemother. (2014) In press | 0 | 789 789PR 789RT |
789 789PR 789RT |
100 | HIVDB |
| Parczewski (2015) | Distribution and time-trends for HIV-1 variants in Poland: characteristics of non-B clades and recombinant viruses | 26851192 | 0 | |
98 98PR 98RT |
0 | Pending |
| Pardons (2023) | Potent latency reversal by tat RNA enables multi-omic analysis of the HIV-1 reservoir | 38110433 | 0 | |
68 68PR 68RT 68IN |
0 | Proviral DNA Reservoir |
| Paredes (2011) | A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy | J. Infect. Dis. 204 (5), 741-752 (2011) | 0 | 271 269PR 266RT |
271 269PR 271RT |
100 | HIVDB |
| Parera (2003) | LACK of Evidence for Protease Evolution in HIV-1-Infected Patients after 2 Years of Successful Highly Active Antiretroviral Therapy | J. Infect. Dis. 189 (8), 1444-1451 (2004) | 3e-53 | |
288 288PR |
0 | Proviral DNA Reservoir |
| Parfenova (2012) | Direct Submission | Submitted (04-JUN-2012) Russian Inspectorate for P | 0 | |
107 107PR 107RT |
0 | HIVDB |
| Parfenova (2015) | Direct Submission | Submitted (11-JUN-2015) Russian Inspectorate for P | 0 | |
14 14PR 14RT |
0 | HIVDB |
| Parfenova (2018) | Direct Submission | Submitted (25-OCT-2016) Russian Inspectorate for P | 0 | |
30 30PR 30RT |
0 | Pending |
| Parfenova (2019) | Direct Submission | Submitted (16-OCT-2018) Russian Inspectorate for P | 0 | |
15 15PR 15RT |
0 | Unpublished |
| Parfenova (2020) | Direct Submission | Submitted (08-OCT-2019) Russian Inspectorate for P | 0 | |
30 30PR 30RT |
0 | Unpublished |
| Parham (2011) | Short Communication: High Prevalence of Drug Resistance in HIV Type 1-Infected Children Born in Honduras and Belize 2001 to 2004 | AIDS Res. Hum. Retroviruses 27 (10), 1055-1059 (20 | 2.1e-176 | 66 66PR 66RT |
66 66PR 66RT |
100 | HIVDB |
| Pariente (2004) | LONG-TERM suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes | J. Med. Virol. 73 (3), 350-361 (2004) | 0 | 56 56PR 56RT |
175 175PR 175RT |
32 | HIVDB |
| Parikh (2006) | ANTAGONISM between the HIV-1 Reverse-Transcriptase Mutation K65R and Thymidine-Analogue Mutations at the Genomic Level | J. Infect. Dis. 194 (5), 651-660 (2006) | 1e-174 | |
320 1PR 320RT |
0 | Pending |
| Park (1998) | MUTATIONS in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes | J. Virol. 72 (9), 7099-7107 (1998) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Park (2021) | Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada | Viruses 13 (4), 601 (2021) | 0 | 19 19PR 19RT |
19 19PR 19RT |
100 | HIVDB |
| Park (2003) | GENOTYPIC Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy | AIDS Res. Hum. Retroviruses 19 (11), 1039-1043 (2003) | 1e-126 | 86 39PR 47RT |
86 39PR 47RT |
100 | HIVDB |
| Park (2021) | Microdrop HIV sequencing for incidence and drug resistance surveillance | J Infect Dis (2021) In press | 0 | |
252 252PR 252RT 252IN |
0 | Pending |
| Park (2024) | Portable Nanopore sequencing solution for next-generation HIV drug resistance testing | J Clin Virol 171, 105639 (2024) | 0 | 857 857PR 857RT 857IN |
857 857PR 857RT 857IN |
100 | HIVDB |
| Parker (2002) | Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naive, HIV-infected individuals in New York State | AIDS Patient Care STDS 21 (9), 644-652 (2007) | 0 | 107 107PR 107RT 2IN |
165 136PR 136RT 2IN |
64 | HIVDB |
| Parker (2003) | DETECTION of resistance mutations in HIV-infected individuals who have discontinued antiretroviral therapy | Unpublished | 1e-123 | |
78 39PR 39RT |
0 | Proviral DNA Reservoir |
| Parkin (2000) | Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients. | AIDS | 1e-126 | 50 50PR 50RT |
51 51PR 51RT |
98 | HIVDB |
| Parkin (2006) | THE K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors | Antimicrob. Agents Chemother. 50 (1), 351-354 (2006) | 1e-172 | 76 76RT |
76 76RT |
100 | HIVDB |
| Parreira (2004) | Natural polymorphism of HIV-1 subtype G protease and cleavage sites. | AIDS | 5e-52 | 51 51PR |
55 55PR 53RT |
92 | HIVDB |
| Parreira (2006) | Natural polymorphisms of HIV type 2 pol sequences from drug-naive individuals | AIDS Res. Hum. Retroviruses 22 (11), 1178-1182 (20 | 2.43e-114 | 15 15PR 15RT |
30 30PR 30RT |
50 | HIVDB |
| Parreira (2006) | GENETIC characterization of human immunodeficiency virus type 1 from Beira, Mozambique | Microbes Infect. 8 (9-10), 2442-2451 (2006) | 5.07e-149 | 43 43PR 43RT |
43 43PR 43RT |
100 | HIVDB |
| Parrish (2012) | Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin alpha4beta7 | PLoS Pathog. 8 (5), E1002686 (2012) | 0 | |
212 102PR 102RT 212IN |
0 | Quasispecies |
| Parrish (2013) | Phenotypic properties of transmitted founder HIV-1 | Proc. Natl. Acad. Sci. U.S.A. 110 (17), 6626-6633 | 0 | |
651 326PR 326RT 651IN |
0 | Quasispecies |
| Parry (2009) | Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1 | J. Virol. 83 (18), 9094-9101 (2009) | 0 | |
2 2PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Partsuneva (2025) | Distinct Molecular Epidemiology, Transmission Patterns, and Resistance Mutations of HIV-1 Subtypes A1, A6, and A7 in Bulgaria | Microorganisms 13 (5), 1108 (2025) | 0 | |
106 106PR 106RT |
0 | Unpublished |
| Pasquier (2001) | HIV-1 subtyping using phylogenetic analysis of pol gene sequences | J. Virol. Methods 94 (1-2), 45-54 (2001) | 1e-127 | 84 33PR 51RT |
84 33PR 51RT |
100 | HIVDB |
| Passaes (2009) | Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil | AIDS Res. Hum. Retroviruses 25 (12), 1339-1344 (20 | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Passaes (2010) | Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil | J. Acquir. Immune Defic. Syndr. 51 (1), 7-12 (2009 | 1e-167 | 105 105IN |
105 105IN |
100 | HIVDB |
| Patil (2020) | Direct Submission | Submitted (12-SEP-2019) HIV Drug Resistance Labora | 0 | 85 85PR 85RT |
85 85PR 85RT |
100 | HIVDB |
| Patil (2011) | Emergence of drug resistance amongst human immunodeficiency virus type 1 infected individuals at the end of 12 months of first line ART initiation in India | 25006528 | 0 | |
16 16PR 16RT |
0 | Case report(s) / study subset |
| Patino-Galindo (2017) | The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters | 28912478 | 0 | 1763 1763PR 1763RT |
1763 1763PR 1763RT |
100 | HIVDB |
| Patino-Galindo (2018) | Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Patro (2020) | Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors | Proc. Natl. Acad. Sci. U.S.A. 116 (51), 25891-2589 | 0 | |
231 231PR 231RT 11IN |
0 | SGS |
| Patro (2022) | New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir | Viruses 13 (12), 2475 (2021) | 2.41e-175 | |
52 52PR 52RT |
0 | Proviral DNA Reservoir |
| Peeters (1999) | CHARACTERIZATION of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient | J. Virol. 73 (9), 7368-7375 (1999) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Peeters (2002) | RISK to human health from a plethora of simian immunodeficiency viruses in primate bushmeat | Emerging Infect. Dis. 8 (5), 451-457 (2002) | 1e-75 | |
21 21IN |
0 | NHPL/SIV |
| Pei (2019) | Multiple HIV-1 subtypes were found circulating in Suqian district of Jiangsu province, China | AIDS Res. Hum. Retroviruses (2019) In press | 0 | 84 83PR 84RT |
84 83PR 84RT |
100 | HIVDB |
| Peksheva (2021) | Direct Submission | Submitted (09-NOV-2021) Russian Inspectorate for P | 0 | |
15 15PR 15RT |
0 | Unpublished |
| Peksheva (2023) | Direct Submission | Submitted (27-OCT-2022) Russian Inspectorate for P | 0 | |
30 15PR 15RT 15IN |
0 | Unpublished |
| Peksheva (2024) | Direct Submission | Submitted (06-NOV-2024) Russian Inspectorate for P | 0 | |
15 15PR 15RT |
0 | Unpublished |
| Peksheva (2025) | Direct Submission | Submitted (16-OCT-2025) Russian Inspectorate for P | 0 | |
15 15PR 15RT |
0 | Unpublished |
| Peng (2018) | Untitled | Unpublished | 9.92e-175 | |
46 46PR 46RT |
0 | Unpublished |
| Peng (2016) | Near Full-Length Genome Identification of a Novel HIV-1 Recombinant Form (CRF01_AE/CRF07_BC) in Zhejiang, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Peng (2020) | Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure | AIDS Res Hum Retroviruses (2020) In press | 0 | |
89 89PR 89RT |
0 | Quasispecies |
| Pere (2011) | Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in bangui, central african republic | AIDS Res. Hum. Retroviruses 28 (4), 315-323 (2012) | 0 | 34 32PR 33RT |
34 32PR 34RT |
100 | HIVDB |
| Pereira-Vaz (2008) | HIGH prevalence of the protease codon 35 amino acid insertion in treatment-naive HIV-1 subtype C infected individuals in the central region of Portugal | 19625212 | 0 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Pereira-Vaz (2010) | Molecular epidemiology of HIV-1 in the central region of Portugal | Unpublished | 0 | |
146 146PR 146RT |
0 | Unpublished - Final |
| Pereira-Vaz (2020) | Direct Submission | Submitted (06-JAN-2020) Laboratory of Molecular Bi | 0 | |
2 2IN |
0 | Case report(s) / study subset |
| Pereira-Vaz (2025) | Direct Submission | Submitted (17-JUL-2025) Clinical Pathology Unit, C | 1.29e-127 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (16-JUL-2025) Clinical Pathology Unit, C | 1e-134 | |
1 1PR 1RT |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (17-JUL-2025) Clinical Pathology Unit, C | 5.39e-159 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (16-JUL-2025) Clinical Pathology Unit, C | 1.01e-134 | |
1 1PR 1RT |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (17-JUL-2025) Clinical Pathology Unit, C | 9.13e-141 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (10-NOV-2025) Clinical Pathology Unit, C | 2.26e-127 | |
2 2PR 2RT 2IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (11-NOV-2025) Clinical Pathology Unit, C | 4.99e-130 | |
4 3PR 3RT 4IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (11-NOV-2025) Clinical Pathology Unit, C | 1.1e-128 | |
5 4PR 4RT 5IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (11-NOV-2025) Clinical Pathology Unit, C | 1.19e-132 | |
5 5PR 5RT 4IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (10-NOV-2025) Clinical Pathology Unit, C | 6.58e-130 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (10-NOV-2025) Clinical Pathology Unit, C | 5.17e-127 | |
2 2PR 2RT 2IN |
0 | Unpublished |
| Pereira-Vaz (2025) | Direct Submission | Submitted (10-NOV-2025) Clinical Pathology Unit, C | 1.46e-129 | |
2 2PR 2RT 2IN |
0 | Unpublished |
| Perez Bercoff (2010) | Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir | Retrovirology 7 (1), 98 (2010) | 0 | 84 32PR 32RT 52IN |
86 32PR 32RT 54IN |
97 | HIVDB |
| Perez (2001) | HUMAN immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients | J. Infect. Dis. 183 (4), 579-588 (2001) | 1e-130 | 45 26PR 19RT |
45 26PR 19RT |
100 | HIVDB |
| Perez (2006) | HIV Type 1 Molecular Epidemiology in Cuba: High Genetic Diversity, Frequent Mosaicism, and Recent Expansion of BG Intersubtype Recombinant Forms | AIDS Res. Hum. Retroviruses 22 (8), 724-733 (2006) | 0 | 425 425PR 425RT |
425 425PR 425RT |
100 | HIVDB |
| Perez (2011) | Drug resistance in HIV Cuban children | 21654588 | 0 | |
22 22PR 22RT |
0 | Pending |
| Perez (2016) | Phylodinamic and phylogeographic profiles of subtype B HIV-1 epidemics in south Spain | PLoS ONE (2017) In press | 8.66e-146 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Perez-Losada (2017) | Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC | PLoS ONE 12 (9), E0185644 (2017) | 0 | 1883 1660PR 1660RT 223IN |
1883 1660PR 1660RT 223IN |
100 | HIVDB |
| Perez-Parra (2017) | High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach | PLoS ONE 12 (10), E0186928 (2017) | 7.15e-143 | 142 142PR 142RT |
142 142PR 142RT |
100 | HIVDB |
| Perez-Romero (2010) | Assay design for genotyping HIV-patients with viral loads below 1,000 copies/mL | Unpublished | 5.66e-162 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Permar (2013) | Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis | Retrovirology 10, 88 (2013) | 0 | |
94 72PR 72RT 80IN |
0 | Quasispecies |
| Pernas (2016) | A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection | J. Acquir. Immune Defic. Syndr. 42 (1), 12-18 (200 | 2.56e-56 | |
101 101RT |
0 | Quasispecies |
| Perno (2001) | Impact of mutations conferring reduced susceptibility to lamivudine(3TC) on the response to antiretroviral therapy. | Antivir Ther | 1e-130 | 203 202PR 203RT |
203 203PR 203RT |
100 | HIVDB |
| Persaud (2000) | A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children | J. Clin. Invest. 105 (7), 995-1003 (2000) | 1e-130 | |
26 21PR 23RT |
0 | Proviral DNA Reservoir |
| Persaud (2004) | CONTINUED Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads | J. Virol. 78 (2), 968-979 (2004) | 3e-53 | |
116 116PR |
0 | Proviral DNA Reservoir |
| Persaud (2007) | SLOW human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy | AIDS Res. Hum. Retroviruses 23 (3), 381-390 (2007) | 1.84e-150 | |
101 101PR 101RT |
0 | Proviral DNA Reservoir |
| Persaud (2011) | Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended Nevirapine Prophylaxis for Prevention of Mother-to-Child HIV Transmission | AIDS Res. Hum. Retroviruses 27 (8), 823-829 (2011) | 1.58e-167 | |
2981 2981RT |
0 | Pending |
| Persaud (2016) | Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States | J. Infect. Dis. 195 (10), 1402-1410 (2007) | 1.21e-157 | |
571 571RT |
0 | Proviral DNA Reservoir |
| Pessoa (2014) | Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71-BF1 among blood donors in Pernambuco, Brazil | 25401747 | 0 | 25 24PR 24RT 24IN |
26 25PR 25RT 25IN |
96 | HIVDB |
| Pessoa (2014) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF72_BF1) in Deep Sequencing Data from Blood Donors in Southeastern Brazil | Genome Announc 2 (3), e00386-14 (2014) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Pessoa (2014) | Genetic Characterization of HIV-1 Subtype D Near-Full-Length Proviral Genomes by Illumina Massively Parallel Sequencing Technology | Genome Announc 2 (3), e00586-14 (2014) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Pessoa (2014) | Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors | PLoS ONE 11 (3), E0152499 (2016) | 0 | 241 236PR 234RT 226IN |
254 236PR 241RT 241IN |
94 | HIVDB |
| Petch (2005) | GENOTYPIC Analysis of the Protease and Reverse Transcriptase of HIV Type 1 Subtype C Isolates from Antiretroviral Drug-Naive Adults in Malawi | AIDS Res. Hum. Retroviruses 21 (9), 799-805 (2005) | 1e-119 | 42 21PR 21RT |
42 21PR 21RT |
100 | HIVDB |
| Petroni (2003) | B/F intersubtype recombinants of HIV-1 in Argentina: impact on genotypic patterns associated with antiretroviral drug resistance | Unpublished | 0 | |
316 316PR 316RT |
0 | ARV Rx and/or other data are N/A |
| Petroni (2006) | UPDATE on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Nonnucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients | J. Acquir. Immune Defic. Syndr. 42 (4), 506-510 (2006) | 0 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Petroni (2012) | Direct Submission | Submitted (09-FEB-2012) Microbiology, Laboratorio | 0 | |
8 8PR 8RT |
0 | ARV Rx and/or other data are N/A |
| Petropoulos (2002) | APPENDIX 2: Retroviral taxonomy, protein structure, sequences, and genetic maps | (in) Coffin,J.M. (Ed.); RETROVIRUSES: 757; Cold Spring Harbo | 1e-163 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Peytavin (2018) | Assessing antiviral activity of integrase inhibitors against HIV-2 isolates revealed a new drug resistance mechanism: a 5 amino-acid insertion in the C-terminal domain of HIV-2 integrase | 30383215 | 3.97e-129 | 12 12IN |
12 12IN |
100 | HIVDB |
| Pham (2014) | Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam | 25332224 | 0 | |
85 35PR 56RT |
0 | Pending |
| Pham (2014) | Change in the Prevalence of HIV-1 and the Rate of Transmitted Drug-Resistant HIV-1 in Haiphong, Northern Vietnam | AIDS Res. Hum. Retroviruses 31 (7), 757-759 (2015) | 0 | 61 61RT |
61 7PR 61RT |
100 | HIVDB |
| Pham (2025) | HIV-1 Drug Resistance Patterns and Subtype Distribution Among Male PWID in Vietnam: Results from the National HIV Sentinel Surveillance, 2019 | Unpublished | 2.45e-172 | |
51 51PR 51RT |
0 | Unpublished |
| Phan (2015) | Genetic analyses of HIV-1 strains transmitted from mother to child in Northern Vietnam | AIDS Res. Hum. Retroviruses (2015) In press | 4.46e-148 | |
18 18PR 17RT |
0 | Pending |
| Phan (2007) | SEQUENCE variation in pol gene of HIV-1 isolated from Bach Mai hospital in Hanoi | Unpublished | 0 | |
1 1RT |
0 | Case report(s) / study subset |
| Phan (2011) | Sequence analysis of protease encoding gene of HIV type isolated in Vietnam | Unpublished | 6e-60 | |
7 7PR |
0 | ARV Rx and/or other data are N/A |
| Phan (2010) | Characterization of HIV Type 1 Genotypes and Drug Resistance Mutations Among Drug-Naive HIV Type 1-Infected Patients in Northern Vietnam | AIDS Res. Hum. Retroviruses 26 (2), 233-235 (2010) | 6.93e-150 | 184 173PR 155RT |
184 173PR 155RT |
100 | HIVDB |
| Philpott (2004) | HUMAN immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination | J. Virol. 79 (1), 353-363 (2005) | 0 | |
20 20PR 20RT 20IN |
0 | Quasispecies |
| Phung (2016) | Prevalence of drug resistance and associated mutation among HIV-1 na ve infected children at the National Hospital of Pediatrics, Hanoi Vietnam | Unpublished | 2.31e-150 | 102 85PR 68RT |
102 85PR 68RT |
100 | HIVDB |
| Piantadosi (2018) | Metagenomic sequencing of HIV-1 in the blood and female genital tract reveals little quasispecies diversity during acute infection | J. Virol. (2018) In press | 0 | |
11 11PR 11RT 11IN |
0 | Case report(s) / study subset |
| Picchio (2001) | ALTERED viral fitness of HIV-1 following failure of protease inhibitor-based therapy | J. Acquir. Immune Defic. Syndr. 25 (4), 289-295 (2000) | 1e-121 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Pieniazek (1991) | Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction. | AIDS. 1991 Nov;5(11):1293-9. | 1e-126 | |
16 16PR |
0 | Case report(s) / study subset |
| Pieniazek (1998) | INTRODUCTION of HIV-2 and multiple HIV-1 subtypes to Lebanon | Emerging Infect. Dis. 4 (4), 649-656 (1998) | 1e-126 | 26 26PR |
26 26PR |
100 | HIVDB |
| Pieniazek (1999) | PRESENCE of human immunodeficiency virus type 2 subtypes A and B in Abidjan, Cote d' Ivoire | 10221538 | 2e-24 | 31 31PR |
31 31PR |
100 | HIVDB |
| Pieniazek (2003) | HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1 | AIDS 18 (3), 495-502 (2004) | 6e-25 | 27 27PR |
27 27PR |
100 | HIVDB |
| Pilcher (1999) | GENOTYPIC resistance and the treatment of HIV-1 infection in Espirito Santo, Brazil | J. Infect. Dis. 179 (5), 1259-1263 (1999) | 1e-128 | |
72 72PR 72RT |
0 | Sequence quality |
| Pillay (2002) | HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa | AIDS Res. Hum. Retroviruses 18 (8), 605-610 (2002) | 2e-67 | 37 37RT |
37 37RT |
100 | HIVDB |
| Pillay (2004) | EMERGENCE of resistance mutations in children treated with ddI plus d4T after treatment to prevent mother-to-child transmission | 15839752 | 1e-174 | 40 40RT |
46 46RT |
86 | HIVDB |
| Pillay (2004) | POLYMORPHISMS in HIV Subtype C protease encode secondary drug resistance mutations | Unpublished | 1e-50 | |
31 31PR |
0 | Case report(s) / study subset |
| Pillay (2014) | Drug resistance in children with virological failure on first-line antiretroviral therapy: rural KwaZulu-Natal, South Africa | 24444369 | 0 | 89 88PR 89RT |
89 88PR 89RT |
100 | HIVDB |
| Pillay (2005) | HIV Type 1 Subtype C Drug Resistance among Pediatric and Adult South African Patients Failing Antiretroviral Therapy | AIDS Res. Hum. Retroviruses 24 (11), 1449-1454 (2008) | 0 | 68 68PR 68RT |
68 68PR 68RT |
100 | HIVDB |
| Pillay (2012) | Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004 | Antivir. Ther. (Lond.) 13 (SUPPL 2), 101-107 (2008 | 4e-170 | 101 101RT |
101 80PR 101RT |
100 | HIVDB |
| Pilon (2011) | Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs Recruited through Respondent-Driven Sampling | 21799802 | 1e-168 | |
29 29PR 29RT |
0 | ARV Rx and/or other data are N/A |
| Pilon (2011) | Molecular Epidemiology of an HIV-1 Outbreak among Intravenous Drug Users in Pakistan | Unpublished | 0 | |
158 88PR 158RT |
0 | ARV Rx and/or other data are N/A |
| Pimenta (2018) | HIV-1 genetic diversity and resistance to antiretroviral drugs in pregnant women in Ribeirao Preto, Sao Paulo, Brazil | 29791608 | 0 | |
35 35PR 34RT |
0 | Case report(s) / study subset |
| Pingen (2012) | Therapy failure resulting from superinfection by a drug resistant HIV variant | 22846173 | 2.39e-156 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Pinheiro (2020) | Different risk factors for HIV and syphilis among homeless people in a large city in the midwestern of Brazil | Unpublished | 1.07e-166 | |
8 8PR 8RT |
0 | Unpublished |
| Pinnetti (2024) | Cerebrospinal Fluid and Peripheral Blood Lymphomonocyte Single-Cell Transcriptomics in a Subject with Multiple Sclerosis Acutely Infected with HIV | Int J Mol Sci 25 (19), 10459 (2024) | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Pinzone (2019) | Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion | Nat Commun 10 (1), 728 (2019) | 0 | |
1717 1337PR 1499RT 1475IN |
0 | Pending |
| Pircher (2012) | Molecular Characterization of HIV Type 1 in Brazzaville, Republic of Congo, and First Data on Resistance to Antiretroviral Drugs | AIDS Res. Hum. Retroviruses 28 (12), 1798-1802 (20 | 0 | 166 89PR 77RT |
171 91PR 80RT |
97 | HIVDB |
| Pires (2004) | PREVALENCE of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, Brazil | J. Clin. Microbiol. 42 (1), 426-430 (2004) | 1e-114 | 98 49PR 49RT |
99 49PR 50RT |
98 | HIVDB |
| Pirkl (2024) | Direct Submission | Submitted (10-JAN-2024) Institute of Virology, Uni | 0 | |
28 13PR 28RT |
0 | Case report(s) / study subset |
| Pirkl (2024) | Geno2pheno: Recombination detection for HIV-1 and HEV subtypes | Unpublished | 0 | |
14 7PR 7RT 7IN |
0 | Case report(s) / study subset |
| Piterskiy (2019) | Circulation of HIV in the Ural region in 2016-2018 | Unpublished | 7.33e-180 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Piterskiy (2019) | Direct Submission | Submitted (21-JUN-2019) Ural District Center for t | 0 | |
235 235PR 235RT |
0 | Unpublished |
| Piterskiy (2020) | Zakharova Yu.A., Peterskiy M.V., Bolgarova E.V., Gusev A.G., Khodakov O.A., Sannikova L.B., Alimov A.V. Drug resistance mutations and other polymorphism detected in HIV-1 strains isolated from patients in Chelyabinsk Oblast | Unpublished | 0 | |
38 38PR 38RT |
0 | Unpublished |
| Piterskiy (2023) | Drug resistance mutations and other polymorphism detected in HIV-1 strains isolated from patients in Tumen Oblast | Unpublished | 0 | |
20 20PR 20RT |
0 | Unpublished |
| Piterskiy (2023) | Phylogenetic position and genetic features of HIV subpopulations in the central nervous system | Unpublished | 0 | |
57 57PR 57RT |
0 | Pending |
| Piterskiy (2023) | Prevalence of resistant HIV-1 strains to antiretroviral drugs in the Tyumen region | Unpublished | 0 | |
72 72PR 72RT |
0 | Unpublished |
| Piterskiy (2024) | Prevalence of resistant HIV-1 strains to antiretroviral drugs in the Tyumen region | Unpublished | 0 | |
35 35PR 35RT |
0 | Unpublished |
| Piterskiy (2025) | Prevalence of resistant HIV-1 strains to antiretroviral drugs in the Tyumen region in the first half of 2024 | Unpublished | 0 | |
135 93PR 93RT 42IN |
0 | Unpublished |
| Piterskiy (2025) | Prevalence of resistant HIV-1 strains to antiretroviral drugs in the Tyumen region in 2024 | Unpublished | 0 | |
94 94PR 94RT |
0 | Unpublished |
| Piterskiy (2025) | HIV genetic diversity in the Ural Federal District | Unpublished | 0 | |
40 40IN |
0 | Unpublished |
| Piterskiy (2025) | HIV genetic diversity in the Ural Federal District | Unpublished | 0 | |
67 67PR 67RT |
0 | Unpublished |
| Piyasirisilp (2000) | A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant | J. Virol. 74 (23), 11286-11295 (2000) | 1e-165 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Pizzi (2023) | Direct Submission | Submitted (19-MAY-2022) Core Facilities, Istituto | 0 | |
47 46PR 47RT |
0 | Pending |
| Planinic (2023) | Direct Submission | Submitted (26-SEP-2023) Department for Immunologic | 0 | 522 258PR 258RT 264IN |
522 258PR 258RT 264IN |
100 | HIVDB |
| Planinic (2023) | Direct Submission | Submitted (28-SEP-2023) Department for Immunologic | 0 | 10 10PR 10RT |
12 12PR 12RT |
83 | HIVDB |
| Plantier (2009) | A new immunodeficiency virus derived from gorillas | Nat. Med. (2009) In press | 0 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Plantier (2025) | DNA HIV-1/O sequences | Unpublished | 8.99e-46 | |
38 38PR |
0 | Unpublished |
| Poddubskaya (2009) | The sequence of fragment of HIV-1 pol gene from Russia patient | Unpublished | 0 | |
47 47PR 47RT |
0 | ARV Rx and/or other data are N/A |
| Policicchio (2018) | Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART) | 29466356 | 5.59e-86 | |
16 8RT 8IN |
0 | NHPL/SIV |
| Pollakis (2003) | RECOMBINATION of HIV Type 1C (C'/C') in Ethiopia: Possible Link of EthHIV-1C' to Subtype C Sequences from the High-Prevalence Epidemics in India and Southern Africa | AIDS Res. Hum. Retroviruses 19 (11), 999-1008 (2003) | 0 | 26 23PR 25RT |
30 27PR 29RT |
86 | HIVDB |
| Polotan (2023) | Reconstructing the phylodynamic history and geographic spread of the CRF01_AE-predominant HIV-1 epidemic in the Philippines from PR/RT sequences sampled from 2008-2018 | Unpublished | 0 | |
1404 1393PR 1399RT |
0 | ARV Rx and/or other data are N/A |
| Ponce-Alonso (2023) | Direct Submission | Submitted (11-MAY-2023) Microbiology, Hospital Ram | 0 | |
2 2PR 2RT 2IN |
0 | Pending |
| Poon (2018) | Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays | 29976219 | 2.38e-112 | |
34 34RT |
0 | Proviral DNA Reservoir |
| Powell (2007) | CIRCULATING Recombinant Form (CRF) 37_cpx: An Old Strain in Cameroon Composed of Diverse, Genetically Distant Lineages of Subtypes A and G | AIDS Res. Hum. Retroviruses 23 (7), 923-933 (2007) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Powell (2007) | QUASISPECIES analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG | J. Med. Virol. 79 (9), 1270-1285 (2007) | 0 | |
3 3RT |
0 | Case report(s) / study subset |
| Powell (2007) | IDENTIFICATION of a Novel Circulating Recombinant Form (CRF) 36_cpx in Cameroon That Combines Two CRFs (01_AE and 02_AG) with Ancestral Lineages of Subtypes A and G | AIDS Res. Hum. Retroviruses 23 (8), 1008-1019 (2007) | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Powell (2009) | Longitudinal quasispecies analysis of viral variants in HIV type 1 dually infected individuals highlights the importance of sequence identity in viral recombination | AIDS Res. Hum. Retroviruses 26 (3), 253-264 (2010) | 0 | |
562 187RT 375IN |
0 | Quasispecies |
| Powell (2016) | The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials | 2107214 | 3.3e-38 | |
76 76PR |
0 | Gene fragment(s) |
| Pradeesh (2025) | Direct Submission | Submitted (15-OCT-2025) Virology, Central Public H | 0 | |
1 1PR 1RT |
0 | Unpublished |
| Prakash (2010) | Drug Resistant Mutations in HIV Infected Clade C Patients | Unpublished | 5.56e-102 | |
1 1RT |
0 | ARV Rx and/or other data are N/A |
| Praparattanapan (2011) | Current Molecular Epidemiology and Recombination of HIV Type 1 Subtypes in Northern Thailand | AIDS Res. Hum. Retroviruses (2011) In press | 1.67e-175 | 412 412PR 412RT |
412 412PR 412RT |
100 | HIVDB |
| Prasetyo (2011) | Direct Submission | Submitted (20-AUG-2010) Department of Microbiology | 8e-56 | |
13 13IN |
0 | Gene fragment(s) |
| Prejdova (2003) | RESISTANCE development in HIV positive patients treated by protease inhibitors: correlation of the genotype and disease progression | Unpublished | 6e-52 | |
23 23PR |
0 | ARV Rx and/or other data are N/A |
| Prellwitz (2013) | HIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern Brazil. | PLoS One. 2013 Jul 9;8(7):e69033. | 0 | 38 32PR 38RT |
336 199PR 336RT |
11 | HIVDB |
| Prendergast (2016) | Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants | AIDS 22 (11), 1333-1343 (2008) | 1.15e-169 | |
57 57PR 57RT |
0 | Pending |
| Price (2013) | Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa | AIDS Res. Hum. Retroviruses 27 (1), 5-12 (2011) | 0 | 638 634PR 637RT 48IN |
638 635PR 637RT 48IN |
100 | HIVDB |
| Protasova (2025) | The role of HIV-1 non-structural proteins in determining genetic variation | Unpublished | 0 | |
3 3PR 3RT |
0 | Case report (Small sample size) |
| Pujari (2018) | Integrase Resistance-Associated Mutations on Raltegravir Failure in Western India: A Preliminary Analysis | J. Acquir. Immune Defic. Syndr. 77 (5), e42-e45 (2 | 0 | 22 22IN |
22 22IN |
100 | HIVDB |
| Pujol-Hodge (2022) | Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa | Viruses 14 (8), 1673 (2022) | 2.05e-177 | 488 488PR 488RT |
488 487PR 488RT |
100 | HIVDB |
| Punzi (2004) | HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic | J. Med. Virol. 77 (4), 457-459 (2005) | 1e-147 | 12 12PR 2RT |
12 12PR 2RT |
100 | HIVDB |
| Pushkarsky (2003) | DIRECT Submission | Submitted (28-FEB-2003) Microbiology and Tropical Medicine, | 0 | |
3 2RT 2IN |
0 | Case report(s) / study subset |
| Pyne (2013) | Large-Scale Analysis of the Prevalence and Geographic Distribution of HIV-1 Non-B Variants in the United States | J. Clin. Microbiol. 51 (8), 2662-2669 (2013) | 0 | 798 798PR 798RT |
798 798PR 798RT |
100 | HIVDB |
| Qari (2002) | A rapid phenotypic assay for detecting multiple nucleoside analog reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 in plasma | Antivir. Ther. (Lond.) (2002) In press | 1e-116 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Qi (2012) | HIV-1 Diversity, Drug-Resistant Mutations, and Viral Evolution among High-Risk Individuals in Phase II HIV Vaccine Trial Sites in Southern China | PLoS ONE 8 (7), E68656 (2013) | 3.17e-85 | 65 65PR 65RT |
65 65PR 65RT |
100 | HIVDB |
| Qiu (2005) | CHARACTERIZATION of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China | AIDS Res. Hum. Retroviruses 21 (12), 1051-1056 (2005) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Quan (2003) | DRUG resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C | AIDS Res. Hum. Retroviruses 19 (9), 743-753 (2003) | 2e-61 | |
3 3RT |
0 | Laboratory/experimental isolate |
| Quansah (2022) | Transmitted Drug Resistance of Circulating HIV-1 Sub-types in ART-naive HIV Patients in Ghana | Unpublished | 0 | 36 32PR 28RT |
36 32PR 28RT |
100 | HIVDB |
| Quarleri (2004) | DIRECT Submission | Submitted (01-DEC-2003) National Reference Center for AIDS-M | 0 | |
16 16PR 16RT |
0 | ARV Rx and/or other data are N/A |
| Quesnel-Vallieres (2011) | Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada | Emerging Infect. Dis. 17 (2), 271-274 (2011) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Quinones-Mateu (1996) | Molecular characterization of human immunodeficiency virus type 1 isolates from Venezuela | AIDS Res. Hum. Retroviruses 11 (5), 605-616 (1995) | 0 | 8 8RT |
8 8RT |
100 | HIVDB |
| Quinones-Mateu (1997) | CHARACTERIZATION of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate | Virology 236 (2), 364-373 (1997) | 0.00000007 | |
1 1RT |
0 | Case report(s) / study subset |
| Quinones-Mateu (1998) | ANALYSIS of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1 | J. Virol. 72 (11), 9002-9015 (1998) | 1e-21 | 11 11RT |
88 88RT |
12 | HIVDB |
| Quirola (2023) | HIV drug resistance in a group of Patients at healthcare center in Quito Ecuador | Unpublished | 0 | |
40 39PR 39RT 38IN |
0 | Pending |
| Rachinger (2013) | Time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of HIV-1 transmission | AIDS 25 (8), 1035-1039 (2011) | 4.18e-159 | |
66 66PR 66RT |
0 | Case report(s) / study subset |
| Rachman (2024) | Genotypic Analysis of Transmitted and Acquired HIV Drug Resistance in People Living with HIV/AIDS in Surabaya, Indonesia, from 2018 to 2019 | Acta Med Indones 56 (2), 168-175 (2024) | 1.55e-180 | |
38 17PR 21RT |
0 | Pending |
| Ragonnet-Cronin (2010) | Longitudinal Phylogenetic Surveillance Identifies Distinct Patterns of Cluster Dynamics | J. Acquir. Immune Defic. Syndr. (2010) In press | 0 | 875 875PR 875RT |
876 876PR 876RT |
99 | HIVDB |
| Ragonnet-Cronin (2012) | Genetic Diversity as a Marker for Timing Infection in HIV-Infected Patients: Evaluation of a 6-Month Window and Comparison With BED. | J Infect Dis | 1e-178 | 535 535PR 535RT |
536 536PR 536RT |
99 | HIVDB |
| Ragonnet-Cronin (2012) | Adaptive Evolution of HIV at HLA Epitopes Is Associated with Ethnicity in Canada | PLoS ONE 7 (5), E36933 (2012) | 0 | 483 483PR 483RT |
483 483PR 483RT |
100 | HIVDB |
| Ragonnet-Cronin (2016) | Transmission of non-B HIV subtypes in the UK is increasingly driven by large non-heterosexual clusters | J. Infect. Dis. (2016) In press | 0 | |
1109 1107PR 1109RT |
0 | ARV Rx and/or other data are N/A |
| Ragonnet-Cronin (2016) | A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland | Sci Rep 6, 32251 (2016) | 0 | 2281 2280PR 2262RT |
2281 2280PR 2262RT |
100 | HIVDB |
| Ragonnet-Cronin (2018) | Recent and Rapid Transmission of HIV among People who Inject Drugs in Scotland Revealed through Phylogenetic Analysis | J. Infect. Dis. (2018) In press | 6.09e-159 | 11 11PR 11RT |
11 11PR 11RT |
100 | HIVDB |
| Ragupathy (2011) | Identification of New, Emerging HIV-1 Unique Recombinant Forms and Drug Resistant Viruses Circulating in Cameroon | Virol. J. 8 (1), 185 (2011) | 1.8e-137 | |
26 26PR 26RT |
0 | Gene fragment(s) |
| Ragupathy (2016) | PCR amplicon free whole genome charecterization of Human immunodeficiency virus type -1 genotypes | Unpublished | 0 | |
27 27PR 27RT 27IN |
0 | Unpublished - Final |
| Rahayu (2019) | The Prevalence of Transmitted Drug Resistance Associated Mutations in Protease and Reverse Transcriptase Gene among HIV-1 Infected Drug-Naive Patients in Jakarta, Indonesia | 32874468 | 4.14e-171 | |
30 21PR 9RT |
0 | Case report (Small sample size) |
| Rahayu (2020) | The Prevalence of Drug Resistance Associated Mutations in Protease and Reverse Transcriptase Gene among HIV-1 Infected Drug-Naive Patients in Jakarta, Indonesia | Unpublished | 3.47e-172 | |
6 6RT |
0 | Unpublished |
| Rahman (2021) | Drug resistance pattern among ART naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh | 34636431 | 0 | 21 9PR 10RT 10IN |
21 9PR 19RT 10IN |
100 | HIVDB |
| Rahman (2024) | Direct Submission | Submitted (16-MAY-2024) Virology laboratory, icddr | 0 | |
32 30PR 31RT |
0 | Unpublished |
| Rainwater (2005) | NO Evidence for Rapid Subtype C Spread within an Epidemic in Which Multiple Subtypes and Intersubtype Recombinants Circulate | AIDS Res. Hum. Retroviruses 21 (12), 1060-1065 (2005) | 1e-166 | |
23 23RT 23IN |
0 | Pending |
| Rainwater-Lovett (2017) | Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection | PLoS ONE 12 (2), E0170548 (2017) | 0 | |
47 20PR 45RT 45IN |
0 | Gene fragment(s) |
| Rajesh (2009) | Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients | AIDS Res. Hum. Retroviruses 25 (11), 1179-1185 (20 | 2e-173 | 231 112PR 119RT |
231 112PR 119RT |
100 | HIVDB |
| Rakgole (2012) | HIV-1 sequence diversity in the Pretoria region, South Africa | Unpublished | 0 | |
31 31PR 31RT |
0 | Case report(s) / study subset |
| Rakotomalala (2024) | High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar | Infect Genet Evol 125, 105679 (2024) | 0 | 604 195PR 188RT 221IN |
604 195PR 188RT 221IN |
100 | HIVDB |
| Ramalingam (2018) | Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen | Infect Dis (Lond) (2018) In press | 0 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Ramesh (2019) | Prevalence and pattern of drug resistant mutations in HIV-1 isolates from a representative population of South Indian children recently diagnosed to be HIV-infected through the national early infant diagnosis program | Unpublished | 2.36e-174 | |
115 115RT |
0 | Unpublished |
| Ramesh (2022) | Molecular characterisation of the pol gene of vertically transmitted HIV-1 strains in children with virological failure | 35302390 | 0 | 145 112PR 145RT |
145 98PR 145RT |
100 | HIVDB |
| Ramirez de Arellano (2004) | GENETIC Analysis of Regulatory, Promoter, and TAR Regions of LTR Sequences Belonging to HIV Type 1 Non-B Subtypes | AIDS Res. Hum. Retroviruses 21 (11), 949-954 (2005) | 1e-131 | |
15 15PR 12RT |
0 | Case report(s) / study subset |
| Ramkissoon (2012) | Analysis of Reverse Transcriptase and Protease Genes of HIV for Antiretroviral Drug Resistance in Treatment-Exposed Jamaican Pediatrics | AIDS Res. Hum. Retroviruses 31 (9), 932-937 (2015) | 0 | 40 40PR 40RT |
41 41PR 41RT |
97 | HIVDB |
| Ramos (1999) | DUAL and recombinant infections: an integral part of the HIV-1 epidemic in Brazil | Emerging Infect. Dis. 5 (1), 65-74 (1999) | 1e-124 | 24 24PR |
25 25PR |
96 | HIVDB |
| Ramos (2002) | NEW HIV Type 1 CRF01_AE/B Recombinants Displaying Unique Distribution of Breakpoints from Incident Infections among Injecting Drug Users in Thailand | AIDS Res. Hum. Retroviruses 19 (8), 667-674 (2003) | 1e-164 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Rangel (2009) | Deletion, insertion and stop codon mutations in vif genes of HIV-1 infecting slow progressor patients | J Infect Dev Ctries 3 (7), 531-538 (2009) | 2e-21 | |
36 36IN |
0 | Gene fragment(s) |
| Rangel (2009) | HIV diversity in Venezuela: predominance of HIV type 1 subtype B and genomic characterization of non-B variants | AIDS Res. Hum. Retroviruses 25 (3), 347-350 (2009) | 0 | |
337 333PR 337RT |
0 | ARV Rx and/or other data are N/A |
| Rangel (2010) | Absence of primary integrase resistance mutations in HIV type 1-infected patients in Venezuela | AIDS Res. Hum. Retroviruses 26 (8), 923-926 (2010) | 0 | 103 36PR 36RT 67IN |
103 36PR 36RT 67IN |
100 | HIVDB |
| Rangel (2012) | Evidence of at Least Two Introductions of HIV-1 in the Amerindian Warao Population from Venezuela | PLoS ONE 7 (7), E40626 (2012) | 0 | |
49 45PR 45RT 4IN |
0 | ARV Rx and/or other data are N/A |
| Rashid (2023) | Genomic Characterization of a Novel HIV-1 DG intersubtype recombinant strain in Karachi, Pakistan | Unpublished | 0 | |
8 8PR 8RT 4IN |
0 | Case report(s) / study subset |
| Rashid (2023) | Characterization of HIV-1 unique recombinant forms identified among children in Larkana, Pakistan | Unpublished | 0 | |
7 7PR 7RT 7IN |
0 | Case report(s) / study subset |
| Rashid (2024) | HIV-1 genetic diversity and drug resistance mutations among people living with HIV in Karachi, Pakistan | 38932254 | 0 | 268 268PR 268RT |
268 268PR 268RT |
100 | HIVDB |
| Rasmussen (2018) | Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa | 30555720 | 0 | 212 212PR 212RT |
212 212PR 212RT |
100 | HIVDB |
| Rassler (2015) | Reconstruction of Residual HIV-1 from Plasma Viral RNA of a Patient on Suppressive Antiretroviral Therapy Identifies a Novel Mutation in the Viral 5'-Major Splice Donor Motif: Implication for Residual HIV-1 Persistence in vivo | 27655142 | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Raugi (2013) | Complex Patterns of Protease Inhibitor Resistance among Antiretroviral Treatment-Experienced HIV-2 Patients from Senegal: Implications for Second-Line Therapy | Antimicrob. Agents Chemother. 57 (6), 2751-2760 (2 | 0 | 356 356PR 356RT |
356 356PR 356RT |
100 | HIVDB |
| Raugi (2020) | Direct Submission | Submitted (09-SEP-2020) Medicine/Allergy & Infecti | 1.59e-158 | 135 118PR 118RT 17IN |
140 123PR 123RT 17IN |
96 | HIVDB |
| Ravuri (2006) | PRIMARY Drug Resistance Studies by Genotypic Analysis in HIV-1 Indian Subtype C-Infected Individuals | Unpublished | 0 | 50 50RT |
50 50RT |
100 | HIVDB |
| Rawizza (2013) | Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria | PLoS ONE 8 (9), E73582 (2013) | 0 | 55 55PR 55RT |
55 55PR 55RT |
100 | HIVDB |
| Raymond (2013) | Direct Submission | Submitted (16-MAY-2013) Centre de Recherche en Inf | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Raymond (2021) | Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance | J Clin Virol 122, 104229 (2020) | 0 | 61 31PR 31RT 30IN |
61 31PR 31RT 30IN |
100 | HIVDB |
| Razafindratsimandresy (2006) | HIGH HIV Type 1 Subtype Diversity and Few Drug Resistance Mutations among Seropositive People Detected during the 2005 Second Generation HIV Surveillance in Madagascar | AIDS Res. Hum. Retroviruses 22 (6), 595-597 (2006) | 5.85e-149 | 60 29PR 31RT |
60 29PR 31RT |
100 | HIVDB |
| Razafindratsimandresy (2007) | HIV Type 1 Diversity in the Seychelles | AIDS Res. Hum. Retroviruses 23 (6), 761-763 (2007) | 4e-160 | 84 42PR 42RT |
84 42PR 42RT |
100 | HIVDB |
| Recordon-Pinson (2010) | Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study | Antimicrob. Agents Chemother. 54 (8), 3335-3340 (2 | 0 | 178 121PR 91RT |
198 141PR 140RT |
89 | HIVDB |
| Recordon-Pinson (2012) | K65R in Subtype C HIV-1 Isolates from Patients Failing on a First-Line Regimen Including d4T or AZT: Comparison of Sanger and UDP Sequencing Data | PLoS ONE 7 (5), E36549 (2012) | 3e-173 | 53 53RT |
53 53RT |
100 | HIVDB |
| Recordon-Pinson (2018) | A new HIV-1 circulating recombinant form (CRF98_cpx) between CRF06_cpx and subtype B identified in Southwestern France | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 19 8PR 8RT 3IN |
21 10PR 10RT 5IN |
90 | HIVDB |
| Recordon-Pinson (2020) | Phylogenetic analysis of HIV-1 archived DNA in blood and gut-associated lymphoid tissue in patients receiving antiretroviral therapy: a study from Provir/Latitude45 project | Unpublished | 0 | |
62 62RT |
0 | Proviral DNA Reservoir |
| Redd (2019) | Longitudinal antibody responses in people who inject drugs infected with similar HIV strains | J. Infect. Dis. (2019) In press | 9.99e-120 | |
23 23RT |
0 | Case report(s) / study subset |
| Reddy (2024) | Direct Submission | Submitted (14-DEC-2023) Basic and Translational Sc | 0 | |
360 337PR 345RT 324IN |
0 | Unpublished |
| Reed (2005) | HIGH prevalence of a new SIV in cercopithecus erythrotis from the island of Bioko, Equatorial Guinea : molecular characterization of SIVery from tissue samples | Unpublished | 1e-76 | |
11 1RT 11IN |
0 | NHPL/SIV |
| Reeve (2009) | Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection | AIDS Res. Hum. Retroviruses 25 (6), 583-601 (2009) | 1e-102 | |
1238 1238RT 1238IN |
0 | Quasispecies |
| Rego (2025) | Immunological and virological characterization of HIV-1-infected individuals in the state of Bahia and identification of disease progression markers and HIV/AIDS treatment failure | Unpublished | 5.65e-173 | |
157 157PR 157RT |
0 | Unpublished |
| Rehman (2021) | Phylogenetic analysis and drug resistance genotyping of HIV pol gene in HIV patients receiving ART in Lahore | Unpublished | 1.97e-62 | |
11 11PR |
0 | Unpublished |
| Reid (2005) | NATURAL resistance of human immunodeficiency virus type 2 to zidovudine | Virology 336 (2), 251-264 (2005) | 0 | 4 4RT |
10 10RT |
40 | HIVDB |
| Reigadas (2012) | HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and-experienced patients with different HIV-1 subtypes | 23184711 | 1e-167 | 554 554IN |
554 554IN |
100 | HIVDB |
| Reina (2020) | Direct Submission | Submitted (13-JAN-2020) Microbiology, Clinica Univ | 0 | 5 3RT 3IN |
15 6PR 12RT 7IN |
33 | HIVDB |
| Reinis (2002) | HUMAN immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing | Acta Virol. 45 (5-6), 279-286 (2001) | 4e-96 | |
32 32RT |
0 | ARV Rx and/or other data are N/A |
| Reinis (2006) | GENOMIC Analysis of HIV Type 1 Strains Derived from a Mother and Child Pair of Long-Term Nonprogressors | AIDS Res. Hum. Retroviruses 23 (2), 309-315 (2007) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Reinke (2002) | NATURAL selection results in conservation of HIV-1 integrase activity despite sequence variability | AIDS 15 (7), 823-830 (2001) | 1e-164 | 4 4IN |
4 4IN |
100 | HIVDB |
| Reinke (2002) | INHIBITION of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid | Antimicrob. Agents Chemother. 46 (10), 3301-3303 (2002) | 1e-166 | |
6 6IN |
0 | Laboratory/experimental isolate |
| Reis (2017) | Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions | PLoS ONE 12 (6), E0178578 (2017) | 0 | 11 11PR 11RT 10IN |
11 11PR 11RT 10IN |
100 | HIVDB |
| Reis (2019) | Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms | Front Microbiol 10 (2019) In press | 0 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Reitz (1995) | VIRAL variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB) | AIDS Res. Hum. Retroviruses 10 (9), 1143-1155 (1994) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Ren (2017) | HIV-1 epidemiological survey reveals the CRF07_BC and CRF08_BC subtypes are the main epidemic subtypes in Zhaotong City, different from other parts of Yunnan Province | 29091580 | 0 | 88 88PR 88RT |
88 88PR 88RT |
100 | HIVDB |
| Resch (2004) | EVOLUTION of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir | J. Virol. 79 (16), 10638-10649 (2005) | 3e-53 | |
458 458PR 15RT |
0 | HIVDB |
| Reuman (2009) | Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector | Antimicrob. Agents Chemother. 54 (2), 934-936 (201 | 1e-166 | 7 7IN |
16 16IN |
43 | HIVDB |
| Rey-Cuille (1994) | HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis | Virology 202 (1), 471-476 (1994) | 1e-101 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Reynolds (2011) | Antiretroviral Drug Susceptibility Among HIV-Infected Adults Failing Antiretroviral Therapy in Rakai, Uganda | AIDS Res. Hum. Retroviruses 28 (12), 1739-1744 (20 | 0 | 73 73PR 73RT |
73 73PR 73RT |
100 | HIVDB |
| Reynolds (2013) | Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda | BMC Infect. Dis. 12 (1), 381 (2012) | 1.08e-125 | 103 103RT |
103 103RT |
100 | HIVDB |
| Reynolds (2016) | Low Rates of Transmitted Drug Resistance among Newly Identified HIV-1 Seroconverters in Rural Rakai,Uganda | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 24 24PR 24RT |
24 24PR 24RT |
100 | HIVDB |
| Rhee SY (2022) | Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations | Pathogens 11 (5), 546 (2022) | 2.73e-66 | 33 33PR |
33 33PR |
100 | HIVDB |
| Rhee SY (2022) | Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens | Open Forum Infect Dis 7 (9), ofaa316 (2020) | 0 | 656 302PR 306RT 48IN |
656 302PR 306RT 48IN |
100 | HIVDB |
| Rhee SY (2022) | Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population | Clin Infect Dis 68 (2), 213-221 (2019) | 0 | 413 147PR 147RT 119IN |
413 147PR 147RT 119IN |
100 | HIVDB |
| Rhee (2012) | Virologic Outcome Associated with Genotype-Guided Therapy in Patients with Transmitted HIV-1 Drug Resistance (TDR) Between 2003 and 2006 | 17065321 | 0 | 36 36PR 29RT |
36 36PR 29RT |
100 | HIVDB |
| Rhee (2016) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 0 | 29 23PR 31RT |
31 31RT |
93 | HIVDB |
| Rhee (2018) | Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance in a Large U.S. Clinic Population | 25849352 | 0 | 3163 3125PR 3118RT |
3194 3156PR 3149RT |
99 | HIVDB |
| Rhee (2005) | HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance | J. Infect. Dis. 192 (3), 456-465 (2005) | 0 | 3862 1939PR 1974RT |
3958 1963PR 1995RT |
97 | HIVDB |
| Rhee (2007) | Genotypic predictors of human immunodeficiency virus type 1 drug resistance. | Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17355-60. | 0 | 8 4PR 4RT |
166 71PR 95RT |
4 | HIVDB |
| Rhee (2009) | Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms | J. Infect. Dis. 200 (3), 453-463 (2009) | 0 | 427 217PR 212RT |
432 218PR 214RT |
98 | HIVDB |
| Rhee (2016) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 0 | 79 23PR 83RT 1IN |
87 87PR 87RT 1IN |
90 | HIVDB |
| Rhee (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration | EBioMedicine (2017) In press | 1.22e-173 | 18 21PR 21RT |
21 21PR 21RT |
85 | HIVDB |
| Rhee (2019) | National and International Dimensions of Human Immunodeficiency Virus-1 Sequence Clusters in a Northern California Clinical Cohort | Open Forum Infect Dis 6 (4), ofz135 (2019) | 0 | 45 45PR 45RT |
61 58PR 61RT |
73 | HIVDB |
| Rhee (2022) | Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations | Pathogens 11 (5), 546 (2022) | 2.2e-66 | 137 137PR |
701 701PR |
19 | HIVDB |
| Rhodehouse (2025) | Dynamics of Natural and Pharmacologic Control of an SIV Variant with an Envelope Trafficking Defect | Unpublished | 0 | |
151 151PR 151RT 151IN |
0 | NHPL/SIV |
| Richard (2004) | HIGH prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1 | AIDS Res. Hum. Retroviruses 20 (4), 355-364 (2004) | 1e-116 | 90 90RT |
90 90RT |
100 | HIVDB |
| Richard (2018) | Prevalence and genetic diversity of SIVagm infecting urban-restricted African green monkeys and olive baboons in Kenya | Unpublished | 1.44e-94 | |
3 3IN |
0 | NHPL/SIV |
| Ridolfi (2020) | Direct Submission | Submitted (01-JUL-2019) National AIDS Center, Isti | 0 | 192 190PR 189RT |
192 192PR 192RT |
100 | HIVDB |
| Rios (2007) | ANTIRETROVIRAL drug resistance and phylogenetic diversity of HIV-1 in Chile | J. Med. Virol. 79 (6), 647-656 (2007) | 1e-163 | 157 157PR 157RT |
157 157PR 157RT |
100 | HIVDB |
| Riva (2002) | EVALUATION of two commercial kits for testing genotypic drug-resistance on a panel of human immunodeficiency virus type 1 subtypes A-J | Unpublished | 1e-118 | |
22 22PR 22RT |
0 | ARV Rx and/or other data are N/A |
| Riva (2008) | IDENTIFICATION of a Possible Ancestor of the Subtype A1 HIV Type 1 Variant Circulating in the Former Soviet Union | AIDS Res. Hum. Retroviruses 24 (10), 1319-1325 (2008) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Rivera-Morales (2010) | Genotype analysis of protease and reverse transcriptase genes on children with HIV-1 under structured treatment interruptions | 26807922 | 0 | |
4 2PR 4RT |
0 | Gene fragment(s) |
| Roberts (2016) | Structured observations reveal slow HIV-1 CTL escape | PLoS Genet. 11 (2), E1004914 (2015) | 0 | 115 115PR 115RT |
227 227PR 227RT |
50 | HIVDB |
| Rodenburg (2001) | NEAR full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents | AIDS Res. Hum. Retroviruses 17 (2), 161-168 (2001) | 1e-165 | 13 13PR 13RT 13IN |
13 13PR 13RT 13IN |
100 | HIVDB |
| Rodes (2000) | EMERGENCE of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy | J. Clin. Microbiol. 38 (4), 1370-1374 (2000) | 6.56e-28 | 13 4PR 11RT |
13 4PR 12RT |
100 | HIVDB |
| Rodes (2002) | RAPID Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O | J. Clin. Microbiol. 40 (11), 4313-4316 (2002) | 1.6 | 5 5PR |
5 5PR |
100 | HIVDB |
| Rodes (2004) | TREATMENT Response and Drug Resistance in Patients Infected with HIV Type 1 Group O Viruses | AIDS Res. Hum. Retroviruses 21 (7), 602-607 (2005) | 0 | 20 10PR 10RT |
22 10PR 13RT |
90 | HIVDB |
| Rodes (2005) | Viral response to antiretroviral therapy in a patient with dual HIV-1 and HIV-2 infection | 15983906 | 4.35e-134 | |
3 1PR 2RT |
0 | Case report(s) / study subset |
| Rodes (2016) | HIV-2 protease sequences from naive patients diagnosed in Spain and Guinea Bissau | Unpublished | 4.88e-31 | 44 44PR |
44 44PR 1RT |
100 | HIVDB |
| Rodes (2016) | HIV-2 protease sequences from treatment naive patients attending a hospital in Coimbra, Portugal | Unpublished | 3.02e-29 | 6 6PR |
6 6PR |
100 | HIVDB |
| Rodes (2016) | Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy | J. Antimicrob. Chemother. 57 (4), 709-713 (2006) | 4.01e-30 | 6 6PR |
6 6PR |
100 | HIVDB |
| Rodes (2016) | High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART | 16327332 | 5.82e-31 | 3 3PR |
3 3PR |
100 | HIVDB |
| Rodgers (2017) | Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo | J. Virol. (2017) In press | 0 | 20 14PR 14RT 20IN |
28 14PR 14RT 28IN |
71 | HIVDB |
| Rodgers (2017) | Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon | Virology 504, 141-151 (2017) | 0 | 1 1PR 1RT 1IN |
3 1PR 1RT 3IN |
33 | HIVDB |
| Rodgers (2018) | ARCHITECT HIV Combo Ag/Ab(R) and RealTime(R) HIV-1 assays detect diverse HIV strains in clinical specimens | AIDS Res. Hum. Retroviruses (2017) In press | 0 | 185 185IN |
185 185IN |
100 | HIVDB |
| Rodgers (2020) | Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India | Sci Rep 10 (1), 7214 (2020) | 0 | 636 636IN |
739 739IN |
86 | HIVDB |
| Rodrigues (2003) | Prevalence of ARV resistance mutations and impact of genotyping test in HIV patients with advance disease in Sao Paulo, Brazil. | J Clin Virol | 0 | 175 89PR 86RT |
301 153PR 149RT |
58 | HIVDB |
| Rodrigues (2005) | LOW prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil | Virus Res. 116 (1-2), 201-207 (2006) | 2.5e-144 | 184 87PR 97RT |
184 87PR 97RT |
100 | HIVDB |
| Rodrigues (2008) | Molecular characterization and predictors of HIV infection among VCT users of Curitiba, Brazil | 19148420 | 1.96e-169 | 12 12PR 12RT |
12 12PR 12RT |
100 | HIVDB |
| Rodrigues (2008) | HIV Resistance monitoring in the state of Sao Paulo, Brazil | Unpublished | 6.29e-163 | |
4 2PR 3RT |
0 | Unpublished - Final |
| Rodrigues (2009) | Young pregnant women living with HIV/AIDS in Criciuma, Southern Brazil, are infected almost exclusively with HIV type 1 clade C | AIDS Res. Hum. Retroviruses 26 (3), 351-357 (2010) | 0 | 43 41PR 39RT |
43 41PR 39RT |
100 | HIVDB |
| Rodrigues (2010) | Brazilian HIV-1 Surveillance | Unpublished | 5.09e-169 | |
5 5PR 5RT |
0 | Unpublished - Final |
| Rodrigues (2025) | Molecular characterization of HIV-1 intersubtype recombinants in patients from Sao Paulo State | Unpublished | 0 | |
199 190PR 199RT |
0 | Unpublished |
| Rodriguez (2005) | CONSTRUCTION and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin | Virology 345 (2), 328-336 (2006) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Rodriguez-Lopez (2020) | Sanger and Next-Generation Sequencing Insight into HIV-1 Drug Resistance Mutations from Patients in Haiti | Unpublished | 8.17e-177 | |
26 26PR 26RT 11IN |
0 | Unpublished |
| Roege (2003) | K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine | Antivir. Ther. (Lond.) 8 (2), 173-182 (2003) | 3e-97 | 20 20RT |
20 20RT |
100 | HIVDB |
| Roge (2003) | DRUG resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART | HIV Med. 4 (1), 38-47 (2003) | 1e-131 | |
95 48PR 47RT |
0 | ARV Rx and/or other data are N/A |
| Rojas Sanchez (2018) | Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis | Pediatr. Infect. Dis. J. 37 (3), e48-e57 (2018) | 0 | 22 22PR 22RT |
23 23PR 23RT |
95 | HIVDB |
| Rokx (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 25273080 | 0 | 68 67PR 68RT |
68 67PR 68RT |
100 | HIVDB |
| Rolland (2011) | Direct Submission | Submitted (08-FEB-2011) Microbiology, University o | 0 | 65 64PR 64RT 65IN |
632 442PR 442RT 632IN |
10 | HIVDB |
| Rolland (2012) | Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V1/V2 revealed by sieve analysis | 22960785 | 0 | 121 121PR 121RT 121IN |
1359 1023PR 1024RT 1357IN |
8 | HIVDB |
| Rolland (2020) | Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand | PLoS Pathog. 16 (2), e1008179 (2020) | 0 | |
1369 974PR 974RT 1369IN |
0 | SGS |
| Romani (2017) | Functional conservation and coherence of HIV-1 subtype A Vpu alleles | Unpublished | 1.54e-35 | |
10 10PR |
0 | Gene fragment(s) |
| Romano (2000) | DETECTION of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy | AIDS 14 (14), 2204-2206 (2000) | 1e-132 | 232 116PR 116RT |
232 116PR 116RT |
100 | HIVDB |
| Romano (2002) | PROLONGED low capability to reinfect peripheral blood lymphocytes by circulating protease inhibitor-resistant HIV-1 in a patient under antiretroviral therapy | Unpublished | 1e-123 | |
80 40PR 40RT |
0 | ARV Rx and/or other data are N/A |
| Romano (2002) | TREATMENT with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 30, 533-535 | 1e-124 | 80 80PR 80RT |
80 80PR 80RT |
100 | HIVDB |
| Ronsard (2015) | Genetic characterization of HIV-1 protease and reverse transcriptase genes from HIV-1 infected individuals from North India | Unpublished | 1.38e-122 | |
64 32PR 32RT |
0 | ARV Rx and/or other data are N/A |
| Roques (2000) | PHYLOGENETIC characteristics of three new HIV-1 N strains and implications for the origin of group N | AIDS 18 (10), 1371-1381 (2004) | 0 | 3 3PR 3RT 3IN |
8 3PR 3RT 8IN |
37 | HIVDB |
| Ross (2019) | Virologic failure and HIV drug resistance on second line antiretroviral therapy among adults living with HIV in the Asia-Pacific | 33151020 | 0 | |
69 53PR 50RT 6IN |
0 | Pending |
| Ross (2001) | THYMIDINE analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens | AIDS Res. Hum. Retroviruses 17 (12), 1107-1115 (2001) | 1e-130 | |
86 70PR 86RT |
0 | ARV Rx and/or other data are N/A |
| Ross (2013) | HIV-1 Transmission Patterns in Antiretroviral Therapy-Naive, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing | PLoS ONE 9 (2), E89611 (2014) | 8.2e-150 | 690 690PR 690RT |
690 690PR 690RT |
100 | HIVDB |
| Rossenkhan (2025) | Bayesian estimation of HIV acquisition dates for prevention trials | mBio (2025) | 4.8e-177 | |
9069 8931PR 9068RT |
0 | Pending |
| Rossi (2013) | Sequence Variability in p6 gag Protein and gag/pol Coevolution in Human Immunodeficiency Type 1 Subtype F Genomes | AIDS Res. Hum. Retroviruses 29 (7), 1056-1060 (201 | 0 | 95 95PR 95RT |
95 95PR 95RT |
100 | HIVDB |
| Rossouw (2015) | Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa | PLoS ONE 10 (7), E0133452 (2015) | 0 | 65 65PR 65RT |
65 65PR 65RT |
100 | HIVDB |
| Rottinghaus (2014) | Evaluation of Dried Blood Spots Collected on Filter Papers from Three Manufacturers Stored at Ambient Temperature for Application in HIV-1 Drug Resistance Monitoring | PLoS ONE 9 (10), E109060 (2014) | 8.15e-174 | 33 33PR 33RT |
33 33PR 33RT |
100 | HIVDB |
| Roudinskii (2004) | Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations. | J Virol | 5e-40 | 27 27PR |
30 30PR |
90 | HIVDB |
| Rouet (2017) | Nosocomial Outbreak of HIV-1 in Rural Cambodia, 2014-2015 | 29211835 | 2.18e-170 | 216 216PR 216RT |
216 216PR 216RT |
100 | HIVDB |
| Rousseau (2003) | LARGE-SCALE amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes | J. Virol. Methods 136 (1-2), 118-125 (2006) | 0 | 272 271PR 265RT 266IN |
273 272PR 273RT 270IN |
99 | HIVDB |
| Rousseau (2008) | HLA Class-I Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load | 18434400 | 0 | |
152 152RT |
0 | Pending |
| Rousseau (2000) | PATTERNS of resistance mutations to antiretroviral drugs in extensively pretreated HIV-1-infected patients with failure of highly active antiretroviral therapy | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 26, 36-43 ( | 1e-112 | 22 22PR 22RT |
22 22PR 22RT |
100 | HIVDB |
| Roux-Cil Ferreira (2024) | Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen | EBioMedicine (2024) In press | 0 | |
18 18PR 18RT 18IN |
0 | Proviral DNA Reservoir |
| Roye (2010) | Genotypic Characterization of HIV-1 in Jamaica | 20929350 | 0 | |
7 7PR 7RT 7IN |
0 | ARV Rx and/or other data are N/A |
| Rubio (2014) | Similar Replicative Fitness Is Shared by the Subtype B and Unique BF Recombinant HIV-1 Isolates that Dominate the Epidemic in Argentina | PLoS ONE 9 (4), E92084 (2014) | 0 | |
29 29PR 29RT |
0 | Case report(s) / study subset |
| Rubio-Garrido (2019) | Direct Submission | Submitted (30-SEP-2019) Laboratrio de Epidemiologi | 0 | 38 26PR 36RT 23IN |
93 59PR 75RT 57IN |
40 | HIVDB |
| Ruchansky (2008) | IDENTIFICATION of a new HIV Type 1 Circulating Recombinant Form (CRF38_BF1) in Uruguay | AIDS Res. Hum. Retroviruses 25 (3), 351-356 (2009) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Rud (1992) | INFECTIOUS molecular clones of SIVmac32H: Nef deletion controls ability to reisolate virus from rhesus macaques | (in) Brown,F., Chanock,R.M. and Ginsberg,H.S. (Eds.); VACCIN | 1e-99 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Rudicell (2010) | Impact of simian immunodeficiency virus infection on chimpanzee population dynamics | PLoS Pathog. 6 (9), e1001116 (2010) | 3e-86 | |
2 2RT 2IN |
0 | NHPL/SIV |
| Rudicell (2011) | High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees | J. Virol. (2011) In press | 0 | |
6 3PR 6RT 6IN |
0 | NHPL/SIV |
| Rudometova (2020) | Drug Resistance Mutations in Reverse Transcriptase and Protease genes of HIV-1 isolates from Siberia, Russia | 33677988 | 0 | |
36 36PR 36RT |
0 | Pending |
| Rudometova (2020) | Genetic diversity and drug resistance mutations in reverse transcriptase and protease genes of HIV-1 isolates from Southwestern Siberia | Unpublished | 0 | |
19 19PR 19RT |
0 | HIVDB |
| Ruelle (2007) | Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database | BMC Infect. Dis. 8, 21 (2008) | 1.29e-154 | 30 27PR 29RT |
30 27PR 29RT |
100 | HIVDB |
| Ruelle (2016) | Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso | AIDS Res. Hum. Retroviruses 23 (8), 955-964 (2007) | 2.65e-124 | 31 14PR 17RT |
31 14PR 18RT |
100 | HIVDB |
| Ruff (2002) | PERSISTENCE of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure | J. Virol. 76 (18), 9481-9492 (2002) | 1e-130 | |
81 81PR 81RT |
0 | Proviral DNA Reservoir |
| Rugemalila (2025) | Direct Submission | Submitted (23-AUG-2024) Microbiology and Immunolog | 1.16e-166 | |
68 68PR 68RT |
0 | Unpublished |
| Ruiz (1998) | Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC. | AIDS | 1e-98 | 41 41RT |
41 41RT |
100 | HIVDB |
| Rumyantseva (2009) | Molecular epidemiology of HIV-1 in Krasnoyarsk region, Russia | AIDS Res Hum Retroviruses. 2009 Sep;25(9):931-6. | 0 | 80 80PR 80RT |
80 80PR 80RT |
100 | HIVDB |
| Rusconi (2000) | SUSCEPTIBILITY to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors | Antimicrob. Agents Chemother. 44 (5), 1328-1332 (2000) | 1e-113 | |
10 10PR |
0 | ARV Rx and/or other data are N/A |
| Rusconi (2002) | ACCUMULATION of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects | J. Antimicrob. Chemother. 49 (2), 427-429 (2002) | 1e-116 | |
17 8PR 9RT |
0 | ARV Rx and/or other data are N/A |
| Rusconi (2007) | DISCOVERY of a novel non-conventional (folding) protease inhibitor with in vitro activity against Human Immunodeficiency Virus type 1 | Unpublished | 1e-142 | |
1 1PR 1RT |
0 | Laboratory/experimental isolate |
| Rusine (2013) | Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda | 23950859 | 0 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Ruta (2015) | Direct Submission | Submitted (28-NOV-2014) Virology, University of Me | 0 | 33 33PR 33RT |
33 33PR 33RT |
100 | HIVDB |
| Rutere (2017) | HIV drug resistance in co-infections | Unpublished | 1.02e-150 | |
31 11PR 31RT |
0 | Unpublished |
| Rutvisuttinunt (2012) | Two Unique Recombinant Forms Identified in Incident HIV-1 Infections in Thai Blood Donors | AIDS Res Hum Retroviruses. 2012 May 16 | 0 | 9 9PR 9RT 9IN |
9 9PR 9RT 9IN |
100 | HIVDB |
| Rychert (2006) | HIV-1 Sequence Variation Occurs in CD4 Epitopes During Acute Infection | 18167642 | 1e-166 | |
14 14IN |
0 | Case report(s) / study subset |
| Sa Filho (2002) | MUTATIONS associated with drug resistance in a population of drug naive HIV-1 infected individuals | Unpublished | 1e-98 | 89 89RT |
90 90RT |
98 | HIVDB |
| Sa Filho (2004) | ANALYSIS of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil | AIDS Res. Hum. Retroviruses 21 (2), 145-151 (2005) | 0 | 6 6PR 6RT 6IN |
221 221PR 221RT 6IN |
2 | HIVDB |
| Sa Filho (2006) | IDENTIFICATION of Two HIV Type 1 Circulating Recombinant Forms in Brazil | AIDS Res. Hum. Retroviruses 22 (1), 1-13 (2006) | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Sa-Filho (2003) | ANALYSIS of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy | J. Clin. Virol. 28 (2), 186-202 (2003) | 1e-123 | 50 50PR |
50 50PR |
100 | HIVDB |
| Sa-Filho (2007) | CHARACTERIZATION of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil | AIDS Res. Hum. Retroviruses 23 (9), 1087-1094 (2007) | 0 | 12 12PR 12RT 12IN |
12 12PR 12RT 12IN |
100 | HIVDB |
| Sa-Filho (2009) | HIV-1 diversity from newly diagnosed patients in Santos Metropolitan Area/Brazil | AIDS Res Hum Retroviruses. 2009 Sep;25(9):925-9. | 0 | 32 32PR 31RT |
32 32PR 32RT |
100 | HIVDB |
| Saad (2004) | HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen | AIDS Res. Hum. Retroviruses 21 (7), 644-648 (2005) | 0 | 19 19PR 19RT 6IN |
25 25PR 25RT 6IN |
76 | HIVDB |
| Saad (2005) | MOLECULAR Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic | AIDS Res. Hum. Retroviruses 22 (8), 709-714 (2006) | 0 | 163 163PR 163RT 12IN |
175 175PR 175RT 12IN |
93 | HIVDB |
| Saad (2006) | GENETIC Forms of HIV Type 1 in the Former Soviet Union Dominate the Epidemic in Azerbaijan | AIDS Res. Hum. Retroviruses 22 (8), 796-800 (2006) | 1e-138 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Saah (2003) | TREATMENT with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy | J. Infect. Dis. 187 (7), 1157-1162 (2003) | 1e-130 | 354 354PR 354RT |
354 354PR 354RT |
100 | HIVDB |
| Sabah (2024) | Direct Submission | Submitted (10-AUG-2024) Genetics, Evogenomix, Mans | 5.7e-101 | |
1 1RT |
0 | Case report(s) / study subset |
| Sabour (2024) | Immunocapture of cell surface proteins embedded in HIV envelopes uncovers considerable virion genetic diversity associated with different source cell types | PLoS One 19 (2), e0296891 (2024) | 2.53e-82 | |
13 13RT |
0 | Laboratory/experimental isolate |
| Sacks-Davis (2020) | Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia | PLoS ONE 15 (9), e0237469 (2020) | 1.54e-176 | 702 702PR 702RT |
702 702PR 702RT |
100 | HIVDB |
| Sadeghi (2014) | CRF35_AD is predominant HIV-1 strain circulating among both injecting drug users and sex workers in Tehran, Iran | Unpublished | 8.28e-166 | |
25 25PR 25RT |
0 | ARV Rx and/or other data are N/A |
| Saeng-aroon (2016) | Distribution of HIV-1 subtypes in female sex workes recently infected with HIV-1 in Thailand | 26892382 | 0 | 158 151PR 158RT |
158 158PR 158RT |
100 | HIVDB |
| Safina (2022) | Molecular epidemiology of HIV-1 in Oryol Oblast, Russia | 35775027 | 0 | 759 759PR 759RT |
767 767PR 767RT |
98 | HIVDB |
| Sagar (2005) | DIVERSITY in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome But Does Not Predict the Extent of Sequence Diversity During Chronic Infection | AIDS Res. Hum. Retroviruses 22 (5), 430-437 (2006) | 1e-155 | |
163 163PR 163RT |
0 | SGS |
| Sagoe (2007) | VARIABILITY of the human immunodeficiency virus type 1 polymerase gene from treatment naive patients in Accra, Ghana | J. Clin. Virol. 40 (2), 163-167 (2007) | 0 | 25 25PR 25RT |
25 25PR 25RT |
100 | HIVDB |
| Sagoe (2012) | Distinct patterns of protease gene polymorphisms in human immunodeficiency virus type 1 strains found in drug naive individuals in Ghana | Unpublished | 0 | 15 15PR 15RT |
15 15PR 15RT |
100 | HIVDB |
| Sagoe (2012) | Outcomes of short-term antiretroviral therapy in human immunodeficiency virus infected patients with hepatitis B and C viral infections | 27251610 | 3.11e-162 | 22 18PR 22RT |
28 24PR 28RT |
78 | HIVDB |
| Sagoe (2017) | HIV-1 treatment failure and drug resistance in Ghanaian patients during the first three years of antiretroviral therapy | Unpublished | 5.59e-167 | |
21 21PR 21RT |
0 | Unpublished |
| Sagoe (2023) | Comparison of majority and minority HIV-1 drug resistance mutations in crf02_ag strains from Ghana | Unpublished | 2.28e-157 | 20 20PR 20RT |
20 20PR 20RT |
100 | HIVDB |
| Sahbandar (2009) | Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia | AIDS Res. Hum. Retroviruses 25 (7), 637-646 (2009) | 1.71e-101 | 3 3PR 3RT |
13 13PR 3RT |
23 | HIVDB |
| SahBandar (2010) | The Indonesian Variant of CRF33_01B: Near-Full Length Sequence Analysis | 20958201 | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| SahBandar (2017) | Ultra Deep Sequencing Analysis on HIV Drug Resistant Associated Mutations among HIV-Infected Individuals: First Report from the Philippines | 28569550 | 3.39e-96 | |
110 110RT |
0 | Gene fragment(s) |
| Sahoo (2020) | Development and Clinical Evaluation of a Next-Generation Sequencing Approach for HIV-1 Genotypic Resistance Testing | Unpublished | 0 | |
62 53PR 53RT 9IN |
0 | Unpublished |
| Sahu (2010) | Recovery of replication-competent residual HIV-1 from plasma of a patient receiving prolonged, suppressive highly active antiretroviral therapy | J. Virol. 84 (16), 8348-8352 (2010) | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Saini (2009) | Drug-resistance associated mutations in HIV-1 among patients failing fixed dose combinations of antiretroviral drugs | 21990611 | 4.41e-167 | 32 32PR 32RT |
33 33PR 33RT |
96 | HIVDB |
| Sakamoto (2006) | INFECTIOUS DNA clones of CRF01_AE HIV-1 derived from Thainian isolates | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Laboratory/experimental isolate |
| Sakamoto (2006) | INFECTIOUS molecular clones of subtype B HIV-1 derived from Japanese patients | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Sakamoto (2006) | Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious clones | Unpublished | 0 | 1 1PR 1RT 1IN |
132 132PR 132RT 132IN |
0 | ARV Rx and/or other data are N/A |
| Sakamoto (2006) | CONSTRUCTION and characterization of an unique mosaic HIV-1 subtype C infectious molecular clones derived from a japanese patients | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Sakamoto (2009) | Molecular characterization of subtype F infectious molecular clones possibly derived from Brazil | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Laboratory/experimental isolate |
| Saladini (2010) | Near full-length sequence analysis of HIV-1 BF recombinants from Italy | 21740272 | 0 | |
15 15PR 15RT 14IN |
0 | ARV Rx and/or other data are N/A |
| Saladini (2017) | The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro | AIDS (2017) In press | 0 | 6 6IN |
6 6IN |
100 | HIVDB |
| Saladini (2018) | The Human immunodeficiency virus type 1 reverse transcriptase E138A mutation decreases the genetic barrier to resistance to etravirine in vitro | 30462235 | 0 | |
20 20RT |
0 | Pending |
| Saladini (2019) | Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations | 31611362 | 0 | 19 19IN |
19 19IN |
100 | HIVDB |
| Salazar-Gonzalez (2009) | Full-length Genomes of Transmitted/Founder Viruses Reveal Biological Properties and Precise Evolutionary Pathways of HIV-1 in Acute and Early Infection | 19487424 | 0 | |
346 213PR 243RT 346IN |
0 | Quasispecies |
| Salazar-Gonzalez (2016) | Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes | Pathog Immun 1 (1), 129-153 (2016) | 0 | |
59 35PR 35RT 59IN |
0 | Quasispecies |
| Salemovic (2024) | HIV-1 subtypes distribution in Serbia | Unpublished | 0 | |
2 2RT |
0 | Case report(s) / study subset |
| Saleri (2021) | Direct Submission | Submitted (26-OCT-2020) Biochemistry, University o | 6.9e-161 | 5 5PR 5RT |
5 5PR 5RT |
100 | HIVDB |
| Salgado (2009) | Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity | J Clin Virol. 2009 Oct;46(2):173-5. Epub 2009 Jul 22. | 1e-100 | 5 5IN |
5 5IN |
100 | HIVDB |
| Salgado (2012) | Prolonged control of replication-competent dual tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy | Retrovirology 8 (1), 97 (2011) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Salgado (2013) | HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. | J Virol. 2014 Mar;88(6):3340-52. | 0 | |
18 18PR 18RT 18IN |
0 | Laboratory/experimental isolate |
| Salimovic-Besic (2019) | Direct Submission | Submitted (12-AUG-2019) Unit for Clinical Microbio | 0 | |
2 2PR 2RT |
0 | Unpublished |
| Sallam (2017) | Decreasing prevalence of transmitted drug resistance among ART-naive, HIV-1-infected patients in Iceland, 1996-2012 | 28649306 | 3.7e-176 | |
30 30PR 30RT |
0 | Case report(s) / study subset |
| Salminen (1995) | RECOVERY of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction | Virology 213 (1), 80-86 (1995) | 1e-165 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Salminen (1996) | FULL-LENGTH sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C | AIDS Res. Hum. Retroviruses 12 (14), 1329-1339 (1996) | 1e-160 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Salminen (1997) | EVOLUTION and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple | J. Virol. 71 (4), 2647-2655 (1997) | 2e-71 | |
2 2PR |
0 | Case report(s) / study subset |
| Salminen (1998) | RAPID and simple characterization of in vivo HIV-1 sequences using solid-phase direct sequencing | AIDS Res. Hum. Retroviruses 8 (9), 1733-1742 (1992) | 1e-162 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Salminen (2000) | CONSTRUCTION and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction | Virology 278 (1), 103-110 (2000) | 1e-164 | |
4 4PR 4RT 4IN |
0 | Laboratory/experimental isolate |
| Salou M (2021) | Challenges of scale-up to dolutegravir-based regimens in sub-Saharan Africa | AIDS 34 (5), 783-787 (2020) | 0 | 359 169PR 181RT 178IN |
359 169PR 181RT 178IN |
100 | HIVDB |
| Salou (2016) | High rates of drug resistance among newly diagnosed HIV-infected children (<18 months) in Togo | 27167115 | 1.16e-180 | |
201 201RT |
0 | Pending |
| Salou (2016) | High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo | J Int AIDS Soc 19 (1), 20683 (2016) | 2.98e-178 | 125 110PR 125RT |
125 110PR 125RT |
100 | HIVDB |
| Salu (2020) | Direct Submission | Submitted (09-JUN-2020) Centre for Human and Zoono | 1.24e-51 | |
1 1PR |
0 | Unpublished |
| Samiee (2012) | HIV-1 isolated protease gene from Kordestan, Iran | Unpublished | 1e-60 | |
68 68PR |
0 | ARV Rx and/or other data are N/A |
| Samiei (2009) | HIV-1 isolated from Lorestan province protease (pol) gene | Unpublished | 1e-59 | |
25 25PR |
0 | Case report(s) / study subset |
| Samiei (2016) | Direct Submission | Submitted (15-JUN-2009) Biochemistry, Iranian Bloo | 2.11e-160 | |
16 16RT |
0 | ARV Rx and/or other data are N/A |
| Sanabani (2004) | FULL-LENGTH genome analysis of human immunodeficiency virus type 1 subtype C in Brazil | AIDS Res. Hum. Retroviruses 22 (2), 171-176 (2006) | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Sanabani (2006) | ANALYSIS of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil | Infect. Genet. Evol. 6 (5), 368-377 (2006) | 0 | 14 14PR 14RT 14IN |
14 14PR 14RT 14IN |
100 | HIVDB |
| Sanabani (2009) | Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in Sao Paulo, Brazil | Virol. J. 6, 78 (2009) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Sanabani (2010) | Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil | Virol. J. 7, 74 (2010) | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Sanabani (2011) | Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil | PLoS ONE 6 (10), E25869 (2011) | 0 | 51 51PR 50RT 51IN |
51 51PR 51RT 51IN |
100 | HIVDB |
| Sanabani (2025) | Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in Sao Paulo, Brazil | PLoS One 6 (10), e25869 (2011) | 0 | |
3 3PR 3RT 3IN |
0 | Pending |
| Sanchez (2004) | Molecular epidemiology of human immunodeficiency virus-infected individuals in Medellin, Colombia. | Am J Trop Med Hyg | 0 | 37 37PR 37RT 8IN |
71 71PR 71RT 34IN |
52 | HIVDB |
| Sanchez (2019) | Direct Submission | Submitted (19-OCT-2019) Laboratorio de Biologia Ce | 0 | |
30 30IN |
0 | Unpublished |
| Sanchez-Merino (2007) | GENETIC Changes Associated with Distinct Patterns of HIV Type 1 Persistence in Chronically Infected Cell Lines | AIDS Res. Hum. Retroviruses 23 (2), 251-260 (2007) | 0 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| Sanders-Buell (2007) | A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD | AIDS Res. Hum. Retroviruses 23 (6), 834-839 (2007) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Sanders-Buell (2010) | Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan | AIDS Res. Hum. Retroviruses 26 (5), 605-608 (2010) | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Sanders-Buell (2021) | Direct Submission | Submitted (05-JAN-2021) U.S. Military HIV Research | 0 | |
89 89PR 89RT 89IN |
0 | Unpublished |
| Sangeda (2020) | Development of HIV drug resistance in a cohort of adults on first-line antiretroviral therapy in Tanzania during the stavudine era | 10.3390/microbiolres12040062 | 0 | 44 43PR 44RT |
44 43PR 44RT |
100 | HIVDB |
| Sannier (2021) | Combined Single-Cell Transcriptional, Translational and Genomic Profiling Reveals HIV-1 Reservoir Diversity | 34469719 | 0 | |
194 141PR 165RT 191IN |
0 | Quasispecies |
| Santhosh (2005) | FULL-LENGTH Genome Characterization of an HIV Type 2 Isolate from India | AIDS Res. Hum. Retroviruses 24 (10), 1315-1317 (2008) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Santiago (2002) | SIVCPZ in wild chimpanzees | Science 295 (5554), 465 (2002) | 1e-136 | 1 1RT 1IN |
1 1RT 1IN |
100 | HIVDB |
| Santiago (2003) | AMPLIFICATION of a complete Simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee | J. Virol. 77 (3), 2233-2242 (2003) | 6.78e-156 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Santiago (2003) | FOCI of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii) | J. Virol. 77 (13), 7545-7562 (2003) | 2e-51 | |
3 3IN |
0 | NHPL/SIV |
| Santiago (2003) | NONINVASIVE Detection of Simian Immunodeficiency Virus Infection in a Wild-Living L'Hoest's Monkey (Cercopithecus lhoesti) | AIDS Res. Hum. Retroviruses 19 (12), 1163-1166 (2003) | 5e-61 | |
1 1IN |
0 | NHPL/SIV |
| Santos da Silva (2013) | Subtype A-specific peculiarities hinder production of an infectious construct | Unpublished | 0 | |
28 28RT |
0 | ARV Rx and/or other data are N/A |
| Santos (2005) | CHARACTERIZATION of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil | AIDS 20 (16), 2011-2019 (2006) | 0 | 148 104PR 105RT 1IN |
148 105PR 105RT 1IN |
100 | HIVDB |
| Santos (2011) | Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naive patients from Southern Brazil | J. Clin. Virol. 52 (4), 373-376 (2011) | 0 | 169 141PR 88RT |
341 160PR 268RT 2IN |
49 | HIVDB |
| Santos (2024) | Direct Submission | Submitted (03-AUG-2023) Virology Center, Adolfo Lu | 0 | 192 192IN |
199 6PR 7RT 192IN |
96 | HIVDB |
| Santos (2024) | Direct Submission | Submitted (11-AUG-2023) Virology Center, Adolfo Lu | 3.44e-168 | |
85 84PR 85RT |
0 | Pending |
| Santos (2015) | Clinical, Virologic and Immunological Outcomes in a Cohort of Long-Term Non-Progressor HIV Infected Patients, Southern Brazil | J AIDS Clin Res 6 (9), 10.4172/2155-6113.1000502 ( | 0 | |
39 39PR 39RT |
0 | Case report(s) / study subset |
| Santos (2011) | Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil | J. Med. Virol. 83 (12), 2066-2072 (2011) | 2.78e-157 | 57 57PR 57RT |
57 57PR 57RT |
100 | HIVDB |
| Santos (2018) | Direct Submission | Submitted (09-NOV-2017) Virology Laboratory, Feder | 2.51e-45 | |
3 3PR |
0 | Gene fragment(s) |
| Saracino (2005) | IMPACT of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors | J. Med. Virol. 78 (1), 9-17 (2006) | 0 | |
37 37PR 37RT |
0 | Case report(s) / study subset |
| Saracino (2007) | Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients. | Curr HIV Res. 2009 Jul;7(4):425-33. | 0 | |
166 166PR 166RT |
0 | ARV Rx and/or other data are N/A |
| Saracino (2008) | ANTIRETROVIRAL genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART | J. Med. Virol. 80 (10), 1695-1706 (2008) | 0 | 146 146PR 145RT |
146 146PR 146RT |
100 | HIVDB |
| Saravanan (2012) | Darunavir is a good third-line antiretroviral agent for HIV-1 infected patients failing second-line protease inhibitor-based regimens in South India | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 87 87PR 87RT |
87 87PR 87RT |
100 | HIVDB |
| Saravanan (2015) | Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses | AIDS Res. Hum. Retroviruses 31 (6), 655-657 (2015) | 6.83e-151 | 546 546RT |
546 546RT |
100 | HIVDB |
| Sarkar (2011) | Emergence of a unique recombinant form of HIV-1 from Manipur (India). | J Clin Virol. 2012 Nov;55(3):274-7. | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Sarker (2010) | Detection of a rare HIV-1 strain CRF16_A2D in Bangladesh | 20929347 | 1e-145 | |
2 2IN |
0 | Case report(s) / study subset |
| Sarker (2020) | HIV-1 genotypes circulating in Bangladesh: 2016 update | 33359062 | 2.37e-175 | 37 32PR 32RT |
37 32PR 37RT |
100 | HIVDB |
| Sarker (2020) | Migrant workers play a key role in HIV-1 strain diversity in Bangladesh | 10.5114/hivar.2020.101794 | 0 | 38 38IN |
38 38IN |
100 | HIVDB |
| Sarkhouh (2021) | CODEHOP-Mediated PCR Improves HIV-1 Genotyping and Detection of Variants by MinION Sequencing | Microbiol Spectr, e0143221 (2021) In press | 0 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Sasinovich (2016) | Direct Submission | Submitted (02-NOV-2015) Laboratory of HIV and Oppo | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Sasinovich (2018) | HIV-1 Recombinant Forms Revealed in Belarus: Diversity, Origin and Domestic Spread | Unpublished | 0 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Sato (2000) | CONVERGENT evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies | J. Virol. 74 (11), 5357-5362 (2000) | 3e-59 | |
7 7RT |
0 | Case report(s) / study subset |
| Sato (2001) | AUGMENTATION of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase | J. Virol. 75 (12), 5604-5613 (2001) | 1e-165 | |
93 11PR 93RT 1IN |
0 | Quasispecies |
| Sato (2007) | CONSTRUCTION and characterization of multidrug-resistant HIV-1 subtype B infectious molecular clones derived from Japanese patients for reference | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Laboratory/experimental isolate |
| Sauermann (1990) | MOLECULAR cloning and characterization of a German HIV-1 isolate | AIDS Res. Hum. Retroviruses 6 (6), 813-823 (1990) | 1e-161 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Saurya (2002) | Characterization of gag gene of plasma HIV type 1 in combination therapy-treated AIDS patients with high viral load and stable CD4+ T cell counts. | AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):73-6. | 1e-124 | |
31 16PR 15RT 15IN |
0 | ARV Rx and/or other data are N/A |
| Sayan (2012) | HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey | 23883841 | 1.28e-127 | |
92 92RT |
0 | Gene fragment(s) |
| Sayan (2013) | First Time Detected HIV-1 Recombinant Strain in Turkey: CRF06_cpx | Unpublished | 7.41e-54 | |
2 2PR |
0 | Case report(s) / study subset |
| Sayan (2022) | Direct Submission | Submitted (19-JAN-2022) PCR Unit, Kocaeli Universi | 0 | |
107 29PR 34RT 82IN |
0 | Unpublished |
| Sayan (2015) | [The first detected HIV-1 recombinant strain in Turkey: CRF08_BC] | Mikrobiyol Bul 47 (2), 339-345 (2013) | 3.64e-57 | |
1 1PR |
0 | Case report(s) / study subset |
| Sayan (2015) | HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral - Naive Patients in Turkey | AIDS Res. Hum. Retroviruses (2015) In press | 8.96e-137 | |
260 260PR 260RT |
0 | Case report(s) / study subset |
| Scaduto (2016) | Inaugural Article: Source identification in two criminal cases using phylogenetic analysis of HIV-1 DNA sequences | Proc. Natl. Acad. Sci. U.S.A. 107 (50), 21242-2124 | 2.73e-163 | |
317 317RT |
0 | Quasispecies |
| Scallon (2025) | Clinical, psychosocial, and structural factors associated with detection of HIV drug resistance mutations in children living with HIV in Kisumu, Kenya: Secondary analysis of data from the Opt4Kids study | Viruses (2025) In press | 6.55e-175 | |
169 169PR 169RT |
0 | ARV Rx and/or other data are N/A |
| Schaefer (2005) | GENETIC analysis of HIV-seropositive, Western Blot indeterminate individuals in Kinshasa, Zaire in the mid 1980s: no evidence for unusual HIV variants | 15324542 | 2e-50 | |
1 1PR |
0 | Case report(s) / study subset |
| Schaefer (2005) | HIV-1 complex recombinant CRF06-cpx was the predominant strain in Burkina Faso by the mid 1980s | Unpublished | 7e-59 | 57 57PR |
93 92PR 1IN |
61 | HIVDB |
| Schapiro (1997) | The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. | Ann Intern Med | 1e-128 | 67 67PR |
68 68PR |
98 | HIVDB |
| Scheibe (2022) | Frequency of genotypic factors possibly associated with cabotegravir/rilpivirine failure in antiretroviral treatment-naive and -experienced HIV-1- infected population | Infect Genet Evol 104, 105358 (2022) | 0 | |
4710 3635PR 3635RT 1075IN |
0 | ARV Rx and/or other data are N/A |
| Schemelev (2023) | Direct Submission | Submitted (11-DEC-2023) Federal Service for Superv | 0 | |
50 38PR 40RT 10IN |
0 | Unpublished |
| Scherrer (2011) | Polymorphic mutations associated with the emergence of the multi-nucleoside/tide resistance mutations 69 insertion and Q151M | J. Acquir. Immune Defic. Syndr. (2011) In press | 0 | 46 46PR 46RT |
46 46PR 46RT |
100 | HIVDB |
| Schinazi (2016) | Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase | Antimicrob. Agents Chemother. 55 (5), 2054-2060 (2 | 1.67e-154 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Schloesser (2019) | Molecular Epidemiology of HIV-1 in South Russia and Neighbouring Regions | 32331438 | 0 | |
275 251PR 275RT 1IN |
0 | ARV Rx and/or other data are N/A |
| Schmidt (2016) | Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations | 28077632 | 4.11e-49 | |
3 3IN |
0 | Gene fragment(s) |
| Schmit (1997) | Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. | AIDS | 1e-121 | |
38 5PR 33RT |
0 | Case report(s) / study subset |
| Schmit (1997) | RESISTANCE-RELATED mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538) | AIDS 10 (9), 995-999 (1996) | 1e-130 | 14 14PR |
15 15PR |
93 | HIVDB |
| Schmitz (2004) | LV2, a Novel Postentry Restriction, Is Mediated by both Capsid and Envelope | J. Virol. 78 (4), 2006-2016 (2004) | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Schneider (2016) | Biochemical characterization of a multiresistant HIV-1 subtype AG Reverse Transcriptase: Antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors | Unpublished | 0 | |
1 1RT |
0 | Case report(s) / study subset |
| Schroeder (2005) | CHARACTERIZATION of Intersubtype Recombinant HIV Type 1 Genomes Using a Nonradioactive Heteroduplex Tracking Assay | AIDS Res. Hum. Retroviruses 21 (4), 314-318 (2005) | 1e-121 | |
4 2PR 2RT |
0 | Case report(s) / study subset |
| Schuurman (2001) | DIRECT Submission | Submitted (31-OCT-2001) Virology, UMCU, Heidelberglaan 100, | 1e-135 | |
2 2PR 2RT |
0 | Laboratory/experimental isolate |
| Schwarzmueller (2024) | Decoupling HIV-1 Antiretroviral Drug Inhibition from Plasma Antibody Activity to Evaluate Broadly Neutralizing Antibody Therapeutics and Vaccines | Cell Rep Med (2024) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Schwem (2013) | Drug Resistance of HIV in the Philippines | Unpublished | 1.91e-162 | |
4 2PR 4RT |
0 | Case report(s) / study subset |
| Schwem (2016) | The Changing Molecular Epidemiology of HIV in the Philippines | 28602726 | 0 | 81 81PR 81RT |
81 81PR 81RT |
100 | HIVDB |
| Schwem (2018) | Responding to the Philippine HIV Epidemic: An HIV Drug Resistance Surveillance Library and Development of Molecular Diagnostics for Drug-Resistance Detection Part 1: Surveillance of Mutations for Acquired Drug Resistance | 32081778 | 0 | 54 53PR 53RT |
54 53PR 54RT |
100 | HIVDB |
| Scriba (2001) | CHARACTERIZATION and phylogenetic analysis of South African HIV-1 subtype C accessory genes | AIDS Res. Hum. Retroviruses 17 (8), 775-781 (2001) | 4e-19 | |
22 22IN |
0 | Gene fragment(s) |
| Scrimieri (2023) | Transcriptionally-active 'defective' HIV-1 provirus and its implication in immunological non-response to antiretroviral therapy | 38226493 | 0 | |
491 465PR 407RT 326IN |
0 | Proviral DNA Reservoir |
| Scriven (2021) | Direct Submission | Submitted (26-OCT-2020) Biochemistry, University o | 6.49e-167 | 108 108PR 108RT |
108 108PR 108RT |
100 | HIVDB |
| Scutari (2021) | Direct Submission | Submitted (29-JUN-2021) Dipartimento di Oncologia | 0 | |
199 199RT |
0 | Unpublished |
| Scutari (2021) | Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors | J Glob Antimicrob Resist 20, 163-169 (2020) | 0 | 214 214IN |
214 214IN |
100 | HIVDB |
| Seatla (2018) | Four class drug resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir based antiretroviral therapy in Botswana | AIDS (2018) In press | 0 | 6 4PR 4RT 2IN |
6 4PR 4RT 2IN |
100 | HIVDB |
| Seatla (2019) | Validation of an affordable and sensitive in-house HIV-1 subtype C integrase genotyping assay | 31751353 | 0 | 30 30IN |
66 66IN |
45 | HIVDB |
| Seatla (2021) | HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana | Viruses 13 (4), 594 (2021) | 0 | 38 38IN |
38 38IN |
100 | HIVDB |
| Seatla (2021) | Low-frequency HIV-1 drug resistance mutations in antiretroviral naive individuals in Botswana | 35838991 | 0 | |
13 13PR 13RT |
0 | HIVDB |
| Sebastiao (2019) | High genetic diversity and transmitted drug resistance in HIV-1 infected pregnant women newly diagnosed in Luanda, Angola | 31770425 | 0 | 34 34PR 34RT |
34 34PR 34RT |
100 | HIVDB |
| Sebastiao (2025) | HIV-1 naive patients from Angola 2022 | Unpublished | 0 | |
48 45PR 45RT 45IN |
0 | HIVDB |
| Seclen (2010) | High prevalence of natural polymorphisms in gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor | AIDS 24, 467 (2010) | 0 | |
389 389PR 389RT |
0 | ARV Rx and/or other data are N/A |
| Segujja (2020) | Pre-treatment HIV-1 Drug Resistance, Virological Suppression Rates and Acquired HIV-1 Drug Resistance in a Cohort of Female Sex workers in Uganda | Unpublished | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Seki (1995) | ISOLATION and characterization of human immunodeficiency virus type-1 mutants resistant to the non-nucleotide reverse transcriptase inhibitor MKC-442 | Antivir. Chem. Chemother. 6, 73-79 (1995) | 3e-69 | |
5 5RT |
0 | Case report(s) / study subset |
| Sekulic (2018) | Molecular characterization of HIV -1 subtype G in Serbia | Unpublished | 6.73e-174 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Selimova (2011) | HIV-1 pol gene subtypes isolated from drug-naive individuals in Russia | Unpublished | 0 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Semengue (2021) | Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings | J Antimicrob Chemother (2021) In press | 0 | 73 73IN |
73 73IN |
100 | HIVDB |
| Sen (2007) | HUMAN immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India | AIDS Res. Hum. Retroviruses 23 (4), 489-497 (2007) | 0 | 23 23PR 23RT |
75 75PR 75RT |
30 | HIVDB |
| Sen (2007) | HIGH Prevalence of Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Antiretroviral Treatment-Experienced Patients from Pune, India | AIDS Res. Hum. Retroviruses 23 (10), 1303-1308 (2007) | 0 | 63 63PR 63RT |
63 63PR 63RT 1IN |
100 | HIVDB |
| Sengupta (2010) | Characterization of the transframe region and full protease gene of HIV-1 from India | Unpublished | 7e-60 | |
32 32PR |
0 | ARV Rx and/or other data are N/A |
| Senjobe (2025) | Markedly reduced mutational frequencies of networked epitopes promote CD8+ T cell cross-recognition and clearance of the latent HIV-1 reservoir | Unpublished | 0 | |
27 27PR 27RT 27IN |
0 | Unpublished |
| Seoighe (2007) | A Model of Directional Selection Applied to the Evolution of Drug Resistance in HIV-1 | Mol. Biol. Evol. (2007) In press | 1e-169 | 600 600RT |
600 276PR 600RT |
100 | HIVDB |
| Serkov (2017) | Genetic variants of HIV type 1 in MSM in Russia | 28443684 | 0 | 15 15PR 15RT |
15 15PR 15RT |
100 | HIVDB |
| Servais (2000) | DIRECT Submission | Thesis (2001) Department of Departement de Microbiologie, Im | 1e-133 | 86 43PR 43RT |
148 74PR 74RT |
58 | HIVDB |
| Servais (2001) | COMPARISON of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy | J. Clin. Microbiol. 39 (2), 454-459 (2001) | 1e-133 | 246 151PR 95RT |
380 268PR 112RT |
64 | HIVDB |
| Serwin (2021) | Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 | Sci Rep 11 (1), 16609 (2021) | 0 | |
288 271PR 271RT 17IN |
0 | Pending |
| Serwin (2022) | Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands | J Med Virol (2022) In press | 0 | |
2 2IN |
0 | Case report(s) / study subset |
| Seu (2015) | Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia | J. Med. Virol. (2015) In press | 0 | 68 68PR 68RT |
136 136PR 68RT |
50 | HIVDB |
| Sevin (2000) | METHODS for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333 | J. Infect. Dis. 182 (1), 59-67 (2000) | 1e-128 | 71 71PR |
72 72PR |
98 | HIVDB |
| Shafer (2001) | ONLINE comparison of HIV-1 drug resistance algorithms identifies rates and causes of discordant interpretations | Antiviral Therapy 6 (Suppl. 1), 101 (2001) | 1e-133 | 2172 2158PR 2159RT |
2206 2192PR 2192RT |
98 | HIVDB |
| Shafer (1995) | DRUG resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team | J. Infect. Dis. 172 (1), 70-78 (1995) | 1e-98 | 53 53RT |
53 53RT |
100 | HIVDB |
| Shafer (1997) | SEQUENCE and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe | J. Virol. 71 (7), 5441-5448 (1997) | 4e-65 | 12 12RT |
12 12RT |
100 | HIVDB |
| Shafer (1999) | SEQUENCE and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe | AIDS Res. Hum. Retroviruses 15 (1), 65-69 (1999) | 8e-92 | 12 12PR |
12 12PR |
100 | HIVDB |
| Shafer (2000) | REPRODUCIBILITY of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals | J. Virol. Methods 86 (2), 143-153 (2000) | 1e-116 | 16 16PR |
51 44PR 7RT |
31 | HIVDB |
| Shafer (2004) | Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients | Ann. Intern. Med. 128 (11), 906-911 (1998) | 2.64e-172 | 29 15PR 14RT |
42 22PR 20RT |
69 | HIVDB |
| Shahid (2011) | HIV-1 Circulating Recombinant Form (CRF) in Nepal | J. Virol. (2011) In press | 1e-166 | 6 6PR 6RT |
6 6PR 6RT |
100 | HIVDB |
| Shahid (2012) | HIV ART resistance in Pakistan | Unpublished | 0 | |
38 38PR 38RT |
0 | ARV Rx and/or other data are N/A |
| Shahriar (2009) | Nonpolymorphic HIV-1 Protease and RT Treatment-Selected Mutations | 19721070 | 0 | 5836 3746PR 3867RT |
7647 3765PR 3882RT |
76 | HIVDB |
| Shanmugasundaram (2008) | DISTINCT patterns of evolution in reverse transcriptase gene of HIV-1 subtype C in anti-retroviral naive and treated patients | AIDS Res Hum Retroviruses. 2010 Sep 19. [Epub ahead of print | 1e-180 | |
55 18PR 55RT |
0 | Case report(s) / study subset |
| Shanmugasundaram (2008) | Short communication: Nucleotide variation and positively selected sites in HIV type 1 reverse transcriptase among heterosexual transmission pairs | AIDS Res. Hum. Retroviruses 26 (8), 895-899 (2010) | 6.1e-157 | |
86 35PR 65RT |
0 | Pending |
| Shanmugasundaram (2016) | Compartmentalization of HIV-1 reverse trancriptase in female genital tract and plasma | Unpublished | 5.72e-156 | |
16 16RT |
0 | Case report(s) / study subset |
| Shao (2014) | HIV-1 drug mutations in children from northern Tanzania | J. Antimicrob. Chemother. 69 (7), 1928-1932 (2014) | 1.77e-147 | |
46 45PR 46RT |
0 | Pending |
| Shao (2019) | Direct Submission | Submitted (14-MAR-2019) Division of Research on Vi | 0 | |
12 5PR 12RT 5IN |
0 | Unpublished |
| Shao (2001) | The genome of the hiv-1 inter-subtype (c/b') and use thereof | Patent: WO 0136614-A2 125 25-MAY-2001; Geneart GMB | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Sharkey (2018) | HIV-1 escape from small molecule antagonism of Vif | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Sharma (2014) | Molecular Diversity of HIV-1 among the HIV Infected People of North Eastern India | 27869320 | 4.59e-173 | 69 51PR 64RT |
83 65PR 80RT |
83 | HIVDB |
| Sharma (2018) | Antiretroviral resistance and genotypic characterization of Human immunodeficiency virus in the recently infected wives of intravenous drug users in Manipur | 30315192 | 5.09e-177 | 77 33PR 44RT |
77 33PR 44RT |
100 | HIVDB |
| Sharma (2015) | The dynamics of sequence insertions in HIV Type 1 subtype C p6 in drug naive patients from India | Unpublished | 0 | |
18 7PR 15RT 6IN |
0 | ARV Rx and/or other data are N/A |
| Shchemelev (2022) | Direct Submission | Submitted (15-NOV-2021) Federal Service for Superv | 0 | 383 373PR 357RT |
389 374PR 389RT |
98 | HIVDB |
| Shchemelev (2025) | Direct Submission | Submitted (30-SEP-2025) Federal Service for Superv | 0 | |
51 51PR 51RT |
0 | Unpublished |
| Shcherbakova (2014) | Short Communication: Molecular Epidemiology, Phylogeny, and Phylodynamics of CRF63_02A1, a Recently Originated HIV-1 Circulating Recombinant Form Spreading in Siberia | AIDS Res. Hum. Retroviruses 30 (9), 912-919 (2014) | 0 | 22 22PR 22RT 3IN |
25 25PR 25RT 3IN |
88 | HIVDB |
| Sheehy (1996) | CONCURRENT evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy | J. Gen. Virol. 77 (Pt 5), 1071-1081 (1996) | 3e-50 | |
46 46RT |
0 | Case report(s) / study subset |
| Shemshura (2018) | Molecular epidemiology of HIV-1 in Krasnodar region, Russia | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Shen (2025) | Direct Submission | Submitted (06-DEC-2024) State Key Laboratory of Pa | 0 | |
16 16RT |
0 | Unpublished |
| Shen (2024) | Sequence Note: Characterization of the near-full-length genome of two novel Unique Recombinant Genome among men who have sex with men in Hebei, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report (Small sample size) |
| Shen (2020) | Prevalence of transmitted drug-resistance among newly confirmed HIV-1 infected men who have sex with men in Zhenjiang, Jiangsu | Unpublished | 0 | |
223 223PR 223RT |
0 | HIVDB |
| Shepherd (2017) | HIV positive patient with GBS-like syndrome | Unpublished | 0 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Sherefa (1998) | FULL-LENGTH sequence of human immunodeficiency virus type 1 subtype A, recombined with subtype C in the env V3 domain | AIDS Res. Hum. Retroviruses 14 (3), 289-292 (1998) | 1e-162 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Shi (2010) | Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy | Virology 404 (1), 5-20 (2010) | 0 | |
137 137PR 137RT 15IN |
0 | SGS |
| Shi (2004) | CONSTRUCTION of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant Virus | AIDS Res. Hum. Retroviruses 20 (9), 1015-1018 (2004) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| shi (2024) | Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021 | Unpublished | 1.23e-180 | |
1161 1161PR 1161RT |
0 | Pending |
| Shi (2023) | Direct Submission | Submitted (10-JAN-2023) Clinical Laboratory, The P | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Shi (2024) | Crf01_ae/c | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Shi (2024) | Bdl123bdd027 | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Shi (2024) | Direct Submission | Submitted (28-OCT-2024) Department of Clinical Lab | 0 | |
222 222PR 222RT 222IN |
0 | Unpublished |
| Shi (2025) | Crf01_ae/crf07_bc/b | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report (Small sample size) |
| Shi (2025) | Crf08_bc/b | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Shi (2025) | Direct Submission | Submitted (27-MAY-2025) Department of Clinical Lab | 0 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Shi (2025) | Direct Submission | Submitted (29-AUG-2025) Department of Clinical Lab | 0 | |
1 1PR 1RT 1IN |
0 | Unpublished |
| Shi (2021) | Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China | PLoS One 16 (12), e0260670 (2021) | 0 | 117 114PR 117RT |
117 117PR 117RT |
100 | HIVDB |
| Shibata (1995) | ISOLATION and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo | J. Virol. 69 (7), 4453-4462 (1995) | 1e-160 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Shibata (2006) | CONSTRUCTION and characterization of an infectious DNA clone and of mutants of simian immunodeficiency virus isolated from the African green monkey | J. Virol. 64 (1), 307-312 (1990) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Shiino (2002) | EVOLUTIONARY analysis of ultra-frequent defective G to A mutations observed in the provirus of HIV-1 infected patients under long-term anti-retroviral drug therapy | Unpublished | 4e-29 | |
30 30PR |
0 | Gene fragment(s) |
| Shiu (2016) | Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy | J. Virol. 83 (19), 9731-9742 (2009) | 2.22e-169 | |
255 255RT |
0 | Proviral DNA Reservoir |
| Shtrek (2022) | Modern methods of studying HIV infection in the Siberian Federal | Unpublished | 0 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Shtrek (2019) | Modern methods of studying HIV infection in the Siberian Federal | Unpublished | 0 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Shtrek (2020) | HIV infection in Western Siberia | Unpublished | 1.11e-180 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Shtrek (2020) | Modern methods of studying HIV infection in the Siberian Federal | Unpublished | 0 | |
9 9PR 9RT |
0 | Unpublished |
| Shtrek (2020) | Direct Submission | Submitted (31-JUL-2020) Siberian Federal District | 0 | |
1 1PR 1RT |
0 | Unpublished |
| Shtrek (2021) | Direct Submission | Submitted (26-APR-2021) Siberian Federal District | 0 | |
9 9PR 9RT |
0 | Unpublished |
| Shtrek (2022) | Direct Submission | Submitted (16-NOV-2021) Siberian Federal District | 0 | |
10 9PR 9RT |
0 | Unpublished |
| Shu (2018) | Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naive individuals | Arch. Virol. (2018) In press | 0 | 51 42PR 51RT 36IN |
51 42PR 51RT 36IN |
100 | HIVDB |
| Si-Mohamed (2000) | SELECTION of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy | J. Infect. Dis. 182 (1), 112-122 (2000) | 1e-128 | 85 42PR 43RT |
85 42PR 43RT |
100 | HIVDB |
| Sichtig (2008) | Evolution of raltegravir resistance during therapy. | J Antimicrob Chemother | 1e-165 | 223 223IN |
224 224IN |
99 | HIVDB |
| Sierra (2004) | THE analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF | Infect. Genet. Evol. (2004) In press | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Sierra (2006) | IDENTIFICATION of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba | J. Acquir. Immune Defic. Syndr. 45 (2), 151-160 (2007) | 0 | 14 14PR 14RT 14IN |
20 20PR 20RT 20IN |
70 | HIVDB |
| Sierra (2007) | ANALYSIS of near full-length genome sequences of HIV-1 isolates of Romanian origin | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Sigaloff (2011) | Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. | JAIDS | 0 | 130 130PR 130RT |
130 130PR 130RT |
100 | HIVDB |
| Sigaloff (2011) | Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa | AIDS Res. Hum. Retroviruses 28 (2), 171-175 (2012) | 0 | 69 69PR 69RT |
69 69PR 69RT |
100 | HIVDB |
| Sigaloff (2011) | Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa | J. Infect. Dis. (2012) In press | 0 | 53 53PR 53RT |
68 68PR 68RT |
77 | HIVDB |
| Sigaloff (2012) | Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya | AIDS Res. Hum. Retroviruses 28 (9), 833-837 (2012) | 1.99e-171 | 73 71PR 72RT |
73 72PR 72RT |
100 | HIVDB |
| Sigaloff (2012) | Short Communication: High Rates of Thymidine Analogue Mutations and Dual-Class Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy | AIDS Res. Hum. Retroviruses 29 (6), 925-930 (2013) | 0 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Siljic (2013) | Molecular typing of the local HIV-1 epidemic in Serbia | Infect. Genet. Evol. (2013) In press | 0 | 102 102PR 101RT |
143 143PR 143RT |
71 | HIVDB |
| Siljic (2017) | Forensic application of phylogenetic analyses - Exploration of suspected HIV-1 transmission case | Forensic Sci Int Genet 27, 100-105 (2017) | 5.16e-158 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Siljic (2022) | Reconstructing the temporal origin and the transmission dy- namics of the HIV subtype B epidemic in St Petersburg, Russia | Unpublished | 0 | |
247 247PR 247RT |
0 | Pending |
| Siljic (2024) | HIV-1 subtypes distribution in Serbia | Unpublished | 6.37e-161 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Silva (2020) | HIV-1 prevalence, associated factors, genetic diversity and transmitted drug resistance mutations in a populations of men who have sex with men in Midwestern Brazil | Unpublished | 4.1e-180 | 78 78PR 77RT |
78 78PR 78RT |
100 | HIVDB |
| Silva (2025) | Epidemiological dynamics and molecular characteristics of HIV-1 among transgender women in the midwest region of Brazil | Unpublished | 0 | |
82 82PR 82RT |
0 | ARV Rx and/or other data are N/A |
| Silver (2019) | A highly unusual V1 region of Env in an elite controller 1 of HIV infection | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Simon (2002) | IDENTIFICATION of a new human immunodeficiency virus type 1 distinct from group M and group O | Nat. Med. 4 (9), 1032-1037 (1998) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Simon (2008) | COMPLEMENTATION of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes | J. Virol. 69 (7), 4166-4172 (1995) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Simon (2002) | EVOLVING patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals | AIDS 16 (11), 1511-1519 (2002) | 1e-135 | 184 152PR 152RT |
184 152PR 152RT |
100 | HIVDB |
| Simon (2003) | INFECTIVITY and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary Infection | J. Virol. 77 (14), 7736-7745 (2003) | 1e-144 | |
36 36PR 18RT |
0 | Case report(s) / study subset |
| Simon (2005) | NATURAL Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification | PLoS Pathog. 1 (1), e6 (2005) | 0 | |
26 13PR 13RT 13IN |
0 | Case report(s) / study subset |
| Simonetti (2016) | Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo | Proc. Natl. Acad. Sci. U.S.A. 113 (7), 1883-1888 ( | 0 | |
282 282PR 282RT 1IN |
0 | Quasispecies |
| Simonetti (2019) | Local epidemics gone viral: evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC | Front Microbiol (2019) In press | 0 | |
26 26PR 26RT |
0 | Pending |
| Simonetti (2021) | Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo | J Clin Invest (2021) In press | 0 | |
49 37PR 42RT 35IN |
0 | Quasispecies |
| Singh (2013) | Wild type Human immunodeficiency virus type 1 in adults with virological failure of first-line antiretroviral therapy in KwaZulu-Natal, South Africa | Unpublished | 0 | |
11 11RT |
0 | Case report(s) / study subset |
| Singh (2023) | Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy | AIDS 37 (14), 2119-2130 (2023) | 0 | |
348 339PR 319RT 147IN |
0 | Proviral DNA Reservoir |
| Singh (2024) | HIV1 near complete genomes from India | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Sinha (2012) | Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India. | AIDS Res Treat. 2012;2012:905823. Epub 2012 Mar 15. | 0 | 31 31PR 31RT |
31 31PR 31RT |
100 | HIVDB |
| Sirivichayakul (2001) | SURVEY of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000 | AIDS Res. Hum. Retroviruses 17 (11), 1077-1081 (2001) | 1e-81 | 42 3PR 42RT |
43 3PR 43RT |
97 | HIVDB |
| Sirivichayakul (2005) | RT and protease sequences from HIV-1 non-B infected persons from Thailand | 15839752 | 1e-138 | 109 14PR 95RT |
109 14PR 95RT |
100 | HIVDB |
| Sirivichayakul (2012) | HIV drug resistance transmission threshold survey in Bangkok, Thailand | Antivir. Ther. (Lond.) 13 SUPPL 2, 109-113 (2008) | 4e-172 | 172 88PR 84RT |
172 88PR 84RT |
100 | HIVDB |
| Sirivichayakul (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 3.16e-174 | 281 282RT |
282 282RT |
99 | HIVDB |
| Sirivichayakul (2021) | Direct Submission | Submitted (21-MAR-2021) Department of Medicine, Ch | 0 | |
137 134PR 136RT |
0 | Unpublished |
| Sisay (2017) | Molecular Epidemiology of HIV-1 in Ethiopia | Unpublished | 0 | |
20 20PR 20RT |
0 | Unpublished |
| Sivamalar (2016) | Accumulation of HIV-1 drug resistance mutations after first-line immunological failure to evaluate the options of recycling NRTI drugs in second-line treatment: A Study from South India | AIDS Res. Hum. Retroviruses (2016) In press | 3.79e-157 | |
202 101PR 202RT |
0 | Pending |
| Sivay (2018) | HIV diversity among young women attending high school in rural South Africa: HPTN 068 | 29985265 | 0 | 201 201PR 201RT |
201 201PR 201RT |
100 | HIVDB |
| Sivay (2020) | HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075 | Clin. Infect. Dis. (2020) In press | 0 | 136 136PR 136RT |
178 178PR 178RT |
76 | HIVDB |
| Skaria (2011) | Genetic compartmentalization of antiretroviral resistance mutations, HLA-associated polymorphisms and envelope V3 genotype in plasma viruses during advanced HIV infection | Unpublished | 0 | |
70 70PR 70RT |
0 | ARV Rx and/or other data are N/A |
| Skhosana (2015) | High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa | PLoS ONE 10 (2), E0118145 (2015) | 0 | 160 160PR 160RT |
160 160PR 160RT |
100 | HIVDB |
| Skinner (1998) | ANALYSIS of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (2), 99- | 1e-165 | 102 102IN |
102 102IN |
100 | HIVDB |
| Smeti (2024) | Direct Submission | Submitted (12-MAR-2024) Laboratoire des Maladies T | 1.92e-175 | |
77 77PR 77RT |
0 | Unpublished |
| Smith (2015) | Direct Submission | Submitted (27-JAN-2015) Medicine, UCSD, 9500 Gilma | 1.72e-100 | |
93 93RT |
0 | ARV Rx and/or other data are N/A |
| Smith (2005) | HIV Drug Resistance Acquired Through Superinfection (DRATS) | 16052079 | 0 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Smith (2000) | DIRECT Submission | Submitted (30-DEC-1996) Medical Microbiology and Immunology, | 7.47e-25 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Smith (2016) | Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells | MBio 7 (3) (2016) | 6.18e-22 | |
39 39PR |
0 | Proviral DNA Reservoir |
| Smolen (2010) | HIV type 1 genetic diversity in Silesia, Poland: a retrospective analysis | AIDS Res. Hum. Retroviruses 26 (7), 767-776 (2010) | 1e-172 | 101 101RT |
101 101RT |
100 | HIVDB |
| Smolen (2013) | HIV-1 pol gene variability among recently infected individuals in Poland | 23822819 | 9e-61 | 53 53PR |
53 53PR |
100 | HIVDB |
| Smolen-Dzirba (2012) | Molecular epidemiology of recent HIV-1 infections in southern Poland | J. Med. Virol. 84 (12), 1857-1868 (2012) | 2e-172 | 54 54RT |
54 54RT |
100 | HIVDB |
| Smolen-Dzirba (2016) | Baseline HIV-1 reverse transcriptase, protease and fusion inhibitors resistance-associated mutations and polymorphisms among patients with recent infection in Southern Poland | 28167814 | 1.52e-176 | 56 28PR 28RT |
56 28PR 28RT |
100 | HIVDB |
| Smolskaya (2016) | HIV Epidemiology in the Northwestern Federal District of Russia: Dominance of HIV Type 1 Subtype A | AIDS Res. Hum. Retroviruses 22 (11), 1074-1080 (20 | 0.000000000000708 | |
15 15PR |
0 | Gene fragment(s) |
| Snoeck (2002) | PREVALENCE and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999 | Virus Res. 85 (1), 95-107 (2002) | 1e-120 | 18 15PR 16RT |
45 39PR 42RT |
40 | HIVDB |
| Soares (2004) | Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. | JAIDS | 1e-138 | 86 69PR 71RT |
91 70PR 77RT 4IN |
94 | HIVDB |
| Soares (2010) | Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naive Cameroonian subjects with advanced disease | J. Clin. Virol. 48 (3), 173-179 (2010) | 2.19e-180 | 54 49PR 49RT |
86 49PR 81RT |
62 | HIVDB |
| Soares (1997) | A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys | Virology 228 (2), 394-399 (1997) | 7.8e-117 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Soares (2003) | A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil | AIDS 17 (1), 11-21 (2003) | 1e-133 | 190 97PR 93RT |
190 97PR 93RT |
100 | HIVDB |
| Sodroski (1993) | A second post-transcriptional trans-activator gene required for HTLV-III replication | Nature 321 (6068), 412-417 (1986) | 0.0000000002 | |
1 1IN |
0 | Laboratory/experimental isolate |
| Sofie (2006) | LONG-TERM Foscarnet Therapy Remodels Thymidine Analog Mutations and Alters Resistance to Zidovudine and Lamivudine in Human Immunodeficiency Virus-1 | Unpublished | 0 | |
40 20PR 40RT |
0 | ARV Rx and/or other data are N/A |
| Soheili (2011) | HIV-1 Isolated from Mashad-Iran Reverse Transcriptase (RT) gene | Unpublished | 4.58e-163 | |
18 18RT |
0 | ARV Rx and/or other data are N/A |
| Soheilli (2009) | Presence of HIV-1 CRF35_AD in Iran | AIDS Res. Hum. Retroviruses 25 (1), 123-124 (2009) | 4e-170 | 20 12PR 8RT |
20 12PR 8RT |
100 | HIVDB |
| Soldi (2019) | Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in Sao Paulo State, Brazil | PLoS ONE 14 (10), e0223210 (2019) | 2.08e-165 | 1696 1696PR 1689RT |
1696 1696PR 1696RT |
100 | HIVDB |
| Solomon (2006) | HIGH prevalence of treatment failure among treatment-experienced HIV-infected individuals in Chennai, India | Unpublished | 1e-177 | |
33 33RT |
0 | Unpublished - Final |
| Somda (2013) | Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso | Clin. Infect. Dis. 54 (SUPPL 4), S317-S319 (2012) | 0 | 48 48PR 48RT |
48 48PR 48RT |
100 | HIVDB |
| Song (2013) | Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. | Retrovirology. 2014 Sep 12;11:69. | 0 | |
906 279PR 279RT 906IN |
0 | Case report(s) / study subset |
| Song (2018) | Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection | Nat Commun (2018) In press | 0 | |
3209 728PR 1148RT 3199IN |
0 | SGS |
| Song (2024) | Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype | Res Sq (2023) | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Song (2020) | Near Full-Length Genomic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF107_01B) Identified among Men Who Have Sex with Men in Heilongjiang province of China | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Song (2019) | Direct Submission | Submitted (22-OCT-2019) Department of Clinical Lab | 0 | 216 216PR 216RT |
216 216PR 216RT |
100 | HIVDB |
| Song (2025) | Study on HIV Low Viral Load Genotypic Drug Resistance Detection Based on Exosome Enrichment Technology | Unpublished | 0 | |
37 21PR 22RT 15IN |
0 | Unpublished |
| Song (2016) | Near-full-length genome identification of a novel HIV-1 circulating recombinant form, CRF01_AE/B'/C (CRF78_cpx) in Yunnan, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Songok (2003) | ACTIVE generation and selection for A/D recombinant forms of HIV-1 in Kenya | 15018715 | 1e-122 | |
24 24RT |
0 | Case report(s) / study subset |
| Soria (2012) | Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, Peru | AIDS Res. Hum. Retroviruses 28 (4), 333-338 (2012) | 3.38e-150 | 37 37RT |
54 54RT |
68 | HIVDB |
| Soria (2019) | Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru | AIDS Res. Hum. Retroviruses (2019) In press | 4.36e-154 | 122 122RT |
122 122RT |
100 | HIVDB |
| Soto-Ramirez (1997) | HIV-1 pol sequences from India fit distinct subtype pattern | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (4), 299 | 5e-58 | 5 5RT |
5 5RT |
100 | HIVDB |
| Souda (2013) | No Clinically Significant Drug Resistance Mutations in HIV-1 subtype C infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana | 23542639 | 0 | |
54 54PR 54RT |
0 | Pending |
| Soulie (2009) | Presence of HIV-1 R5 viruses in CSF even in patients harboring R5X4/X4 viruses in plasma | 19390328 | 3.15e-168 | |
85 43PR 51RT |
0 | Case report(s) / study subset |
| Soulie (2014) | Antiretroviral-experienced HIV-1-infected patients treated with maraviroc: factors associated with virological response | AIDS Res. Hum. Retroviruses (2014) In press | 0 | 96 96RT |
96 96RT |
100 | HIVDB |
| Soundararajan (2007) | CHARACTERIZATION of HIV-1 Isolates from Antiretroviral Drug-Naive Children in Southern India | AIDS Res. Hum. Retroviruses 23 (9), 1119-1126 (2007) | 6.96e-159 | 59 26PR 33RT |
59 26PR 33RT |
100 | HIVDB |
| Souquiere (2001) | WILD Mandrillus sphinx are carriers of two types of lentivirus | J. Virol. 75 (15), 7086-7096 (2001) | 1e-123 | |
19 1PR 2RT 19IN |
0 | NHPL/SIV |
| Souquiere (2006) | THE two distinct SIVs infecting Mandrillus sphinx were subjected to differential selection in env region | Unpublished | 3e-88 | |
14 2RT 14IN |
0 | NHPL/SIV |
| Souza Cavalcanti (2012) | In-vivo selection of the mutation F121Y in a patient failing raltegravir containing salvage regimen | Antiviral Res. 95 (1), 9-11 (2012) | 1e-167 | 4 4IN |
20 20IN |
20 | HIVDB |
| Souza (2008) | MOLECULAR Characterization of HIV Type 1 BF Pol Recombinants from Sao Paulo, Brazil | AIDS Res. Hum. Retroviruses 24 (12), 1521-1525 (2008) | 0 | |
37 37PR 37RT |
0 | ARV Rx and/or other data are N/A |
| Souza (2020) | Direct Submission | Submitted (18-JUN-2020) Instituto de Estudos Coste | 4.15e-125 | |
8 8RT |
0 | Unpublished |
| Spire (1989) | NUCLEOTIDE sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus | Gene 81 (2), 275-284 (1989) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Spivak (2009) | A Case of Seronegative HIV-1 Infection | J Infect Dis. 2010 Feb 1;201(3):341-5. | 1e-171 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Srinivasan (1993) | MOLECULAR characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene | Gene 52 (1), 71-82 (1987) | 3e-79 | |
1 1IN |
0 | Gene fragment(s) |
| Ssemwanga (2010) | Multiple HIV-1 Infections in Sexual Partnerships in a Rural Clinical Cohort in Uganda | 21749285 | 5e-57 | 241 241IN |
899 899IN |
26 | HIVDB |
| Ssemwanga (2011) | Transmitted antiretroviral drug resistance among drug-naive commercial sex workers with recent infection in Kampala, Uganda | 22544200 | 1.82e-170 | 42 40PR 40RT |
42 42PR 40RT |
100 | HIVDB |
| Ssemwanga (2012) | Low Drug Resistance Levels Among Drug-Naive Individuals with Recent HIV Type 1 Infection in a Rural Clinical Cohort in Southwestern Uganda | AIDS Res. Hum. Retroviruses 28 (12), 1784-1787 (20 | 1.58e-170 | 72 72PR 72RT |
72 72PR 72RT |
100 | HIVDB |
| Ssemwanga (2018) | Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection | J. Infect. Dis. (2018) In press | 3.25e-116 | |
951 951RT |
0 | SGS |
| Ssemwanga (2019) | Viral Suppression and Drug Resistance among HIV Positive Women at High Risk of Sexually-Transmitted Infections on Antiretroviral Therapy in Kampala, Uganda | Unpublished | 0 | 26 26PR 26RT |
28 28PR 28RT |
92 | HIVDB |
| Ssemwanga (2020) | Prevalence of Viral Load Suppression, Predictors of Virological Failure and Patterns of HIV Drug Resistance after 12 and 48 Months on Antiretroviral Therapy: A National Cross-Sectional Survey in Uganda | 32025714 | 0 | 149 149PR 149RT |
149 149PR 149RT |
100 | HIVDB |
| Ssemwanga (2020) | High Pre-treatment HIV Drug Resistance in Uganda | Unpublished | 1.97e-176 | 351 351PR 351RT |
351 351PR 351RT |
100 | HIVDB |
| Ssemwanga (2020) | The Molecular Epidemiology and Transmission Dynamics of HIV Type 1 in a General Population Cohort in Uganda | Viruses 12 (11), 1283 (2020) | 0 | 380 379PR 380RT |
380 379PR 380RT |
100 | HIVDB |
| Ssemwanga (2022) | High levels of drug-resistant HIV-1 among newly diagnosed antiretroviral treatment naive children in Uganda | https://www.abstract-archive.org/Abstract/Share/83174 | 1.31e-179 | |
141 141PR 141RT |
0 | Pending |
| Stanojevic (2002) | HIV-1 subtypes in Yugoslavia | AIDS Res. Hum. Retroviruses 18 (7), 519-522 (2002) | 2e-97 | 33 33RT |
33 33RT |
100 | HIVDB |
| Stanojevic (2003) | GENOTYPIC resistance of HIV-1 among patients in Serbia and Montenegro | Unpublished | 1e-49 | |
10 10PR |
0 | Gene fragment(s) |
| Stanojevic (2013) | Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance. | AIDS Res Hum Retroviruses. 2014 Jul;30(7):634-41. | 6.71e-165 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Starcich (1986) | IDENTIFICATION and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS | Cell 45 (5), 637-648 (1986) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Steain (2016) | HIV-1 sequence diversity and dual infections in Kenya | Unpublished | 0.000000000292 | |
22 22PR |
0 | Gene fragment(s) |
| Stecher (2018) | Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016 | Sci Rep 8 (1), 6799 (2018) | 2.42e-177 | |
2774 2766PR 2769RT |
0 | Sequence quality |
| Steegen (2008) | Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya. | AIDS Res Ther | 7.92e-145 | 32 16PR 16RT |
32 16PR 16RT |
100 | HIVDB |
| Steegen (2014) | High-level cross-resistance to Didanosine observed in South african children failing an abacavir- or Stavudine-based 1st-line regimen | PLoS ONE 9 (5), E97067 (2014) | 0 | 370 353PR 369RT |
370 369PR 370RT |
100 | HIVDB |
| Steegen (2016) | HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa | J. Antimicrob. Chemother. (2016) In press | 0 | 788 788PR 788RT |
788 787PR 788RT |
100 | HIVDB |
| Steegen (2016) | Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey | PLoS ONE 11 (12), E0166305 (2016) | 0 | 277 277PR 277RT |
277 277PR 277RT |
100 | HIVDB |
| Steegen (2017) | Prevalence of protease inhibitor and triple-class resistance in patients failing 2nd-line ART: results from a national survey in South Africa | 27923946 | 0 | 350 350PR 350RT |
350 350PR 350RT |
100 | HIVDB |
| Steegen (2019) | Resistance in patients failing integrase strand transfer inhibitors: a call to replace raltegravir with dolutegravir in third-line treatment in South Africa | Open Forum Infect Dis (2019) In press | 0 | 43 43IN |
43 43IN |
100 | HIVDB |
| Steegen (2021) | Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa | J Int AIDS Soc 24 (5), e25706 (2021) | 4.02e-174 | 584 582PR 584RT |
584 582PR 584RT |
100 | HIVDB |
| Steegen (2022) | Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment | Pediatr Infect Dis J (2022) In press | 0 | 650 650PR 650RT |
711 711PR 711RT |
91 | HIVDB |
| Stekler (2015) | Lack of Resistance to Integrase Inhibitors Among Antiretroviral-Naive Subjects With Primary HIV-1 Infection, 2007-2013 | 24831260 | 0 | 69 69IN |
69 69IN |
100 | HIVDB |
| Stekler (2018) | Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort | PLoS Med. 15 (3), e1002537 (2018) | 0 | |
52 52PR 52RT 22IN |
0 | Pending |
| Steve (2017) | High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo | Ecohealth 14 (1), 100-114 (2017) | 5.64e-63 | |
13 13IN |
0 | NHPL/SIV |
| Stoeckli (2002) | PHENOTYPIC and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with Zidovudine and Lamivudine | Antimicrob. Agents Chemother. 46 (12), 4000-4003 (2002) | 4e-96 | |
41 41RT |
0 | Case report(s) / study subset |
| Stone (2004) | HIV-1 reverse transcriptase (RT) mutation selection during in vitro exposure to Tenofovir +/- Abacavir and Tenofovir +/- Lamivudine | 15047556 | 0 | |
21 21RT |
0 | Pending |
| Strain (2005) | GENETIC Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy | J. Virol. 79 (3), 1772-1788 (2005) | 0 | |
36 36PR 36RT |
0 | Quasispecies |
| Streeck (2008) | IMMUNE-DRIVEN recombination and loss of control after HIV superinfection | J. Exp. Med. 205 (8), 1789-1796 (2008) | 0 | |
9 9PR 9RT 9IN |
0 | Case report(s) / study subset |
| Struck (2007) | A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis | Unpublished | 0 | 20 20PR 20RT 20IN |
21 21PR 21RT 21IN |
95 | HIVDB |
| Struck (2014) | Near Full-Length Characterization and Population Dynamics of the Human Immunodeficiency Virus Type I Circulating Recombinant Form 42 (CRF42_BF) in Luxembourg | AIDS Res. Hum. Retroviruses 31 (5), 554-558 (2015) | 0 | 24 24PR 24RT |
24 24PR 24RT |
100 | HIVDB |
| Strunnikova (1998) | EVOLUTION of human immunodeficiency virus type 1 in relation to disease progression in children | J. Hum. Virol. 1 (3), 224-239 (1998) | 1e-135 | |
61 61RT |
0 | Quasispecies |
| Struyve (2025) | Longitudinal analysis of integration site features and composition of the inducible HIV-1 reservoir in early-treated people | Unpublished | 0 | |
45 45PR 45RT 44IN |
0 | Proviral DNA Reservoir |
| Sturmer (2005) | PHYLOGENETIC analysis of HIV-1 transmission: pol gene sequences are insufficient to clarify true relationships between patient isolates | AIDS 18 (16), 2109-2113 (2004) | 1e-172 | |
23 23PR 23RT |
0 | ARV Rx and/or other data are N/A |
| Stuyver (2001) | LINE probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene | Antimicrob. Agents Chemother. 41 (2), 284-291 (1997) | 0 | |
25 25RT |
0 | ARV Rx and/or other data are N/A |
| Su (2011) | HIV-1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. | ARHR | 1e-166 | 124 124PR 124RT |
124 124PR 124RT |
100 | HIVDB |
| Su (2003) | HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China | AIDS 17 (17), 2515-2520 (2003) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Su (2020) | The origin and spread of CRF85_BC, driven by heterosexual transmission among older people in Sichuan, China | BMC Infect Dis 20 (1), 772 (2020) | 4.22e-180 | 149 149PR 149RT |
149 149PR 149RT |
100 | HIVDB |
| Su (2016) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 10 10PR 10RT 10IN |
10 10PR 10RT 10IN |
100 | HIVDB |
| Suaysod (2019) | Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy | Clin. Infect. Dis. 61 (1), 95-101 (2015) | 3.93e-158 | |
3 3RT |
0 | ARV Rx and/or other data are N/A |
| Subbarao (2002) | FULL-LENGTH HIV-1 CRF01_AE sequence | Unpublished | 1e-164 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Sudhakar (2023) | Molecular epidemiology of the HIV-1 epidemic in Fiji | 40295841 | 0 | 53 53PR 53RT 38IN |
53 51PR 53RT 42IN |
100 | HIVDB |
| Sugimoto (2010) | Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV | PLoS ONE 5 (7), E11678 (2010) | 3.49e-158 | |
26 9PR 15RT 15IN |
0 | Laboratory/experimental isolate |
| Sukasem (2005) | SURVEILLANCE of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand | Infection 35 (2), 81-88 (2007) | 8.22e-143 | 186 79PR 107RT |
751 300PR 451RT |
24 | HIVDB |
| Sulistina (2024) | Direct Submission | Submitted (15-OCT-2024) Institute of Tropical Dise | 5.14e-180 | |
52 36PR 16RT |
0 | Unpublished |
| Sun (2025) | Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China | Unpublished | 0 | |
45 4PR 4RT 41IN |
0 | HIVDB |
| Sun (2018) | Near Full-Length Genome Sequence of a Novel HIV-1 Recombinant Form (CRF01_AE/07_BC) Detected Among Men Who Have Sex with Men in Zhejiang, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Sun (2019) | Direct Submission | Submitted (11-JAN-2019) School of Medicine, Zhejia | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Sun (2019) | Multiple HIV-1 subtypes were found circulating in Shijingshan District of Beijing, China | AIDS Res. Hum. Retroviruses (2019) In press | 0 | 110 109PR 110RT 62IN |
110 109PR 110RT 62IN |
100 | HIVDB |
| Sun (2023) | Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy | bioRxiv (2023) | 0 | |
444 366PR 368RT 341IN |
0 | Quasispecies |
| Sun (2016) | Direct Submission | Submitted (18-JUL-2016) AIDS Prevention and Contro | 0 | |
77 77PR 77RT |
0 | Unpublished - Final |
| Sundaravaradan (2005) | GENETIC Characterization of HIV Type 1 Reverse Transcriptase Gene From Mothers and Infants Following Perinatal Transmission | 15918905 | 0 | |
131 131RT |
0 | Quasispecies |
| Sung (2000) | NATURAL polymorphisms of protease in protease inhibitor-naive HIV-1 infected patients in Korea: a novel L63M in subtype B | AIDS Res. Hum. Retroviruses 19 (6), 525-530 (2003) | 1e-161 | 1 1PR 1RT 1IN |
160 93PR 132RT 1IN |
0 | ARV Rx and/or other data are N/A |
| Sung (2001) | PHYLOGENETIC analysis of reverse transcriptase in antiretroviral drug-naive Korean HIV type 1 patients | AIDS Res. Hum. Retroviruses 17 (16), 1549-1554 (2001) | 4e-96 | 9 9RT |
24 24RT |
37 | HIVDB |
| Sung (2006) | HIGH frequency of drug resistance mutations in human immunodeficiency virus type 1-infected korean patients treated with HAART | AIDS Res. Hum. Retroviruses 23 (10), 1223-1229 (2007) | 1.32e-158 | |
31 29PR 31RT |
0 | Case report(s) / study subset |
| Sutar (2018) | Genetic characterization of HIV-1 subtype C reverse transcriptase gene from individuals at different stages of antiretroviral therapy | Unpublished | 4.18e-170 | |
93 31PR 31RT 31IN |
0 | Unpublished |
| Sutherland (2015) | Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa | AIDS Res. Hum. Retroviruses 31 (10), 1032-1037 (20 | 3e-58 | 46 46PR |
46 46PR |
100 | HIVDB |
| Sutthent (2001) | EFFECT of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants | J. Clin. Virol. 25 (1), 47-56 (2002) | 6e-64 | 30 30RT |
30 30RT |
100 | HIVDB |
| Sutthent (2004) | SURVEILLANCE of HIV-1 drug resistance in Thailand | 16286051 | 1e-150 | |
104 36PR 68RT |
0 | Pending |
| Sutthent (2004) | Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand. | Southeast Asian J Trop Med Public Health. 2007 Sep;38(5):814 | 6e-44 | |
67 67RT |
0 | Gene fragment(s) |
| Sutthent (2005) | STUDY of HIV-1 drug resistant mutation in GPO-VIR treated HIV-1 infected Thais | Unpublished | 0 | |
140 66PR 74RT |
0 | Pending |
| Sutthent (2007) | HIV-1 envelope gene evolution in antiretroviral drug resistant strains | Unpublished | 8.9e-142 | |
20 10PR 10RT |
0 | Case report(s) / study subset |
| Suzuki (2001) | NOVEL deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine | AIDS Res. Hum. Retroviruses 17 (13), 1293-1296 (2001) | 2e-91 | |
6 6RT |
0 | Case report(s) / study subset |
| Suzuki (2002) | AMINO acid insertions in p6gag of the human immunodeficiency virus type 1 alter incorporation of vpr into virions | Unpublished | 1e-126 | |
5 5PR 5RT |
0 | Case report(s) / study subset |
| Svard (2017) | Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy | PLoS ONE 12 (6), E0178942 (2017) | 0 | 82 82PR 82RT |
82 82PR 82RT |
100 | HIVDB |
| Svicher (2005) | NOVEL human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors | Antimicrob. Agents Chemother. 49 (5), 2015-2025 (2005) | 0 | |
148 148PR 148RT |
0 | ARV Rx and/or other data are N/A |
| Svicher (2006) | INVOLVEMENT of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors | J. Virol. 80 (14), 7186-7198 (2006) | 0 | 386 386PR 386RT |
424 424PR 424RT |
91 | HIVDB |
| Swanson (2003) | MOLECULAR Characterization of 39 HIV-1 Isolates Representing Group M (Subtypes A-G) and Group O: Sequence Analysis of gag p24, pol integrase, and env gp41 | AIDS Res. Hum. Retroviruses 19 (7), 625-629 (2003) | 1e-165 | 39 39IN |
39 39IN |
100 | HIVDB |
| Swanson (2003) | FULL-LENGTH Sequence Analysis of HIV-1 Isolate CM237: A CRF01_AE/B Intersubtype Recombinant from Thailand | AIDS Res. Hum. Retroviruses 19 (8), 707-712 (2003) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Switzer (2016) | Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Cote d'Ivoire | PLoS ONE 11 (6), E0157709 (2016) | 3.41e-163 | |
8 1PR 2RT 6IN |
0 | Case report(s) / study subset |
| Sylla (2007) | Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso. | Antivir Ther | 0 | 88 88PR 88RT |
88 88PR 88RT |
100 | HIVDB |
| Szubert (2017) | Virological response and resistance among HIV-infected children receiving first-line antiretroviral therapy without routine virological monitoring in Uganda and Zimbabwe | 28027281 | 0 | 236 236RT |
236 236RT |
100 | HIVDB |
| Tabernilla (2021) | Direct Submission | Submitted (11-DEC-2018) Virology and Pathogenesis, | 5.34e-62 | |
90 90PR |
0 | Unpublished |
| Tachbele (2018) | Virological failure and acquired drug resistance mutations detected by deep sequencing among ART experienced HIV-1 patients in South Omo, Ethiopia | 34819737 | 3.07e-153 | 111 111RT |
111 111RT |
100 | HIVDB |
| Tachedjian (1995) | CHARACTERISATION of foscarnet-resistant strains of human immunodeficiency virus type 1 | Virology 212 (1), 58-68 (1995) | 9e-97 | |
9 9RT |
0 | Laboratory/experimental isolate |
| Tachedjian (1996) | ZIDOVUDINE resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet | J. Virol. 70 (10), 7171-7181 (1996) | 5e-89 | |
2 2RT 1IN |
0 | Laboratory/experimental isolate |
| Tachedjian (1998) | CORESISTANCE to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase | Antimicrob. Agents Chemother. 42 (11), 3038-3043 (1998) | 2e-79 | |
2 2RT |
0 | ARV Rx and/or other data are N/A |
| Tadesse (2018) | High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia | Viruses 10 (2), E60 (2018) | 0 | 90 90PR 90RT |
197 197PR 197RT |
45 | HIVDB |
| Tadesse (2019) | Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia | Viruses 11 (9), E877 (2019) | 1.65e-167 | |
57 57PR 57RT |
0 | Pending |
| Tagnouokam Ngoupo (2018) | Characterization of a new HIV-1 group N isolate originating from a Cameroonian patient | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Tagnouokam-Ngoupo (2021) | Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon | PLoS One 16 (3), e0248642 (2021) | 1.94e-176 | |
57 56PR 56RT |
0 | Pending |
| Taiaroa (2024) | Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study | Lancet Reg Health West Pac 47, 101103 (2024) | 4.12e-177 | 3507 3507PR 3507RT |
3507 3507PR 3507RT |
100 | HIVDB |
| Taieb (2014) | Alarming High Frequency of Virological Failure and HIV-1 Drug Resistance in a Rural Treatment Site in Cameroon | Unpublished | 2.1e-175 | |
70 70PR 70RT |
0 | ARV Rx and/or other data are N/A |
| Takahoko (2001) | INFECTIOUS DNA clone of HIV type 1 A/G recombinant (CRF02_AG) replicable in peripheral blood mononuclear cells | AIDS Res. Hum. Retroviruses 17 (11), 1083-1087 (2001) | 1e-161 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Takebe (2003) | High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination. | AIDS | 0 | 9 9PR 9RT 9IN |
9 9PR 9RT 9IN |
100 | HIVDB |
| Takebe (2014) | Inter-continental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan: Proposal of a nomenclature for region- and risk-group specific HIV-1 variants | 24942575 | 0 | |
37 37PR 37RT |
0 | Pending |
| Takehisa (1998) | VARIOUS types of HIV mixed infections in Cameroon | Virology 245 (1), 1-10 (1998) | 8e-49 | |
48 48IN |
0 | Gene fragment(s) |
| Takehisa (1999) | HUMAN immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon | J. Virol. 73 (8), 6810-6820 (1999) | 4e-95 | |
9 9IN |
0 | Gene fragment(s) |
| Takehisa (2001) | PHYLOGENETIC analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2 | AIDS Res. Hum. Retroviruses 13 (7), 621-623 (1997) | 2e-48 | |
11 11IN |
0 | Gene fragment(s) |
| Takehisa (2001) | NATURAL infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus | AIDS Res. Hum. Retroviruses 17 (12), 1143-1154 (2001) | 3.42e-140 | |
6 1PR 1RT 6IN |
0 | NHPL/SIV |
| Takehisa (2001) | TRIPLE HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14 (1), 81- | 6e-44 | |
3 3IN |
0 | Case report(s) / study subset |
| Takehisa (2007) | GENERATION of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees | J. Virol. 81 (14), 7463-7475 (2007) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Takehisa (2009) | Origin and biology of simian immunodeficiency virus in wild-living western gorillas | J. Virol. 83 (4), 1635-1648 (2009) | 0 | |
7 5PR 5RT 7IN |
0 | NHPL/SIV |
| Takehisa (2012) | Complete SIVcpz genome sequence from Pan troglodytes schweinfurthii feces from Gombe National Park, Tanzania | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Takehisa (2013) | Complete SIVcpz genome from Pan troglodytes troglodytes feces from Cameroon | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Takekawa (2006) | CONSTRUCTION and characterization of HIV-1 subtype G infectious molecular clones derived from a Ghananian patient | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Takekawa (2009) | A new generation of recombinants between CRF02_AG and subtype A detected in Ghana : analysis by infectious molecular clones | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Laboratory/experimental isolate |
| Takekawa (2009) | Molecular characterization of infectious molecular clones derived from multidrug-resistant HIV-1 subtype B in Japan | Unpublished | 0 | |
7 7PR 7RT 7IN |
0 | Laboratory/experimental isolate |
| Takekawa (2009) | A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel | Unpublished | 0 | |
40 40PR 40RT 40IN |
0 | ARV Rx and/or other data are N/A |
| Takemura (2005) | A novel simian immunodeficiency virus from black mangabey (Lophocebus aterrimus) in the Democratic Republic of Congo | J. Gen. Virol. 86 (PT 7), 1967-1971 (2005) | 1e-152 | |
1 1RT 1IN |
0 | NHPL/SIV |
| Takeuchi (2002) | ISOLATION and characterization of an infectious HIV type 1 molecular clone from a patient with primary infection | AIDS Res. Hum. Retroviruses 18 (15), 1127-1133 (2002) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Takou (2019) | HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon | BMC Infect. Dis. 19 (1), 246 (2019) | 0 | 76 76PR 76RT |
76 76PR 76RT |
100 | HIVDB |
| Talbott (1995) | Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity. | PNAS | 1e-100 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Talei (2019) | prevalence of HIV in Lorestan | Unpublished | 1.07e-48 | |
2 2PR |
0 | Case report(s) / study subset |
| Talei (2020) | prevalence of HIV in Lorestan | Unpublished | 2.03e-55 | |
29 29PR |
0 | Unpublished |
| Talei (2022) | HIV-1 RT gene region sequences from Iranian patients | Unpublished | 4.27e-101 | |
1 1RT |
0 | Case report(s) / study subset |
| Tamalet (2013) | Primary HIV-1 Infection from Marseille, France | 25873310 | 2.8e-162 | 146 73PR 73RT |
146 73PR 73RT |
100 | HIVDB |
| Tamalet (2015) | Direct Submission | Submitted (21-FEB-2014) Virologie, CHU Timone, 264 | 1.07e-145 | |
2 2PR 2RT |
0 | Case report(s) / study subset |
| Tamalet (2018) | Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France | J. Med. Virol. (2018) In press | 0 | 48 5PR 38RT 5IN |
74 14PR 47RT 13IN |
64 | HIVDB |
| Tan (2007) | CONSTRUCTION and characterization of an infectious molecular clone of HIV-1 subtype B' isolated from Hubei Province, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Tanaka (2022) | Molecular epidemiology of HIV-1 among prisoners in Central Brazil and evidence of transmission clusters | Viruses (2022) In press | 0 | |
84 84PR 84RT |
0 | Pending |
| Tanaka (2018) | HIV-1 molecular epidemiology, transmission network and transmitted drug resistance mutations in Central West Brazil | 30804893 | 0 | 149 149PR 149RT |
149 149PR 149RT |
100 | HIVDB |
| Tang (2024) | Identification of two HIV-1 CRF01_AE/B recombinant forms and a CRF01_AE/B/C recombinant forms in Hebei Province, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Tang (2023) | Brain microglia are a persistent HIV reservoir despite durable antiretroviral therapy | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Tang (2009) | Viral attenuation due to HLA-B57 escape mutations enables control of HIV following vertical transmission despite depletion of CD8 T cell targets | Unpublished | 3e-50 | |
90 90PR |
0 | Case report(s) / study subset |
| Tang (2016) | Viral attenuation due to HLA-B57 escape mutations enables control of HIV following vertical transmission despite depletion of CD8 T cell targets | Unpublished | 0.000106 | |
18 18PR |
0 | Gene fragment(s) |
| Tanuma (2013) | HIV pol sequencing | 24815852 | 0 | 1745 1308PR 1389RT |
1777 1311PR 1423RT |
98 | HIVDB |
| Tanuma (2011) | Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors | Microbes Infect. 12 (14-15), 1170-1177 (2010) | 1e-162 | |
38 38RT 2IN |
0 | Case report(s) / study subset |
| Tanuri (1999) | GENETIC variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil | Antimicrob. Agents Chemother. 43 (2), 253-258 (1999) | 1e-126 | 8 8PR |
8 8PR |
100 | HIVDB |
| Tanuri (1999) | PRIMARY infections with HIV-1 of women and their offspring in Rio de Janeiro, Brazil: Finding of recombinant of HIV-1 subtypes B and F | Unpublished | 1e-109 | |
1 1PR |
0 | Case report(s) / study subset |
| Tao (2025) | HIV-1 Subtype Diversity Trends in a Northern California Cohort, 2000-2019 | Unpublished | 0 | 3306 3085PR 2950RT 348IN |
3582 3085PR 2950RT 348IN |
92 | HIVDB |
| Tapia (2016) | HIV-2 protease amino acid polymorphisms are associated with high phenotypic resistance to HIV-1 protease inhibitors | Unpublished | 2.04e-29 | |
1 1PR |
0 | Case report(s) / study subset |
| Tariq (2018) | HIV ART resistance in Pakistan | Unpublished | 2.03e-166 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Tariq (2019) | HIV ART resistance in Pakistan | Unpublished | 4.85e-113 | |
1 1PR 1RT |
0 | Unpublished |
| Tariq (2019) | HIV ART resistance in Pakistan | 32060792 | 2.8e-121 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Tatsumi (2003) | INFECTIOUS DNA clones of HIV-1 subtype A | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Laboratory/experimental isolate |
| Tatsumi (2006) | INFECTIOUS DNA clones of subtype G and CRF02_AG HIV-1 derived from Ghananian isolates | Unpublished | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Tatsumi (2006) | CONSTRUCTION and characterization of HIV-1 laboratory strain Ba-L infectious molecular clones | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Tatsumi (2006) | CONSTRUCTION and characterization of HIV-1 subtype C infectious molecular clones derived from Zambian isolates | Unpublished | 0 | |
16 16PR 16RT 16IN |
0 | ARV Rx and/or other data are N/A |
| Tau (2013) | Favorable Therapeutic Response with an Antiretroviral Salvage Regimen in an HIV-1-Positive Subject Infected with a CRF11-cpx Virus | AIDS Res. Hum. Retroviruses 30 (5), 480-483 (2014) | 5.81e-135 | |
3 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Taylor (2003) | HIV-1 Costa Rican novel sequences | Unpublished | 1e-122 | |
31 31PR 31RT |
0 | Gene fragment(s) |
| Taylor (2003) | IDENTIFICATION of a transmission chain of HIV typd 1 containing drug resistance-associated mutations | AIDS Res. Hum. Retroviruses 19 (5), 353-361 (2003) | 1e-130 | |
31 31PR 31RT |
0 | Quasispecies |
| Tazi (2011) | HIV-1 infected monozygotic twins: a tale of two outcomes | BMC Evol. Biol. 11 (1), 62 (2011) | 1.08e-130 | |
112 59PR 53RT |
0 | Quasispecies |
| Tchiakpe (2015) | The prediction of integrase inhibitors efficacy in third line regimen after first and second line antiretroviral therapy failure in SENEGAL | Unpublished | 0 | |
10 9PR 10RT |
0 | Case report(s) / study subset |
| Tchiakpe (2015) | Third line regimens prediction among the Senegalese HIV-1 infected patients failing second line antiretroviral therapy | Unpublished | 0 | |
24 10PR 12RT 12IN |
0 | Case report(s) / study subset |
| Tchiakpe (2020) | Moderate rate of resistance mutations transmitted to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin | Unpublished | 0 | 409 248PR 248RT |
409 248PR 248RT |
100 | HIVDB |
| Tchiakpe (2020) | Contribution of the classical polymerase chain reaction in the diagnosis of a HIV-1 infected patient in Benin | Unpublished | 2.6e-166 | |
1 1PR 1RT |
0 | Case report (Small sample size) |
| Tchiakpe (2024) | Evaluation of HIV-1 resistance to integrase strand-transfer inhibitors (INSTIs) before introduction of Dolutegravir in first-line treatment among newly diagnosed patients in Benin, West Africa | 32616057 | 0 | 54 54IN |
54 54IN |
100 | HIVDB |
| Tchiakpe (2024) | Resistance of HIV-1 to Dolutegravir in Benin. The Need to improve and strengthen therapeutic education strategies to achieve the third objective 95 of UNAIDS 3X95 | 39879199 | 0 | |
2 1PR 1RT 1IN |
0 | HIVDB |
| Tchiakpe (2025) | Efficacy of Dolutegravir on HIV-1 Strains in Newly Diagnosed Patients in the General Population in Benin and Naive to Antiretroviral Treatment, West Africa | Unpublished | 0 | |
107 107IN |
0 | HIVDB |
| Tchiakpe (2025) | High rate of resistance mutations associated with nucleoside and non-nucleoside reverse transcriptase inhibitors and great genetic diversity in HIV-1 infected patients followed for at least 12 months before roll out dolutegravir as first-line antiretroviral therapy in Benin, West Africa | Unpublished | 0 | |
184 169PR 178RT |
0 | Unpublished |
| Tchouwa (2018) | High Prevelance of Pre-treatment HIV Drug Resistance and NNRTI-Associated Resistance in Cameroon: the First Nationally Representative WHO Survey | 29931063 | 7.56e-179 | 337 329PR 323RT |
337 329PR 335RT |
100 | HIVDB |
| Tchouwa (2018) | First Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance Indicate Alarming Levels of Failures and Emerging Resistant Viruses in Cameroon | 31193678 | 1.89e-176 | 262 239PR 235RT |
262 250PR 257RT |
100 | HIVDB |
| Tchurikov (2014) | Conserved sequences in the current strains of HIV-1 subtype A in Russia are effectively targeted by artificial RNAi in vitro. | Gene. 2016 May 25;583(1):78-83. | 1e-59 | |
32 17RT 15IN |
0 | Gene fragment(s) |
| Tchurikov (2014) | Analysis of pol region in HIV-1 isolates subtype CRF02_AG in Russia selected as containing perspective targets for artificial RNAi | Unpublished | 2e-58 | |
23 18RT 5IN |
0 | Gene fragment(s) |
| Tebit (2002) | GENOTYPIC and phenotypic analysis of HIV type 1 primary isolates from western Cameroon | AIDS Res. Hum. Retroviruses 18 (1), 39-48 (2002) | 1e-163 | 19 19PR 1RT 1IN |
20 20PR 20RT 1IN |
95 | HIVDB |
| Tebit (2003) | CONSTRUCTION and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate | Virology 313 (2), 645-652 (2003) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Tebit (2004) | CONSTRUCTION and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives | Virology 326 (2), 329-339 (2004) | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Tebit (2009) | Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naive patients in Burkina Faso | J. Med. Virol. 81 (10), 1691-1701 (2009) | 1e-178 | 104 104PR 104RT |
104 104PR 104RT |
100 | HIVDB |
| Tebit (2016) | Diversity of Human immunodeficiency virus in rural Burkina Faso | J. Acquir. Immune Defic. Syndr. (2006) In press | 1.07e-84 | 33 33PR |
41 41PR 41RT |
80 | HIVDB |
| Tee (2005) | THE Evolving Molecular Epidemiology of HIV Type 1 among Injecting Drug Users (IDUs) in Malaysia | AIDS Res. Hum. Retroviruses 21 (12), 1046-1050 (2005) | 1e-147 | 36 24PR 36RT |
53 24PR 53RT |
67 | HIVDB |
| Tee (2005) | EMERGENCE of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia | AIDS 19 (2), 119-126 (2005) | 1e-138 | 200 100PR 100RT |
200 100PR 100RT |
100 | HIVDB |
| Tee (2005) | PREVALENCE and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia | Med. Microbiol. Immunol. (Berl.) 195 (2), 107-112 (2006) | 5.17e-140 | 100 50PR 50RT |
100 50PR 50RT |
100 | HIVDB |
| Tee (2006) | IDENTIFICATION of a Novel Circulating Recombinant Form (CRF33_01B) Disseminating Widely Among Various Risk Populations in Kuala Lumpur, Malaysia | J. Acquir. Immune Defic. Syndr. 43 (5), 523-529 (2006) | 0 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Tee (2009) | Estimating the date of origin of an HIV-1 circulating recombinant form | Virology 387 (1), 229-234 (2009) | 0 | 9 9PR 9RT |
9 9PR 9RT |
100 | HIVDB |
| Tee (2009) | Isolation and characterization of a replication-competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B) | PLoS ONE 4 (8), E6666 (2009) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Teixeira (2010) | The Detection of in Vivo and in Vitro HIV Type 1 B/F Profiles in Brazil Using a Real-Time PCR Assay for Five HIV Type 1 Genomic Regions | AIDS Res. Hum. Retroviruses 26 (9), 981-990 (2010) | 0 | |
357 154PR 153RT 50IN |
0 | ARV Rx and/or other data are N/A |
| Telan (2012) | Possible HIV transmission modes among at-risk groups at an early epidemic stage in the Philippines. | J Med Virol. 2013 Dec;85(12):2057-64. | 0 | 174 174PR 174RT |
174 174PR 174RT |
100 | HIVDB |
| Telan (2010) | An Early Phase of HIV Epidemic in a Population Previously Exposed to HCV in the Philippines | 21503904 | 0 | 22 22PR 22RT |
22 22PR 22RT |
100 | HIVDB |
| Telele (2018) | Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing | Sci Rep 8 (1), 7556 (2018) | 1.84e-171 | 461 461PR 461RT |
461 461PR 461RT |
100 | HIVDB |
| Telele (2018) | A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort | 31262272 | 1.36e-178 | 76 76PR 75RT |
76 76PR 76RT |
100 | HIVDB |
| Tello Ayllon (2016) | Molecular epidemiology of HIV in a third level hospital in Lima Peru | Unpublished | 5.79e-148 | |
51 51PR 51RT |
0 | Unpublished - Final |
| Temereanca (2013) | Transmitted HIV drug resistance in treatment-naive Romanian patients | J. Med. Virol. (2013) In press | 0 | 50 50PR 50RT |
50 50PR 50RT |
100 | HIVDB |
| Tendeiro (2006) | HIV-1 sequences variation in Portugal | Unpublished | 0 | |
93 93PR 93RT |
0 | Unpublished - Final |
| TenoRes Study Group (2017) | Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study | Lancet Infect Dis 16 (5), 565-575 (2016) | 0 | 78 102PR 102RT |
102 102PR 102RT |
76 | HIVDB |
| Ternette (2014) | The First Glance at the HLA Class I-Associated Immunopeptidome from HIV-1-Infected Cells | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Teto (2018) | Direct Submission | Submitted (22-SEP-2016) Pharmacology and Experimen | 0 | 125 125PR 125RT |
125 125PR 125RT |
100 | HIVDB |
| Teyssou (2025) | Direct Submission | Submitted (25-APR-2024) Virology, IPLESP, 83 Boule | 3.77e-107 | |
80 80RT |
0 | Unpublished |
| Thans (2019) | Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression | J. Virol. (2019) In press | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Theodore (1996) | CONSTRUCTION and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions | AIDS Res. Hum. Retroviruses 12 (3), 191-194 (1996) | 1e-163 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Theys (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 0 | 121 121PR 121RT |
121 121PR 121RT |
100 | HIVDB |
| Theys (2013) | HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir | Antimicrob. Agents Chemother. 57 (2), 1053-1056 (2 | 2.81e-149 | 3059 3059RT |
3075 3075RT |
99 | HIVDB |
| Theys (2017) | Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir | 23027713 | 0 | 30 30PR 30RT |
30 30PR 30RT |
100 | HIVDB |
| Thiam (2012) | Performance of Viroseq HIV-1 Genotyping System on Senegalese Strains | 23266258 | 0 | 45 45PR 45RT |
147 147PR 147RT |
30 | HIVDB |
| Thiam (2013) | HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system | J. Clin. Microbiol. 51 (2), 578-584 (2013) | 0 | 27 27PR 27RT |
34 31PR 34RT |
79 | HIVDB |
| Thirunavukkarasu (2014) | HIV-1 RT sequence of first line therapy failure cases | 26385878 | 0 | 25 1PR 25RT |
32 7PR 32RT |
78 | HIVDB |
| Thitithanyanont (2006) | PERSISTENT seronegativity in an asymptomatic 27-month-old child with vertical HIV-1-infection | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Thompson (2018) | Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial | Clin. Infect. Dis. (2018) In press | 0 | 363 363PR 363RT |
363 363PR 363RT |
100 | HIVDB |
| Thomson (2000) | WIDESPREAD circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina | AIDS 14 (7), 897-899 (2000) | 9e-98 | 38 38RT |
52 3PR 52RT |
73 | HIVDB |
| Thomson (2001) | HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users | AIDS 15 (4), 509-516 (2001) | 1e-106 | 21 21PR 21RT |
21 21PR 21RT |
100 | HIVDB |
| Thomson (2002) | DIVERSITY of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences | J. Gen. Virol. 83 (Pt 1), 107-119 (2002) | 1e-164 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Thomson (2004) | ANALYSIS of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF | AIDS Res. Hum. Retroviruses 20 (10), 1126-1133 (2004) | 0 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Thomson (2005) | IDENTIFICATION of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba | AIDS (2005) In press | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Thomson (2005) | DIRECT Submission | Submitted (18-JAN-2005) Patogenia Viral, Instituto de Salud | 0 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Thomson (2007) | NEW Insights into the Origin of the HIV Type 1 Subtype A Epidemic in Former Soviet Union's Countries Derived from Sequence Analyses of Preepidemically Transmitted Viruses | AIDS Res. Hum. Retroviruses 23 (12), 1599-1604 (2007) | 0 | 106 106PR 106RT 1IN |
110 110PR 110RT 1IN |
96 | HIVDB |
| Thomson (2009) | Molecular Epidemiology of HIV-1 in St Petersburg, Russia: Predominance of Subtype A, Former Soviet Union Variant, and Identification of Intrasubtype Subclusters | J. Acquir. Immune Defic. Syndr. (2009) In press | 0 | 102 102PR 102RT |
102 102PR 102RT |
100 | HIVDB |
| Thomson (2011) | Rapid expansion of HIV-1 subtype F cluster of recent origin among men who have sex with men in Galicia, Spain | J. Acquir. Immune Defic. Syndr (2012) | 0 | |
41 41PR 41RT |
0 | Case report(s) / study subset |
| Thorat (2011) | Surveillance of Transmitted HIV-1 Drug Resistance Among HIV-1 Positive Women Attending Antenatal Clinic in Kakinada, India | AIDS Res. Hum. Retroviruses (2011) In press | 0 | 47 47PR 47RT |
47 47PR 47RT |
100 | HIVDB |
| Thorat (2012) | Virological Outcomes and Drug Resistance after 12 months among HIV-1 Subtype C Infected Patients Receiving First Line Antiretroviral Regimen through National ART Program in Mumbai, India | Unpublished | 0 | |
100 100PR 100RT |
0 | ARV Rx and/or other data are N/A |
| Thu (2023) | Direct Submission | Submitted (04-NOV-2023) National Reference Laborat | 0 | |
105 105PR 105RT |
0 | Pending |
| Tirado (2003) | COMPARTMENTALIZATION of Drug Resistance-Associated Mutations in a Treatment-Naive HIV-Infected Female | AIDS Res. Hum. Retroviruses 20 (6), 684-686 (2004) | 1e-128 | |
4 2PR 2RT |
0 | Quasispecies |
| Tirado (2004) | DIFFERENTIAL Evolution of Cell-Associated Virus in Blood and Genital Tract of HIV-infected Females during HAART | 15780880 | 1e-124 | |
40 20PR 20RT |
0 | Quasispecies |
| Tobin (2004) | GENETICS Studies Reveal Two Causes of Low-level Viremias During HAART: Proliferation of HIV-1 Infected Cells and Viral Replication | 16014925 | 1.06e-137 | |
822 439PR 383RT |
0 | Proviral DNA Reservoir |
| Tongo (2015) | Near full-length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under-sampled lineages in the country | Evol Med Public Health (2015) In press | 0 | 9 9PR 8RT 8IN |
9 9PR 9RT 9IN |
100 | HIVDB |
| Toni (2005) | PRESENCE of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa | AIDS Res. Hum. Retroviruses 21 (7), 667-672 (2005) | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Toni (2007) | HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d Ivoire: a four year survey, 2002-2006 | AIDS Res. Hum. Retroviruses 23 (9), 1155-1160 (2007) | 2.67e-158 | 176 89PR 87RT |
176 89PR 87RT |
100 | HIVDB |
| Toni (2006) | PRIMARY HIV-1 drug resistance in Abidjan (Cote d'Ivoire): a genotypic and phenotypic study | AIDS 16 (3), 488-491 (2002) | 1e-147 | 195 97PR 98RT |
195 97PR 98RT |
100 | HIVDB |
| Toni (2008) | DETECTION of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection | Antimicrob. Agents Chemother. 53 (4), 1670-1672 (2009) | 0 | |
26 26PR 26RT |
0 | Case report(s) / study subset |
| Toni (2003) | PRESENCE of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire : ANRS 1257 Study | AIDS Res. Hum. Retroviruses 19 (8), 713-717 (2003) | 1e-90 | 196 100PR 96RT |
198 101PR 97RT |
98 | HIVDB |
| Toni (2005) | CHARACTERIZATION of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Cote d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission | AIDS Res. Hum. Retroviruses 21 (12), 1031-1034 (2005) | 1e-145 | 29 29RT |
29 29RT |
100 | HIVDB |
| Topcu (2022) | First Description of a New HIV-1 Recombinant Form CRF91_cpx Among Men Who Have Sex with Men | Unpublished | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Topcu (2022) | Comparative HIV-1 Phylogenies Characterized by PR/RT, Pol and Near-Full-Length Genome Sequences | Viruses 14 (10), 2286 (2022) | 0 | 129 129PR 129RT 129IN |
129 129PR 129RT 129IN |
100 | HIVDB |
| Topcu (2022) | Characterization of Four Novel HIV-1 Circulating Recombinant Forms, CRF129_56G, CRF130_A1B, CRF131_A1B, and CRF138_cpx | Unpublished | 0 | 7 7PR 7RT 7IN |
9 9PR 9RT 9IN |
77 | HIVDB |
| Topcu (2024) | Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021) | 39339925 | 0 | 168 168PR 168RT 168IN |
168 168PR 168RT 168IN |
100 | HIVDB |
| Torimiro (2011) | Direct Submission | Submitted (28-JAN-2011) Molecular Biology Lab, CIR | 0 | 9 9PR 9RT |
32 31PR 32RT |
28 | HIVDB |
| Torimiro (2019) | Transmitted Drug Resistance in HIV-1 Protease-Reverse transcriptase region among Rural and Urban Populations of the North West Region of Cameroon | 31416460 | 0 | 19 19RT |
19 19RT |
100 | HIVDB |
| Toro (2005) | MOLECULAR and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain | J. Med. Virol. 78 (12), 1599-1608 (2006) | 3.68e-142 | |
38 38PR 36RT |
0 | ARV Rx and/or other data are N/A |
| Torti (2009) | Heterogeneity and penetration of HIV-1 non-subtype B viruses in Brescia Province (northern Italy): public health implications | 20109261 | 4.63e-149 | |
250 250PR 250RT |
0 | ARV Rx and/or other data are N/A |
| Totmenin (2012) | Molecular epidemiology of HIV-1 in Novosibirsk region, Russia | 15346946 | 0 | |
64 64PR 64RT |
0 | ARV Rx and/or other data are N/A |
| Totmenin (2013) | Molecular epidemiology of HIV-1 in Siberia, Russia | Unpublished | 0 | 225 225PR 225RT |
225 225PR 225RT |
100 | HIVDB |
| Totmenin (2016) | HIV-1 epidemiology, genetic diversity and primary drug resistance in Tyumen Oblast, Russia | 27957489 | 0 | 135 68PR 68RT 67IN |
135 68PR 68RT 67IN |
100 | HIVDB |
| Totmenin (2016) | Central Asian CRF02_AG (CRF_02A1) dominates the epidemic in Uzbekistan | 28814231 | 0 | 62 62IN |
124 61PR 61RT 63IN |
50 | HIVDB |
| Totmenin (2018) | Molecular Epidemiology of HIV-1 in Tomsk Region, Russia | Unpublished | 0 | |
260 124PR 124RT 136IN |
0 | Unpublished |
| Totmenin (2018) | HIV-1 Genetic Diversity and Drug Resistance in Tajikistan | Unpublished | 0 | |
419 419PR 419RT |
0 | Unpublished |
| Totmenin (2018) | Molecular epidemiology of HIV-1 in Kyrgyzstan | 34721358 | 0 | |
641 641PR 641RT |
0 | ARV Rx and/or other data are N/A |
| Totmenin (2018) | Genetic Diversity and Drug Resistance Mutations in HIV-1 in Khujand, Tajikistan | Unpublished | 0 | |
199 143PR 143RT 56IN |
0 | Unpublished |
| Totmenin (2018) | HIV-1 Genetic Diversity in Krasnoyarsk Region, Russia | 32964045 | 0 | |
215 140PR 140RT 75IN |
0 | Pending |
| Totmenin (2019) | Natural polymorphisms of HIV-1 integrase coding region in ARV-naive individuals in Tajikistan | Unpublished | 0 | 120 120IN |
120 120IN |
100 | HIVDB |
| Totmenin (2019) | Natural polymorphisms of HIV-1 integrase coding region in ARV-naive individuals in Novosibirsk region, Russia | Unpublished | 0 | 25 25IN |
25 25IN |
100 | HIVDB |
| Totmenin (2019) | HIV-1 Epidemiology, Genetic Diversity, and Drug Resistance in the Omsk Region, Russia | Unpublished | 0 | |
102 102PR 102RT |
0 | Unpublished |
| Totmenin (2020) | Molecular epidemiology of HIV-1 in Kyrgyzstan | Unpublished | 0 | |
398 131PR 131RT 267IN |
0 | Unpublished |
| Totmenin (2022) | HIV-1 Genetic Diversity and Drug Resistance in Altai Krai, Russia | Unpublished | 0 | |
111 111PR 111RT |
0 | Unpublished |
| Totmenin (2022) | HIV-1 Epidemiology, Genetic Diversity, and Drug Resistance in the Omsk Region, Russia | 36118194 | 0 | |
93 76PR 93RT |
0 | Pending |
| Totmenin (2023) | Direct Submission | Submitted (09-NOV-2022) Department of Retroviruses | 0 | |
190 187PR 190RT |
0 | Unpublished |
| Totmenin (2023) | Molecular epidemiology of HIV-1 in Novosibirsk region, Russia | Unpublished | 0 | |
317 313PR 317RT |
0 | Unpublished |
| Totmenin (2023) | Identification of a Novel HIV-1 Circulating Recombinant Form CRF157_A6C in Primorsky Krai, Russia | Unpublished | 0 | |
16 16PR 16RT 16IN |
0 | Case report(s) / study subset |
| Toure-Kane (2001) | FULL-LENGTH genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal | AIDS Res. Hum. Retroviruses 17 (12), 1211-1216 (2001) | 1e-143 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Tovanabutra (2001) | FIRST CRF01_AE/B recombinant of HIV-1 is found in Thailand | AIDS 15 (8), 1063-1065 (2001) | 1e-161 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Tovanabutra (2003) | A New Circulating Recombinant Form, CRF15_01B, Reinforces the Linkage between IDU and Heterosexual Epidemics in Thailand | AIDS Res. Hum. Retroviruses 19 (7), 561-567 (2003) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Tovanabutra (2004) | THE Changing Molecular Epidemiology of HIV Type 1 among Northern Thai Drug Users, 1999 to 2002 | AIDS Res. Hum. Retroviruses 20 (5), 465-475 (2004) | 0 | 38 38PR 38RT 38IN |
38 38PR 38RT 38IN |
100 | HIVDB |
| Tovanabutra (2005) | CHARACTERIZATION of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel | AIDS Res. Hum. Retroviruses 21 (5), 424-429 (2005) | 0 | 13 13PR 12RT 13IN |
13 13PR 13RT 13IN |
100 | HIVDB |
| Tovanabutra (2007) | IDENTIFICATION of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand | AIDS Res. Hum. Retroviruses 23 (6), 829-833 (2007) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Tovanabutra (2009) | HIV-1 subtype C gag gene from an incident infection identified in Tanzania | Unpublished | 1.05e-40 | |
1 1PR |
0 | Gene fragment(s) |
| Tovanabutra (2010) | Evaluation of HIV-1 strains in men having sex with men and in female sex workers in Mombasa, Kenya | AIDS Res. Hum. Retroviruses 26 (2), 123-131 (2010) | 0 | 21 21PR 21RT 21IN |
22 22PR 22RT 22IN |
95 | HIVDB |
| Tovanabutra (2014) | Full Genome Characterization of HIV-1 subtype B from Thailand | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Tovanabutra (2017) | Direct Submission | Submitted (08-AUG-2017) Laboratory of Molecular Vi | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Tovanabutra (2020) | Direct Submission | Submitted (07-DEC-2018) Laboratory of Molecular Vi | 0 | |
397 264PR 264RT 397IN |
0 | Unpublished |
| Towler (2008) | ANALYSIS of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq) | AIDS Res. Hum. Retroviruses 24 (9), 1209-1213 (2008) | 0 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Towler (2010) | Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda | AIDS Res. Hum. Retroviruses 26 (5), 563-568 (2010) | 0 | 94 94PR 94RT |
94 94PR 94RT |
100 | HIVDB |
| Trabaud (2014) | Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient. | AIDS Res Hum Retroviruses. 2015 Jan;31(1):142-9. | 0 | |
2 2IN |
0 | Case report(s) / study subset |
| Tramuto (2003) | DETECTION of HIV type 1 non-B subtypes in Sicily, Italy | AIDS Res. Hum. Retroviruses 20 (2), 251-254 (2004) | 0 | |
8 8PR 8RT |
0 | ARV Rx and/or other data are N/A |
| Tramuto (2004) | DETECTION of a New 3-Base Pair Insertion Mutation in the Protease Gene of Human Immunodeficiency Virus Type 1 during Highly Active Antiretroviral Therapy (HAART) | AIDS Res. Hum. Retroviruses 21 (5), 420-423 (2005) | 0 | |
27 27PR 27RT |
0 | Case report(s) / study subset |
| Tramuto (2007) | GENETIC Diversity of HIV-1 Non-B Strains in Sicily: Evidence of Intersubtype Recombinants by Sequence Analysis of gag, pol, and env Genes | AIDS Res. Hum. Retroviruses 23 (9), 1131-1138 (2007) | 0 | 2 2PR 2RT |
6 6PR 6RT |
33 | HIVDB |
| Tramuto (2011) | How is changing HIV-1 molecular epidemiology in Sicily? The role of immigrant flows and viral dynamic evolution | 23470353 | 0 | 44 44PR 44RT |
44 44PR 44RT |
100 | HIVDB |
| Tran (2024) | Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naive patients in Northern Vietnam from 2019 to 2022 | Glob Health Med 2023.01112 (2024) | 0 | 391 387PR 391RT |
391 387PR 391RT |
100 | HIVDB |
| Tran (2025) | Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naive patients in Northern Vietnam from 2019 to 2022 | Glob Health Med 6 (2), 117-123 (2024) | 0 | |
261 261PR 261RT 1IN |
0 | HIVDB |
| Tran (2015) | A strong association of HLA-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection | 26595539 | 0 | 359 359PR 359RT 359IN |
359 359PR 359RT 359IN |
100 | HIVDB |
| Tran (2012) | No Increase of Drug-Resistant HIV Type 1 Prevalence Among Drug-Naive Individuals in Northern Vietnam | AIDS Res. Hum. Retroviruses 28 (10), 1349-1351 (20 | 1e-179 | 209 107PR 102RT |
209 107PR 102RT |
100 | HIVDB |
| Trebelcock (2021) | HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru | J Int AIDS Soc 22 (11), e25411 (2019) | 2.51e-157 | 470 470RT |
470 470RT |
100 | HIVDB |
| Tremeaux (2023) | In-depth characterization of full-length archived viral genomes after nine years of posttreatment HIV control | Unpublished | 0 | |
922 331PR 901RT 287IN |
0 | Proviral DNA Reservoir |
| Treurnicht (2010) | Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure | Virology 396 (2), 213-225 (2010) | 0 | |
20 20PR 20RT 20IN |
0 | Pending |
| Trinh (2009) | Short Communication: Drug Resistance Mutations in the HIV Type 1 Protease and Reverse Transcriptase Genes in Antiretroviral-Naive Vietnamese Children | AIDS Res. Hum. Retroviruses 28 (10), 1305-1307 (20 | 3e-172 | 151 76PR 75RT |
160 81PR 160RT |
94 | HIVDB |
| Trinh (2011) | HIV vaccine development based on Vietnamese HIV-1 strains | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Triques (2000) | NEAR-FULL-LENGTH genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K | AIDS Res. Hum. Retroviruses 16 (2), 139-151 (2000) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Tristem (1991) | NUCLEOTIDE sequence of a Guinea-Bissau-derived human immunodeficiency virus type 2 proviral clone (HIV-2CAM2) | J. Gen. Virol. 72 (PT 3), 721-724 (1991) | 3e-97 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Troyer (2005) | CHANGES in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression | J. Virol. 79 (14), 9006-9018 (2005) | 1e-127 | |
18 18PR 18RT |
0 | Case report(s) / study subset |
| Troyer (2007) | A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV-1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda | 18284323 | 3.34e-169 | |
137 137RT |
0 | Case report(s) / study subset |
| Truong (2006) | ROUTINE surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance | AIDS 20 (17), 2193-2197 (2006) | 7.12e-150 | 129 129PR 129RT |
129 129PR 129RT |
100 | HIVDB |
| Truong (2012) | Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection | PLoS ONE 6 (10), E25281 (2011) | 2.06e-150 | 213 213RT |
213 213PR 213RT |
100 | HIVDB |
| Tscherning-Casper (2001) | EVIDENCE of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1 | AIDS Res. Hum. Retroviruses 16 (13), 1313-1318 (2000) | 3e-82 | 15 15PR |
15 15PR 15RT |
100 | HIVDB |
| Tseng (2016) | The 4.2kb NC-p6-Pol-Vif-Vpr Gene of the HIV-1 CRF07_BC Subtype is Associated with Lower Multiplications than those of the B' and CRF01_AE Subtypes: Findings from Transfection and in-vitro Infections | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Tshabalala (2011) | Surveillance of Transmitted Antiretroviral Drug Resistance among HIV-1 Infected Women Attending Antenatal Clinics in Chitungwiza, Zimbabwe | PLoS ONE 6 (6), E21241 (2011) | 2.3e-169 | 150 150RT |
150 150RT |
100 | HIVDB |
| Tsui (2005) | Full genome analysis of an emerging cluster of human immunodeficiency virus type 1 subtype B infection in Hong Kong. | AIDS Res Hum Retroviruses. 2010 Jan;26(1):117-22. | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Tsuiji (2006) | V118 mutations in the transcriptase gene of HIV-1 from drug-naive hemophiliac patients in Japan | Unpublished | 1e-153 | 41 21PR 20RT |
42 21PR 21RT |
97 | HIVDB |
| Tsujimoto (2002) | SEQUENCE of a novel simian immunodeficiency virus from a wild-caught African mandrill | Nature 341 (6242), 539-541 (1989) | 3e-99 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Tu (2009) | Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China | Transfusion 49 (9), 1865-1873 (2009) | 5.56e-172 | 98 98PR 98RT |
98 98PR 98RT |
100 | HIVDB |
| Tuaillon (2005) | PHENOTYPIC Susceptibility to Nonnucleoside Inhibitors of Virion-Associated Reverse Transcriptase From Different HIV Types and Groups | J. Acquir. Immune Defic. Syndr. 37 (5), 1543-1549 (2004) | 1e-138 | |
7 7RT |
0 | Case report(s) / study subset |
| Tuladhar (2024) | Human immunodeficiency virus-1 genome from patient with fever, Nepal | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Tully (2016) | Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus | PLoS Pathog. 12 (5), E1005619 (2016) | 0 | 71 71PR 71RT 71IN |
92 73PR 71RT 92IN |
77 | HIVDB |
| Tumanov (2017) | The molecular epidemiological analysis of HIV infection in Sakhalin region, Russia | 10.22328/2077-9828-2017-9-3-113-120 | 0 | |
53 53PR 53RT |
0 | ARV Rx and/or other data are N/A |
| Tumanov (2019) | The molecular epidemiological aspects of HIV-1 in southern regions of Russia | Unpublished | 0 | |
56 56PR 56RT |
0 | Unpublished |
| Tumanov (2021) | Molecular-epidemiological characteristics of HIV-1 variants circulating in Moscow region | Unpublished | 0 | 41 41PR 41RT |
344 344PR 51RT |
11 | HIVDB |
| Tumiotto (2017) | Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA | PLoS ONE 12 (9), E0185211 (2017) | 0 | |
16 1PR 15RT |
0 | Case report(s) / study subset |
| Turnbull (2010) | Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection | J. Immunol. 182 (11), 7131-7145 (2009) | 0 | |
178 17PR 53RT 142IN |
0 | SGS |
| Turner (2003) | NUCLEOTIDE and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B Subtype HIV-1 Variants | 15273111 | 0 | |
4 2PR 2RT |
0 | Case report(s) / study subset |
| Tymchuk (2010) | Baseline HIV Resistance in Malawi | Unpublished | 0 | 20 20PR 20RT |
20 20PR 20RT |
100 | HIVDB |
| Tzitzivacos (2008) | VIRAL genetic determinants of nonprogressive HIV-1 subtype C infection in antiretroviral drug naive children | 19895210 | 0 | 7 7PR 7RT 7IN |
7 7PR 7RT 7IN |
100 | HIVDB |
| Tzou (2018) | Comparison of an in vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing | J. Clin. Microbiol. (2018) In press | 0 | 281 277PR 277RT 178IN |
282 277PR 277RT 178IN |
99 | HIVDB |
| Tzou (2019) | Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2 | 30383215 | 0 | 93 43PR 49RT 62IN |
93 43PR 49RT 62IN |
100 | HIVDB |
| Udeze (2018) | Phylogenetic analysis of partial gag, pol and env genes show predominance of subtype g and crf02_ag in southeastern Nigeria, with evidence of new recombinant forms | 32267869 | 1.96e-61 | 28 28PR |
28 28PR |
100 | HIVDB |
| Ueda (2018) | Genetic Diversity and Drug Resistance of HIV-1 Circulating in North Sulawesi, Indonesia | AIDS Res. Hum. Retroviruses (2018) In press | 0 | 70 33PR 37RT |
70 33PR 37RT |
100 | HIVDB |
| Ueda (2019) | Transmission dynamics of HIV-1 subtype B strains in Indonesia | Sci Rep 9 (1), 13986 (2019) | 0 | |
9 9PR 9RT 9IN |
0 | Pending |
| Ulenga (2021) | Direct Submission | Submitted (11-FEB-2020) Research, Management and D | 1.98e-177 | |
659 659PR 659RT |
0 | Unpublished |
| Ulenga (2021) | HIV-1 drug resistance in pregnant women, Tanzania | Unpublished | 4.9e-176 | |
173 173PR 173RT |
0 | Unpublished |
| Ulenga (2023) | HIV-1 drug resistance in pregnant women, Tanzania | Unpublished | 4.7e-178 | |
170 170PR 170RT |
0 | Unpublished |
| Ulenga (2024) | Direct Submission | Submitted (12-FEB-2023) Research, Management and D | 6.02e-173 | |
19 19PR 19RT |
0 | Unpublished |
| Ulenga (2015) | High rates of early virologic failure in a cohort of Tanzanian HIV-infected adults | 27076106 | 0 | 115 115PR 115RT |
115 115PR 115RT |
100 | HIVDB |
| Uluer Biceroglu (2015) | Analysis of pol gene sequences among a cohort of HIV-1 infected patients from western part of Turkey | 25052108 | 0 | |
172 172PR 172RT |
0 | ARV Rx and/or other data are N/A |
| Umeki-Sakamoto (2013) | Molecular characterization of infectious molecular clones derived from HIV-2 CRF01_AB isolated in Japan | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Laboratory/experimental isolate |
| Umeki-Sakamoto (2013) | Molecular characterization of infectious molecular clones derived from mult-idrug-resistant HIV-1 subtype B in Japan | Unpublished | 0 | |
8 8PR 8RT 8IN |
0 | Laboratory/experimental isolate |
| Umeki-Sakamoto (2013) | Molecular characterization of infectious molecular clones derived from HIV-2 group A isolated in Japan | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Umviligihozo (2021) | Increased frequency of inter-subtype HIV-1 recombinants identified by near full-length virus sequencing in a Rwanda acute heterosexual transmission cohort | 34690973 | 0 | |
265 265PR 265RT 265IN |
0 | HIVDB |
| Umviligihozo (2021) | Increased frequency of inter-subtype HIV-1 recombinants identified by near full-length virus sequencing in Rwandan acute transmission cohorts | Front Microbiol (2021) In press | 0 | 21 21PR 21RT 21IN |
21 21PR 21RT 21IN |
100 | HIVDB |
| Underwood (2021) | Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults With HIV-1 Infection Treated With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study | Antimicrob Agents Chemother, AAC0164321 (2022) In | 0 | 78 78IN |
78 78IN |
100 | HIVDB |
| Unger (1991) | SIMIAN immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA | Virology 182 (1), 177-185 (1991) | 8e-99 | |
2 1PR 1RT 2IN |
0 | Gene fragment(s) |
| Ur Rehman (2021) | Phylogenetic analysis and drug resistance genotyping of HIV protease (pol) gene in HIV patients receiving ART in Lahore | Unpublished | 1.97e-62 | |
11 11PR |
0 | Unpublished |
| Vachot (2004) | SHORT communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples | AIDS Res. Hum. Retroviruses 20 (7), 687-691 (2004) | 0 | |
4 4RT 4IN |
0 | Case report(s) / study subset |
| Vadaq (2025) | Longitudinal Plasma Proteomic Signatures of Elite and Viremic Spontaneous HIV Controllers | Unpublished | 0 | |
120 119PR 120RT 120IN |
0 | Unpublished |
| Vahabpour (2016) | HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals | Arch. Virol. (2017) In press | 0 | 42 42PR 42RT |
83 71PR 73RT |
50 | HIVDB |
| Vahey (1999) | PERFORMANCE of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms | J. Clin. Microbiol. 37 (8), 2533-2537 (1999) | 1e-111 | |
35 35PR 35RT |
0 | Case report(s) / study subset |
| Vaillancourt (1999) | THE HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance | AIDS Res. Hum. Retroviruses 15 (4), 355-363 (1999) | 1e-128 | |
135 135PR |
0 | Pending |
| Vallari (2010) | Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low | AIDS Res. Hum. Retroviruses 26 (1), 109-115 (2010) | 0 | 4 3PR 3RT 4IN |
4 3PR 3RT 4IN |
100 | HIVDB |
| Vallari (2011) | Confirmation of Putative HIV-1 Group P in Cameroon | J. Virol. 85 (3), 1403-1407 (2011) | 0 | 1 1PR 1RT 1IN |
2 1PR 1RT 2IN |
50 | HIVDB |
| Valle-Bahena (2004) | FREQUENCY of Protease and Reverse Transcriptase Drug Resistance Mutations in Naive HIV-Infected Patients | Arch. Med. Res. 37 (8), 1022-1027 (2006) | 0 | 39 33PR 36RT |
39 33PR 39RT |
100 | HIVDB |
| Vallejo (2001) | TROPISM, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates | J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 (5), 417 | 0.0000000005 | 3 3PR |
3 3PR |
100 | HIVDB |
| van Beveren (1995) | APPENDIX B: ARV-2 genome | (in) Weiss,R.L., Teich,N., Varmus,H. and Coffin,J. (Eds.); R | 0 | |
3 3PR 3RT 3IN |
0 | Laboratory/experimental isolate |
| van de Klundert (2022) | Molecular Epidemiology of HIV-1 in Eastern Europe and Russia | Viruses 14 (10), 2099 (2022) | 0 | 596 406PR 406RT 190IN |
596 406PR 406RT 190IN |
100 | HIVDB |
| van der Ende (2000) | Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy. | JAIDS | 0.001 | 6 6RT |
6 6RT |
100 | HIVDB |
| van der Hoek (2005) | INCREASED multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase | J. Virol. 79 (6), 3536-3543 (2005) | 1e-169 | |
13 13PR 13RT |
0 | Case report(s) / study subset |
| van der Hoek (2006) | CHARACTERIZATION of An HIV-1 Group M Variant That Is Distinct from The Known Subtypes | AIDS Res. Hum. Retroviruses 23 (3), 466-470 (2007) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| van Hal (2009) | HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure | Retrovirology 6, 12 (2009) | 1e-168 | 133 133IN |
133 133IN |
100 | HIVDB |
| van Harmelen (2002) | CHARACTERIZATION of full-length HIV type 1 subtype C sequences from South Africa | AIDS Res. Hum. Retroviruses 17 (16), 1527-1531 (2001) | 1e-163 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Van Heuverswyn (2006) | HUMAN immunodeficiency viruses: SIV infection in wild gorillas | Nature 444 (7116), 164 (2006) | 1e-147 | |
4 3RT 4IN |
0 | NHPL/SIV |
| Van Laethem (2000) | PATIENT HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir | AIDS 14 (4), 469-471 (2000) | 1e-86 | 5 5RT |
5 5RT |
100 | HIVDB |
| Van Laethem (2001) | MUTATIONS in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype | AIDS 15 (5), 553-561 (2001) | 3e-90 | |
10 10RT |
0 | Laboratory/experimental isolate |
| Van Laethem (2002) | Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. | Antimicrob Agents Chemother. 2000 Aug;44(8):2109-17. | 1e-74 | |
6 6RT |
0 | Case report(s) / study subset |
| Van Laethem (2005) | A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene | J. Virol. Methods 123 (1), 25-34 (2005) | 0 | |
8 8PR 8RT |
0 | Case report(s) / study subset |
| Van Laethem (2008) | A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes | J. Virol. Methods 153 (2), 176-181 (2008) | 1e-167 | 70 70IN |
70 4RT 70IN |
100 | HIVDB |
| van Marle (2007) | Compartmentalization of the gut viral reservoir in HIV-1 infected patients | Retrovirology 4, 87 (2007) | 2.14e-154 | |
179 179RT |
0 | Quasispecies |
| van Marle (2016) | Higher Levels of Zidovudine Drug-Resistance in the Colon Compared to Blood and Other Gastro-Intestinal Compartments in HIV Infection | 20836880 | 2.14e-154 | |
791 791RT |
0 | Quasispecies |
| van Vaerenbergh (2002) | INITIATION of HAART in drug-naive HIV-1 infected patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients | 11958685 | 1e-135 | |
69 34PR 35RT |
0 | Case report(s) / study subset |
| Van Zyl (2008) | ANTIRETROVIRAL resistance mutations in patients with prolonged failure on antiretroviral therapy in Tygerberg Family Clinic, Western Cape, South Africa: An observational study using statistical models | 21837793 | 0 | |
85 83PR 85RT |
0 | HIVDB |
| van Zyl (2011) | Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the western cape, South Africa | J. Med. Virol. 83 (10), 1764-1769 (2011) | 0 | 167 163PR 167RT |
167 163PR 167RT |
100 | HIVDB |
| Van Zyl (2011) | Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens | PLoS ONE 8 (6), E67188 (2013) | 0 | 1602 1598PR 1602RT |
1651 1651PR 1651RT |
97 | HIVDB |
| Van Zyl (2016) | Direct Submission | Submitted (21-NOV-2016) Division of Medical Virolo | 0 | 152 150PR 152RT |
152 150PR 152RT |
100 | HIVDB |
| van Zyl (2017) | Moderate levels of pre-therapy drug resistance (PDR) in a generalised epidemic: time for better first-line ART? | 28857824 | 0 | 59 59PR 59RT |
59 59PR 59RT |
100 | HIVDB |
| Van Zyl (2017) | Direct Submission | Submitted (27-MAR-2017) HIV Dynamics and Replicati | 6.27e-160 | |
317 317PR 317RT |
0 | Proviral DNA Reservoir |
| Vancoillie (2017) | Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus | Virology 510, 185-193 (2017) | 3.69e-76 | |
219 219PR 219RT |
0 | Proviral DNA Reservoir |
| Vandamme (1994) | CHARACTERIZATION of HIV-1 strains isolated from patients treated with TIBO R82913 | AIDS Res. Hum. Retroviruses 10 (1), 39-46 (1994) | 2e-57 | |
7 7RT |
0 | Case report(s) / study subset |
| Vanden Haesevelde (1994) | GENOMIC cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate | J. Virol. 68 (3), 1586-1596 (1994) | 1e-142 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Vanden Haesevelde (1996) | SEQUENCE analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee | Virology 221 (2), 346-350 (1996) | 1e-138 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| VanRompay (1996) | Zidovudine-resistant simian immunodeficiency virus | Unpublished | 0 | |
1 1RT |
0 | NHPL/SIV |
| Varghese (2010) | Direct Submission | Submitted (24-AUG-2009) Infectious Diseases, Stanf | 2e-56 | 2 2PR |
2 2PR |
100 | HIVDB |
| Varghese (2010) | HIV-1 Integrase Sequence Variability in Antiretroviral Naive Patients and in Triple-Class Experienced Patients Subsequently Treated with Raltegravir | AIDS Res. Hum. Retroviruses (2010) In press | 1e-167 | 148 148IN |
150 150IN |
98 | HIVDB |
| Varghese (2013) | Prototypical Recombinant Multi-Protease Inhibitor Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type-1. | Antimicrob Agents Chemother. 2013 Sep;57(9):4290-4299. | 1e-58 | 14 14PR |
16 16PR |
87 | HIVDB |
| Varghese (2015) | Direct Submission | Submitted (22-OCT-2014) Medicine/ID, Stanford Univ | 3e-58 | 1 1PR |
1 1PR |
100 | HIVDB |
| Varghese (2015) | Evolution of Gag and GP41 in Patients Receiving Ritonavir-Boosted Atazanavir and Lopinavir | 28912582 | 0 | 52 27PR 26RT |
53 27PR 26RT |
98 | HIVDB |
| Varghese (2016) | Q148N, a Novel Integrase Inhibitor Resistance Mutation Associated with Low-Level Reduction in Elvitegravir Susceptibility | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 1 1IN |
2 1PR 1IN |
50 | HIVDB |
| Varghese (2017) | Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Atazanavir | 23148287 | 1.19e-179 | 16 16PR 16RT |
18 18PR 18RT |
88 | HIVDB |
| Vartanian (2001) | SUSTAINED G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome | J. Gen. Virol. 83 (Pt 4), 801-805 (2002) | 1e-145 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Vasilyev (2013) | Molecular genetic analysis of HIV-1 variants circulating in Armenia | 25845390 | 0 | 98 58PR 60RT 37IN |
132 80PR 78RT 49IN |
74 | HIVDB |
| Vasylyeva (2018) | Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine | Proc. Natl. Acad. Sci. U.S.A. (2018) In press | 0 | 427 427PR 427RT |
427 427PR 427RT |
100 | HIVDB |
| Vasylyeva (2018) | The changing epidemiological profile of HIV-1 subtype B epidemic in Ukraine | AIDS Res. Hum. Retroviruses (2018) In press | 7.11e-163 | |
46 46RT |
0 | Pending |
| Vasylyeva (2020) | Phylodynamics Helps to Evaluate the Impact of an HIV Prevention Intervention | Viruses 12 (4), E469 (2020) | 6.73e-73 | |
150 150PR 150RT |
0 | Gene fragment(s) |
| Vatteroni (2008) | HIV-1 subtypes | Unpublished | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Vaughan (2003) | Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. | ARHR | 1e-139 | 71 71PR 71RT |
71 71PR 71RT |
100 | HIVDB |
| Vautrin (2023) | Direct Submission | Submitted (02-MAR-2023) Seine Maritime, CHU de Rou | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Vautrin (2023) | First evidence of a mother to child transmission of an HIV-1/MO intergroup recombinant form | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Vavro (2021) | Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study | Antimicrob Agents Chemother, AAC0164521 (2022) In | 0 | 81 81IN |
81 81IN |
100 | HIVDB |
| Vaz (2016) | Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique | Clin. Infect. Dis. 54 (SUPPL 4), S369-S374 (2012) | 0 | 112 112PR 112RT |
112 112PR 112RT |
100 | HIVDB |
| Vaz (2015) | Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children | AIDS Res. Hum. Retroviruses 31 (10), 1046-1051 (20 | 3.76e-170 | |
41 41PR 41RT |
0 | Pending |
| Vazquez de Parga (2008) | ANALYSIS of drug resistance-associated mutations in treatment-naive individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union | J. Med. Virol. 77 (3), 337-344 (2005) | 0 | 246 246PR 246RT |
246 246PR 246RT |
100 | HIVDB |
| Vazquez Valls (2013) | Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. | BMC Bioinformatics. 2014 Mar 15;15:72. | 7e-61 | 16 16PR |
93 93PR |
17 | HIVDB |
| Vazquez-Valls (2010) | Molecular epidemiology of HIV type 1 in Mexico: emergence of BG and BF intersubtype recombinants | AIDS Res. Hum. Retroviruses 26 (7), 777-781 (2010) | 1.76e-151 | 187 97PR 187RT |
190 97PR 190RT |
98 | HIVDB |
| Vazquez-Valls (2016) | HIV drug resistance in antiretroviral-naive patients in Mexico after 10 years: Is there a difference? | 27353350 | 8.58e-152 | 247 123PR 124RT |
247 123PR 124RT |
100 | HIVDB |
| Vega (2013) | Identification of New and Unusual rev and nef Transcripts Expressed by an HIV Type 1 Primary Isolate | AIDS Res. Hum. Retroviruses 29 (7), 1075-1078 (201 | 0.004 | |
1 1IN |
0 | Gene fragment(s) |
| Vega (2015) | Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations | PLoS ONE 10 (5), E0125699 (2015) | 3.8e-148 | |
43 43PR 43RT |
0 | Case report(s) / study subset |
| Vega (2016) | Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes | PLoS ONE 11 (6), E0158525 (2016) | 2.57e-46 | |
11 11IN |
0 | Gene fragment(s) |
| Vela (2024) | Profound reduction of HIV-1 reservoir cells over three decades of antiretroviral therapy started in early infancy | JCI Insight (2024) In press | 0 | |
216 192PR 205RT 195IN |
0 | Proviral DNA Reservoir |
| Velasco-De-Castro (2014) | HIV-1 Diversity and Drug Resistance Mutations among People Seeking HIV Diagnosis in Voluntary Counseling and Testing Sites in Rio de Janeiro, Brazil | PLoS ONE 9 (1), E87622 (2014) | 7.24e-165 | 245 244PR 245RT |
245 244PR 245RT |
100 | HIVDB |
| Ventura (2008) | Impact of extensive HIV-1 variability on early molecular diagnosis of vertical transmission in the Congo Basin | 25970260 | 6.88e-145 | 27 27PR 27RT |
28 28PR 28RT |
96 | HIVDB |
| Ventura (2021) | Direct Submission | Submitted (13-JAN-2021) Center for Virology and Va | 0 | |
105 105PR 105RT 98IN |
0 | Unpublished |
| Venturi (1999) | GENOTYPIC resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors | Eur. J. Clin. Microbiol. Infect. Dis. 18 (4), 274-282 (1999) | 1e-98 | 78 78RT |
78 78RT |
100 | HIVDB |
| Venturi (2000) | ANTIRETROVIRAL resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples | J. Infect. Dis. 181 (2), 740-745 (2000) | 1e-130 | 68 26PR 42RT |
68 26PR 42RT |
100 | HIVDB |
| Venturi (2002) | Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. | Antivir Ther. 2002 Dec;7(4):245-50. | 7.44e-162 | 67 66PR 66RT |
270 270PR 270RT |
24 | HIVDB |
| Veras (2006) | HIV Type 1 Genetic Variability in Central Brazil | AIDS Res. Hum. Retroviruses 23 (12), 1481-1489 (2007) | 1.94e-148 | |
106 97PR 67RT |
0 | Gene fragment(s) |
| Veras (2011) | Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy | AIDS Res. Hum. Retroviruses 27 (11), 1173-1182 (20 | 0 | |
53 52PR 53RT |
0 | ARV Rx and/or other data are N/A |
| Veras (2016) | Direct Submission | Submitted (11-JUL-2007) Biologia Celular, Universi | 3.59e-131 | |
6 3PR 3RT |
0 | Gene fragment(s) |
| Vercauteren (2008) | PREVALENCE and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006 | AIDS Res. Hum. Retroviruses (2008) In press | 0 | 298 298PR 298RT |
298 298PR 298RT 7IN |
100 | HIVDB |
| Vercauteren (2009) | Transmission of drug-resistant HIV-1 is stabilizing in Europe | J. Infect. Dis. 200 (10), 1503-1508 (2009) | 0 | 2198 2198PR 2197RT |
2198 2198PR 2198RT |
100 | HIVDB |
| Vergani (2007) | EVOLUTION of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir | J. Clin. Virol. 41 (2), 154-159 (2008) | 5.72e-159 | 30 30PR 30RT |
30 30PR 30RT |
100 | HIVDB |
| Vergne (2000) | GENETIC diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients | J. Clin. Microbiol. 38 (11), 3919-3925 (2000) | 1e-135 | 125 125PR 125RT |
125 125PR 125RT |
100 | HIVDB |
| Vergne (2002) | RESISTANCE to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries | J. Acquir. Immune Defic. Syndr. 29 (2), 165-168 (2002) | 1e-121 | 32 32PR 31RT |
32 32PR 32RT |
100 | HIVDB |
| Vergne (2003) | LOW rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy | AIDS 17 SUPPL 3, S31-S38 (2003) | 0 | 45 45PR 45RT |
45 45PR 45RT |
100 | HIVDB |
| Vergne (2006) | NATURAL polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients | J. Clin. Virol. 36 (1), 43-49 (2006) | 0 | 19 19PR 19RT |
19 19PR 19RT |
100 | HIVDB |
| Vergne (2009) | HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon | Antivir. Ther. (Lond.) 11 (5), 575-579 (2006) | 0 | 195 195PR 195RT |
195 195PR 195RT |
100 | HIVDB |
| Verhofstede (2003) | DRUG-RESISTANT Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1-Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy | J. Acquir. Immune Defic. Syndr. 35 (5), 473-483 (2004) | 1e-126 | |
319 156PR 182RT |
0 | Proviral DNA Reservoir |
| Verhofstede (2017) | Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection | BMC Infect. Dis. 17 (1), 738 (2017) | 2.23e-141 | 539 539PR 539RT |
539 539PR 539RT |
100 | HIVDB |
| Verhofstede (2018) | Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migrant communities | Infect. Genet. Evol. (2018) In press | 2.78e-141 | |
84 84PR 84RT |
0 | Pending |
| Verschoor (2003) | A novel simian immunodeficiency virus isolated from a Schmidt's guenon (Cercopithecus ascanius schmidti) | J. Gen. Virol. 85 (PT 1), 21-24 (2004) | 1e-144 | |
1 1RT 1IN |
0 | NHPL/SIV |
| Vessiere (2006) | HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaounde, Cameroon. | JAIDS | 1e-147 | 173 90PR 83RT |
173 90PR 83RT |
100 | HIVDB |
| Vessiere (2009) | First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon | AIDS. 2010 Apr 24;24(7):1079-82. | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Vessiere (2016) | HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug naive pregnant women, in Yaounde, Cameroon | 16639353 | 9.71e-151 | 19 6PR 13RT |
19 6PR 13RT |
100 | HIVDB |
| Vetter (2014) | A Recombinant HIV-1 Gag Virus Panel for the Evaluation of HIV-1 Diagnostic Tests and Anti-p24 Antibodies | 25343245 | 1e-59 | |
42 42PR |
0 | Pending |
| Viani (2006) | PREVALENCE of Primary HIV-1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study | J. Infect. Dis. 194 (11), 1505-1509 (2006) | 1e-174 | 55 55PR 55RT |
55 55PR 55RT |
100 | HIVDB |
| Vibholm (2019) | Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption | 30700598 | 0 | |
480 480PR 480RT 480IN |
0 | SGS |
| Vicente (2001) | GENETIC variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance | Virus Genes 22 (2), 181-186 (2001) | 4e-81 | 10 10PR |
10 10PR |
100 | HIVDB |
| Vicente (2001) | THE HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F | J. Acquir. Immune Defic. Syndr. 23 (4), 327-331 (2000) | 1e-112 | 10 10PR |
10 10PR |
100 | HIVDB |
| Vicenti (2007) | USE of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects | Clin. Infect. Dis. 44 (12), 1657-1661 (2007) | 1e-142 | 650 325PR 325RT |
650 325PR 325RT |
100 | HIVDB |
| Viciana (2016) | Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain | J. Antimicrob. Chemother. 71 (2), 357-361 (2016) | 1e-149 | 12 12RT |
60 60RT |
20 | HIVDB |
| Vidal (2002) | Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine. | Antivir Ther | 1e-133 | 51 25PR 26RT |
51 25PR 26RT |
100 | HIVDB |
| Vidal (2003) | DIRECT Submission | Submitted (03-JUN-2002) Vidal N., UR 36, I.R.D, BP 64501, 34 | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Vidal (1998) | GENETIC follow-up of SIVagm in its natural host Cercopithecus aethiops sabaeus, and experimental infection of Erythrocebus patas | Unpublished | 3e-41 | |
8 8IN |
0 | Gene fragment(s) |
| Vidal (2001) | IDENTIFICATION of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes | AIDS Res. Hum. Retroviruses 16 (18), 2059-2064 (2000) | 0 | 1 1PR 1RT 1IN |
3 1PR 2RT 2IN |
33 | HIVDB |
| Vidal (2006) | IDENTIFICATION and molecular characterization of subsubtype A4 in central Africa | AIDS Res. Hum. Retroviruses 22 (2), 182-187 (2006) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Vidal (2006) | HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC) | AIDS Res. Hum. Retroviruses 22 (2), 202-206 (2006) | 0 | 69 69PR 69RT |
70 70PR 70RT |
98 | HIVDB |
| Vidal (2007) | HIV Type 1 Diversity and Antiretroviral Drug Resistance Mutations in Burundi | AIDS Res. Hum. Retroviruses 23 (1), 175-180 (2007) | 0 | 105 105PR 105RT |
105 105PR 105RT |
100 | HIVDB |
| Vidal (2007) | CHARACTERIZATION of an Old Complex Circulating Recombinant Form, CRF27_cpx, Originating from the Democratic Republic of Congo (DRC) and Circulating in France | AIDS Res. Hum. Retroviruses 24 (2), 315-321 (2008) | 0 | 2 2PR 2RT 2IN |
3 2PR 2RT 3IN |
66 | HIVDB |
| Vidal (2009) | Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U | AIDS Res. Hum. Retroviruses 25 (8), 823-832 (2009) | 0 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Vignoles (2006) | HIGH frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children | Antivir. Ther. (Lond.) 12 (7), 1133-1137 (2007) | 0 | 67 65PR 67RT |
67 65PR 67RT |
100 | HIVDB |
| Villa (2024) | Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa | EClinicalMedicine 18, 100231 (2020) | 0 | 87 87PR 87RT |
87 86PR 87RT |
100 | HIVDB |
| Villabona Arenas (2018) | Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C | Virus Evol 3 (2), vex032 (2017) | 0 | 12 10PR 12RT 8IN |
12 10PR 12RT 8IN |
100 | HIVDB |
| Villabona-Arenas (2015) | HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges | Infect. Genet. Evol. (2015) In press | 0 | 74 36PR 38RT 36IN |
74 37PR 38RT 36IN |
100 | HIVDB |
| Villabona-Arenas (2018) | Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon | Ecol Evol 8 (22), 10698-10710 (2018) | 3.07e-55 | |
32 32IN |
0 | Gene fragment(s) |
| Villalba (2013) | HIV-1 epidemic in Warao Amerindians from Venezuela: spatial phylodynamics and epidemiological patterns | AIDS 27 (11), 1783-1791 (2013) | 0 | |
53 53PR 53RT |
0 | ARV Rx and/or other data are N/A |
| Villandre (2019) | Assessing the role of transmission chains in the HIV-1 epidemic among men who have sex with men in Quebec, Canada | 30840706 | 2.37e-150 | |
233 233PR 233RT |
0 | Pending |
| Villena (2007) | RELATIVE Fitness and Replication Capacity of a Multinucleoside Analogue-Resistant Clinical Human Immunodeficiency Virus Type 1 Isolate with a Deletion of Codon 69 in the Reverse Transcriptase Coding Region | J. Virol. 81 (9), 4713-4721 (2007) | 0 | 5 5RT |
5 5RT |
100 | HIVDB |
| Vinken (2019) | Earlier initiation of antiretroviral treatment coincides with an initial control of the HIV-1 sub-subtype F1 outbreak among men-having-sex-with-men in Flanders, Belgium | Front Microbiol (2019) In press | 1.24e-146 | |
89 89PR 89RT |
0 | Pending |
| Vinner (2010) | Sequence analysis of near full-length Human immunodeficiency virus type 1 sequences from Guinea-Bissau; selection of vaccine epitopes relevant in both West African and European countries | 21749448 | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Vinogradova (2010) | Short communication: Molecular epidemiology of HIV type 1 in the Republic of Dagestan, Russian Federation: virtually uniform circulation of subtype A, former Soviet Union variant, with predominance of the V77I(PR) subvariant | AIDS Res. Hum. Retroviruses 26 (4), 395-400 (2010) | 0 | 41 41PR 41RT |
41 41PR 41RT |
100 | HIVDB |
| Vinoles (2005) | SEROINCIDENCE AND PHYLOGENY OF HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS IN A COHORT OF COMMERCIAL SEX WORKERS IN MONTEVIDEO, URUGUAY | Am. J. Trop. Med. Hyg. 72 (4), 495-500 (2005) | 0 | 5 5PR 5RT 4IN |
5 5PR 5RT 4IN |
100 | HIVDB |
| Violari (2019) | A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation | Nat Commun 10 (1), 412 (2019) | 0.000000177 | |
20 20PR |
0 | Case report(s) / study subset |
| Viputtijul (2002) | HETEROSEXUALLY Acquired CRF01_AE/B Recombinant HIV Type 1 Found in Thailand | AIDS Res. Hum. Retroviruses 18 (16), 1235-1237 (2002) | 1e-157 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Visawapoka (2006) | CIRCULATING and Unique Recombinant Forms of HIV Type 1 Containing Subsubtype A2 | AIDS Res. Hum. Retroviruses 22 (7), 695-702 (2006) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Visseaux (2021) | HIV-2 Diversity Displays Two Clades within group A with Distinct Geographical Distribution and Evolution | Virus Evol (2021) In press | 4.73e-150 | 98 98RT |
101 101RT |
97 | HIVDB |
| Volz (2017) | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics | Virus Evol 3 (2), VEX014 (2017) | 3.12e-180 | |
147 147PR 147RT |
0 | Methods paper |
| von Stockenstrom (2015) | Longitudinal genetic characterization reveals that cell proliferation maintains persistent HIV-1 during effective HIV therapy | J. Infect. Dis. (2015) In press | 1.06e-163 | |
1694 1608PR 1694RT |
0 | Proviral DNA Reservoir |
| von Truchsess (2006) | THE first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays | J. Med. Virol. 78 (3), 311-317 (2006) | 1e-163 | |
1 1IN |
0 | Case report(s) / study subset |
| von Wyl (2007) | EMERGENCE of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types | Arch. Intern. Med. 167 (16), 1782-1790 (2007) | 8.22e-158 | 254 252PR 253RT |
254 252PR 253RT |
100 | HIVDB |
| von Wyl (2010) | Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase | J. Infect. Dis. 201 (7), 1054-1062 (2010) | 0 | 57 57PR 57RT |
57 57PR 57RT |
100 | HIVDB |
| von Wyl (2010) | HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy | Clin. Infect. Dis. 51 (5), 620-628 (2010) | 0 | 11 11RT |
11 11RT |
100 | HIVDB |
| von Wyl (2011) | The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland | J. Infect. Dis. 204 (7), 1095-1103 (2011) | 0 | |
75 75PR 75RT |
0 | Pending |
| Vrancken (2014) | The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates | PLoS Comput. Biol. 10 (4), E1003505 (2014) | 0 | |
245 245PR 245RT |
0 | Methods paper |
| Vu (2016) | HIV-1 Drug Resistance in Antiretroviral-Naive Individuals with HIV-Associated Tuberculous Meningitis Initiating Antiretroviral Therapy in Viet Nam | 22473024 | 0 | 219 219PR 219RT |
219 219PR 219RT |
100 | HIVDB |
| Vubil (2016) | Genetic Diversity and Transmitted Drug Resistance of HIV-1 Subtypes in Northern Mozambique | Unpublished | 5.21e-146 | 95 95PR 95RT |
95 95PR 95RT |
100 | HIVDB |
| Wagh (2018) | Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth | Cell Rep 25 (4), 893-908 (2018) | 2.6e-30 | |
4214 4214IN |
0 | Gene fragment(s) |
| Wagner T (2023) | HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018 | Viruses 14 (9), 1970 (2022) | 5.35e-148 | 185 184PR 185RT |
185 185PR 185RT |
100 | HIVDB |
| Wagner (2021) | HIV-1 infection among women in Israel, 2010-2018 | BMC Infect Dis 20 (1), 660 (2020) | 3.28e-151 | 623 311PR 312RT |
624 312PR 312RT |
99 | HIVDB |
| Wagner (2013) | An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells | J. Virol. 87 (3), 1770-1778 (2013) | 2.43e-148 | |
627 627RT |
0 | Proviral DNA Reservoir |
| Wagner (2016) | Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses | AIDS 23 (8), 923-928 (2009) | 1.54e-149 | |
320 320RT |
0 | SGS |
| Wain-Hobson (1985) | NUCLEOTIDE sequence of the AIDS virus, LAV | Cell 40 (1), 9-17 (1985) | 1e-164 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Wallis (2010) | Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient | Virus Genes 41 (3), 358-360 (2010) | 1e-158 | 2 2PR 2RT |
3 3PR 3RT |
66 | HIVDB |
| Wallis (2014) | Drug susceptibility and resistance mutations after first-line failure in resource limited settings | Clin. Infect. Dis. 59 (5), 706-715 (2014) | 3.55e-159 | 148 148PR 148RT |
148 148PR 148RT |
100 | HIVDB |
| Walter (2000) | PHENOTYPIC HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy | Antivir. Ther. (Lond.) 5 (4), 249-256 (2000) | 1e-123 | 19 19PR |
19 19PR |
100 | HIVDB |
| Wang (2004) | FIRST demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection | Virology 312 (1), 135-150 (2003) | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Wang (2024) | Identification of two novel HIV-1 unique recombinant forms (CRF01_AE/CRF07_BC) and genomic characterization in Tongzhou district of Beijing, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Wang (2024) | Genetic characteristics of two unique recombinant forms of HIV-1 (CRF01_AE/CRF07_BC) by near full-length genome in Hebei, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report (Small sample size) |
| Wang (2019) | Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques | Microbiol. Immunol. (2019) In press | 0 | |
58 58PR 58RT 58IN |
0 | NHPL/SIV |
| Wang (2017) | Immunologic and Virologic Mechanisms for Partial Protection from Vigorous Intravenous Challenge by an Integration-defective SIV Vaccine | Unpublished | 0.0000092 | |
212 212PR |
0 | Laboratory/experimental isolate |
| Wang (2017) | Characterization of a Novel HIV-1 Second-Generation Recombinant Form in Men Who Have Sex with Men in Beijing, China | AIDS Res. Hum. Retroviruses (2017) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2018) | Direct Submission | Submitted (16-NOV-2017) Division of Virology and I | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2024) | Direct Submission | Submitted (13-JUN-2024) Health Quarantine Lab, Zhu | 8.43e-176 | |
127 125PR 127RT |
0 | Unpublished |
| Wang (2024) | Direct Submission | Submitted (09-OCT-2024) Health Quarantine Lab, Zhu | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2016) | Direct Submission | Submitted (31-MAR-2016) Zhuhai International Trave | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2005) | HIV-1 genotypic drug resistance variants in antiretroviral treatment naive patients in southern China | Cell Res. 2005 Nov-Dec;15(11-12):843-9. | 1e-149 | |
41 41PR 41RT |
0 | ARV Rx and/or other data are N/A |
| Wang (2018) | HIV-1 prevalence and subtype distribution among entry-exit populations at frontier ports of China between 2012 and 2016 | 30086369 | 4.28e-179 | 270 270PR 270RT |
270 270PR 270RT |
100 | HIVDB |
| Wang (2018) | Identification of a novel recombinant HIV-1 01BC virus in Jilin, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2024) | Identification of an imported HIV-1 A1/A7/G recombinant in Heilongjiang, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report (Small sample size) |
| Wang (2018) | Identification of a new HIV-1 circulating recombinant form CRF65_cpx strain in Jilin, China | AIDS Res. Hum. Retroviruses (2018) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2022) | Neutralization Sensitivity of HIV-1 CRF07_BC from an Untreated Patient With a Focus on Evolution Over Time | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2014) | Direct Submission | Submitted (11-NOV-2013) Division of Research on Vi | 0 | |
135 135PR 135RT |
0 | Unpublished - Final |
| Wang (2014) | Near Full-Length Genome Characterization of a New CRF01_AE/CRF08_BC Recombinant Transmitted Between a Heterosexual Couple in Guangxi, China | AIDS Res. Hum. Retroviruses 30 (5), 484-488 (2014) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2001) | GENOTYPING analysis of HIV-1 isolate protease from VGH Taipei | Unpublished | 1e-121 | |
15 15PR |
0 | Case report(s) / study subset |
| Wang (2008) | IDENTIFICATION of Subtype B, Multiple Circulating Recombinant Forms and Unique Recombinants of HIV Type 1 in an MSM Cohort in China | AIDS Res. Hum. Retroviruses 24 (10), 1245-1254 (2008) | 0 | 36 36PR 36RT |
36 36PR 36RT |
100 | HIVDB |
| Wang (2011) | Near Full-Length Sequence Analysis of Two New HIV Type 1 Unique (CRF01_AE/B) Recombinant Forms among MSM in China | 21902589 | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Wang (2011) | The Dynamic Face of HIV-1 Subtypes Among Men who Have Sex with Men in Beijing, China | Curr. HIV Res. (2011) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2018) | Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015 | PLoS ONE 13 (6), e0198005 (2018) | 0 | 525 525PR 525RT |
525 525PR 525RT |
100 | HIVDB |
| Wang (2015) | Targeting Prevention based on Molecular Epidemiology among Deeply Sampled Sub-Networks of Men Have who Sex with Men | Clin. Infect. Dis. (2015) In press | 0 | 175 175PR 175RT |
176 176PR 176RT |
99 | HIVDB |
| Wang (2017) | Genetic Characterization of a Unique Recombinant strain identified in Yunnan with genome comprised of B and C | AIDS Res. Hum. Retroviruses (2017) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2020) | Identification of a novel HIV-1 second-generation Circulating Recombinant Form CRF109_0107 in China | J Infect 81 (5), 816-846 (2020) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Wang (2022) | Markers of immune activation and inflammation are associated with higher levels of genetically-intact HIV in HIV-HBV co-infected individuals | 35916523 | 0 | |
1053 1009PR 992RT 859IN |
0 | Proviral DNA Reservoir |
| Wang (2016) | Identification of a novel HIV-1 unique (B/C) recombinant isolate in Sichuan of China | 27334687 | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2016) | Near Full-Length Genome Identification of a Novel HIV type 1 CRF01_AE/B /C Recombinant Isolate in Sichuan, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2016) | Identification of a Novel CRF01_AE/CRF07_BC Recombinant Form in Men Who Have Sex with Men in Sichuan, China | AIDS Res. Hum. Retroviruses 32 (7), 718-721 (2016) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wang (2009) | Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1 | J. Virol. 83 (4), 1845-1855 (2009) | 0 | 91 91PR 91RT 91IN |
91 91PR 91RT 91IN |
100 | HIVDB |
| Wang (2000) | MOLECULAR evidence for drug-induced compartmentalizaion of HIV-1 quasispecies in a patient with periodic changes to the HAART regimens | AIDS (2001) In press | 1e-118 | |
30 16PR 14RT |
0 | Quasispecies |
| Wang (2013) | Construction and Characterization of Highly Infectious Full-Length Molecular Clones of a HIV-1 CRF07_BC Isolate from Xinjiang, China | PLoS ONE 8 (11), E79177 (2013) | 0 | |
6 6PR 6RT 6IN |
0 | Laboratory/experimental isolate |
| Wang (2008) | CONSTRUCTION and Characterization of a Full-Length Infectious Molecular Clone from the HIV Type 1 Subtype Thai-B Isolated in Henan Province, China | AIDS Res. Hum. Retroviruses 24 (2), 251-257 (2008) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Wang (2019) | Direct Submission | Submitted (27-FEB-2019) Department of Infections a | 0 | 80 80RT |
80 80PR 80RT |
100 | HIVDB |
| Warachit (2007) | ABERRANT life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines | Microbes Infect. 9 (4), 449-459 (2007) | 0 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Warachit (2007) | DIRECT Submission | Submitted (22-DEC-2006) Virology, Research Institute of Micr | 1e-163 | |
4 4RT 4IN |
0 | Case report(s) / study subset |
| Warren (2020) | The HIV-1 latent reservoir is largely sensitive to circulating T cells | Elife 9 (2020) In press | 0 | |
905 525PR 525RT 905IN |
0 | Proviral DNA Reservoir |
| Warren (1992) | COMPARATIVE purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product | Protein Expr. Purif. 3 (6), 479-487 (1992) | 4.2 | |
1 1RT |
0 | Laboratory/experimental isolate |
| Washaya (2025) | Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe | Unpublished | 0 | |
102 72PR 72RT 84IN |
0 | HIVDB |
| Watanabe (2018) | Clinical characteristics of patients infected with HIV-1 having high levels of plasma interferon-gamma: Multicenter observational study | 30611204 | 3.64e-172 | |
59 59PR 59RT |
0 | Case report(s) / study subset |
| Watanabe (2016) | The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility | Retrovirology 13 (1), 64 (2016) | 0 | |
5 5PR 4RT |
0 | Case report(s) / study subset |
| Watanaveeradej (2003) | DIRECT Submission | Submitted (26-MAR-2003) Threat Assessment, U.S. Military HIV | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Watanaveeradej (2006) | Molecular epidemiology of HIV type 1 in preparation for a phase III prime-boost vaccine trial in Thailand and a new approach to HIV type 1 genotyping. | ARHR | 0 | 27 27PR 26RT 27IN |
27 27PR 27RT 27IN |
100 | HIVDB |
| Watkins (2003) | SELECTION of high-level resistance to human immunodeficiency virus type 1 protease inhibitors | Antimicrob. Agents Chemother. 47 (2), 759-769 (2003) | 2e-53 | |
116 116PR |
0 | Pending |
| Weber (2002) | Role of baseline pol genotype in HIV-1 fitness evolution. | JAIDS | 1e-133 | 25 25PR 25RT |
25 25PR 25RT |
100 | HIVDB |
| Weber (2005) | DIMINISHED Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 Isolates Harboring the K65R Mutation | J. Clin. Microbiol. 43 (3), 1395-1400 (2005) | 1e-171 | 10 10PR 10RT |
10 10PR 10RT |
100 | HIVDB |
| Weber (2019) | Prospective Evaluation of the VelaDx Next-Generation Sequencing platform for HIV-1 Genotypic Resistance Testing | 31382033 | 0 | 309 260PR 260RT 49IN |
309 260PR 260RT 49IN |
100 | HIVDB |
| Wei (2014) | Direct Submission | Submitted (04-APR-2013) Division of Virology and I | 0 | 224 224PR 224RT 20IN |
224 224PR 224RT 20IN |
100 | HIVDB |
| Wei (2015) | Direct Submission | Submitted (29-SEP-2013) Division of Research on Vi | 2.72e-149 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Wei (2014) | Identification of a Novel HIV-1 Circulating Recombinant Form (CRF62_BC) in Western Yunnan of China | AIDS Res. Hum. Retroviruses 30 (4), 380-383 (2014) | 0 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Wei (2014) | Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF57_BC) Identified from Yunnan, China | AIDS Res. Hum. Retroviruses 29 (2014) In press | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Wei (2013) | Near Full-Length Genomic Characterization of a Novel HIV Type 1 CRF07_ BC/01_AE Recombinant in Men Who Have Sex with Men from Sichuan, China | AIDS Res. Hum. Retroviruses 29 (8), 1173-1176 (201 | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Wei (2018) | Env-defective HIV-1 mutant affects the variety of proviruses by recombination with the wild type virus | Unpublished | 0 | |
8 8PR 8RT 8IN |
0 | Case report(s) / study subset |
| Wei (2004) | BIASED G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor | AIDS 18 (13), 1863-1865 (2004) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wei (2019) | Identification of a Novel HIV-1 CRF01_AE/ B Recombinant Isolate in Guangxi, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Weidle (2000) | PRESENCE of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States | J. Infect. Dis. 181 (2), 470-475 (2000) | 1e-118 | 6 6PR |
6 6PR |
100 | HIVDB |
| Weidle (2002) | RESISTANCE to antiretroviral therapy among patients in Uganda | J. Acquir. Immune Defic. Syndr. 26 (5), 495-500 (2001) | 1e-106 | 15 15PR |
15 15PR |
100 | HIVDB |
| Weidt (1992) | CHARACTERIZATION of a new German HIV-1 isolate: HIV-1NH5 | Unpublished (1992) | 5e-89 | |
2 1RT 1IN |
0 | Case report(s) / study subset |
| Weinstock (2004) | THE Epidemiology of Antiretroviral Drug Resistance among Drug-Naive HIV-1-Infected Persons in 10 US Cities | J. Infect. Dis. 189 (12), 2174-2180 (2004) | 1e-146 | |
149 148PR 149RT |
0 | Case report(s) / study subset |
| Whitcomb (2006) | DIRECT Submission | Submitted (09-SEP-2006) Monogram Biosciences, 345 Oyster Poi | 1e-167 | |
3 3PR 3RT |
0 | Laboratory/experimental isolate |
| Whitcomb (2014) | Reference sequence used by Monogram Biosciences for genotyping assays of HIV | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| White (2023) | Clonally expanded HIV-1 proviruses with 5 prime-Leader defects can give rise to nonsuppressible residual viremia | 36602866 | 0 | |
130 130PR 130RT 6IN |
0 | Quasispecies |
| Wichukchinda (2005) | HETEROSEXUAL Transmission of Novel CRF01_AE and Subtype B Recombinant Forms of HIV Type 1 in Northern Thailand | AIDS Res. Hum. Retroviruses 21 (8), 734-738 (2005) | 0 | |
4 4PR 4RT |
0 | Case report(s) / study subset |
| Wiegand (2017) | Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART | Proc. Natl. Acad. Sci. U.S.A. (2017) In press | 0 | |
897 897PR 897RT |
0 | Proviral DNA Reservoir |
| Wilantho (2011) | HIV-1 integrase was isolated from infected patients in Thailand | Unpublished | 1e-166 | 167 167IN |
168 168IN |
99 | HIVDB |
| Wilbe (2002) | IDENTIFICATION of Two CRF11-cpx Genomes and Two Preliminary Representatives of a New Circulating Recombinant Form (CRF13-cpx) of HIV Type 1 in Cameroon | AIDS Res. Hum. Retroviruses 18 (12), 849-856 (2002) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Wilbe (2003) | CHARACTERIZATION of novel recombinant HIV-1 genomes using the branching index | Virology 316 (1), 116-125 (2003) | 0 | 4 4PR 4RT 4IN |
4 4PR 4RT 4IN |
100 | HIVDB |
| Wildemann (1993) | In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients. | Neurology. 1993 Dec;43(12):2659-63. | 9e-94 | |
80 80RT |
0 | Case report(s) / study subset |
| Wilhelmson (2018) | Prevalence of HIV-1 primary drug resistance among treatment naive pregnant women in Bissau, Guinea Bissau | 30379960 | 6.26e-180 | 54 54PR 54RT |
54 54PR 54RT |
100 | HIVDB |
| Wilkinson (2009) | Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa | Infect Genet Evol. 2009 Sep;9(5):840-6. Epub 2009 May 14. | 0 | |
11 4PR 4RT 11IN |
0 | Case report(s) / study subset |
| Wilkinson (2014) | Detection of Transmission Clusters of HIV-1 Subtype C over a 21-Year Period in Cape Town, South Africa | PLoS ONE 9 (10), E109296 (2014) | 1.21e-155 | |
106 106PR 106RT |
0 | Pending |
| Wilkinson (2016) | Origin, imports and exports of HIV-1 subtype C in South Africa: A historical perspective | Infect. Genet. Evol. (2016) In press | 6.3e-177 | 1072 1070PR 1072RT |
5248 5248PR 5248RT |
20 | HIVDB |
| Willey (1996) | IDENTIFICATION of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus | Proc. Natl. Acad. Sci. U.S.A. 83 (14), 5038-5042 (1986) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Williamson (2003) | CHARACTERIZATION and Selection of HIV-1 Subtype C Isolates For Use in Vaccine Development | AIDS Res. Hum. Retroviruses 19 (2), 133-144 (2003) | 1e-163 | 28 1PR 28RT 1IN |
28 1PR 28RT 1IN |
100 | HIVDB |
| Wilson (1999) | FREQUENT detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant | J. Virol. 73 (5), 3975-3985 (1999) | 1e-127 | |
112 112RT |
0 | Quasispecies |
| Winckelmann (2016) | Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin | 28107222 | 1.09e-178 | |
246 246PR 246RT |
0 | Proviral DNA Reservoir |
| Winckelmann (2018) | Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals during suppressive ART | 29762162 | 3.09e-172 | |
1159 1159PR 1159RT |
0 | SGS |
| Winslow (1995) | LIMITED sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors | AIDS Res. Hum. Retroviruses 11 (1), 107-113 (1995) | 1e-127 | 13 13PR |
21 21PR |
61 | HIVDB |
| Winters (1997) | HUMAN immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years | Antimicrob. Agents Chemother. 41 (4), 757-762 (1997) | 1e-135 | 95 51PR 44RT |
95 51PR 44RT |
100 | HIVDB |
| Winters (1998) | A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors | J. Clin. Invest. 102 (10), 1769-1775 (1998) | 1e-124 | 10 9PR 10RT |
14 12PR 14RT |
71 | HIVDB |
| Winters (2004) | GENOTYPIC, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors | J. Virol. 74 (22), 10707-10713 (2000) | 1e-166 | 7 7RT |
7 7RT |
100 | HIVDB |
| Winters (2005) | NEW Two-Amino Acid Insertion Near Codon 70 of the HIV Type 1 Protease Gene | AIDS Res. Hum. Retroviruses 21 (4), 311-313 (2005) | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Winters (2012) | Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations | PLoS ONE 7 (7), E40514 (2012) | 0 | |
3834 1278PR 1278RT 1278IN |
0 | Pending |
| Wirden (2024) | Epidemiological and molecular evolution of the HIV-1 crf94: birth of crf132, abstract 844, croi 2024 | Unpublished | 0 | |
87 87PR 87RT |
0 | Transmission cluster |
| Wirden (2018) | Direct Submission | Submitted (29-MAR-2018) Virologie, APHP Hopital Pi | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Wirden (2022) | CRF94 and CRF132 HIV recombinants | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Witaningrum (2016) | Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral therapy-naive individuals residing in Sorong, West Papua | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 72 41PR 31RT |
72 41PR 31RT |
100 | HIVDB |
| Wittkop (2010) | Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort | J. Antimicrob. Chemother. 63 (6), 1251-1255 (2009) | 1e-167 | 34 34IN |
34 34IN |
100 | HIVDB |
| Wolf (2016) | Phylogenetic evidence of HIV-1 transmission between adult and adolescent men who have sex with men | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 2850 2849PR 2850RT |
3102 3101PR 3102RT |
91 | HIVDB |
| Wolinsky (2007) | COMPLEX Pathways of HIV Immune Escape | Unpublished | 1e-175 | |
26 26PR 26RT |
0 | Case report(s) / study subset |
| Womack (2001) | IDENTIFICATION of non-B human immunodeficiency virus type 1 subtypes in rural Georgia | J. Infect. Dis. 183 (1), 138-142 (2001) | 9e-57 | |
2 2RT |
0 | Case report(s) / study subset |
| Wonderlich ER (2022) | Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals | PLoS Pathog 15 (10), e1008074 (2019) | 2.29e-172 | |
97 97PR 97RT |
0 | Proviral DNA Reservoir |
| Wong (1997) | DIRECT Submission | Submitted (02-SEP-1996) Department of Medicine, University o | 1e-101 | |
314 314RT |
0 | Gene fragment(s) |
| Wong (1997) | RECOVERY of replication-competent HIV despite prolonged suppression of plasma viremia | Science 278 (5341), 1291-1295 (1997) | 1e-126 | |
14 14PR 14RT |
0 | Proviral DNA Reservoir |
| Wong-Staal (1993) | COMPLETE nucleotide sequence of the AIDS virus, HTLV-III | Nature 313 (6000), 277-284 (1985) | 0 | 1 1PR 1RT 1IN |
4 4PR 4RT 3IN |
25 | HIVDB |
| Worobey (2010) | Island biogeography reveals the deep history of SIV | Science 329 (5998), 1487 (2010) | 2e-68 | |
22 22IN |
0 | NHPL/SIV |
| Worobey (2016) | Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 | Nature 455 (7213), 661-664 (2008) | 0.0000000521 | |
29 29RT |
0 | Gene fragment(s) |
| Worobey (2016) | 1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America | Nature 539, 98-101 (2016) | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Wright (2010) | Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters | J. Virol. 84 (20), 10820-10831 (2010) | 5.29e-57 | 405 405PR |
405 405PR |
100 | HIVDB |
| Wright (2011) | Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C | J. Virol. 85 (8), 3996-4006 (2011) | 7.81e-57 | 73 73PR |
73 73PR |
100 | HIVDB |
| Wu (2025) | Persistent viremia and CD4 self-reactivity: Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia | Unpublished | 0 | |
236 236PR 236RT |
0 | Proviral DNA Reservoir |
| Wu (2012) | Sequential Evolution and Escape from Neutralization of Simian Immunodeficiency Virus SIVsmE660 Clones in Rhesus Macaques | J. Virol. 86 (16), 8835-8847 (2012) | 0 | |
4 4PR 4RT 4IN |
0 | NHPL/SIV |
| Wu (2020) | Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Shanghai, China, 2013-2015 | Unpublished | 0 | 334 167PR 167RT 167IN |
334 167PR 167RT 167IN |
100 | HIVDB |
| Wu (2012) | Identification of Drug Resistant Mutations in HIV-1 CRF07_BC Variants Selected by Nevirapine In Vitro | PLoS ONE 7 (9), E44333 (2012) | 0 | |
1 1PR 1RT 1IN |
0 | Pending |
| Wu (2014) | In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors | 25482475 | 0 | |
1 1PR 1RT 1IN |
0 | Pending |
| Wu (2025) | Direct Submission | Submitted (03-DEC-2024) Anhui Medical University, | 0 | |
1126 1126PR 1126RT |
0 | Unpublished |
| Wu (2016) | Molecular characteristic of HIV-1 circulating in Hetian, Xingjiang | 27824268 | 1.36e-180 | |
203 203PR 203RT |
0 | Pending |
| Wu (2013) | New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk | PLoS ONE 8 (1), E54322 (2013) | 0 | 133 133PR 133RT 9IN |
133 133PR 133RT 9IN |
100 | HIVDB |
| Wu (2015) | The Predominant Cluster of CRF01_AE Circulating Among Newly Diagnosed HIV-1-Positive People in Anhui Province, China | AIDS Res. Hum. Retroviruses 31 (9), 926-931 (2015) | 3.34e-172 | 99 99PR 99RT |
99 99PR 99RT |
100 | HIVDB |
| Wu (2019) | Direct Submission | Submitted (25-JAN-2019) Department of AIDS Researc | 0 | 362 362PR 362RT |
362 362PR 362RT |
100 | HIVDB |
| Wu (2025) | CRF08_BC subtype is more prone to ART failure and new-generation NNRTI-resistance under long-term first-line ART | Int J Antimicrob Agents 64 (2), 107215 (2024) | 0 | 1296 1296PR 1296RT |
1296 1296PR 1296RT |
100 | HIVDB |
| Wu (2016) | HIV-1 drug-resistance profiles of treated AIDS patients in Liaoning: genetic characteristics and prevalence | 20193313 | 6.04e-167 | |
37 37PR 37RT |
0 | ARV Rx and/or other data are N/A |
| Wu (2009) | Construction and characterization of a full-length infectious clone from a fast-replicating, X4-tropic HIV-1 subtype B isolate. | Arch Virol. 2010 Dec;155(12):1923-31. | 0 | |
4 4PR 4RT 4IN |
0 | Laboratory/experimental isolate |
| Wu (2002) | MUTATION Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments | J. Virol. 77 (8), 4836-4847 (2003) | 1e-133 | 216 216PR |
216 216PR |
100 | HIVDB |
| Wu (2020) | Characterization of a novel HIV-1 unique recombinant form between CRF07_BC and CRF55_01B in men who have sex with men in Guangzhou, China | PLoS ONE 12 (4), E0175770 (2017) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Wulan (2023) | Development of a Multiassay Algorithm (MAA) to Identify Recent HIV Infection in Newly Diagnosed Individuals in Indonesia | 37854696 | 0 | 30 26PR 27RT 25IN |
30 26PR 29RT 25IN |
100 | HIVDB |
| Wymant (2020) | A hypervirulent strain of HIV-1 circulating in the Netherlands | Unpublished | 0 | |
5 5PR 5RT 5IN |
0 | Case report(s) / study subset |
| Wymant (2021) | A hypervirulent strain of HIV-1 circulating in the Netherlands | Unpublished | 0 | |
12 12PR 12RT 12IN |
0 | Case report(s) / study subset |
| Xi (2019) | Direct Submission | Submitted (16-JUL-2019) Department of AIDS Researc | 0 | |
3 3PR 3RT 2IN |
0 | Unpublished |
| Xia (2014) | HIV-1 prevalence and subtype/recombinant distribution among travelers entering China from Vietnam at the HeKou port in the Yunnan province, China, between 2003 and 2012. | J Med Virol. 2015 Sep;87(9):1500-9. | 0 | 78 78PR 78RT |
83 83PR 83RT |
93 | HIVDB |
| Xia (2016) | Phylogenetic characteristics of HIV-1 infection among Myanmar entering Yunnan, China between 2003 and 2012 | 27922196 | 0 | 223 223PR 223RT |
223 223PR 223RT |
100 | HIVDB |
| Xia (2018) | HIV prevalence and phylogenetic characteristics among entry women in Yunnan Province between 2003 to 2012 | 27922196 | 0 | |
42 42PR 42RT |
0 | HIVDB |
| Xia (2016) | HIV Prevalence and Phylogenetic Characteristics among Entry Travelers in Xishuangbanna Prefecture, Yunnan Province, between 2003 and 2012 | 28198547 | 0 | 81 81PR 81RT |
81 81PR 81RT |
100 | HIVDB |
| Xia (2018) | High Prevalence of HIV-1 Transmitted Drug Resistance among Burmese Entering Travelers at Dehong Ports in Yunnan Province, China | 29739342 | 0 | 32 32PR 32RT |
32 32PR 32RT |
100 | HIVDB |
| Xiang (2005) | HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau | AIDS Res. Hum. Retroviruses 13 (6), 501-505 (1997) | 6e-43 | |
128 128IN |
0 | Gene fragment(s) |
| Xiao (2022) | Characterization of a Newly Emerging HIV-1 Second-Generation Recombinant Form (CRF126_0107) Among Heterosexuals in Yunnan, China | J Infect (2022) In press | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Xiao (2025) | A novel HIV-1 circulating recombinant form (CRF168_0107) identified from men who have sex with men in Beijing, China | J Infect 90 (1), 106368 (2025) | 0 | |
4 4PR 4RT 4IN |
0 | Case report (Small sample size) |
| Xie (2020) | The Genetic Diversity of HIV-1 Within Antiretroviral-Naive Outpatients in Ganzhou, China | AIDS Res. Hum. Retroviruses (2020) In press | 0 | 6 6PR 6RT 6IN |
6 6PR 6RT 6IN |
100 | HIVDB |
| Xie (2021) | Genetic Characteristics of Three Unique Recombinant Forms of HIV-1 in Yunnan, China | AIDS Res Hum Retroviruses (2021) In press | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Xie (2025) | Genetic diversity of HIV in Yunnan, China: the role of second-generation recombination involving circulating and unique recombinant forms | Virol J 22 (1), 240 (2025) | 0 | |
8 8PR 8RT 8IN |
0 | Pending |
| Xin (2020) | Untitled | Unpublished | 0 | |
8 8PR 8RT 8IN |
0 | Unpublished |
| Xing (2023) | A case report of accidental grandmother-to-child HIV-1 transmission identified in Shijiazhuang, China | Unpublished | 0 | |
6 6PR 6RT |
0 | Case report(s) / study subset |
| Xing (2025) | The origin and spread of CRF68_01B, driven by homosexual transmission route in eastern China | Unpublished | 3.87e-166 | |
4 3PR 4RT |
0 | Case report (Small sample size) |
| Xing (2025) | Direct Submission | Submitted (24-APR-2025) Key Laboratory of Respirat | 0 | |
2 2PR 2RT 2IN |
0 | Unpublished |
| Xing (2022) | Identification of a new HIV-1 intersubtype circulating recombinant form (CRF123_0107) in Hebei province, China | J Infect 84 (3), e36-e39 (2022) | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Xu (2023) | Exploring HIV-1 transmission features among older individuals in developed eastern China | 38386498 | 0 | |
146 146PR 146RT |
0 | Transmission cluster |
| Xu (2007) | GENETIC Diversity of Integrase (IN) Sequences in Antiretroviral Treatment-Naive and Treatment-Experienced HIV Type 2 Patients | AIDS Res. Hum. Retroviruses 24 (7), 1003-1007 (2008) | 1e-101 | 11 11IN |
11 11IN |
100 | HIVDB |
| Xu (2009) | Dynamics of raltegravir resistance profile in an HIV type 2-infected patient. | AIDS Res Hum Retroviruses. 2009 Aug;25(8):843-7. | 1e-100 | 211 211IN |
216 216IN |
97 | HIVDB |
| Xu (2022) | Islatravir has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved NRTIs | Antimicrob. Agents Chemother. (2022) In press | 0 | |
3 3RT |
0 | Case report(s) / study subset |
| Xu (2010) | Development and evaluation of national reference panel for HIV-1 genotypic resistance assay on HIV-1 protease and reverse transcriptase in China | Mol Diagn Ther. 14(1):31-41 (2010) | 0 | |
7 7PR 7RT |
0 | Case report(s) / study subset |
| Xu (2024) | Microglia and macrophages alterations in the CNS during acute SIV infection: A single-cell analysis in rhesus macaques | PLoS Pathog 20 (9), e1012168 (2024) | 0 | |
1 1PR 1RT 1IN |
0 | NHPL/SIV |
| Xu (2018) | HIV-1 partial pol sequence, Zhejiang, China | 29637428 | 0 | 153 153PR 153RT |
153 153PR 153RT |
100 | HIVDB |
| Xu (2017) | Identification of a Novel HIV Type 1 Recombinant Form (CRF01_AE/CRF07_BC) in Men Who Have Sex with Men in Zhejiang, China | AIDS Res. Hum. Retroviruses 33 (7), 728-734 (2017) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yabar (2021) | Social, epidemiological and virological characteristics of Peruvian subjects living with HIV / AIDS with different sexual risk behavior | 34569275 | 1.48e-180 | |
132 132PR 132RT |
0 | Pending |
| Yabar (2012) | New Subtypes and Genetic Recombination in HIV Type 1-Infecting Patients with Highly Active Antiretroviral Therapy in Peru (2008-2010) | AIDS Res. Hum. Retroviruses 28 (12), 1712-1722 (20 | 0 | 244 244PR 244RT |
244 244PR 244RT |
100 | HIVDB |
| Yahi (2001) | USE of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale | J. Infect. Dis. 183 (9), 1311-1317 (2001) | 1e-101 | 135 68PR 67RT |
135 68PR 67RT |
100 | HIVDB |
| Yamaguchi (1995) | CLINICAL isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations | Biochim. Biophys. Acta 1253 (2), 136-140 (1995) | 1e-135 | 21 21PR |
28 28PR 16RT |
75 | HIVDB |
| Yamaguchi (2002) | EVALUATION of HIV type 1 group O isolates: identification of five phylogenetic clusters | AIDS Res. Hum. Retroviruses 18 (4), 269-282 (2002) | 1e-147 | 22 22IN |
37 37IN |
59 | HIVDB |
| Yamaguchi (2003) | NEAR full-length genomes of 15 HIV type 1 group O isolates | AIDS Res. Hum. Retroviruses 19 (11), 979-988 (2003) | 0 | 15 15PR 15RT 15IN |
15 15PR 15RT 15IN |
100 | HIVDB |
| Yamaguchi (2005) | HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections | AIDS Res. Hum. Retroviruses 20 (9), 944-957 (2004) | 1e-164 | 15 15IN |
15 15IN |
100 | HIVDB |
| Yamaguchi (2006) | IDENTIFICATION of HIV Type 1 Group N Infections in a Husband and Wife in Cameroon: Viral Genome Sequences Provide Evidence for Horizontal Transmission | AIDS Res. Hum. Retroviruses 22 (1), 83-92 (2006) | 0 | 2 2PR 2RT 2IN |
3 2PR 3RT 2IN |
66 | HIVDB |
| Yamaguchi (2006) | HIV-1 Group N: Evidence of Ongoing Transmission in Cameroon | AIDS Res. Hum. Retroviruses 22 (5), 453-457 (2006) | 1e-155 | 1 1IN |
1 1RT 1IN |
100 | HIVDB |
| Yamaguchi (2008) | HIV Type 2 Intergroup Recombinant Identified in Cameroon | AIDS Res. Hum. Retroviruses 24 (1), 86-91 (2008) | 0 | 1 1PR 1RT 1IN |
2 2PR 2RT 2IN |
50 | HIVDB |
| Yamaguchi (2009) | HIV type 1 group M subtype G in Cameroon: five genome sequences | AIDS Res. Hum. Retroviruses 25 (4), 469-473 (2009) | 0 | 5 5PR 5RT 5IN |
5 5PR 5RT 5IN |
100 | HIVDB |
| Yamaguchi (2010) | Near full-length sequence of HIV type 1 subtype J strain 04CMU11421 from Cameroon | AIDS Res. Hum. Retroviruses 26 (6), 693-697 (2010) | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Yamaguchi (2016) | HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression | AIDS Res. Hum. Retroviruses (2016) In press | 0 | 8 8PR 8RT 8IN |
8 8PR 8RT 8IN |
100 | HIVDB |
| Yamaguchi (2018) | Universal Target Capture of HIV Sequences From NGS Libraries | Front Microbiol 9, 2150 (2018) | 0 | |
31 31PR 31RT 31IN |
0 | Pending |
| Yamaguchi (2019) | Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L | J. Acquir. Immune Defic. Syndr. (2019) In press | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Yamamura (2016) | Migration of b-clade HIV-1 epidemics between North America and the Caribbean | Unpublished | 1.43e-124 | |
120 120RT |
0 | Unpublished - Final |
| Yan (2015) | Epidemiological and Molecular Characteristics of HIV Infection among Money Boys and General Men Who Have Sex with Men in Shanghai, China | Infect. Genet. Evol. (2015) In press | 0 | 52 52PR 52RT |
52 52PR 52RT |
100 | HIVDB |
| Yan (2020) | Direct Submission | Submitted (23-AUG-2020) Clinical and Research Cent | 0 | |
3 3PR 3RT |
0 | Case report(s) / study subset |
| Yan (2014) | HIV-1 Diversity and Drug-Resistant Mutations in Infected Individuals in Changchun, China | PLoS ONE 9 (6), E100540 (2014) | 5.15e-105 | 35 35PR 35RT |
35 35PR 35RT |
100 | HIVDB |
| Yang Hsu (2005) | CHARACTERIZATION of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore | J. Acquir. Immune Defic. Syndr. (2005) In press | 0 | 104 104PR 104RT |
104 104PR 104RT |
100 | HIVDB |
| Yang (2012) | Direct Submission | Submitted (02-FEB-2012) CGH/DGHA/ILB, CDC, 1600 Cl | 2e-178 | 381 381PR 381RT |
381 381PR 381RT |
100 | HIVDB |
| Yang (2000) | PHYLOGENETIC analysis of protease and transmembrane region of HIV type 1 group O | AIDS Res. Hum. Retroviruses 16 (11), 1075-1081 (2000) | 0.000000000000008 | 20 20PR |
20 20PR |
100 | HIVDB |
| Yang (2004) | GENETIC diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya | AIDS Res. Hum. Retroviruses 20 (5), 565-574 (2004) | 1e-157 | 38 38PR 38RT |
38 38PR 38RT |
100 | HIVDB |
| Yang (2012) | Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV-1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Yang (2010) | Development and Application of a Broadly Sensitive Dried-Blood-Spot-Based Genotyping Assay for Global Surveillance of HIV-1 Drug Resistance | J. Clin. Microbiol. 48 (9), 3158-3164 (2010) | 3e-172 | |
132 132PR 132RT |
0 | Case report(s) / study subset |
| Yang (2025) | Unraveling HIV-1 transmission patterns through molecular surveillance in a hotspot in Yunnan Province, China | Sci Rep 15 (1), 9964 (2025) | 0 | |
809 809PR 809RT |
0 | Pending |
| Yang (2010) | First case of HIV-1 CRF06_cpx in Taiwan | Unpublished | 0 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Yang (2010) | An uncommon case of HIV-1 transmission due to a knife fight | 20939682 | 0 | |
47 47PR 47RT |
0 | Case report(s) / study subset |
| Yang (2019) | A Novel HIV-1 Recombinant Form from Henan Province | Unpublished | 0 | |
6 6PR 6RT 6IN |
0 | Case report(s) / study subset |
| Yang (2020) | A recombinant between CRF01_AE and CRF07_BC from Henan Province, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Yang (2020) | A novel recombinant from Henan Province, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yang (2020) | Genomic Characterization of a Novel HIV-1 CRF01_AE /B Recombinant in Henan Province, China | Unpublished | 0 | 2 2PR 2RT 2IN |
2 2PR 2RT 2IN |
100 | HIVDB |
| Yang (2021) | The significant changes of gene types for HIV-1 strains circulating in Henan province, China | Unpublished | 0 | |
194 183PR 177RT 184IN |
0 | Unpublished |
| Yang (2008) | GENETIC and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins | 16306608 | 0 | |
23 23RT 23IN |
0 | Quasispecies |
| Yang (2003) | IDENTIFICATION and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China | J. Virol. 77 (1), 685-695 (2003) | 0 | 5 5PR 5RT 2IN |
5 5PR 5RT 2IN |
100 | HIVDB |
| Yang (2007) | DRUG-RESISTANT associated mutations in RT of AIDS patients with ART in Hubei, China | Unpublished | 0 | |
179 173PR 179RT |
0 | Case report(s) / study subset |
| Yang (2002) | ON-GOING generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China | AIDS 16 (10), 1401-1407 (2002) | 1e-121 | 39 39PR 39RT |
39 39PR 39RT |
100 | HIVDB |
| Yang (2025) | Direct Submission | Submitted (18-FEB-2025) Clinical Center for HIV/AI | 0 | |
4 4PR 4RT |
0 | Case report (Small sample size) |
| Yang (2024) | Characterization of two novel HIV-1 second-generation recombinants (CRF01_AE/CRF07_BC) identified in Hebei Province, China | Front Microbiol 14, 1159928 (2023) | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yang (2019) | Characterization of a novel HIV-1 recombinant form (crf01_ae/ crf07_bc/ crf08_bc) identified from Guangxi, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yang (2019) | Identification of a Novel HIV-1 Recombinant Form (CRF01_AE/ CRF07_BC) Identified from an Intravenous Drug User in Guangxi, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yang (2020) | Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019) | 32279138 | 0 | |
657 657PR 657RT |
0 | ARV Rx and/or other data are N/A |
| Yang (2021) | Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020) | Infection (2021) In press | 1.4e-158 | 999 999IN |
999 999IN |
100 | HIVDB |
| Yao (2020) | Direct Submission | Submitted (16-DEC-2019) Department of AIDS Researc | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Yao (2015) | Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China | Virus Genes 50 (1), 22-28 (2015) | 0 | 229 229PR 229RT |
229 229PR 229RT |
100 | HIVDB |
| Yao (2020) | Untitled | Unpublished | 0 | |
4 4PR 4RT 4IN |
0 | Unpublished |
| Yao (2015) | Clinical and Epidemiologic Characteristics of 92 HIV-1 clinical isolates from Antiretroviral-naive HIV-1-infected individuals in Yunnan Province, China | Unpublished | 0 | 92 92PR 92RT |
92 92PR 92RT |
100 | HIVDB |
| Yao (2015) | Current Molecular Epidemiology and Recombination of Human Immunodeficiency Virus Type 1 Subtypes Circulating in Yunnan, China | Unpublished | 0 | |
121 121PR 121RT |
0 | Unpublished - Final |
| Yaotse (2016) | Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients | Infect. Genet. Evol. 9 (4), 646-652 (2009) | 0 | 78 78PR 78RT |
78 78PR 78RT |
100 | HIVDB |
| Yaqub (2019) | Circulation of multiple subtypes (A, G and CRFs 02_AG) of Human immunodeficiency virus type-1 (HIV-1) in Punjab, Pakistan | 31576459 | 9.19e-164 | 18 18PR 18RT |
18 18PR 18RT |
100 | HIVDB |
| Yaqub (2020) | Direct Submission | Submitted (03-SEP-2019) Microbiology, University o | 8.67e-164 | |
26 26PR 26RT |
0 | Unpublished |
| Ye (2020) | Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study | AIDS (2020) In press | 9.22e-175 | 6547 6547PR 6547RT |
6547 6547PR 6547RT |
100 | HIVDB |
| Ye (2024) | Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China | J Infect Dis (2024) In press | 6.24e-174 | |
10039 10039PR 10039RT |
0 | Pending |
| Ye (2014) | Phylogenetic and Temporal Dynamics of Human Immunodeficiency Virus Type 1B in China: Four Types of B Strains Circulate in China | AIDS Res. Hum. Retroviruses 30 (9), 920-926 (2014) | 0 | 197 197PR 197RT |
197 197PR 197RT |
100 | HIVDB |
| Ye (2011) | Sequence analysis of gag-pol gene of Human Immunodeficiency Virus Type 1 of Inersubtype (B'/C) Recombinant Strain in Beijing of China | 20950146 | 1.69e-172 | 39 39PR 39RT |
39 39PR 39RT |
100 | HIVDB |
| Ye (2011) | The Prevalence of Drug Resistance Mutations Among Treatment-Naive HIV-Infected Individuals in Beijing, China | AIDS Res. Hum. Retroviruses (2011) In press | 1e-174 | 139 139PR 139RT |
139 139PR 139RT |
100 | HIVDB |
| Ye (2023) | Direct Submission | Submitted (03-NOV-2022) Public Health, Guangxi Med | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Ye (2021) | Identification of three novel HIV-1 circulating recombinant forms in southwestern Yunnan of China | Unpublished | 0 | |
15 15PR 15RT 15IN |
0 | Case report(s) / study subset |
| Yebra (2008) | CLINICAL differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007) | AIDS Res. Hum. Retroviruses 25 (1), 37-44 (2009) | 0 | 74 73PR 68RT |
79 79PR 78RT |
93 | HIVDB |
| Yebra (2010) | HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability | Antiviral Res. 85 (2), 409-417 (2010) | 0 | 223 223PR 218RT |
223 223PR 220RT |
100 | HIVDB |
| Yebra (2012) | Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population | PLoS ONE 6 (10), E26757 (2011) | 0 | |
37 37PR 33RT |
0 | Case report(s) / study subset |
| Yebra (2015) | Analysis of the History and Spread of HIV-1 in Uganda using Phylodynamics | J. Gen. Virol. (2015) In press | 0 | |
11 11PR 11RT |
0 | Case report(s) / study subset |
| Yebra (2018) | A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project | PLoS ONE 13 (2), e0192081 (2018) | 0 | 325 314PR 268RT 251IN |
369 364PR 294RT 317IN |
88 | HIVDB |
| Yendewa (2021) | Direct Submission | Submitted (17-DEC-2018) VIP, IISGS, Estrada Clara | 0 | |
201 108RT 93IN |
0 | Unpublished |
| Yerly (2001) | Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir. | Antivir Ther. 2001 Sep;6(3):185-9. | 1e-130 | |
188 94PR 94RT |
0 | ARV Rx and/or other data are N/A |
| Yerly (2004) | HIV-1 co/super-infection in intravenous drug users | AIDS 18 (10), 1413-1421 (2004) | 1e-109 | 57 57RT |
57 57RT |
100 | HIVDB |
| Yerly (2005) | NOSOCOMIAL outbreak of multiple bloodborne viral infections | J. Infect. Dis. 184 (3), 369-372 (2001) | 1.11e-132 | 68 34PR 34RT |
68 34PR 34RT |
100 | HIVDB |
| Yin (2020) | Identification of a novel HIV-1 second-generation recombinant form (CRF01_AE/CRF07_BC) among men who have sex with men in Jiangsu, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yin (2020) | A cluster novel HIV-1 second-generation recombinant forms (CRF01_AE/CRF07_BC) were identified in Jiangsu, China | Unpublished | 0 | |
9 9PR 9RT 9IN |
0 | Case report (Small sample size) |
| Yin (2020) | Molecular epidemiology of HIV-1 in Jiangsu province, Southeast of China: genotypes and HIV-1 transmission networks among newly diagnosed MSM in 2017 | AIDS Res Hum Retroviruses (2020) In press | 1.51e-174 | 765 765PR 765RT |
765 765PR 765RT |
100 | HIVDB |
| Ying (2022) | Direct Submission | Submitted (09-MAR-2021) AIDS Research, Beijing Ins | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| York-Higgins (2003) | HUMAN immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome | J. Virol. 64 (8), 4016-4020 (1990) | 0 | |
1 1PR 1RT 1IN |
0 | Laboratory/experimental isolate |
| Young (1998) | RESISTANCE mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure | J. Infect. Dis. 178 (5), 1497-1501 (1998) | 1e-127 | |
39 39PR 39RT |
0 | HIVDB |
| Young-Keol (2012) | Phylogenetic Analysis of Near Full-Length Genomic Sequences of HIV-1 in 20 Long-Term Slow Progressors treated with Korean Red Ginseng | Unpublished | 0 | |
6 4PR 5RT 5IN |
0 | Case report(s) / study subset |
| Youngpairoj (2006) | Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon. | AIDS Res Hum Retroviruses. | 0 | 57 57PR 57RT |
57 57PR 57RT |
100 | HIVDB |
| Youngpairoj (2014) | Reference panel of cloned HIV-2 plasmid DNA for nucleic acid assay development, evaluation, and quality monitoring. | J Clin Virol. 2014 Oct;61(2):293-7. | 0 | 11 11PR 11RT 11IN |
11 11PR 11RT 11IN |
100 | HIVDB |
| Yousef (2016) | Inferring HIV-1 transmission dynamics in Germany from recently transmitted viruses | J. Acquir. Immune Defic. Syndr. (2016) In press | 1.69e-178 | 1943 1943PR 1943RT |
1943 1943PR 1943RT |
100 | HIVDB |
| Yu (2021) | Prevalence of drug resistance and genetic transmission networks among HIV/AIDS patients with ART failure in Guangxi, China | 35972723 | 0 | |
316 316PR 316RT |
0 | Pending |
| Yu (2023) | HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020 | 37803893 | 0 | 241 241PR 241RT |
241 241PR 241RT |
100 | HIVDB |
| Yu (2023) | Phylodynamic and molecular networks of a novel HIV-1 circulating recombinant form 65_cpx strain in Hainan Island, China | Unpublished | 1.18e-172 | |
51 51PR 51RT |
0 | Case report(s) / study subset |
| Yu (2024) | High genetic diversity of HIV-1 and molecular transmission networks among HIV-1 infected patients in Haikou, South China, 2005-2022 | Unpublished | 0 | |
879 878PR 879RT |
0 | ARV Rx and/or other data are N/A |
| Yu (2022) | Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China | Pharmgenomics Pers Med 15, 195-203 (2022) | 0 | 859 859IN |
865 865IN |
99 | HIVDB |
| Yu (2008) | Genetic diversity and drug resistance of HIV type 1 circulating recombinant Form_BC among drug users in Guangdong Province | AIDS Res. Hum. Retroviruses 25 (9), 869-875 (2009) | 0 | 101 100PR 101RT |
101 100PR 101RT |
100 | HIVDB |
| Yu (2019) | HIV-1 CRF55_01B pol genes genetic diversity, primary drug resistance and evolutionary analysis | Unpublished | 0 | 119 119PR 119RT |
119 119PR 119RT |
100 | HIVDB |
| Yu (2024) | Near full-length sequence analysis of two new recombinants (CRF_01AE/CRF_07BC) in MSM populations in Beijing, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Yuan (2018) | Characteristics of HIV-1 Molecular Epidemiology in Suzhou, China, from 2009 to 2014 | Virol Sin (2018) In press | 0 | 37 36PR 37RT |
37 37PR 37RT |
100 | HIVDB |
| Yue (2015) | Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients | PLoS Pathog. 11 (1), E1004565 (2015) | 0 | |
111 89PR 90RT 111IN |
0 | Quasispecies |
| Yue (2024) | Phenotypic characterization of subtype A and AC recombinant transmitted/founder viruses from a Rwandan heterosexual transmission cohort | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Yuhui (2025) | Direct Submission | Submitted (30-OCT-2025) Ningbo Center for Disease | 0 | |
1387 1387PR 1387RT |
0 | Unpublished |
| Yunifiar M (2017) | Sero- and molecular epidemiological studies on HIV-1 in Papua province, Indonesia | 29093230 | 0 | |
24 11PR 13RT |
0 | Case report(s) / study subset |
| Yuste (2000) | UNUSUAL distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1 | J. Virol. 74 (20), 9546-9552 (2000) | 1e-165 | |
8 8PR 8RT 8IN |
0 | Quasispecies |
| Zagury (1996) | GENETIC variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1 | Proc. Natl. Acad. Sci. U.S.A. 85 (16), 5941-5945 (1988) | 9e-98 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Zahid (2019) | Detection and genetic analysis of an unassigned CRF BG in HIV-1 infected Pakistani Patient | Unpublished | 2.94e-161 | |
1 1PR 1RT |
0 | Case report (Small sample size) |
| Zahid (2021) | Antiretroviral drug resistance mutation analysis in pol gene of HIV-1 infected patients, in Pakistan | Unpublished | 1.52e-168 | |
142 140PR 140RT |
0 | Unpublished |
| Zahid (2021) | Identification of an unassigned unique recombinant in HIV-1 infected patient in Pakistan | Unpublished | 1.28e-161 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Zahid (2021) | Molecular epidemiological investigation of HIV-1 Larkana outbreak: detection and genetic analysis of unassigned recombinant CRF02_36cpx | Unpublished | 3.77e-175 | 14 13PR 8RT |
15 15PR 15RT |
93 | HIVDB |
| Zahid (2021) | Discovery and genetic analysis of an unassigned complex unique recombinant CRF36cpx/02AG/H in HIV-1 infected Larkana outbreak patient, Pakistan | Unpublished | 1.34e-165 | 1 1PR 1RT |
1 1PR 1RT |
100 | HIVDB |
| Zahra (2020) | Molecular analysis of HIV-1 isolates from regions of outbreak in Pakistan | Unpublished | 0 | |
4 4PR 4RT |
0 | Unpublished |
| Zahra (2020) | Direct Submission | Submitted (07-MAY-2020) Department of Biochemistry | 0 | |
8 8PR 8RT |
0 | Unpublished |
| Zaikos (2018) | Hematopoietic stem and progenitor cells are a unique HIV reservoir that contribute to persistent viremia in suppressed patients | 30590047 | 0 | |
10 10PR 10RT 10IN |
0 | Proviral DNA Reservoir |
| Zarandia (2005) | HIV-1 Genetic Diversity and Genotypic Drug Susceptibility in the Republic of Georgia | AIDS Res. Hum. Retroviruses 22 (5), 470-476 (2006) | 0 | 48 48PR 48RT 5IN |
48 48PR 48RT 5IN |
100 | HIVDB |
| Zeb (2024) | Direct Submission | Submitted (04-JUN-2023) Biotechnology, Quaid-i-Aza | 1.25e-164 | |
13 13RT |
0 | Unpublished |
| Zeh (2016) | Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya | PLoS ONE 11 (2), E0147436 (2016) | 3.86e-159 | 258 258PR 258RT |
258 258PR 258RT |
100 | HIVDB |
| Zeh (2003) | NIGERIAN HIV Type 2 Subtype A and B from Heterotypic HIV Type 1 and HIV Type 2 or Monotypic HIV Type 2 Infections | AIDS Res. Hum. Retroviruses 21 (1), 17-27 (2005) | 1e-50 | 106 106PR |
106 106PR |
100 | HIVDB |
| Zeh (2010) | Emergence of HIV-1 Drug Resistance among Breastfeeding Infants Born to HIV-infected Mothers taking Highly Active Antiretroviral Therapy for Prevention of Mother-to-Child Transmission | 21468304 | 0 | 16 16PR 16RT |
20 20PR 20RT |
80 | HIVDB |
| Zeng (2011) | The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. | Transfusion | 1.01e-174 | 113 113PR 113RT |
113 113PR 113RT |
100 | HIVDB |
| Zeng (2012) | Emergence of a New HIV-1 CRF01_AE Variant in Guangxi, Southern China | AIDS Res. Hum. Retroviruses (2012) In press | 0 | 225 221PR 222RT 224IN |
328 324PR 226RT 226IN |
68 | HIVDB |
| Zeng (2014) | Reconstituting the epidemic history of mono lineage of HIV-1 CRF01_AE in Guizhou province, Southern China | Infect. Genet. Evol. 26C, 139-145 (2014) | 0 | |
83 82PR 83RT 29IN |
0 | Pending |
| Zeng (2013) | HIV-1 genotypic diversity and prevalence of drug resistance among treatment naive HIV-infected individuals in Chengdu of China | Virus Genes. 2013 Aug 14 | 1.43e-169 | 159 159PR 159RT |
159 159PR 159RT |
100 | HIVDB |
| Zeng (2016) | Direct Submission | Submitted (21-MAR-2016) Research Center of Blood T | 3.27e-173 | 205 205PR 205RT |
205 205PR 205RT |
100 | HIVDB |
| Zeng (2020) | Genetic diversity and high-level of pretreatment HIV drug resistance in Tianjin, China | 32539490 | 0 | 301 33PR 301RT |
305 303PR 305RT |
98 | HIVDB |
| Zetterberg (2016) | Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia | AIDS Res. Hum. Retroviruses 20 (11), 1148-1156 (20 | 2.25e-28 | |
19 19PR |
0 | Gene fragment(s) |
| Zhang (2023) | Identification of two near-identical novel HIV-1 unique recombinant forms (CRF01_AE/B) among men who have sex with men in baoding, hebei, China | Front Genet 14, 1105739 (2023) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhang (2024) | Unique Molecular Signatures in Rebound Viruses from Antiretroviral Drug and CRISPR Treated HIV-1-Infected Humanized Mice | 37126704 | 0 | |
58 58PR 58RT 29IN |
0 | Laboratory/experimental isolate |
| Zhang (2025) | A comparative analysis of near-full-length HIV-1 DNA quasispecies genome across distinct virologic responses reveals notable genetic variations in low-level viremia | Unpublished | 0 | |
196 193PR 196RT 196IN |
0 | Unpublished |
| Zhang (2020) | Direct Submission | Submitted (31-OCT-2019) Department of AIDS Researc | 0 | |
487 487PR 487RT 1IN |
0 | Unpublished |
| Zhang (2021) | Molecular surveillance of HIV-1 newly diagnosed infections in Shenzhen, China from 2011 to 2018 | J Infect (2021) In press | 0 | 1388 1387PR 1387RT |
10378 10377PR 10378RT |
13 | HIVDB |
| Zhang (2022) | Analysis of HIV-1 molecular transmission network reveals the prevalence characteristics of three main HIV-1 subtypes in Shenzhen, China | J Infect (2022) In press | 4.64e-166 | 542 542PR 542RT |
542 541PR 542RT |
100 | HIVDB |
| Zhang (2021) | Untitled | 34567064 | 0 | |
165 165PR 165RT |
0 | Pending |
| Zhang (2022) | Direct Submission | Submitted (02-APR-2021) School of Public Health, G | 0 | |
837 832PR 837RT 1IN |
0 | Unpublished |
| Zhang (2017) | Mutational correlates of virological failure in individuals receiving a WHO-recommended TDF-containing first-line regimen | 28365230 | 5.69e-175 | 77 94PR 94RT |
94 94PR 94RT |
81 | HIVDB |
| Zhang (2018) | Utilization of Dried Blood Spot Specimens Can Expedite Nationwide Surveillance of HIV Drug Resistance in Resource-Limited Settings | 30192818 | 2.54e-175 | 462 462PR 462RT |
462 462PR 462RT |
100 | HIVDB |
| Zhang (2018) | Identification of a Long-standing HIV-1 Subtype B Transmission Cluster among Men Who Have Sex with Men in China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Zhang (2010) | Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China | AIDS Res. Hum. Retroviruses 26 (1), 99-103 (2010) | 4e-172 | 47 47PR 47RT |
47 47PR 47RT |
100 | HIVDB |
| Zhang (2012) | HIV Type 1 Virological Response and Prevalence of HIV Type 1 Drug Resistance Among Patients Receiving Antiretroviral Therapy, Shandong, China | AIDS Res. Hum. Retroviruses 28 (12), 1658-1665 (20 | 3e-178 | |
21 21PR 21RT |
0 | Case report(s) / study subset |
| Zhang (2015) | Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China | J. Med. Virol. (2015) In press | 0 | 200 200PR 200RT |
200 200PR 200RT |
100 | HIVDB |
| Zhang (2015) | Genetic Characteristics of CRF01_AE Among Newly Diagnosed HIV-1-Infected 16- to 25-Year Olds in 3 Geographic Regions of Guangxi, China | Medicine (Baltimore) 94 (21), E894 (2015) | 3.96e-175 | 216 216PR 216RT |
216 216PR 216RT |
100 | HIVDB |
| Zhang (2023) | Direct Submission | Submitted (15-JUN-2022) Department of HIV/AIDS Con | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhang (2024) | Near-full-length genomic characterization of two novel HIV-1 unique recombinants (CRF01_AE/ CRF68_01B) and (CRF01_AE/CRF07_BC) in Shijiazhuang, Hebei Province, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhang (1999) | QUANTIFYING residual HIV-1 replication in patients receiving combination antiretroviral therapy | N. Engl. J. Med. 340 (21), 1605-1613 (1999) | 1e-121 | |
50 50PR 6RT |
0 | Proviral DNA Reservoir |
| Zhang (2017) | Near full length genomic analysis of a HIV-1 G subtype strain identified in Guangxi province | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhang (2018) | Direct Submission | Submitted (28-DEC-2017) AIDS Prevention and Contro | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhang (2018) | Identification of two novel HIV-1 second-generation recombinant forms (CRF01_AE07_BC) in Shaanxi, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhang (2019) | Genome sequences of a novel HIV-1 circulating recombinant form (CRF100_0107) identified among men who have sex with men in Shaanxi, China | Unpublished | 0 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Zhang (2019) | Characterization of three HIV-1 unique (B/C) recombinant forms in Shaanxi, China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Zhang (2019) | HIV-1 genetic diversity and recombinant forms among men who have sex with men at a sentinel surveillance point in Xi'an, China | 32087346 | 0 | 80 79PR 80RT 6IN |
82 80PR 81RT 7IN |
97 | HIVDB |
| Zhang (2019) | Near full-length genome of two unique (B/C) recombinant forms identified in Shaanxi, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhang (2020) | HIV-1 genetic characteristics and transmission network in Yulin Prefecture, Shaanxi Province, China | Unpublished | 0 | |
193 193PR 193RT |
0 | Unpublished |
| Zhang (2017) | Near full-length genomic identification of a novel HIV-1 recombinant form CRF01_AE/CRF07_BC in Shaanxi, China | Unpublished | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhang (2012) | Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC | PLoS ONE 7 (2), E31233 (2012) | 0 | |
2 2PR 2RT 2IN |
0 | Laboratory/experimental isolate |
| Zhang (2019) | Direct Submission | Submitted (31-JAN-2019) The First Affiliated Hospi | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhang (2014) | Identification and Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men-Who-Have-Sex-with-Men in China | PLoS ONE 9 (6), E99693 (2014) | 0 | 4 4PR 4RT 3IN |
4 4PR 4RT 3IN |
100 | HIVDB |
| Zhang (2023) | Near-full-length genomic characteristics of three novel HIV-1 CRF01_AE/C recombinant forms among men who have sex with men in Hebei province, China | AIDS Res Hum Retroviruses (2023) In press | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Zhang (2025) | Characterization of a novel HIV-1 second-generation circulating recombinant form (CRF144_07C) in Ganzhou, China | Genes Dis 12 (4), 101443 (2024) | 0 | |
14 14PR 14RT 14IN |
0 | Case report (Small sample size) |
| Zhang (2004) | CULTURED HIV-1, Group M, Subtype A | Unpublished | 6e-46 | |
1 1IN |
0 | Case report(s) / study subset |
| Zhang (2016) | Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China | PLoS Med. 3 (11), E443 (2006) | 4.74e-87 | |
43 43RT |
0 | Gene fragment(s) |
| Zhang (2018) | Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF80_0107) among Men Who Have Sex with Men in China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhang (2019) | Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa | AIDS 32 (10), 1301-1306 (2018) | 0 | |
11 11PR 11RT |
0 | Pending |
| Zhang (2020) | Genetic diversity, complicated recombination and deteriorating drug resistance among HIV-1 infected individuals in Wuhan, China | 32878449 | 0 | 199 101PR 98RT |
199 101PR 98RT |
100 | HIVDB |
| Zhang (2022) | Using molecular network analysis to explore the characteristics of HIV-1 transmission in a China-Myanmar border area | PLoS One 17 (5), e0268143 (2022) | 0 | 480 476PR 480RT |
480 476PR 480RT |
100 | HIVDB |
| Zhang (2022) | Immunological control of HIV-1 disease progression by rare protective HLA allele | Unpublished | 1.63e-68 | |
18 9PR 9RT |
0 | Case report(s) / study subset |
| Zhang (1997) | DRUG resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites | J. Virol. 71 (9), 6662-6670 (1997) | 1e-130 | 566 566PR |
567 567PR |
99 | HIVDB |
| Zhang (2017) | Direct Submission | Submitted (27-JUN-2017) National AIDS Reference La | 5.36e-159 | |
1 1PR 1RT |
0 | Case report(s) / study subset |
| Zhao (2020) | HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-naive blood donors in China | 32371875 | 0 | 338 168PR 168RT 170IN |
338 168PR 168RT 170IN |
100 | HIVDB |
| Zhao (2014) | Origin and outbreak of HIV-1 CRF55_01B among MSM in Shenzhen, China | J. Acquir. Immune Defic. Syndr. (2014) In press | 9.25e-177 | |
104 104PR 104RT |
0 | Pending |
| Zhao (2016) | The dynamics of the HIV epidemic among men who have sex with men (MSM) from 2005 to 2012 in Shenzhen, China | Sci Rep 6, 28703 (2016) | 0 | 1316 1316PR 1316RT |
1316 1316PR 1316RT |
100 | HIVDB |
| Zhao (2020) | Identification, genetic characterization, and validation of diverse HIV viruses collected from Cameroon for HIV panel development | 34372623 | 0 | |
23 23PR 23RT 23IN |
0 | Pending |
| Zhao (2021) | Identification, Genetic Characterization and Validation of Highly Diverse HIV-1 Viruses for Reference Panel Development | Viruses 13 (7), 1417 (2021) | 0 | |
14 14PR 14RT 14IN |
0 | Case report(s) / study subset |
| Zhao (2009) | Identification of new recombinant of CRF22 with subtype A1 or CRF02_AG of HIV-1 in Cameroon | AIDS Res Hum Retroviruses. 2010 Sep;26(9):1033-45. | 0 | 3 3PR 3RT 3IN |
4 4PR 4RT 4IN |
75 | HIVDB |
| Zhao (2012) | CRF22_01A1 Prevalence in Cameroon involved in new HIV-1 recombinants | 22549382 | 0 | 13 13PR 13RT 13IN |
13 13PR 13RT 13IN |
100 | HIVDB |
| Zhao (2009) | Prevalence of drug resistance in treatment-naive HIV-1 patients in Shenzhen, China | Unpublished | 0 | |
21 21PR 21RT |
0 | Case report(s) / study subset |
| Zhao (2014) | HIV-1 transmission among injection drug users leads to novel recombinants circulating in southern China. | AIDS Res Hum Retroviruses. 2014 Oct;30(10):1006-9. | 0 | |
4 4PR 4RT 4IN |
0 | Case report(s) / study subset |
| Zheng (2013) | HIV-1 drug resistance analysis in recent infections | 24147046 | 2.58e-144 | 49 49PR 49RT |
49 49PR 49RT |
100 | HIVDB |
| Zheng (2014) | HIV-1 drug resistance analysis before ART | 22544206 | 6e-173 | 4 4PR 4RT |
4 4PR 4RT |
100 | HIVDB |
| Zheng (1996) | Sequence analyses of the reverse transcriptase region of HIV type 1 isolates from Sydney, Australia. | AIDS Res Hum Retroviruses. 1996 Dec 10;12(18):1731-2. | 1e-98 | |
91 91RT |
0 | ARV Rx and/or other data are N/A |
| Zhong (2003) | GENETIC and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity | AIDS Res. Hum. Retroviruses 19 (12), 1167-1178 (2003) | 1e-49 | 4 4PR |
4 4PR |
100 | HIVDB |
| Zhong (2007) | GENETIC Diversity and Drug Resistance of Human Immunodeficiency Virus Type 1 (HIV-1) Strains Circulating in Shanghai | AIDS Res. Hum. Retroviruses 23 (7), 847-856 (2007) | 1e-151 | 70 70PR 70RT |
70 70PR 70RT |
100 | HIVDB |
| Zhou (2007) | HIV-1 subtypes and recombinants in Heilongjiang province | Chin Med J (Engl). 2007 Nov 20;120(22):2006-10. | 1e-141 | 25 25RT |
25 25RT |
100 | HIVDB |
| Zhou (2010) | A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China | AIDS 22 (13), 1690-1693 (2008) | 4.35e-169 | 5 5RT |
5 5RT |
100 | HIVDB |
| Zhou (2019) | Direct Submission | Submitted (13-JUN-2019) Virus and Immunology Labor | 0 | |
4 4PR 4RT 4IN |
0 | Unpublished |
| Zhou (2020) | Direct Submission | Submitted (03-OCT-2019) Division of Research on Vi | 0 | |
7 7PR 7RT 7IN |
0 | Case report(s) / study subset |
| Zhou (2024) | Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy Indicating A Lack Of Ongoing Viral Replication | 38756763 | 0 | |
156 156PR 156RT 156IN |
0 | Proviral DNA Reservoir |
| Zhou (2015) | Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission | BMC Infect. Dis. 14, 463 (2014) | 0 | 82 82PR 82RT |
161 161PR 161RT |
50 | HIVDB |
| Zhou (2015) | Near full-length identification of a novel HIV-1 CRF01_AE/B/C recombinant in northern Myanmar | AIDS Res. Hum. Retroviruses (2015) In press | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhou (2019) | Characterization of a New HIV-1 CRF01_AE/ CRF07_BC recombinant virus in Tianjin, China | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zhou (2011) | Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings | PLoS ONE 6 (11), E28184 (2011) | 1e-169 | |
87 87PR 87RT |
0 | Case report(s) / study subset |
| Zhu (2022) | Identification of a novel HIV-1 second-generation Circulating Recombinant Form CRF117_0107 in China | Unpublished | 0 | |
3 3PR 3RT 3IN |
0 | Case report(s) / study subset |
| Zhu (2022) | Direct Submission | Submitted (13-APR-2022) Department of Virology, St | 0 | |
216 9PR 216RT 9IN |
0 | Unpublished |
| Zhu (2023) | NFLG analysis first demonstrated the hidden circulation of second-generation recombination strains in HIV-1 CRF07_BC | Unpublished | 0 | |
178 177PR 178RT 178IN |
0 | Unpublished |
| Zhu (2023) | Direct Submission | Submitted (24-APR-2022) Department of Virology, St | 0 | |
1 1PR 1RT 1IN |
0 | Case report(s) / study subset |
| Zhu (2025) | NFLG analysis first demonstrated the hidden circulation of second-generation recombination strains in HIV-1 CRF07_BC | Unpublished | 0 | |
33 29PR 33RT 33IN |
0 | Unpublished |
| Zhu (2016) | Molecular characterization of HIV-1 among men who have sex with men in Nanchang, China | Unpublished | 9.22e-37 | |
2 2PR |
0 | Gene fragment(s) |
| Zhu (2021) | Direct Submission | Submitted (06-OCT-2020) Department of AIDS Researc | 0 | |
16 16PR 16RT 16IN |
0 | Unpublished |
| Zhu (2024) | Epidemiological Dynamics and Molecular Characterization of HIV drug resistance in developed eastern China: Insights from 2020-2023 | 39493858 | 0 | |
49 49PR 49RT |
0 | Pending |
| Zhu (1995) | WAS HIV present in 1959? | Nature 374 (6522), 503-504 (1995) | 1e-163 | 1 1PR 1RT 1IN |
1 1PR 1RT 1IN |
100 | HIVDB |
| Zhu (2001) | AN African HIV-1 sequence from 1959 and implications for the origin of the epidemic | Nature 391 (6667), 594-597 (1998) | 2e-17 | |
15 15RT |
0 | Gene fragment(s) |
| Zhuang (2024) | Direct Submission | Submitted (25-NOV-2023) Department of Microbiology | 2.24e-172 | |
1 1RT |
0 | Case report(s) / study subset |
| Zhukova (2021) | Cuban history of CRF19 recombinant subtype of HIV-1 | PLoS Pathog 17 (8), e1009786 (2021) | 0 | 253 253PR 253RT |
253 253PR 253RT |
100 | HIVDB |
| Zolfo (2010) | Genotypic Impact of Prolonged Detectable HIV Type 1 RNA Viral Load after HAART Failure in a CRF01_AE-Infected Cohort | AIDS Res. Hum. Retroviruses 27 (7), 727-735 (2011) | 6.08e-147 | 250 126PR 124RT |
250 126PR 124RT |
100 | HIVDB |
| Zolopa (1999) | HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed | Ann. Intern. Med. 131 (11), 813-821 (1999) | 1e-121 | 102 54PR 48RT |
108 55PR 54RT |
94 | HIVDB |
| Zolt (2017) | Implementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres | Transfus Med Hemother 43 (3), 183-189 (2016) | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |
| Zsichla (2025) | Comparative Evaluation of Open-Source Bioinformatics Pipelines for Full-Length Viral Genome Assembly | Viruses 16 (12), 1824 (2024) | 0 | |
78 36PR 36RT 41IN |
0 | Laboratory/experimental isolate |
| Zubair (2024) | Direct Submission | Submitted (18-DEC-2023) Biotechnology, Quaid-I-Aza | 6.84e-65 | |
1 1RT |
0 | Case report(s) / study subset |
| Zubair (2025) | Direct Submission | Submitted (30-JUL-2024) Biotechnology, Quaid-I-Aza | 1.05e-126 | |
1 1RT |
0 | Unpublished |
| Zubair (2025) | Direct Submission | Submitted (26-JUL-2024) Biotechnology, Quaid-I-Aza | 7.89e-160 | |
4 4RT |
0 | Unpublished |
| Zubair (2025) | Direct Submission | Submitted (25-JUL-2024) Biotechnology, Quaid-I-Aza | 4.5e-152 | |
2 2RT |
0 | Unpublished |
| Zubair (2025) | Direct Submission | Submitted (31-JUL-2024) Biotechnology, Quaid-I-Aza | 1.79e-159 | |
2 2RT |
0 | Unpublished |
| Zubair (2025) | Direct Submission | Submitted (29-AUG-2024) Biotechnology, Quaid-I-Aza | 4.18e-130 | |
1 1RT |
0 | Unpublished |
| Zuckerman (2018) | Sexual intermingling of arab and jewish men who have sex with men in israel: results of a molecular epidemiology study | AIDS (2018) In press | 1.33e-151 | 1102 558PR 544RT |
1102 558PR 544RT |
100 | HIVDB |
| zur Megede (2002) | NOVEL evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa | AIDS Res. Hum. Retroviruses 18 (17), 1327-1332 (2002) | 1e-164 | 3 3PR 3RT 3IN |
3 3PR 3RT 3IN |
100 | HIVDB |
| Zyryanova (2019) | Construction and characterization of infectious molecular clones of HIV-1 CRF63_02A1 | Unpublished | 0 | |
2 2PR 2RT 2IN |
0 | Case report(s) / study subset |